
<html lang="en"     class="pb-page"  data-request-id="f0482b42-3de6-47e7-bc57-fd2a4ed8178a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2013.56.issue-21;pageGroup:string:Publication Pages;article:article:10.1021/jm4008455;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis and Discovery of Picomolar Selective α4β2 Nicotinic Acetylcholine Receptor Ligands" /></meta><meta name="dc.Creator" content="Venkata M.  Yenugonda" /></meta><meta name="dc.Creator" content="Yingxian  Xiao" /></meta><meta name="dc.Creator" content="Edward D.  Levin" /></meta><meta name="dc.Creator" content="Amir H.  Rezvani" /></meta><meta name="dc.Creator" content="Thao  Tran" /></meta><meta name="dc.Creator" content="Nour  Al-Muhtasib" /></meta><meta name="dc.Creator" content="Niaz  Sahibzada" /></meta><meta name="dc.Creator" content="Teresa  Xie" /></meta><meta name="dc.Creator" content="Corinne  Wells" /></meta><meta name="dc.Creator" content="Susan  Slade" /></meta><meta name="dc.Creator" content="Joshua E.  Johnson" /></meta><meta name="dc.Creator" content="Sivanesan  Dakshanamurthy" /></meta><meta name="dc.Creator" content="Hye-Sik  Kong" /></meta><meta name="dc.Creator" content="York  Tomita" /></meta><meta name="dc.Creator" content="Yong  Liu" /></meta><meta name="dc.Creator" content="Mikell  Paige" /></meta><meta name="dc.Creator" content="Kenneth J.  Kellar" /></meta><meta name="dc.Creator" content="Milton L.  Brown" /></meta><meta name="dc.Description" content="Developing novel and selective compounds that desensitize α4β2 nicotinic acetylcholine receptors (nAChRs) could provide new effective treatments for nicotine addiction, as well as other disorders. ..." /></meta><meta name="Description" content="Developing novel and selective compounds that desensitize α4β2 nicotinic acetylcholine receptors (nAChRs) could provide new effective treatments for nicotine addiction, as well as other disorders. ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 18, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm4008455" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm4008455" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm4008455" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm4008455" /></link>
        
    
    

<title>Design, Synthesis and Discovery of Picomolar Selective α4β2 Nicotinic Acetylcholine Receptor Ligands | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm4008455" /></meta><meta property="og:title" content="Design, Synthesis and Discovery of Picomolar Selective α4β2 Nicotinic Acetylcholine Receptor Ligands" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0009.jpeg" /></meta><meta property="og:description" content="Developing novel and selective compounds that desensitize α4β2 nicotinic acetylcholine receptors (nAChRs) could provide new effective treatments for nicotine addiction, as well as other disorders. Here we report a new class of nAChR ligands that display high selectivity and picomolar binding affinity for α4β2 nicotinic receptors. The novel compounds have Ki values in the range of 0.031–0.26 nM and properties that should make them good candidates as drugs acting in the CNS. The selected lead compound 1 (VMY-2-95) binds with high affinity and potently desensitizes α4β2 nAChRs. At a dose of 3 mg/kg, compound 1 significantly reduced rat nicotine self-administration. The overall results support further characterizations of compound 1 and its analogues in preclinical models of nicotine addiction and perhaps other disorders involving nAChRs." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm4008455"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm4008455">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm4008455&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm4008455&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm4008455&amp;href=/doi/10.1021/jm4008455" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 8404-8421</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm400828u" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm4008505" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis and Discovery of Picomolar Selective α4β2 Nicotinic Acetylcholine Receptor Ligands</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Venkata+M.++Yenugonda">Venkata M. Yenugonda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yingxian++Xiao">Yingxian Xiao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edward+D.++Levin">Edward D. Levin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amir+H.++Rezvani">Amir H. Rezvani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thao++Tran">Thao Tran</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nour++Al-Muhtasib">Nour Al-Muhtasib</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Niaz++Sahibzada">Niaz Sahibzada</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Teresa++Xie">Teresa Xie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Corinne++Wells">Corinne Wells</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan++Slade">Susan Slade</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joshua+E.++Johnson">Joshua E. Johnson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sivanesan++Dakshanamurthy">Sivanesan Dakshanamurthy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hye-Sik++Kong">Hye-Sik Kong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=York++Tomita">York Tomita</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yong++Liu">Yong Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mikell++Paige">Mikell Paige</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+J.++Kellar">Kenneth J. Kellar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Milton+L.++Brown">Milton L. Brown</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Center for Drug Discovery, Georgetown University Medical Center, 3970 Reservoir Road NW, Research Building, EP-07, Washington, D.C. 20057, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Pharmacology and Physiology, Georgetown University School of Medicine, Washington, D.C. 20057, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina 27710, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3970 Reservoir Road NW, Research Building, Washington, D.C. 20057, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: +1-202-687-8603. Fax: +1-202-687-7659. Email: <a href="/cdn-cgi/l/email-protection#38555a0d0c0c785f5d574a5f5d4c574f56165d5c4d"><span class="__cf_email__" data-cfemail="8ae7e8bfbebecaedefe5f8edeffee5fde4a4efeeff">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm4008455&amp;href=/doi/10.1021%2Fjm4008455" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 8404–8421</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 18, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 June 2013</li><li><span class="item_label"><b>Published</b> online</span>18 October 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 November 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm4008455" title="DOI URL">https://doi.org/10.1021/jm4008455</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8404%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DVenkata%2BM.%2BYenugonda%252C%2BYingxian%2BXiao%252C%2BEdward%2BD.%2BLevin%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D21%26contentID%3Djm4008455%26title%3DDesign%252C%2BSynthesis%2Band%2BDiscovery%2Bof%2BPicomolar%2BSelective%2B%25CE%25B14%25CE%25B22%2BNicotinic%2BAcetylcholine%2BReceptor%2BLigands%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8421%26publicationDate%3DNovember%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm4008455"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1576</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm4008455" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis and Discovery of Picomolar Selective α4β2 Nicotinic Acetylcholine Receptor Ligands&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Venkata&quot;,&quot;last_name&quot;:&quot;M. Yenugonda&quot;},{&quot;first_name&quot;:&quot;Yingxian&quot;,&quot;last_name&quot;:&quot;Xiao&quot;},{&quot;first_name&quot;:&quot;Edward&quot;,&quot;last_name&quot;:&quot;D. Levin&quot;},{&quot;first_name&quot;:&quot;Amir&quot;,&quot;last_name&quot;:&quot;H. Rezvani&quot;},{&quot;first_name&quot;:&quot;Thao&quot;,&quot;last_name&quot;:&quot;Tran&quot;},{&quot;first_name&quot;:&quot;Nour&quot;,&quot;last_name&quot;:&quot;Al-Muhtasib&quot;},{&quot;first_name&quot;:&quot;Niaz&quot;,&quot;last_name&quot;:&quot;Sahibzada&quot;},{&quot;first_name&quot;:&quot;Teresa&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Corinne&quot;,&quot;last_name&quot;:&quot;Wells&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;Slade&quot;},{&quot;first_name&quot;:&quot;Joshua&quot;,&quot;last_name&quot;:&quot;E. Johnson&quot;},{&quot;first_name&quot;:&quot;Sivanesan&quot;,&quot;last_name&quot;:&quot;Dakshanamurthy&quot;},{&quot;first_name&quot;:&quot;Hye-Sik&quot;,&quot;last_name&quot;:&quot;Kong&quot;},{&quot;first_name&quot;:&quot;York&quot;,&quot;last_name&quot;:&quot;Tomita&quot;},{&quot;first_name&quot;:&quot;Yong&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Mikell&quot;,&quot;last_name&quot;:&quot;Paige&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;J. Kellar&quot;},{&quot;first_name&quot;:&quot;Milton&quot;,&quot;last_name&quot;:&quot;L. Brown&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;8404-8421&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm4008455&quot;},&quot;abstract&quot;:&quot;Developing novel and selective compounds that desensitize α4β2 nicotinic acetylcholine receptors (nAChRs) could provide new effective treatments for nicotine addiction, as well as other disorders. Here we report a new class of nAChR ligands that display high selectivity and picomolar binding affinity for α4β2 nicotinic receptors. The novel compounds have Ki values in the range of 0.031–0.26 nM and properties that should make them good candidates as drugs acting in the CNS. The selected lead compound 1 (VMY-2-95) binds with high affinity and potently desensitizes α4β2 nAChRs. At a dose of 3 mg/kg, compound 1 significantly reduced rat nicotine self-administration. The overall results support further characterizations of compound 1 and its analogues in preclinical models of nicotine addiction and perhaps other disorders involving nAChRs.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4008455&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4008455" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4008455&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4008455" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4008455&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4008455" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm4008455&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4008455&amp;href=/doi/10.1021/jm4008455" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm4008455" /></input><a href="/doi/pdf/10.1021/jm4008455" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm4008455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm4008455%26sid%3Dliteratum%253Aachs%26pmid%3D24047231%26genre%3Darticle%26aulast%3DYenugonda%26date%3D2013%26atitle%3DDesign%252C%2BSynthesis%2Band%2BDiscovery%2Bof%2BPicomolar%2BSelective%2B%25CE%25B14%25CE%25B22%2BNicotinic%2BAcetylcholine%2BReceptor%2BLigands%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D21%26spage%3D8404%26epage%3D8421%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291184" title="Nicotine">Nicotine</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jmcmar.2013.56.issue-21/production/jmcmar.2013.56.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/medium/jm-2013-008455_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008455&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Developing novel and selective compounds that desensitize α4β2 nicotinic acetylcholine receptors (nAChRs) could provide new effective treatments for nicotine addiction, as well as other disorders. Here we report a new class of nAChR ligands that display high selectivity and picomolar binding affinity for α4β2 nicotinic receptors. The novel compounds have <i>K</i><sub>i</sub> values in the range of 0.031–0.26 nM and properties that should make them good candidates as drugs acting in the CNS. The selected lead compound <b>1</b> (VMY-2-95) binds with high affinity and potently desensitizes α4β2 nAChRs. At a dose of 3 mg/kg, compound <b>1</b> significantly reduced rat nicotine self-administration. The overall results support further characterizations of compound <b>1</b> and its analogues in preclinical models of nicotine addiction and perhaps other disorders involving nAChRs.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56265" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56265" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand gated ion channels with significant potential as molecular targets for drugs designed to treat a variety of central nervous system disorders.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> In vertebrates, 12 neuronal nAChR subunits have been identified including nine alpha subunits (α2−α10) and three beta subunits (β2−β4).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> These subunits may coassemble as either heteromeric and homomeric pentameric receptors, forming a theoretically large array of receptor subtypes.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> The predominant nAChRs in the CNS are the heteromeric α4β2* subtype, composed of α4 and β2 subunits (the * indicates that some of these nAChRs may contain one or more other subunits) and the homomeric α7 subtype. Certain areas of brain also contain a high density of α3β4* nAChRs, and this subtype appears to be the predominant nAChR in several autonomic nervous system ganglia.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">Nicotine interacts with α4β2, α4β2α6*, and α7 nAChRs in the dopaminergic mesolimbic pathway, which connects the ventral tegmental area of the midbrain and the limbic system via the nucleus accumbens,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and these effects of nicotine on brain dopaminergic systems are important in reinforcing drug self-administration. The mesolimbic dopamine system is assumed to mediate the pleasurable and rewarding effects of most drugs of abuse, including nicotine.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> There is convincing evidence from in vivo studies that mesolimbic α4β2* nAChRs play a pivotal role in nicotine self-administration in mice.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> Furthermore, differential activation and desensitization of nAChR subtypes on dopamine and GABA neurons and possibly glutamate neurons results in stimulated dopamine release in the nucleus accumbens, leading to positive reinforcement of nicotine.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p">The α4β2 subtype of nAChR serves as an important target for treating nicotine addiction as well as anxiety, depression, and cognitive disorders, and thus these receptors have been targeted with a wide array of compounds to develop potential therapies (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A). Many of the new compounds are structurally related to the natural nAChR ligands, including nicotine, epibatidine, and cytisine.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/medium/jm-2013-008455_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Selected examples of natural and synthetic nAChR ligands. (B) Design strategy for compound <b>1</b>. (C) General structures of the present series of compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008455&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2006, varenicline (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A) emerged as the newest drug approved by U.S. FDA as a therapeutic aid for smoking cessation.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Clinical studies indicate that varenicline is the most effective drug currently available to help people stop smoking,<a onclick="showRef(event, 'ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20">(17-20)</a> but its effects may be temporary.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> Furthermore, varenicline shows notable adverse side effects that limit the use of this compound.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> These side effects of varenicline are thought to be mediated predominantly through its action at non-α4β2 receptors, most likely the α3β4* and α7 subtypes.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> Pharmacological studies indicate that the interactions of varenicline with α4β2 nAChRs play essential roles in the clinical effect of varenicline as a smoking cessation aid. In addition, varenicline also interacts with nAChRs containing α6 and β2 subunits, which may also contribute to its effect.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">Xiao, et al. previously reported the synthesis and pharmacological properties of sazetidine (Saz-A) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B), which potently and selectively desensitizes β2 containing nicotinic receptors, especially α4β2 nAChRs, as measured by whole cell patch clamp and ion efflux assays.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> In addition to its ability to cause long lasting desensitization of α4β2 receptors, Saz-A also has agonist activity at the receptor subtype. It is highly interesting that Saz-A showed full agonist activity at the (α4)<sub>2</sub>(β2)<sub>3</sub> receptors but nearly no agonist activity at the (α4)<sub>3</sub>(β2)<sub>2</sub> receptors.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In the animal model, Saz-A reduced nicotine self-administration,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> decreased alcohol intake,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and improved performance in tests of attention.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Saz-A was also found to produce behaviors consistent with potential antidepressant and/or antianxiety effects in rats and mice.<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31-33)</a> These promising in vivo results suggest that Saz-A is an excellent starting compound for developing additional potent and subtype-selective drugs that desensitize α4β2 nAChRs. Recent in vivo studies showed a low concentration of Saz-A in rat brain,<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> suggesting that optimization of Saz-A physicochemical properties might enhance the in vivo CNS efficacy of this group of compounds.</div><div class="NLM_p last">In this report, we optimized the Saz-A ligand and provide the design, synthesis, and evaluation of a new class of picomolar active α4β2 selective compounds. These compounds could lead to more effective treatments for nicotine addiction as well as other conditions that involve nAChRs.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81707" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81707" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Design and Synthesis of the New Nicotinic Ligands</h3><div class="NLM_p">Utilizing homologous series, we began our optimization of Saz-A by replacing the alkyl hydroxyl with a benzene group resulting in the design of compound <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B). We anticipated that compound <b>1</b> would have an enhanced CNS profile based on the physicochemical properties of PSA (34.15), lipophilicity (log <i>P</i> = 2.36), and log BB (0.22). From our modeling studies (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), we envisioned that the benzene ring would provide more rigidity and favorable interactions with the α4β2 nAChR subtype. Aromatic optimization of the benzene ring of compound <b>1</b> provided the compounds in series 1 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/medium/jm-2013-008455_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Predicted structural models of α4β2 nAChR. (A) Atomic level interactions between compound <b>1</b> with α4β2 nAChR. Binding site residues are labeled and shown in a stick model rendering. Molecular modeling overlay of compound <b>1</b> (colored green) with <i>S</i>-nicotine (B), varenecline (C), and Saz-A (D) in the α4β2 nAChR binding site. Residues are labeled and shown in a stick model rendering.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008455&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The compounds from route 1 were synthesized as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Compound <b>18</b> was formed from a reaction of the 5-bromopyridin-3-ol <b>16</b> and the Boc-protected alcohol <b>17</b> under Mitsunobu conditions. Aromatic coupling of ethynyltrimethylsilane <b>19</b> to <b>18</b> resulted in the formation of <b>20</b>. Deprotection of TMS group in compound <b>20</b> resulted in the (<i>S</i>)-3-(azetidin-2-ylmethoxy)-5-(phenylethynyl)pyridine <b>21</b>. Substituted aryl iodides were added to the intermediate <b>21</b> under Sonogashira reaction conditions to generate compounds <b>22</b>, <b>23</b>, <b>24</b>, and <b>25</b>. Subsequent deprotection of the Boc group yielded the final compounds (compound <b>1</b>, <b>2</b> (VMY-2-101), <b>3</b> (VMY-2-105), and <b>4</b> (VMY-2-109) in series 1.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/medium/jm-2013-008455_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds in Series 1<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008455&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DEAD, PPh<sub>3</sub>, THF, O °C, 48 h; (b) 2 mol % Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, 4 mol % PPh<sub>3</sub>, 2 mol % CUI, iPr<sub>2</sub>NH, toluene, 80 °C, 18 h; (c) KOH, MeOH/H<sub>2</sub>O (20:1), 25 °C, 3 h; (d) 2 mol % Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, 4 mol % PPh<sub>3</sub>, 2 mol % CUI, iPr<sub>2</sub>NH, toluene, 25 °C, 18 h; (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C–rt 4–6 h then 2 M NaOH methanol in water (9:1), methanol, 18 h; (f) 4 mol% Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, 8 mol % PPh<sub>3</sub>, 8 mol% CUI, iPr<sub>2</sub>NH, toluene, 80 °C, 18 h; (g) KOH, MeOH/H<sub>2</sub>O (4:1), 25 °C, 3 h; (h) substituted aryl iodides, 25 °C, 16 h or substituted aryl bromide, 80 °C, 16 h; (i) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C–rt , 4–6 h then 2M NaOH methanol in water (9:1), methanol, 18 h.</p></p></figure><div class="NLM_p">With the success of the multistep route synthetic strategy, we optimized the chemical synthesis with a more efficient one-pot Sonogashira reaction<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, route 2) to generate the compounds in route 2. Synthesis of compounds <b>12</b> (VMY-2-161), <b>13</b> (VMY-2-177), and <b>14</b> (VMY-2-191) was accomplished by route 2 (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>A–C).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/medium/jm-2013-008455_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds in Series 2<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008455&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DEAD, PPh<sub>3</sub>, THF, 0 °C, 48 h; (b) 4 mol % Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, 8 mol % PPh<sub>3</sub>, 8 mol % CUI, iPr<sub>2</sub>NH, toluene, 80 °C, 18 h; (c) KOH, MeOH/H<sub>2</sub>O (4:1), 25 °C, 3 h; (d) iodobenzene, 25 °C, 16 h; (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C–rt 4–6 h then 2 M NaoH in methanol in water (9:1), methanol, 18 h; (f) HCHO, NaCNBH<sub>3</sub>, PH = 4–5 (CH<sub>3</sub>COOH:CH<sub>3</sub>COONa), ethanol.</p></p></figure><div class="NLM_p">Compound <b>1</b> analogues were also designed and synthesized to investigate the importance of the azetidine ring, N-substitution, and stereochemistry on the binding affinity of ligands for nAChRs (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). The <i>N</i>-methyl azetidine (<b>15</b>, VMY-2-205, Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>D) was prepared by reductive methylation of the secondary amine with formaldehyde. Analogue compound <b>16</b> (VMY-2-203), a previously reported compound, was prepared as a standard to investigate the importance of a spacer group between the benzene and pyridine rings.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Compound <b>16</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) was synthesized by applying the Suzuki reaction to the Mitsunobu product (<i>S</i>)-<i>tert</i>-butyl 2-((5-bromopyridin-3-yloxy)methyl)azetidine-1-carboxylate (<b>18</b>) and phenylboronic acid (<b>41</b>), followed by Boc deprotection.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/medium/jm-2013-008455_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008455&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, toluene:ethanol (3:1), 90 °C, 18 h; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C–rt, 6 h then 2 M NaOH methanol in water (9:1), methanol, 18 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Binding Affinities for nAChR Subtypes</h3><div class="NLM_p">The binding affinities of all compounds synthesized for the receptor subtypes were examined in binding competition studies against [<sup>3</sup>H]epibatidine. <i>K</i><sub>i</sub> values of these compounds at six defined subtypes of rat nAChRs are provided in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1A" href="#tbl1A">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl1B" href="#tbl1B">2</a>. Included in the tables are the <i>K</i><sub>i</sub> values in rat forebrain, which represents a mixture of more than one native nAChR.</div><div class="NLM_table-wrap" id="tbl1A"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Comparison of Binding Affinities of Series 1 Compounds for Rat nAChR Subtypes with Those of Saz-A, Varenicline, and Nicotine<a class="ref internalNav" href="#t1Afn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/medium/jm-2013-008455_0007.gif" alt="" id="GRAPHIC-d471e837-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="8" align="center"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t1Afn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd ID</th><th class="colsep0 rowsep0" align="center">α2β2</th><th class="colsep0 rowsep0" align="center">α2β4</th><th class="colsep0 rowsep0" align="center">α3β2</th><th class="colsep0 rowsep0" align="center">α3β4</th><th class="colsep0 rowsep0" align="center">α4β2</th><th class="colsep0 rowsep0" align="center">α4β4</th><th class="colsep0 rowsep0" align="center">α7</th><th class="colsep0 rowsep0" align="center">forebrain</th><th class="colsep0 rowsep0" align="center" char=".">α3β4/α4β2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center">0.11 (0.01)</td><td class="colsep0 rowsep0" align="center">58 (4)</td><td class="colsep0 rowsep0" align="center">0.53 (0.08)</td><td class="colsep0 rowsep0" align="center">640 (40)</td><td class="colsep0 rowsep0" align="center">0.049 (0.007)</td><td class="colsep0 rowsep0" align="center">11 (1)</td><td class="colsep0 rowsep0" align="center">580 (50)</td><td class="colsep0 rowsep0" align="center">0.5 (0.06)</td><td class="colsep0 rowsep0" align="char" char=".">13000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="center">0.045 (0.016)</td><td class="colsep0 rowsep0" align="center">37 (7)</td><td class="colsep0 rowsep0" align="center">0.41 (0.09)</td><td class="colsep0 rowsep0" align="center">650 (20)</td><td class="colsep0 rowsep0" align="center">0.083 (0.029)</td><td class="colsep0 rowsep0" align="center">7.2 (0.7)</td><td class="colsep0 rowsep0" align="center">2,000 (800)</td><td class="colsep0 rowsep0" align="center">0.50 (0.05)</td><td class="colsep0 rowsep0" align="char" char=".">7800</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="center">0.081 (0.021)</td><td class="colsep0 rowsep0" align="center">47 (6)</td><td class="colsep0 rowsep0" align="center">0.61 (0.07)</td><td class="colsep0 rowsep0" align="center">580 (50)</td><td class="colsep0 rowsep0" align="center">0.072 (0.007)</td><td class="colsep0 rowsep0" align="center">8.7 (0.5)</td><td class="colsep0 rowsep0" align="center">1100 (500)</td><td class="colsep0 rowsep0" align="center">0.58 (0.10)</td><td class="colsep0 rowsep0" align="char" char=".">8100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="center">0.029 (0.005)</td><td class="colsep0 rowsep0" align="center">31 (5)</td><td class="colsep0 rowsep0" align="center">0.19 (0.03)</td><td class="colsep0 rowsep0" align="center">520 (30)</td><td class="colsep0 rowsep0" align="center">0.032 (0.012)</td><td class="colsep0 rowsep0" align="center">5.3 (0.2)</td><td class="colsep0 rowsep0" align="center">720 (180)</td><td class="colsep0 rowsep0" align="center">0.44 (0.05)</td><td class="colsep0 rowsep0" align="char" char=".">16000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="center">0.063 (0.011)</td><td class="colsep0 rowsep0" align="center">23 (1)</td><td class="colsep0 rowsep0" align="center">0.52 (0.34)</td><td class="colsep0 rowsep0" align="center">540 (60)</td><td class="colsep0 rowsep0" align="center">0.050 (0.009)</td><td class="colsep0 rowsep0" align="center">4.7 (0.6)</td><td class="colsep0 rowsep0" align="center">1,800 (700)</td><td class="colsep0 rowsep0" align="center">0.73 (0.05)</td><td class="colsep0 rowsep0" align="char" char=".">28000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="center">0.28 (0.04)</td><td class="colsep0 rowsep0" align="center">54 (7)</td><td class="colsep0 rowsep0" align="center">1.4 (0.6)</td><td class="colsep0 rowsep0" align="center">1,400 (100)</td><td class="colsep0 rowsep0" align="center">0.26 (0.04)</td><td class="colsep0 rowsep0" align="center">11 (2)</td><td class="colsep0 rowsep0" align="center">1,300 (500)</td><td class="colsep0 rowsep0" align="center">3.5 (0.3)</td><td class="colsep0 rowsep0" align="char" char=".">5400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">0.053 (0.004)</td><td class="colsep0 rowsep0" align="center">46 (4)</td><td class="colsep0 rowsep0" align="center">0.34 (0.14)</td><td class="colsep0 rowsep0" align="center">4,000 (2,900)</td><td class="colsep0 rowsep0" align="center">0.046 (0.011)</td><td class="colsep0 rowsep0" align="center">12 (3)</td><td class="colsep0 rowsep0" align="center">200 (80)</td><td class="colsep0 rowsep0" align="center">1.1 (0.4)</td><td class="colsep0 rowsep0" align="char" char=".">87000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="center">0.19 (0.05)</td><td class="colsep0 rowsep0" align="center">150 (1)</td><td class="colsep0 rowsep0" align="center">1.6 (0.1)</td><td class="colsep0 rowsep0" align="center">3,400 (400)</td><td class="colsep0 rowsep0" align="center">0.093 (0.037)</td><td class="colsep0 rowsep0" align="center">17 (8)</td><td class="colsep0 rowsep0" align="center">480 (140)</td><td class="colsep0 rowsep0" align="center">1.7 (1.4)</td><td class="colsep0 rowsep0" align="char" char=".">37000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="center">0.053 (0.012)</td><td class="colsep0 rowsep0" align="center">66 (3)</td><td class="colsep0 rowsep0" align="center">0.46 (0.22)</td><td class="colsep0 rowsep0" align="center">1,000 (30)</td><td class="colsep0 rowsep0" align="center">0.031 (0.003)</td><td class="colsep0 rowsep0" align="center">12 (2)</td><td class="colsep0 rowsep0" align="center">250 (93)</td><td class="colsep0 rowsep0" align="center">0.70 (0.37)</td><td class="colsep0 rowsep0" align="char" char=".">32000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="center">0.064 (0.007)</td><td class="colsep0 rowsep0" align="center">38 (4)</td><td class="colsep0 rowsep0" align="center">0.24 (0.02)</td><td class="colsep0 rowsep0" align="center">1,100 (60)</td><td class="colsep0 rowsep0" align="center">0.043 (0.003)</td><td class="colsep0 rowsep0" align="center">8.1 (0.4)</td><td class="colsep0 rowsep0" align="center">590 (250)</td><td class="colsep0 rowsep0" align="center">1.4 (0.5)</td><td class="colsep0 rowsep0" align="char" char=".">26000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="center">0.091 (0.011)</td><td class="colsep0 rowsep0" align="center">53 (2)</td><td class="colsep0 rowsep0" align="center">0.59 (0.01)</td><td class="colsep0 rowsep0" align="center">1,300 (40)</td><td class="colsep0 rowsep0" align="center">0.076 (0.017)</td><td class="colsep0 rowsep0" align="center">10 (0.3)</td><td class="colsep0 rowsep0" align="center">1,500 (100)</td><td class="colsep0 rowsep0" align="center">1.7 (0.3)</td><td class="colsep0 rowsep0" align="char" char=".">17000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Saz-A</td><td class="colsep0 rowsep0" align="center">0.087 (0.014)</td><td class="colsep0 rowsep0" align="center">210 (30)</td><td class="colsep0 rowsep0" align="center">0.38 (0.07)</td><td class="colsep0 rowsep0" align="center">1,900 (300)</td><td class="colsep0 rowsep0" align="center">0.062 (0.006)</td><td class="colsep0 rowsep0" align="center">52 (2)</td><td class="colsep0 rowsep0" align="center">670 (220)</td><td class="colsep0 rowsep0" align="center">0.17 (0.02)</td><td class="colsep0 rowsep0" align="char" char=".">31000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nicotine<a class="ref internalNav" href="#t1Afn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">12 (2)</td><td class="colsep0 rowsep0" align="center">110 (20)</td><td class="colsep0 rowsep0" align="center">47 (11)</td><td class="colsep0 rowsep0" align="center">440 (60)</td><td class="colsep0 rowsep0" align="center">10 (2)</td><td class="colsep0 rowsep0" align="center">40 (6)</td><td class="colsep0 rowsep0" align="center">520 (140)</td><td class="colsep0 rowsep0" align="center">12 (2)</td><td class="colsep0 rowsep0" align="char" char=".">44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">varenicline</td><td class="colsep0 rowsep0" align="center">0.22 (0.02)</td><td class="colsep0 rowsep0" align="center">71 (5)</td><td class="colsep0 rowsep0" align="center">1.9 (0.1)</td><td class="colsep0 rowsep0" align="center">460 (40)</td><td class="colsep0 rowsep0" align="center">0.13 (0.01)</td><td class="colsep0 rowsep0" align="center">15 (0.2)</td><td class="colsep0 rowsep0" align="center">62 (11)</td><td class="colsep0 rowsep0" align="center">0.71 (0.04)</td><td class="colsep0 rowsep0" align="char" char=".">3500</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1Afn1"><div class="footnote" id="t1Afn1"><sup>a</sup><p class="last">Competition binding assays were carried out in membrane homogenates of stably transfected cells or rat forebrain tissue as described previously.<a onclick="showRef(event, 'ref72 ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref72 ref73 ref74">(72-74)</a> The rat nAChRs were labeled with [<sup>3</sup>H]epibatidine. The <i>K</i><sub>d</sub> values for [<sup>3</sup>H]epibatidine used for calculating <i>K</i><sub>i</sub> values were 0.02 for α2β2, 0.08 for α2β4, 0.03 for α3β2, 0.3 for α3β4, 0.04 for α4β2, 0.09 for α4β4, 1.8 for α7, and 0.05 for rat forebrain.</p></div><div class="footnote" id="t1Afn2"><sup>b</sup><p class="last"><i>K</i><sub>i</sub> values of the compounds shown are the mean of 3–5 independent measurements with SEM values included in brackets.</p></div><div class="footnote" id="t1Afn3"><sup>c</sup><p class="last">The <i>K</i><sub>i</sub> values of (−)-nicotine was published previously.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></p></div></div></div><div class="NLM_table-wrap" id="tbl1B"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Affinities of Series 2 and Series 3 Compounds for Rat nAChR Subtypes<a class="ref internalNav" href="#t1Bfn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/medium/jm-2013-008455_0008.gif" alt="" id="GRAPHIC-d471e1363-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="8" align="center"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t1Bfn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd ID</th><th class="colsep0 rowsep0" align="center">α2β2</th><th class="colsep0 rowsep0" align="center">α2β4</th><th class="colsep0 rowsep0" align="center">α3β2</th><th class="colsep0 rowsep0" align="center">α3β4</th><th class="colsep0 rowsep0" align="center">α4β2</th><th class="colsep0 rowsep0" align="center">α4β4</th><th class="colsep0 rowsep0" align="center">α7</th><th class="colsep0 rowsep0" align="center">forebrain</th><th class="colsep0 rowsep0" align="center" char=".">α3β4/α4β2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b><a class="ref internalNav" href="#t1Bfn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">>100000</td><td class="colsep0 rowsep0" align="center">>50000</td><td class="colsep0 rowsep0" align="center">>25000</td><td class="colsep0 rowsep0" align="center">>1000000</td><td class="colsep0 rowsep0" align="center">>100000</td><td class="colsep0 rowsep0" align="center">>500000</td><td class="colsep0 rowsep0" align="center">>250000</td><td class="colsep0 rowsep0" align="center">>100000</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b><a class="ref internalNav" href="#t1Bfn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">>5000</td><td class="colsep0 rowsep0" align="center">>250000</td><td class="colsep0 rowsep0" align="center">>10000</td><td class="colsep0 rowsep0" align="center">>500000</td><td class="colsep0 rowsep0" align="center">>1000</td><td class="colsep0 rowsep0" align="center">>50000</td><td class="colsep0 rowsep0" align="center">>25000</td><td class="colsep0 rowsep0" align="center">>50000</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="center">0.19 (0.05)</td><td class="colsep0 rowsep0" align="center">46 (16)</td><td class="colsep0 rowsep0" align="center">0.92 (0.26)</td><td class="colsep0 rowsep0" align="center">1700 (130)</td><td class="colsep0 rowsep0" align="center">0.11 (0.03)</td><td class="colsep0 rowsep0" align="center">8.9 (1.8)</td><td class="colsep0 rowsep0" align="center">1,600 (500)</td><td class="colsep0 rowsep0" align="center">1.1 (0.2)</td><td class="colsep0 rowsep0" align="char" char=".">15000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="center">2.9 (0.5)</td><td class="colsep0 rowsep0" align="center">4,100 (400)</td><td class="colsep0 rowsep0" align="center">26 (2)</td><td class="colsep0 rowsep0" align="center">40,000 (4000)</td><td class="colsep0 rowsep0" align="center">1.2 (0.2)</td><td class="colsep0 rowsep0" align="center">1,100 (100)</td><td class="colsep0 rowsep0" align="center">7,700 (3000)</td><td class="colsep0 rowsep0" align="center">30 (2)</td><td class="colsep0 rowsep0" align="char" char=".">33000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="center">0.22 (0.02)</td><td class="colsep0 rowsep0" align="center">36 (3)</td><td class="colsep0 rowsep0" align="center">5.0 (0.4)</td><td class="colsep0 rowsep0" align="center">1300 (200)</td><td class="colsep0 rowsep0" align="center">0.14 (0.01)</td><td class="colsep0 rowsep0" align="center">6.2 (0.3)</td><td class="colsep0 rowsep0" align="center">11,000 (3000)</td><td class="colsep0 rowsep0" align="center">1.1 (0.2)</td><td class="colsep0 rowsep0" align="char" char=".">9285</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1Bfn1"><div class="footnote" id="t1Bfn1"><sup>a</sup><p class="last">Competition binding assays were carried out in membrane homogenates of stably transfected cells or rat forebrain tissue as described previously.<a onclick="showRef(event, 'ref72 ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref72 ref73 ref74">(72-74)</a> The rat nAChRs were labeled with [<sup>3</sup>H]epibatidine. The <i>K</i><sub>d</sub> values for [<sup>3</sup>H]epibatidine used for calculating <i>K</i><sub>i</sub> values were 0.02 for α2β2, 0.08 for α2β4, 0.03 for α3β2, 0.3 for α3β4, 0.04 for α4β2, 0.09 for α4β4, 1.8 for α7, and 0.05 for forebrain.</p></div><div class="footnote" id="t1Bfn2"><sup>b</sup><p class="last"><i>K</i><sub>i</sub> values of the compounds shown are the mean of 3–5 independent measurements with SEM values included in brackets.</p></div><div class="footnote" id="t1Bfn3"><sup>c</sup><p class="last">The compound showed very low binding affinity at all nAChR subtypes. In the range of the concentration tested, no accurate <i>K</i><sub>i</sub> values could be determined. The numbers shown are estimated range of <i>K</i><sub>i</sub> values.</p></div></div></div><div class="NLM_p">All compounds in series 1 exhibited high affinity for the rat α4β2 nAChR subtype with <i>K</i><sub>i</sub> values ranging from 0.031 nM compound <b>9</b> (VMY-2-131) to 0.26 nM compound <b>6</b> (VMY-2-117). These compounds also showed high affinities for the two other subtypes containing β2 subunits, α2β2 and α3β2 nAChRs. In contrast, the binding affinities of these compounds for nAChR subtypes containing β4 subunits are much lower than those for their β2 containing counterparts. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1A" href="#tbl1A">1</a>, the selectivity of these compounds for α4β2 receptors over α3β4 receptors (<i>K</i><sub>i</sub> ratio) were very high, ranging from 5400 times compound <b>6</b> to 87000 times compound <b>7</b> (VMY-2-123). All of these ratios are much greater than that of nicotine or varenicline. Similar to the low affinities for α3β4 receptors, these compounds showed very low affinities for α7 homomeric receptors (Table <a class="ref showTableEvent internalNav" data-ID="tbl1A" href="#tbl1A">1</a>).</div><div class="NLM_p">Because compound <b>1</b> showed a promising binding profile, we synthesized several analogues to evaluate the effects of substitutions on the benzene ring. Substitutions at position 2, 3, or 4 generated compounds <b>2</b>, <b>3</b>, <b>4</b>, <b>7</b>, and <b>8</b> (VMY-2-127). These singly substituted analogues have binding profiles similar to that of compound <b>1</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1A" href="#tbl1A">1</a>). The dual substituted analogues <b>5</b> (VMY-2-113), <b>9</b>, <b>10</b> (VMY-2-135), and <b>11</b>(VMY-2-139), also showed high affinities and selectivity for α4β2 receptors. However, the installation of CF<sub>3</sub> at position 3 decreased the binding affinity for the α4β2 receptor, as shown by the binding profile of <b>6</b>.</div><div class="NLM_p last">Interestingly, two compounds in series 2, compound <b>12</b> (azetidine replaced with cyclobutane) and compound <b>13</b> (ring opened analogue of azetidine), showed very low binding affinities to nAChRs (Table <a class="ref showTableEvent internalNav" data-ID="tbl1B" href="#tbl1B">2</a>), indicating that the azetidine ring is important for the high affinity and selectivity binding profile. In addition, the (<i>S</i>)-<i>N</i>-methyl compound <b>15</b> binds nearly 25 times weaker than the corresponding (<i>S</i>)-N–H compound <b>1</b>, suggesting that N–H provides a potentially important H-bond interaction. For comparing the difference between stereotypes, compound <b>14</b>, which is the (<i>R</i>)-form of compound <b>1</b>, was synthesized. The binding profile of <b>14</b> is similar to that of compound <b>1</b>, although compound <b>14</b> has a slightly lower affinity for α4β2 receptors than compound <b>1</b>. The binding affinity and drug-like properties of compound <b>1</b> prompted us to choose this molecule as a staring compound in the new series developed in this report and to advance this analogue in further in vitro and in vivo studies.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Binding Affinities for Targets Other than nAChRs</h3><div class="NLM_p last">To determine the affinity of compound <b>1</b> to molecular targets other than neuronal nAChRs, 41 binding assays were evaluated including CNS receptors and transporters. As shown in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Table S1">Supporting Information Table S1</a>, the preliminary binding assays using a single concentration of compound <b>1</b> at 10 μM generated 32 “miss” (less than 50% inhibition of binding by specifically labeled ligands) and 9 “hit” (more than 50% inhibition of binding). The <i>K</i><sub>i</sub> values of compound <b>1</b> at these nine targets were determined by performing secondary binding assays using a series of concentrations of compound <b>1</b>. As shown in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Table S2">Supporting Information Table S2</a>, the compound has low binding affinities at these targets; thus, the binding affinity of compound <b>1</b> for α4β2 nAChRs is at least 3000 times higher than that for any of those nine targets.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Molecular Modeling Interactions of Compound <b>1</b> and Other Known Ligands with the Agonist Form of the X-ray Crystal Structure of the AChBP</h3><div class="NLM_p">To better understand the binding interactions between α4β2 nAChR and compound <b>1</b>, molecular models of compound <b>1</b> with the α4β2 nAChR were constructed (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A) and overlaid with known nicotinic ligands (<i>S</i>)-nicotine, varenicline, and Saz-A (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B–D). The docked structural models of the α4β2 nAChR/ligand complex reveal that the binding mode interactions are slightly different from one another as reported previously.<a onclick="showRef(event, 'ref37 ref38 ref39 ref40 ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40 ref41 ref42 ref43">(37-43)</a> To provide a consistent model with the nicotine-AChBP (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UW6">1UW6</a>), the docked position of each compound was remodeled using a step-by-step manual docking methodology with restrained molecular dynamic (MD) simulations followed by energy minimization. In the restrained MD simulations, the optimum van der Waals and H-bond distance constraints was set between the ligand and the α4β2 nAChR ligand binding domain residues. The final binding complex is depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A–D.</div><div class="NLM_p last">The compound <b>1</b>, nicotine, varenicline, and Saz-A are predicted to be buried near aromatic rich residues such as W147α, W55β, Y91α, Y188α, Y195α, and F117β (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A–D) and are expected to occupy a similar binding region. However, MD simulations suggest a slightly different orientation of the compounds in the α4β2 binding site. This may be due to conformational adjustments inside the binding site. The azetidine group in compound <b>1</b> and Saz-A are shown forming stacking interactions with the amino acid W147α (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A,D). However, positioning of the pyridine group is slightly perturbed to compensate for the conformational entropy penalty due to isomeric constraints. The hydroxy group of Saz-A may form a hydrogen bond with Y188α, whereas this residue likely forms a hydrogen bond with the pyrazine ring nitrogen of varenicline, and this hydrogen bond is absent in (<i>S</i>)-nicotine. Compound <b>1</b> and Saz-A have hydrophobic groups extending from the pyridine ring, which may form additional favorable hydrophobic interactions with K76β, K77β, Y112β, V109β, F117β, and L119β. These interactions can be compared with the interactions of varenicline involving V109β, F117β, and L119β (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C). Although Saz-A and compound <b>1</b> are shown to have a similar pattern of interaction, the benzene ring of the ethynylbenzene of compound <b>1</b> can form a stronger stacking and lipophilic interaction with K76β, K77β, Y112β, and V109β than the corresponding hex-5-yn-1-ol group of Saz-A. Moreover, the 3-(2-phenylethynyl) pyridine group of compound <b>1</b> is more rigid and may require a smaller penalty in conformational entropy as compared to the flexible 6-(3-pyridyl) hex-5-yn-1-ol group of Saz-A (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A,B). These additional interactions and favorable entropy penalty may likely confer potency to compound <b>1</b>. The overlay of compound <b>1</b> with (<i>S</i>)-nicotine, varenicline, and Saz-A (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B–D) suggests that compound <b>1</b> forms more favorable hydrophobic interactions with the α4β2 nAChR and occupies different receptor space that may be critical for selective and high affinity binding.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Effects of Compound <b>1</b> on Functions of nAChRs</h3><div class="NLM_p">The functional effect of the lead compound <b>1</b> was assessed by measuring agonist-stimulated <sup>86</sup>Rb<sup>+</sup> efflux from stably transfected cells expressing nAChRs, either human α4β2 subtype or rat α3β4 subtype. Its ability to desensitize nAChRs was determined by measuring nicotine-stimulated <sup>86</sup>Rb<sup>+</sup> efflux after cells were preincubated with compound <b>1</b> for 10 min. For comparison, we also examined three other nicotinic ligands in the same manner, Saz-A, varenicline, and (−)-nicotine.</div><div class="NLM_p">As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">3</a>, compound <b>1</b> did not show any detectable agonist activity at rat α3β4 nAChRs in <sup>86</sup>Rb<sup>+</sup> efflux assays. At human α4β2 receptors, the compound showed agonist activity with an EC<sub>50</sub> value as 10 nM and a maximal efficacy (<i>E</i><sub>max</sub>) relative to the maximal stimulation by nicotine of 24%. In parallel experiments, varenicline also showed partial agonist activity at α4β2 receptors (45%) and, at much higher concentrations, near-full agonist activity at α3β4 nAChRs (85%). The full activation and desensitization curves of compound <b>1</b> are shown in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Figure S1">Supporting Information Figure S1</a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Activation and Inhibition of nAChR Function by Compound <b>1</b>, Saz-A, Varenicline, and Nicotine<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">α4β2 nAChRs<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="3" align="center">α3β4 nAChRs<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">EC<sub>50</sub><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (nM)</th><th class="colsep0 rowsep0" align="center" char="±"><i>E</i><sub>max</sub><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a> (%)</th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50(10′)</sub><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a> (nM)</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> (%)</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50(10′)</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">10 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">24 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">16 ± 2</td><td class="colsep0 rowsep0" align="center">ND<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sazetidine-A</td><td class="colsep0 rowsep0" align="char" char="±">24 ± 12</td><td class="colsep0 rowsep0" align="char" char="±">40 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">11 ± 4</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">varenicline</td><td class="colsep0 rowsep0" align="char" char="±">950 ± 30</td><td class="colsep0 rowsep0" align="char" char="±">45 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">94 ± 18</td><td class="colsep0 rowsep0" align="center">21,000 ± 1,000</td><td class="colsep0 rowsep0" align="center">82 ± 3</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(−)-nicotine</td><td class="colsep0 rowsep0" align="char" char="±">2400 ± 300</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 5</td><td class="colsep0 rowsep0" align="char" char="±">370 ± 110</td><td class="colsep0 rowsep0" align="center">24,000 ± 1,000</td><td class="colsep0 rowsep0" align="center">100 ± 2</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Functional properties of each compounds were determined in using stable cell lines expressing human α4β2 or rat α3β4 nAChRs.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">EC<sub>50</sub> values show potencies of agonist activities.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last"><i>E</i><sub>max</sub> values show relative efficacies of agonist activities, which were normalized to the <i>E</i><sub>max</sub> value of nicotine.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">IC<sub>50(10 min)</sub> values show potencies of desensitizer activities, which were determined by preincubated cells with various concentrations of test compounds for 10 min then exposed to 100 μM nicotine.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">ND indicates no stimulation was detected. All values shown are means ± SEM of 3–9 independent experiments.</p></div></div></div><div class="NLM_p">It is important to note that all four compounds studied, compound <b>1</b>, Saz-A, varenicline, and nicotine inhibited nicotine activation of α4β2 receptors after preincubation with the cells for 10 min, which desensitizes the receptors. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">3</a>, after a 10 min preincubation, compound <b>1</b> potently desensitized α4β2 receptor function with an IC<sub>50</sub> value (IC<sub>50(10″)</sub>) of 16 nM, indicating a potency for desensitization of these receptors similar to that of Saz-A, but 6- and 23-times more potent than varenicline and nicotine, respectively. In contrast to their high potency to desensitize α4β2 nAChRs, the IC<sub>50(10″)</sub> values of these four compounds to desensitize α3β4 nAChRs were greater than 10000 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">3</a>). All of these compounds, especially compound <b>1</b> and Saz-A, are much more potent desensitizers of α4β2 than α3β4 nAChRs.</div><div class="NLM_p last">To confirm that compound <b>1</b> is a low efficacy agonist of α4β2 nAChRs, we evaluated the compound for its agonist activity at α4β2 nAChRs using whole cell patch clamp. In all cells studied (<i>n</i> = 3), the bath application of compound <b>1</b> (200 nM) produced a mean inward whole-cell current that was 12.61 ± 1.8% of the control whole-cell response to 32 μM ACh. This electrophysiological study confirms that compound <b>1</b> has very low agonist efficacy for α4β2 nAChRs.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Effects of Compound <b>1</b> on Nicotine Self-Administration and Locomotor Activity in Rats</h3><div class="NLM_p">The lever press data from the 10 training sessions clearly shows that the nicotine lever is preferred (active lever 12.6 ± 1.2 presses/session, inactive lever 3.2 ± 0.3 presses per session, (<i>F</i>(1,14) = 28.55, <i>p</i> < 0.0005) and that it is stable over this period. We then studied acute effects of compound <b>1</b> on nicotine self-administration in rats. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A, compound <b>1</b> significantly (<i>F</i>(3,42) = 3.36, <i>p</i> < 0.05) decreased intravenous nicotine self-administration. The 3 mg/kg dose of compound <b>1</b>, but not the lower doses, caused a significant (<i>p</i> < 0.025) decrease in the number of nicotine infusions compared with vehicle. The 15 min time periods within each session were analyzed (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B). There was a significant (<i>F</i>(2,28) = 19.85, <i>p</i> < 0.0005) main effect of time period reflecting the commonly seen initial higher rate of nicotine self-administration during each session. However, there was no significant interaction of compound <b>1</b> multiplied by time period within session. The effect of repeated dosing was also analyzed. The entire range of compound <b>1</b> doses and the saline control were given twice. There was no significant effect of the repeated testing and no significant interaction compound <b>1</b> with repeated dosing. These data demonstrate that, similar to Saz-A,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> compound <b>1</b> at 3 mg/kg effectively reduces nicotine self-administration in rats.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/medium/jm-2013-008455_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Acute compound <b>1</b> effects on nicotine self-administration (0.03 mg/kg/infusion). Compound <b>1</b> (3 mg/kg) resulted in a significant (<i>p</i> < 0.025) decrease in nicotine self-administration relative to nicotine self-administration after control saline injections (mean ± SEM; <i>n</i> = 15). (B) Compound <b>1</b> effects on nicotine self-administration during each 15 min time period within session. (C) Acute compound <b>1</b> effects on locomotor activity. Effect of compound <b>1</b> on locomotor activity in the figure-eight maze during the 1 h session (mean + SEM; <i>n</i> = 12). (D) Compound <b>1</b> effects on locomotor activity during each 15 min time period within session.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008455&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Interestingly, the locomotor activity of rats was significantly increased by compound <b>1</b> (<i>F</i>(3,33) = 13.58, <i>p</i> < 0.0005). All three doses of compound <b>1</b> significantly (<i>p</i> < 0.0005 for 0.3 and 1 mg/kg and <i>p</i> < 0.005 for 3 mg/kg) increased the mean activity over the 1 h test session (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C). Therefore, the effect of compound <b>1</b> in decreasing nicotine self-administration did not appear to result from any drug induced sedative effect. Furthermore, the dose–effect function of compound <b>1</b> on locomotor activity did not correspond with the effect on nicotine self-administration, as the peak of increased locomotor activity was at 1 mg/kg, at which dose there was no significant reduction of nicotine self-administration. There was a significant main effect of 15 min time blocks within the session (<i>F</i>(3,33) = 79.68, <i>p</i> < 0.0005), reflecting the normal habituation of locomotor exploration (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>D), but the drug treatment multiplied by the block interaction was not significant.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Physicochemical Properties of the New Ligands</h3><div class="NLM_p">Several key physicochemical properties of compounds may influence the blood–brain barrier (BBB) penetration of CNS drugs,<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> including molecular weight (MW), polar surface area (PSA), and lipophilicity (clogP). These parameters were calculated for all series 1 compounds and are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">4</a>. In general, CNS drugs have a MW ≤ 450 Da. All the compounds in this report have molecular weights less than 450 Da. In addition, all these compounds have clogP values <5, suggesting a reasonable probability of good oral absorption and intestinal permeability.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> In general, a polar surface area (PSA) less than 60 Å<sup>2</sup> is predictive of good penetration of the blood–brain barrier. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">4</a>, all the compounds in series 1 have PSA values less than than 60 Å<sup>2</sup>. We also calculated the log BB, which is a parameter commonly used to express the extent of a drug passing through the blood–brain barrier.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Several QSAR models were developed to calculate the log BB.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> In this study, we used Clark’s equation to predict the log BB values for compounds in series 1.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> In general, a log BB value greater than zero is a favorable factor for BBB penetration. The log BB values of all compounds in series 1 were in the positive range. Ligand efficiency (LE) is an important metric in drug discovery and has been used to measure the relationship of a ligand’s affinity with molecular size. LE is the ratio of the free energy of binding over the number of heavy atoms in a molecule.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> LE is a useful optimization tool to evaluate a ligand’s ability to effectively bind to the targeted protein. Considering the binding affinity (<i>K</i><sub>i</sub>) of the compounds in series 1, we calculated the LE using Hopkin’s equation.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> An LE ≥ 0.3 is considered favorable and suggests that a compound is optimized for receptor occupancy. All compounds in series 1 have an LE value in the range of 0.6 to 1 kcal/mol (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">4</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Calculated Ligand Efficiency and Physicochemical Properties of Compounds in Series 1</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center" char=".">binding affinity <i>K</i><sub>i</sub> (nM)</th><th class="rowsep1 colsep0" align="center" char=".">ligand efficiency kcal/mol</th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">predicted physicochemical properties</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd ID</th><th class="colsep0 rowsep0" align="center" char=".">α4β2</th><th class="colsep0 rowsep0" align="center" char=".">LE<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">MW<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">CLogP<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">PSA<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">log BB<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">0.049</td><td class="colsep0 rowsep0" align="char" char=".">0.70</td><td class="colsep0 rowsep0" align="char" char=".">264.32</td><td class="colsep0 rowsep0" align="char" char=".">3.712</td><td class="colsep0 rowsep0" align="char" char=".">34.15</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">0.083</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td><td class="colsep0 rowsep0" align="char" char=".">282.31</td><td class="colsep0 rowsep0" align="char" char=".">3.855</td><td class="colsep0 rowsep0" align="char" char=".">34.15</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">0.072</td><td class="colsep0 rowsep0" align="char" char=".">0.66</td><td class="colsep0 rowsep0" align="char" char=".">282.31</td><td class="colsep0 rowsep0" align="char" char=".">3.855</td><td class="colsep0 rowsep0" align="char" char=".">34.15</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">0.032</td><td class="colsep0 rowsep0" align="char" char=".">0.68</td><td class="colsep0 rowsep0" align="char" char=".">282.31</td><td class="colsep0 rowsep0" align="char" char=".">3.855</td><td class="colsep0 rowsep0" align="char" char=".">34.15</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">0.050</td><td class="colsep0 rowsep0" align="char" char=".">0.64</td><td class="colsep0 rowsep0" align="char" char=".">300.30</td><td class="colsep0 rowsep0" align="char" char=".">3.998</td><td class="colsep0 rowsep0" align="char" char=".">34.15</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char=".">0.54</td><td class="colsep0 rowsep0" align="char" char=".">332.32</td><td class="colsep0 rowsep0" align="char" char=".">4.595</td><td class="colsep0 rowsep0" align="char" char=".">34.15</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">0.046</td><td class="colsep0 rowsep0" align="char" char=".">0.67</td><td class="colsep0 rowsep0" align="char" char=".">278.35</td><td class="colsep0 rowsep0" align="char" char=".">4.211</td><td class="colsep0 rowsep0" align="char" char=".">34.15</td><td class="colsep0 rowsep0" align="char" char=".">0.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char=".">0.093</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td><td class="colsep0 rowsep0" align="char" char=".">298.77</td><td class="colsep0 rowsep0" align="char" char=".">4.425</td><td class="colsep0 rowsep0" align="char" char=".">34.15</td><td class="colsep0 rowsep0" align="char" char=".">0.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char=".">0.031</td><td class="colsep0 rowsep0" align="char" char=".">0.60</td><td class="colsep0 rowsep0" align="char" char=".">325.38</td><td class="colsep0 rowsep0" align="char" char=".">4.191</td><td class="colsep0 rowsep0" align="char" char=".">37.39</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">0.043</td><td class="colsep0 rowsep0" align="char" char=".">0.64</td><td class="colsep0 rowsep0" align="char" char=".">296.34</td><td class="colsep0 rowsep0" align="char" char=".">4.354</td><td class="colsep0 rowsep0" align="char" char=".">34.15</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">0.076</td><td class="colsep0 rowsep0" align="char" char=".">0.60</td><td class="colsep0 rowsep0" align="char" char=".">312.34</td><td class="colsep0 rowsep0" align="char" char=".">3.914</td><td class="colsep0 rowsep0" align="char" char=".">43.38</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Saz-A</td><td class="colsep0 rowsep0" align="char" char=".">0.062</td><td class="colsep0 rowsep0" align="char" char=".">0.73</td><td class="colsep0 rowsep0" align="char" char=".">260.33</td><td class="colsep0 rowsep0" align="char" char=".">1.47</td><td class="colsep0 rowsep0" align="char" char=".">54.38</td><td class="colsep0 rowsep0" align="char" char=".">–0.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">varenecline</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td><td class="colsep0 rowsep0" align="char" char=".">211.26</td><td class="colsep0 rowsep0" align="char" char=".">0.899</td><td class="colsep0 rowsep0" align="char" char=".">37.81</td><td class="colsep0 rowsep0" align="char" char=".">–0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nicotine</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">1.14</td><td class="colsep0 rowsep0" align="char" char=".">162.23</td><td class="colsep0 rowsep0" align="char" char=".">0.883</td><td class="colsep0 rowsep0" align="char" char=".">16.13</td><td class="colsep0 rowsep0" align="char" char=".">–0.035</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Ligand binding efficiency was calculated according to the Hopkins equation: LE = 1.372 × (−log <i>K</i><sub>i</sub> (moles))/<i>N</i>.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Molecular weight and cLogP were calculated from ChemBioDraw Ultra 11.0.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Polar surface area (PSA) was calculated from <a href="http://www.chemicalize.org" class="extLink">www.chemicalize.org</a>.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Log BB was calculated from the following equation: Log BB = −0.0148PSA + 0.152CLogP + 0.139.</p></div></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Brain Tissue Distribution and Plasma Binding Studies for Compound <b>1</b></h3><div class="NLM_p">To study in vitro unbound brain-to-plasma concentration ratio of compound <b>1</b>, we applied an equilibrium dialysis technique as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Procedures">Experimental Procedures</a>. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A,B, compound <b>1</b> (5 μM) has a significantly less percentage of unbound drug fraction in the rat brain tissue (%<i>f</i><sub>UBrain</sub> = 1.21) as compared to Saz-A (%<i>f</i><sub>UBrain</sub> = 59.8) and varenicline (%<i>f</i><sub>UBrain</sub> = 89.7). We also found that the observed percentage of unbound drug fraction in plasma protein for compound 1 (%<i>f</i><sub>Uplasma</sub> = 8.40) is higher than that of brain tissue (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A,B). These results support that compound 1 may have better brain tissue distribution as compared to Saz-A.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/medium/jm-2013-008455_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Unbound fraction of each compound in the rat brain tissue and plasma protein using an equilibrium dialysis method. (A) Representative percentage of free fraction of rat plasma and brain tissue against each compound tested at 5 μM for 4 h. (B) Representative data summary of free fractions of the brain tissue and plasma protein against each compound.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008455&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11148" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11148" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tobacco use and nicotine addiction imposes a huge health and economic burden. Cytisine, a plant alkaloid, has been used for aiding smoking cession in Eastern and Central European countries since 1964.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> To date, there are only three classes of medications that have been approved by the U.S. Food and Drug Administration for smoking cessation: nicotine replacement therapy, bupropion, and varenicline. Among the three, varenicline, which is a rational designed compound related to cytisine, is considered superior in terms of relative efficacy over a period of 3 months, at which time ∼44% of the subjects were abstinent. However, the percentage of subjects who remained smoke-free for 12 months following treatment with varenicline fell to ∼22%.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> Moreover, although varenicline appears to be safe for most people, exacerbation of schizophrenia and manic episodes associated with treatment with varenicline has been reported.<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53, 54)</a> In addition, based on a very recent report,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> the FDA issued a “notification” warning that varenicline may be associated with increased adverse cardiovascular events, including angina and heart attack. More commonly, nearly 30% of participants taking varenicline in clinical trials reported nausea and 18% reported vomiting.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a></div><div class="NLM_p">Although varenicline was developed as a partial agonist at α4β2 nAChRs,<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> it is also nearly a full agonist at α3β4 nAChRs, which predominate in autonomic ganglia and brainstem autonomic centers, as well as at α7 nAChRs, another important subtype in brain.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> However, it is not known if varenicline reaches concentrations necessary to act at these receptors. More recently, varenicline was found to be a potent agonist of the human 5-hydroxytryptamine<sub>3</sub> receptors (5-HT<sub>3</sub>).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The side effects of varenicline are most likely mediated through its actions at receptors other than α4β2* nAChRs, including α3β4* and/or α7 nAChRS and/or 5-HT<sub>3</sub> receptors.</div><div class="NLM_p">Given the grave health and economic consequences of smoking, there is an obvious great need for significant improvement in the existing smoking cessation therapies. On the basis of a study of Saz-A, which desensitizes α4β2 nAChRs potently and with high selectivity, we previously proposed a strategy to develop novel nicotinic therapeutic drugs, including smoking cessation drugs, based on their ability to selectively desensitize α4β2 nAChRs.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">The high potency of Saz-A to desensitize α4β2 nAChRs in cells in vitro suggested that it would produce important effects similar to some of those produced by nicotine but with much more receptor selectivity. It would therefore potentially be a drug candidate to help people overcome addiction to nicotine, as well as to treat other CNS disorders. Since 2007, Saz-A studies in rodents have found that it reduces nicotine self-administration<a onclick="showRef(event, 'ref28 ref58'); return false;" href="javascript:void(0);" class="ref ref28 ref58">(28, 58)</a> and alcohol intake<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and produces antinociceptive effects<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59, 60)</a> and preclinical effects consistent with anxiolytic<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and possible antidepressant activity.<a onclick="showRef(event, 'ref31 ref33 ref61'); return false;" href="javascript:void(0);" class="ref ref31 ref33 ref61">(31, 33, 61)</a> Interestingly, it also increased attention and reduced errors in rats even after pretreatment with scopolamine and dizocilpine, drugs that normally disrupt attention.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">Recent studies found that the Saz-A reached only low concentrations in brain, even after chronic administration.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> Compound <b>1</b> emerged from an effort to improve brain penetration of drugs that could selectively target α4β2 nAChRs. Thus, while the synthesis and structure of compound <b>1</b> are based on the Saz-A scaffold, its physiochemical properties, especially its PSA and clogP, favor improved entry into the brain. The binding model of α4β2 nAChR with compound <b>1</b> suggests similar occupancy of the binding pocket as that of nicotine and varenicline. Moreover, the phenylethynyl group at the C-5 position of the pyridine in compound <b>1</b> occupies a potentially critical space in the pocket to form favorable hydrophobic interactions with the receptor (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A).</div><div class="NLM_p">In binding studies, compound <b>1</b> and analogues (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) are highly selective for α4β2 nAChRs over α3β4 and α7 subtypes (Table <a class="ref showTableEvent internalNav" data-ID="tbl1A" href="#tbl1A">1</a>). In studies of receptor function as assessed in <sup>86</sup>Rb<sup>+</sup> efflux assays, compound <b>1</b> has less than 30% of the efficacy of nicotine in activating human α4β2 nAChRs (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">3</a>). Importantly, the potency of compound <b>1</b> to desensitize α4β2 nAChRs is similar to that of Saz-A and much more potent than varenicline or nicotine (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">3</a>).</div><div class="NLM_p">Consistent with an excellent pharmacological property profile, improved physicochemical properties and brain tissue distribution (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), compound <b>1</b> significantly reduced nicotine self-administration in the rat model (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). This suggests that compound <b>1</b> has the potential to be developed into a smoking cessation drug.</div><div class="NLM_p">There were differences between the effects of compound <b>1</b> and Saz-A on locomotor activity. Compound <b>1</b> caused a modest but significant increase in locomotor exploration in the figure-eight apparatus at all three doses tested (1–3 mg/kg). In contrast, in the same test, Saz-A did not show any apparent effect on locomotor activity at 1 and 3 mg/kg (Saz-A produced a slight decrease in activity at the beginning of the test session). Compound <b>1</b> may have less risk of sedative side effects than Saz-A.</div><div class="NLM_p">To elucidate SAR for compound <b>1</b>, in addition to compounds in series 1 (compounds <b>1</b>–<b>11</b>), we also synthesized four compounds in series 2, including <b>12</b>, <b>13</b>, <b>14</b>, and <b>15</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>A–D). The very low binding affinities of compounds <b>12</b> and <b>13</b> may be an indication that the azetidine ring is important for good binding property profiles. The binding affinity of (<i>S</i>)-<i>N</i>-methyl compound <b>15</b> is 25 times lower than that of corresponding (<i>S</i>)-N–H compound <b>1</b>. It is conceivable that the N–H provides a potentially important H-bond interaction. It is interesting that the two enantiomers, compound <b>14</b> and compound <b>1</b>, showed a similar binding profile although compound <b>14</b> has a slightly lower affinity for α4β2 receptors than compound <b>1</b>. In series 3, we replaced the alkyne group and made a direct link to pyridine as shown in compound <b>16</b> (scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). The binding data suggested that a spacer is necessary to retain activity similar to that of compound <b>1</b>.</div><div class="NLM_p">It is important to note that all binding data in this study are from rat nAChRs, as well as functional data for α3β4 receptor subtype. Rat nAChRs were instrumental in the discovery of clinically used nicotinic drugs. In the consideration of possible species difference, we are currently studying these novel compounds using human nAChR subtypes. We will report the comparative results once the study is completed.</div><div class="NLM_p">In screening studies, compound <b>1</b> did not show high binding affinity for more than 40 other CNS receptors (<a class="ref internalNav" href="#notes-1" aria-label="Tables S1 and S2, Supporting Information">Tables S1 and S2, Supporting Information</a>), including 5-HT<sub>3</sub> receptors, which could mediate some of varenicline’s adverse side effects, including nausea.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><div class="NLM_p last">In summary, genetic and pharmacological studies suggest that α4β2 nAChRs are crucial to nicotine self-administration in rodents and likely very important in nicotine addiction. Developing novel drug candidates that selectively target the α4β2 nAChR subtype may provide an important therapeutic advance for treating nicotinic addiction/dependence. Compound <b>1</b> represents the lead of a class of novel compounds that maintain the excellent pharmacological profile of Saz-A but with improved physicochemical properties.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63141" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63141" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemistry</h3><div class="NLM_p last">All reagents and solvents used in this study were commercially available and used as obtained. Purification of compounds was performed by chromatography using a Biotage SP-1 system with silica gel cartridges. NMR spectra were recorded on a Varian 400 MR spectrometer at 400 MHz for <sup>1</sup>H and 100 MHz for <sup>13</sup>C. Chemical shifts (δ) are expressed in ppm downfield from tetramethylsilane, and coupling constants (<b>J</b>-values) are reported in hertz (Hz). Molecular mass spectra measured using a Waters Q-TOF premier mass spectrometer. The purity of final compounds was evaluated by C, H, N analysis (Atlantic microlabs) and HPLC methods for compounds <b>9</b> and <b>15</b> (<a class="ref internalNav" href="#notes-1" aria-label="Figure S2, Supporting Information">Figure S2, Supporting Information</a>). The purities of all the final compounds were confirmed to be ≥95% by combustion and HPLC analytical methods. The HPLC method of purity (<b>9</b> and <b>15</b>) was confirmed using two different mobile phases as described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information (Figure S2)">Supporting Information (Figure S2)</a>. Detailed synthetic and characterization data of intermediate compound 3-fluoro-5-iodo-<i>N</i>,<i>N</i>-dimethylaniline (VMY-2-119) was presented in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information  experimental procedures">Supporting Information  experimental procedures</a>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure for the Mitsunobu Reaction (<b>18</b>)</h3><div class="NLM_p last">To a mixture of 5-bromo-3-pyridinol (1.2 equiv) and Ph<sub>3</sub>P (1.6 equiv) in anhydrous THF taken in a flame-dried flask under N<sub>2</sub>, <i>N</i>-Boc protected alcohol (1 equiv) was added and the mixture was cooled to −10 °C. Diethyl azodicarboxylate (40% w/v) in toluene (1.6 equiv) was added dropwise to the mixture and was warmed gradually to the room temperature. After 48 h, the reaction mixture was quenched with 1 mL of water and the solvent was removed under reduced pressure. The resulting yellow oil was purified by column chromatography on silica gel to yield 55–60% as the white solid.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure for Sonogashira Coupling Reaction</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Sequential Desilylation and Sonogashira Coupling of the TMS Protection (<b>22</b>–<b>25</b>)</h4><div class="NLM_p last">Route 1 in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>: An oven-dried and nitrogen-filled round-bottom flask was charged with (<i>S</i>)-<i>tert</i>-butyl-2-((5-((trimethylsilyl)ethynyl)pyridin-3-yloxy)methyl)azetidine-1 carboxylate (<b>20</b>, 1 equiv), KOH (2 equiv) methanol in water (20:1). The whole reaction mixture was stirred 25 °C for 3 h. It was then added to a second flask, which contained a performed mixture of Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (0.02 equiv, 2 mol %), CuI (0.02 equiv, 2 mol %), PPh<sub>3</sub> (0.04 equiv, 4 mol %), i-Pr<sub>2</sub>NH (1 mL), toluene (3–5 mL), and substituted fluoro-iodobenzene that had been prestirred at 25 °C for 30 min. The complete mixture was then stirred at 25 °C for 16 h. The reaction mixture was quenched with a saturated NH<sub>4</sub>Cl solution and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with 2N HCl, water, and saturated NaCl solution. The organic phase was separated and dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to give crude product. The crude product was purified by column chromatography.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> One-Pot Synthesis (<b>22</b>, <b>26</b>–<b>32</b>)</h4><div class="NLM_p last">Route 2 in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>: The Mitsunobu adduct (<b>18</b>, 1 equiv), Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (0.04 equiv, 4 mol %), CuI (0.08 equiv, 8 mol %), and PPh<sub>3</sub> (0.08 equiv, 8 mol %) were placed in a oven-dried round-bottom flask with nitrogen. After addition of i-Pr<sub>2</sub>NH (1 mL) and toluene (3–5 mL), the mixture was stirred at room temperature for 5 min and (trimethylsilyl) acetylene (<b>19</b>, 2.7 equiv) was added and stirred at rt for 10 min. The whole reaction mixture was stirred at 80 °C for 18 h, a solution of KOH in methanol and water (4:1) was added in one portion, and the mixture was stirred for additional 3 h at 25 °C. A second substituted aryl iodide was added and stirred continually for 16 h at 25 °C (80 °C in case of substituted aryl bromide). The reaction mixture was quenched with saturated NH<sub>4</sub>Cl solution and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with 2 N HCl, water, and saturated NaCl solution. The organic phase was separated and dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to give the crude product. The crude product was purified by column chromatography.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedure for the Deprotection of the N-Boc Precursors</h3><div class="NLM_p">Route 1, method e, and route 2, method i: To a stirred solution of <i>N</i>-Boc protected compound in dichloromethane was added trifluoro acetic acid (5–10 equiv) dropwise at 0 °C under a nitrogen atmosphere. The reaction mixture was stirred at room temperature for 4–6 h (TLC showed complete deprotection of Boc after 5 h). The solvent and excess of TFA was removed under reduced pressure. The resulting residue was further apply the nitrogen to remove the traces of TFA and was taken in 2–3 mL methanol followed by dropwise addition 2 M NaOH solution in methanol and water (9:1) at 0 °C until the pH 9–10. The reaction mixture stirred for 18 h, upon which dichloromethane (10–20 mL) was added and rotary evaporated. The resulting residue was purified by column chromatography.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>S</i>)-3-(Azetidin-2-ylmethoxy)-5-(phenylethynyl)pyridine (<b>1</b>)</h4><div class="NLM_p last">Route 2 (method i) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 70% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.37 (s, 1H), 8.31–8.25 (m, 1H), 7.60–7.49 (m, 2H), 7.41–7.29 (m, 4H), 4.33–4.20 (m, 1H), 4.10–3.96 (m, 2H), 3.69 (q, <i>J</i> = 7.9, 1H), 3.45 (td, <i>J</i> = 4.8, 8.1, 1H), 2.45–2.19 (m, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 154.4, 144.5, 137.7, 131.6, 128.7, 128.4, 122.9, 122.4, 120.4, 92.3, 85.8, 72.7, 56.9, 44.2, 23.9. HRMS (ESI): exact mass calcd for C<sub>17</sub>H<sub>16</sub>N<sub>2</sub>O [M + H]<sup>+</sup>, 265.1341; found, 265.1339. [α]<sub>D</sub><sup>23.4</sup> = −6.0 (<i>c</i> = 1.1, CHCl<sub>3</sub>). Anal. Calcd for C<sub>17</sub>H<sub>16</sub>N<sub>2</sub>O: C,77.25; H, 6.10; N, 10.60. Found: C, 77.22; H, 6.13; N, 10.51.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>S</i>)-3-(Azetidin-2-ylmethoxy)-5-((4-fluorophenyl)ethynyl)pyridine (<b>2</b>)</h4><div class="NLM_p last">Route 1 (method e) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 77% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.27 (s, 1H), 8.19 (d, <i>J</i> = 2.8, 1H), 7.47–7.39 (m, 2H), 7.23 (dd, <i>J</i> = 1.5, 2.7, 1H),7.00–6.93 (m, 2H), 4.20 (s, 1H), 4.04–3.90 (m, 2H), 3.62 (d, <i>J</i> = 7.2, 1H), 3.37 (s, 1H), 2.37–2.14 (m, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 162.7 (d, <i>J</i><sub>F–C</sub> = 249 Hz, C), 154.4, 144.5, 137.8,133.6 (d, <i>J</i><sub>F–C</sub> = 8.5), 122.8, 120.3, 118.6 (d, <i>J</i><sub>F–C</sub> = 3.5), 115.7 (d, <i>J</i><sub>F–C</sub> = 23 Hz), 91.2, 85.6, 72.8, 57.0, 44.2, 23.9. HRMS (ESI): exact mass calcd for C<sub>17</sub>H<sub>15</sub>FN<sub>2</sub>O [M + H]<sup>+</sup>, 283.1247; found, 283.1241. [α]<sub>D</sub><sup>24.4</sup> = −6.1 (<i>c</i> = 0.54, CHCl<sub>3</sub>) . Anal. Calcd for C<sub>17</sub>H<sub>15</sub>FN<sub>2</sub>O·0.1H<sub>2</sub>O: C, 71.63; H, 5.41; N, 9.82. Found: C, 71.21; H, 5.41; N, 9.76</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>(S</i>)-3-(Azetidin-2-ylmethoxy)-5-((2-fluorophenyl)ethynyl)pyridine (<b>3</b>)</h4><div class="NLM_p last">Route 1 (method e) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 81% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.31 (d, <i>J</i> = 1.0, 1H), 8.21 (dd, <i>J</i> = 2.7, 0.9, 1H), 7.49–7.41 (m, 1H), 7.31–7.23 (m, 2H), 7.11–7.00 (m, 2H), 4.29–4.14 (m, 1H), 4.05–3.91 (m, 2H), 3.63 (q, <i>J</i> = 7.9, 1H), 3.39 (td, <i>J</i> = 7.8, 5.0, 1H), 2.41–2.11 (m, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 162.5 (d, <i>J</i><sub>F–C</sub> = 251 Hz), 154.4, 144.5, 138.1, 133.3 (d, <i>J</i><sub>F–C</sub> = 1.0), 130.5 (d, <i>J</i><sub>F–C</sub> = 8.0), 124.0 (d, <i>J</i><sub>F–C</sub> = 3.7), 122.8, 120.0, 115.5 (d, <i>J</i><sub>F–C</sub> =21 Hz), 111.0(d, <i>J</i><sub>F–C</sub> =16 Hz), 90.7 (d, <i>J</i><sub>F–C</sub> = 3.3), 85.6, 72.7, 56.9, 44.1, 23.8. HRMS (ESI): exact mass calcd for C<sub>17</sub>H<sub>15</sub>FN<sub>2</sub>O [M + H]<sup>+</sup>, 283.1247; found. 283.1243. [α]<sub>D</sub><sup>24.7</sup> = −11.5 (<i>c</i> = 0.87, CHCl<sub>3</sub>). Anal. Calcd for C<sub>17</sub>H<sub>15</sub>FN<sub>2</sub>O: C, 72.32; H, 5.36; N, 9.92. Found: C, 71.82; H, 5.38; N, 9.77.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>S</i>)-3-(Azetidin-2-ylmethoxy)-5-((3-fluorophenyl)ethynyl)pyridine (<b>4</b>)</h4><div class="NLM_p last">Route 1 (method e) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 78% (liquid). <sup>1</sup>H NMR (399 MHz, CDCl<sub>3</sub>): δ 8.30 (d, <i>J</i> = 1.6, 1H), 8.22 (d, <i>J</i> = 2.8, 1H), 7.30–7.23 (m, 3H), 7.20–7.13 (m, 1H), 7.07–6.95 (m, 1H), 4.29–4.15 (m, 1H), 3.98 (qd, <i>J</i> = 9.5, 5.5, 2H), 3.65 (q, <i>J</i> = 7.9, 1H), 3.46–3.35 (m, 1H), 2.42–2.13 (m, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 162.3 (d, <i>J</i><sub>F–C</sub> = 246 Hz). 154.4, 144.6, 138.0, 130.0 (d, <i>J</i><sub>F–C</sub> =9 Hz), 127.5 (d, <i>J</i><sub>F–C</sub> = 3.1 Hz), 124.2 (d, <i>J</i><sub>F–C</sub> = 9 Hz), 123.0, 120.0, 118.4 (d, <i>J</i><sub>F–C</sub> =23 Hz), 116.1(d, <i>J</i><sub>F–C</sub> =21 Hz), 116.0, 90.9 (d, <i>J</i><sub>F–C</sub> = 3.4), 72.8, 57.0, 44.2, 23.9. HRMS (ESI): exact mass calcd for C<sub>17</sub>H<sub>15</sub>FN<sub>2</sub>O [M + H]<sup>+</sup>, 283.1247; found, 283.1236. [α]<sub>D</sub><sup>24.8</sup>= −8.4 (<i>c</i> = 0.8, CHCl<sub>3</sub>). Anal. Calcd for C<sub>17</sub>H<sub>15</sub>FN<sub>2</sub>O: C, 72.32; H, 5.36; N, 9.92. Found: C, 72.03; H, 5.46; N, 9.78</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>S</i>)-3-(Azetidin-2-ylmethoxy)-5-((3,5-difluorophenyl)ethynyl)pyridine (<b>5</b>)</h4><div class="NLM_p last">Route 2 (method i) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 79% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.29 (d, <i>J</i> = 1.6,1H), 8.24 (d, <i>J</i> = 2.8, 1H), 7.25 (dd, <i>J</i> = 1.7, 2.8, 1H), 7.03–6.94 (m, 2H), 6.77 (tt, <i>J</i> = 2.3, 8.9, 1H), 4.23 (s, 1H), 3.99 (qd, <i>J</i> = 5.5, 9.5, 2H), 3.66 (d, <i>J</i> = 7.6, 1H), 3.39 (s, 1H), 2.48–1.79 (m, 3H).<sup>13</sup>CNMR (100 MHz, CDCl<sub>3</sub>): δ 163.9 (d, <i>J</i><sub>F–C</sub> = 13 Hz), 161.4 (d, <i>J</i><sub>F–C</sub> =13 Hz), 154.4, 144.6, 138.4, 125.1(t), 123.0, 119.5, 114.7 (d, <i>J</i><sub>F–C</sub> = 8 Hz), 114.5 (d, <i>J</i><sub>F–C</sub> = 7.7), 104.9 (t), 89.8 (t, <i>J</i><sub>F–C</sub> = 3.9), 87.7, 72.9, 56.9, 44.2, 23.9. HRMS (ESI): exact mass calcd for C<sub>17</sub>H<sub>14</sub>F<sub>2</sub>N<sub>2</sub>O [M + H]<sup>+</sup>, 301.1152; found, 301.1155. [α]<sub>D</sub><sup>24.5</sup>= −8.0 (<i>c</i> = 0.8, CHCl<sub>3</sub>). Anal. Calcd for C<sub>17</sub>H<sub>14</sub>F<sub>2</sub>N<sub>2</sub>O·0.06H<sub>2</sub>O: C, 67.74; H, 4.72; N, 9.28. Found: C, 67.35; H, 4.68; N, 9.10.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>S</i>)-3-(Azetidin-2-ylmethoxy)-5-((3-(trifluoromethyl)phenyl)ethynyl)pyridine (<b>6</b>)</h4><div class="NLM_p last">Route 2 (method i) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 78% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.31 (d, <i>J</i> = 1.6, 1H), 8.24 (d, <i>J</i> = 2.8, 1H), 7.74 (s, 1H), 7.64 (d, <i>J</i> = 7.7, 1H), 7.55 (d, <i>J</i> = 7.9, 1H), 7.43 (t, <i>J</i> = 7.8, 1H), 7.27 (dd, <i>J</i> = 1.7, 2.8, 1H), 4.23 (td, <i>J</i> = 7.5, 12.3, 1H), 3.99 (qd, <i>J</i> = 5.5, 9.5, 2H), 3.66 (dd, <i>J</i> = 8.1, 15.9, 1H), 3.40 (dt, <i>J</i> = 4.9, 7.6, 1H), 2.52–1.90 (m, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 154.4, 144.6, 138.2, 134.6 (d, <i>J</i> = 1.1), 131.0 (q), 128.9, 128.4 (d, <i>J</i> = 3 Hz), 125.2 (d, <i>J</i> = 3.7), 123.4, 123.0, 119.8, 90.6, 87.3, 72.8, 57.0, 44.2, 23.9. HRMS (ESI): exact mass calcd for C<sub>18</sub>H<sub>15</sub>F<sub>3</sub>N<sub>2</sub>O [M + H]<sup>+</sup>, 333.1215; found, 333.1216. [α]<sub>D</sub><sup>24.7</sup> = −7.8 (<i>c</i> = 4.2, CHCl<sub>3</sub>). Anal. Calcd for C<sub>18</sub>H<sub>15</sub>F<sub>3</sub>N<sub>2</sub>O: C, 65.06; H, 4.55; N, 8.43. Found: C, 64.74; H, 4.45; N, 8.30.</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>S</i>)-3-(Azetidin-2-ylmethoxy)-5-(<i>m</i>-tolylethynyl)pyridine (<b>7</b>)</h4><div class="NLM_p last">Route 2 (method i) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 68% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.26 (t, <i>J</i> = 2.9, 1H), 8.17 (d, <i>J</i> = 2.8, 1H), 7.30–7.21 (m, 3H), 7.15 (t, <i>J</i> = 7.6, 1H), 7.10–7.05 (m, 1H), 4.24–4.12 (m, 1H), 3.94 (qd, <i>J</i> = 9.5, 5.5, 2H), 3.60 (q, <i>J</i> = 8.1, 1H), 3.36 (td, <i>J</i> = 8.2, 4.4, 1H), 2.44 (s, 1H), 2.35–2.09 (m, 5H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 154.4, 144.5, 138.0, 137.6, 132.2, 129.6, 128.7, 128.29, 122.9, 122.2, 120.5, 92.6, 85.5, 72.7, 57.0, 44.2, 23.8, 21.2. HRMS (ESI): exact mass calcd for C<sub>18</sub>H<sub>18</sub>N<sub>2</sub>O [M + H]<sup>+</sup>, 279.1497; found, 279.1512. [α]<sub>D</sub><sup>25.5</sup> = −8.4 (<i>c</i> = 1.9, CHCl<sub>3</sub>). Anal. Calcd for C<sub>18</sub>H<sub>18</sub>N<sub>2</sub>O·0.06CH<sub>2</sub>Cl<sub>2</sub>: C, 76.19; H, 6.60; N, 9.87. Found: C, 75.84; H, 6.34, N, 9.75.</div></div><div id="sec4_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>S</i>)-3-(Azetidin-2-ylmethoxy)-5-((3-chlorophenyl)ethynyl)pyridine (<b>8</b>)</h4><div class="NLM_p last">Route 2 (method i) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 72% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.27 (d, <i>J</i> = 1.6, 1H), 8.20 (d, <i>J</i> = 2.8, 1H), 7.44 (t, <i>J</i> = 1.7, 1H), 7.33 (dt, <i>J</i> = 7.4, 1.4, 1H), 7.27–7.17 (m, 3H), 4.26–4.14 (m, 1H), 4.04–3.89 (m, 2H), 3.62 (q, <i>J</i> = 8.1, 1H), 3.43–3.32 (m, 1H), 2.38–2.11 (m, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 154.4, 144.5, 138.0, 134.2, 131.4, 129.7, 129.6, 128.9, 124.1, 122.9, 119.9, 90.7, 86.9, 72.8, 56.9, 44.2, 23.8. HRMS (ESI): exact mass calcd for C<sub>17</sub>H<sub>15</sub>ClN<sub>2</sub>O [M + H]<sup>+</sup>, 299.0951; found, 299.0965. [α]<sub>D</sub><sup>25.6</sup> = −8.1 (<i>c</i> = 1.6, CHCl<sub>3</sub>). Anal. Calcd for C<sub>17</sub>H<sub>15</sub>ClN<sub>2</sub>O·0.06H<sub>2</sub>O: C, 67.84; H, 5.04; N, 9.30. Found: C, 67.70, H, 5.03; N, 9.11.</div></div><div id="sec4_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>S</i>)-3-((5-(Azetidin-2-ylmethoxy)pyridin-3-yl)ethynyl)-5-fluoro-<i>N</i>,<i>N</i>-dimethylaniline (<b>9</b>)</h4><div class="NLM_p last">Route 2 (method i) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 72% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.29 (d, <i>J</i> = 1.6, 1H), 8.21 (t, <i>J</i> = 4.5, 1H), 7.26 (dd, <i>J</i> = 2.8, 1.7, 1H), 6.58–6.46 (m, 2H), 6.32 (dt, <i>J</i> = 12.5, 2.3, 1H), 4.21 (d, <i>J</i> = 15.8, 1H), 3.99 (qd, <i>J</i> = 9.5, 5.5, 2H),3.65 (q, <i>J</i> = 7.9, 1H), 3.41 (dd, <i>J</i> = 12.0, 8.3, 1H), 2.93–2.85 (s, 6H), 2.40–2.13 (m, 2H), 2.00 (d, <i>J</i> = 19.3, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 163.5 (d, <i>J</i><sub>F–C</sub> = 241 Hz), 154.4, 151.6 (d, <i>J</i><sub>F–C</sub> = 11 Hz), 144.6, 137.8, 123.8 (d, <i>J</i><sub>F–C</sub> =12 Hz), 123.0, 120.3, 111.1 (d, <i>J</i><sub>F–C</sub> = 2.0, 1H), 105.9 (d, <i>J</i><sub>F–C</sub> =24 Hz), 100.1 (d, <i>J</i><sub>F–C</sub> = 26 Hz), 92.3 (d, <i>J</i><sub>F–C</sub> = 4 Hz), 85.2, 72.7,57.0, 44.2, 40.3, 23.9. HRMS (ESI): exact mass calcd for C<sub>19</sub>H<sub>20</sub>FN<sub>3</sub>O [M + H]<sup>+</sup>, 326.1669; found, 326.1668. [α]<sub>D</sub><sup>25.5</sup> = −18.5 (<i>c</i> = 0.18, CHCl<sub>3</sub>).</div></div><div id="sec4_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>S</i>)-3-(Azetidin-2-ylmethoxy)-5-((3-fluoro-5-methylphenyl)ethynyl)pyridine (<b>10</b>)</h4><div class="NLM_p last">Route 2 (method i) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 73% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.33 (d, <i>J</i> = 1.6, 1H), 8.29–8.24 (m, 1H), 7.29 (dd, <i>J</i> = 2.8, 1.7, 1H), 7.12 (dt, <i>J</i> = 2.1, 0.7, 1H), 7.05–6.98 (m, 1H), 6.87 (dddd, <i>J</i> = 9.6, 2.3, 1.4, 0.7, 1H), 4.28 (tt, <i>J</i> = 12.3, 6.2, 1H), 4.03 (qd, <i>J</i> = 9.5, 5.5, 2H), 3.70 (dd, J = 15.9, 8.2, 1H), 3.45 (ddd, <i>J</i> = 7.6, 7.1, 4.4, 1H), 2.43–2.34 (m, 2H), 2.33 (t, <i>J</i> = 1.5, 3H), 2.25 (ddd, <i>J</i> = 16.4, 11.1, 8.2, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 162.3 (d, <i>J</i><sub>F–C</sub> = 246.3), 154.4, 144.6, 140.5 (d, <i>J</i><sub>F–C</sub> = 8.6), 138.0, 128.2 (d, <i>J</i><sub>F–C</sub> = 2.7), 123.7 (d, <i>J</i><sub>F–C</sub> = 10.3), 122.9, 120.1, 116.8 (d, <i>J</i><sub>F–C</sub> = 21.1), 115.4 (d, <i>J</i><sub>F–C</sub> = 23.1), 91.2 (d, <i>J</i><sub>F–C</sub> = 3.7), 86.2, 72.7, 57.0, 44.2, 23.8, 21.1. HRMS (ESI): exact mass calcd for C<sub>18</sub>H<sub>17</sub>FN<sub>2</sub>O [M + H]<sup>+</sup>, 297.1403; found, 297.1403. [α]<sub>D</sub><sup>25.0</sup> = −7.2 (<i>c</i> = 1.8, CHCl<sub>3</sub>). Anal. Calcd for C<sub>18</sub>H<sub>17</sub>FN<sub>2</sub>O·0.04H<sub>2</sub>O: C, 72.59; H, 5.76; N, 9.40. Found: C, 70.86; H, 5.72; N, 9.01.</div></div><div id="sec4_4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>S</i>)-3-(Azetidin-2-ylmethoxy)-5-((3-fluoro-5-methoxyphenyl)ethynyl)pyridine (<b>11</b>)</h4><div class="NLM_p last">Route 2 (method i) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 66% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.29 (d, <i>J</i> = 1.6, 1H), 8.22 (d, <i>J</i> = 2.8, 1H), 7.25 (dd, <i>J</i> = 2.8, 1.7, 1H), 6.83–6.72 (m, 2H), 6.57 (dt, <i>J</i> = 10.6, 2.3, 1H), 4.22 (s, 1H), 4.06–3.92 (m, 2H), 3.75 (s, 3H), 3.64 (s, 1H), 3.39 (s, 1H), 2.54–1.91 (m, 3H).<sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 163.1 (d, <i>J</i><sub>F–C</sub> = 245.6), 160.7 (d, <i>J</i><sub>F–C</sub> = 12.1), 154.4, 144.6, 138.1, 124.3 (d, <i>J</i><sub>F–C</sub> = 12.1), 123.0, 119.9, 112.8 (d, <i>J</i><sub>F–C</sub> = 2.9), 110.9 (d, <i>J</i><sub>F–C</sub> = 23.6), 103.2 (d, <i>J</i><sub>F–C</sub> = 25.0), 91.1 (d, <i>J</i><sub>F–C</sub> = 4.2), 86.4, 72.8, 57.0, 55.6, 44.2, 23.9. HRMS (ESI): exact mass calcd for C<sub>18</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 313.1352; found, 313.1358. [α]<sub>D</sub><sup>25.2</sup> = −8.3 (<i>c</i> = 0.4, CHCl<sub>3</sub>). Anal. Calcd for C<sub>18</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>2</sub>·0.04H<sub>2</sub>O: C, 68.89; H, 5.47; N, 8.92. Found: C, 67.51; H, 5.51; N, 8.60.</div></div><div id="sec4_4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 3-(Cyclobutylmethoxy)-5-(phenylethynyl)pyridine (<b>12</b>)</h4><div class="NLM_p last">Methods of b, c, d in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>A was used and generated a yield of 65% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.36 (d, <i>J</i> = 1.5, 1H), 8.26 (d, <i>J</i> = 2.8, 1H), 7.60–7.50 (m, 2H), 7.40–7.33 (m, 3H), 7.34–7.28 (m, 1H), 3.98 (d, <i>J</i> = 6.6, 2H), 2.88–2.73 (m, 1H), 2.23–2.10 (m, 2H), 2.07–1.82 (m, 4H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 154.7, 144.3, 137.8, 131.6, 128.7, 128.4, 122.8, 122.5, 120.4, 92.2, 85.9, 72.4, 34.4, 24.7, 18.5. HRMS (ESI): exact mass calcd for C<sub>18</sub>H<sub>17</sub>NO [M + H]<sup>+</sup>, 264.1388, found 264.1396. Anal. Calcd for C<sub>18</sub>H<sub>17</sub>NO: C, 82.10; H, 6.51; N, 5.32. Found: C, 81.94; H, 6.44; N, 5.31.</div></div><div id="sec4_4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-(2-(5-(Phenylethynyl)pyridin-3-yloxy)ethyl)propan-1-amine (<b>13</b>)</h4><div class="NLM_p last">Method e in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>B was used and generated a yield of 87% (solid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.29 (d, <i>J</i> = 1.5, 1H), 8.19 (d, <i>J</i> = 2.8, 1H), 7.50–7.41 (m, 2H), 7.33–7.26 (m, 3H), 7.26–7.22 (m, 1H),4.05 (t, <i>J</i> = 5.2, 2H), 2.96 (t, <i>J</i> = 5.2, 2H), 2.58 (t, <i>J</i> = 7.2, 2H), 1.47 (td, <i>J</i> = 14.6, 7.3, 3H), 0.87 (t, <i>J</i> = 7.4, 3H).<sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 154.3, 144.6, 137.7, 131.6, 128.7, 128.4, 122.8, 122.4, 120.5, 92.3, 85.8, 68.0, 51.7, 48.5, 23.1, 11.7. HRMS (ESI): exact mass calcd for C<sub>18</sub>H<sub>20</sub>N<sub>2</sub>O [M + H]<sup>+</sup>, 281.1654; found, 281.1645. Anal. Calcd for C<sub>18</sub>H<sub>20</sub>N<sub>2</sub>O: C, 77.11; H, 7.19; N, 9.99. Found: C, 76.81; H, 7.12; N, 9.84.</div></div><div id="sec4_4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>R</i>)-3-(Azetidin-2-ylmethoxy)-5-(phenylethynyl)pyridine (<b>14</b>)</h4><div class="NLM_p last">Method e in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>C was used and generated a yield of 75% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.28 (s, 1H), 8.19 (d, <i>J</i> = 2.8, 1H), 7.51–7.42 (m, 2H), 7.27 (ddd, <i>J</i> = 10.0, 6.0, 0.8, 4H), 4.26–4.14 (m, 1H), 3.96 (qd, <i>J</i> = 9.5, 5.7, 2H), 3.62 (q, <i>J</i> = 8.0, 1H), 3.38 (td, <i>J</i> = 8.1, 4.4, 1H), 2.38–2.12 (m, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 154.4, 144.6, 137.7, 131.6, 128.7, 128.4, 122.9, 122.4, 120.5, 92.3, 85.8, 72.7, 57.0, 44.2, 23.9. HRMS (ESI): exact mass calcd for C<sub>17</sub>H<sub>16</sub>N<sub>2</sub>O [M + H]<sup>+</sup>, 265.1341; found, 265.1349. [α]<sub>D</sub><sup>24.1</sup> = +13.6 (<i>c</i> = 0.7, CHCl<sub>3</sub>). Anal. Calcd for C<sub>17</sub>H<sub>16</sub>N<sub>2</sub>O·0.6H<sub>2</sub>O: C, 74.21; H, 6.30; N, 10.18. Found: C, 74.50; H, 6.20; N, 10.07.</div></div><div id="sec4_4_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>S</i>)-3-((1-Methylazetidin-2-yl)methoxy)-5-(phenylethynyl)pyridine (<b>15</b>)</h4><div class="NLM_p last">Method f in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>D was used and generated a yield of 48% (liquid). (<i>S</i>)-3-(Azetidin-2-ylmethoxy)-5-(phenylethynyl) pyridine (compound <b>1</b>, 0.12 mmol) was taken in a 2 mL of ethanol. Formalin (37%, 0.3 mL) was added, and the acidity was adjusted to pH 5 with the addition of acetic acid and sodium acetate. The reaction mixture was stirred for 15 min. Sodium cyanoborohydride (0.38 mmol) was added. The whole reaction mixture was allowed to stir for 18 h at room temperature. The solvent was evaporated, and the crude product was purified by column chromatography to yield pure <b>15</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.30 (d, <i>J</i> = 1.4, 1H), 8.20 (d, <i>J</i> = 2.8, 1H), 7.52–7.43 (m, 2H), 7.32–7.28 (m, 3H), 7.25 (dd, <i>J</i> = 2.7, 1.7, 1H), 4.06–3.95 (m, 2H), 3.51–3.35 (m, 2H), 2.86 (dd, <i>J</i> = 15.9, 8.6, 1H), 2.37 (s, 3H), 2.05 (td, <i>J</i> = 8.7, 6.0, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 154.3, 144.6, 137.7, 131.6, 128.7, 128.4, 123.0, 122.4, 120.5, 92.3, 85.8, 71.5, 66.0, 53.4, 44.8, 20.3. HRMS (ESI): exact mass calcd for C<sub>18</sub>H<sub>18</sub>N<sub>2</sub>O [M + H]<sup>+</sup>, 279.149; found, 279.1513. [α]<sub>D</sub><sup>24.5</sup> = −32.2 (<i>c</i> = 0.3, CHCl<sub>3</sub>).</div></div><div id="sec4_4_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>S</i>)-3-(Azetidin-2-ylmethoxy)-5-phenylpyridine (<b>16</b>)</h4><div class="NLM_p last">Methods of a and b in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> was used and generated a yield of 71% (liquid). To a solution of (<i>S</i>)-<i>tert</i>-butyl 2-((5-bromopyridin-3-yloxy)methyl)azetidine-1-carboxylate (<b>18</b>, 0.58 mmol) in 9 mL of toluene and 3 mL of ethanol was added phenyl boronic acid (<b>41</b>, 0.69 mmol) followed by 2 mL of 2 M Na<sub>2</sub>CO<sub>3</sub> and tetrakis(triphenylphosphine)palladium (0) (0.03 mmol). The reaction was stirred for 12 h at 90 °C under nitrogen. The reaction was cooled to room temperature, diluted with water, and extracted three times with ethyl acetate. The combined organic layers dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo to afford a crude product, which was subsequently purified by column chromatography. The resulting pure compound was subjected to Boc deprotection followed by purification of column chromatography to yield a final pure compound <b>16</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.37 (d, <i>J</i> = 1.7, 1H), 8.22 (d, <i>J</i> = 2.7, 1H), 7.49 (dd, <i>J</i> = 5.1, 3.8, 2H), 7.38 (t, <i>J</i> = 7.6, 2H), 7.31 (ddd, <i>J</i> = 7.7, 4.1, 0.5, 2H), 4.31–4.14 (m, 1H), 4.02 (qd, <i>J</i> = 9.5, 5.6, 2H), 3.63 (q, <i>J</i> = 8.0, 1H), 3.39 (td, <i>J</i> = 8.2, 4.4, 1H), 2.39–2.13 (m, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 155.1, 140.7, 137.6, 137.2, 136.5, 128.9, 128.1, 127.1, 119.7, 72.8, 57.1, 44.2, 24.0. HRMS (ESI): exact mass calcd for C<sub>15</sub>H<sub>16</sub>N<sub>2</sub>O [M + H]<sup>+</sup>, 241.1341; found, 241.1348. [α]<sub>D</sub><sup>25.5</sup> = −4.69(<i>c</i> = 1.4, CHCl<sub>3</sub>). Anal. Calcd for C<sub>15</sub>H<sub>16</sub>N<sub>2</sub>O·0.6H<sub>2</sub>O: C, 71.74; H, 6.90; N, 11.15. Found: C, 71.73; H, 6.76; N, 10.88.</div></div><div id="sec4_4_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (<i>S</i>)-<i>tert</i>-Butyl-2-((5-bromopyridin-3-yloxy)methyl)azetidine-1-carboxylate (<b>18</b>)</h4><div class="NLM_p last">Mitsunobu reaction conditions were applied and generated a yield of 55% (white solid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.25–8.19 (m, 2H), 7.36 (s, 1H), 4.44 (d, <i>J</i> = 5.3, 1H), 4.32–4.20 (m, 1H), 4.06 (dd, <i>J</i> = 2.8, 10.1, 1H), 3.81 (t, <i>J</i> = 7.5, 2H), 2.36–2.14 (m, 2H), 1.36 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 156.1,155.4,143.1, 136.7, 124.0, 120.3, 79.8, 69.0, 59.9, 47.1, 28.3, 18.95. HRMS (ESI): exact mass calcd for C<sub>14</sub>H<sub>19</sub>BrN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 343.0657; found, 343.0670.</div></div><div id="sec4_4_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (<i>S</i>)-<i>tert</i>-Butyl-2-((5-((trimethylsilyl)ethynyl)pyridin-3-yloxy)methyl)azetidine-1-carboxylate (<b>20</b>)</h4><div class="NLM_p last">Sonogashira coupling method (route 1 (method b) in Scheme<a class="ref internalNav" href="#sch1" aria-label="1">1</a>) was applied and generated a yield of 62% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.04 (s, 2H), 7.08 (d, 1H), 4.26 (s, 1H), 4.09 (s, 1H), 3.89 (s,1H), 3.63 (s, 2H), 2.07 (d, 2H), 1.18 (s, 9H), 0.16 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 156.2, 154.5, 145.2, 138.4, 123.4, 120.5, 101.5, 98.1, 79.7, 68.9, 60.2, 47.3, 28.6, 19.2, 0.3.</div></div><div id="sec4_4_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (<i>S</i>)-<i>tert</i>-Butyl-2-((5-ethynylpyridin-3-yloxy)methyl)azetidine-1-carboxylate (<b>21</b>)</h4><div class="NLM_p last">Route 1 (method c) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was applied. <sup>1</sup>HNMR (400 MHz, CDCl<sub>3</sub>): δ 8.36 (s, 2H), 7.35 (s, 1H), 4.65–4.46 (m, 1H), 4.35 (s, 1H), 4.16 (dd, <i>J</i> = 2.9, 10.1, 1H), 3.91 (t, <i>J</i> = 7.6, 2H), 3.22 (s, 1H), 2.50–2.19 (m, 2H), 1.45 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 156.1, 155.5, 145.2, 138.5, 123.7, 80.4, 80.1, 79.8, 68.8, 60.0, 47.1, 28.4, 19.0.</div></div><div id="sec4_4_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (<i>S</i>)-<i>tert</i>-Butyl-2-((5-(phenylethynyl)pyridin-3-yloxy)methyl)azetidine-1-carboxylate (<b>22</b>)</h4><div class="NLM_p last">Both routes 1 and 2 in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> were used and generated a yield of 54% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.39 (s, 1H), 8.31 (s, 1H), 7.59–7.51 (m, 2H), 7.37 (ddd, <i>J</i> = 1.5, 3.4, 5.9, 4H), 4.62–4.44 (m, 1H), 4.36 (s, 1H), 4.16 (dd, <i>J</i> = 2.9, 10.1, 1H), 3.90 (t, <i>J</i> = 7.6, 2H), 2.51–2.19 (m, 2H), 1.44 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 156.1, 154.5, 144.8, 137.9, 131.6, 128.8, 128.4, 122.9, 122.4, 120.6, 92.4, 85.8, 79.7, 68.8, 60.0, 47.0, 28.4, 19.0. HRMS (ESI): exact mass calcd for C<sub>22</sub>H<sub>24</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 365.1870; found, 365.1870.</div></div><div id="sec4_4_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (<i>S</i>)-<i>tert</i>-Butyl-2-((5-((4-fluorophenyl)ethynyl)pyridin-3-yloxy)methyl)azetidine-1-carboxylate (<b>23</b>)</h4><div class="NLM_p last">Route 1 (method d) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 63% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.37 (d, <i>J</i> = 1.0, 1H), 8.31 (d, <i>J</i> = 2.8, 1H), 7.57–7.50 (m, 2H), 7.40–7.35 (m, 1H),7.12–7.03 (m, 2H), 4.58–4.50 (m, 1H), 4.36 (s, 1H), 4.16 (dd, <i>J</i> = 2.9, 10.1, 1H), 3.90 (t, <i>J</i> = 7.6, 2H), 2.53–2.18 (m, 2H), 1.44 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 162.7(d, <i>J</i><sub>F–C</sub> = 250 Hz), 156.0, 154.5, 144.6, 137.9, 133.6 (d, <i>J</i><sub>F–C</sub> = 8.4 Hz,), 122.9, 120.4, 118.5 (d, <i>J</i><sub>F–C</sub> = 3.6), 115.7(d, <i>J</i><sub>F–C</sub> = 22), 91.3, 85.5 (d, <i>J</i><sub>F–C</sub> = 1.3) 79.7, 68.7, 60.0, 47.1, 28.3, 19.0. HRMS (ESI): exact mass calcd for C<sub>22</sub>H<sub>23</sub>FN<sub>2</sub>O3 [M + H]<sup>+</sup>, 383.1771; found, 383.1767.</div></div><div id="sec4_4_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (<i>S</i>)-<i>tert</i>-Butyl-2-((5-((2-fluorophenyl)ethynyl)pyridin-3-yloxy)methyl)azetidine-1-carboxylate (<b>24</b>)</h4><div class="NLM_p last">Route 1 (method d) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 77% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.32 (d, <i>J</i> = 4.1, 1H), 8.24 (dd, <i>J</i> = 2.8, 5.7, 1H), 7.45 (d, <i>J</i> = 5.4, 1H), 7.29 (d, <i>J</i> = 16.2, 2H), 7.06 (dd, <i>J</i> = 9.0, 10.1, 2H), 4.45 (s, 1H), 4.28 (s, 1H), 4.08 (dd, <i>J</i> = 3.4, 6.6, 1H), 3.88–3.72 (m, 2H), 2.25 (m, 2H), 1.35 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 162.61 (d, <i>J</i><sub>F–C</sub> =251 Hz), 156.0, 154.4, 144.7, 138.2, 133.4 (d, <i>J</i><sub>F–C</sub> = 0.9), 130.5 (d, <i>J</i><sub>F–C</sub> = 8.0), 124.0 (d, <i>J</i><sub>F–C</sub> = 3.8), 122.9,120.1, 115.5 (d, <i>J</i><sub>F–C</sub> =21 Hz), 111.1(d, <i>J</i><sub>F–C</sub> =15 Hz), 90.7 (d, <i>J</i><sub>F–C</sub> = 3.2 Hz), 85.7, 79.7, 68.7, 60.0, 28.3, 47.1, 19.0. HRMS (ESI): exact mass calcd for C<sub>22</sub>H<sub>23</sub>FN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 383.1771; found. 383.1784.</div></div><div id="sec4_4_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (<i>S</i>)-<i>tert</i>-Butyl-2-((5-((3-fluorophenyl)ethynyl)pyridin-3-yloxy)methyl)azetidine-1-carboxylate (<b>25</b>)</h4><div class="NLM_p last">Route 1 (method d) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 48% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.30 (s, 1H), 8.24 (d, <i>J</i> = 2.6, 1H), 7.26 (ddd, <i>J</i> = 12.6, 8.1, 1.1, 3H), 7.20–7.12 (m, 1H), 7.05–6.94 (m, 1H), 4.45 (s, 1H), 4.29 (s, 1H), 4.08 (dd, <i>J</i> = 10.1, 2.8, 1H), 3.82 (t, <i>J</i> = 7.5, 2H), 2.41–2.12 (m, 2H), 1.37 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 162.3 (d, <i>J</i><sub>F–C</sub> = 246 Hz), 156.1, 154.5, 144.7, 138.2, 130.0 (d, <i>J</i><sub>F–C</sub> = 8.6, 7H), 127.5 (d, <i>J</i><sub>F–C</sub> = 3.1), 124.3 (d, <i>J</i><sub>F–C</sub> = 9 Hz), 123.0, 120.1, 118.4 (d, <i>J</i><sub>F–C</sub> = 23 Hz), 116.1 (d, J<sub>F–C</sub> =21 Hz), 91.0 (d, <i>J</i><sub>F–C</sub> = 3.4), 86.6, 79.7, 68.8, 60.0, 47.1, 28.4, 19.0. HRMS (ESI): exact mass calcd for C<sub>22</sub>H<sub>23</sub>FN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 383.1771; found, 383.1778.</div></div><div id="sec4_4_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (<i>S</i>)-<i>tert</i>-Butyl-2-((5-((3,5-difluorophenyl)ethynyl)pyridin-3 yloxy)methyl)azetidine-1-carboxylate (<b>26</b>)</h4><div class="NLM_p last">Route 2 (methods of f, g, h) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 60% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.30 (s, 1H), 8.26 (d, <i>J</i> = 2.8, 1H), 7.30 (s, 1H), 7.02–6.93 (m, 2H), 6.76 (tt, <i>J</i> = 8.9, 2.2, 1H), 4.54–4.40 (m, 1H), 4.29 (s, 1H), 4.15–4.03 (m, 1H), 3.82 (t, <i>J</i> = 7.6, 2H), 2.40–2.12 (m, 2H), 1.36 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 163.9 (d, <i>J</i><sub>F–C</sub> = 13 Hz), 161.4 (d, <i>J</i><sub>F–C</sub> = 13 Hz), 156.1, 154.4, 144.7, 138.5, 125.1(t), 123.0, 119.5, 114.6 (d, <i>J</i><sub>F–C</sub> = 7.7), 114.4 (d, <i>J</i><sub>F–C</sub> = 7.6), 104.9 (t), 89.8, 87.6, 79.7, 68.8, 60.0, 47.1, 28.3, 18.9. HRMS (ESI): exact mass calcd for C<sub>22</sub>H<sub>22</sub>F<sub>2</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 401.1677; found, 401.1692.</div></div><div id="sec4_4_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (<i>S</i>)-<i>tert</i>-Butyl-2-((5-((3-(trifluoromethyl)phenyl)ethynyl)pyridin-3yloxy)methyl)azetidine-1-carboxylate (<b>27</b>)</h4><div class="NLM_p last">Route 2 (methods of f, g, h) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 50% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.39 (d, <i>J</i> = 1.4, 1H), 8.33 (d, <i>J</i> = 2.8, 1H), 7.80 (s, 1H), 7.70 (d, <i>J</i> = 7.8, 1H), 7.61 (d, <i>J</i> = 7.9, 1H), 7.50 (t, <i>J</i> = 7.8, 1H), 7.40 (d, <i>J</i> = 1.8, 1H), 4.53 (dd, <i>J</i> = 5.4, 8.1, 1H), 4.37 (s, 1H), 4.22–4.10 (m, 1H), 3.90 (t, <i>J</i> = 7.6, 2H), 2.49–2.17 (m, 2H), 1.55–1.32 (m, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 156.0, 154.4, 144.6, 138.4, 134.6, 130.9, 128.9, 128.3, 125.1, 123.4, 122.9, 119.7, 90.6, 87.2, 79.6, 68.7, 60.0,47.1, 28.3, 18.9. HRMS (ESI): exact mass calcd for C<sub>23</sub>H<sub>23</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 433.1739; found, 433.1749.</div></div><div id="sec4_4_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (<i>S</i>)-<i>tert</i>-Butyl-2-((5-(<i>m</i>-tolylethynyl)pyridin-3-yloxy)methyl)azetidine-1-carboxylate (<b>28</b>)</h4><div class="NLM_p last">Route 2 (methods of f, g, h) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 56% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.38 (d, <i>J</i> = 1.6, 1H), 8.30 (d, <i>J</i> = 2.8, 1H), 7.40–7.33 (m, 3H), 7.29–7.24 (m, 1H), 7.19 (d, <i>J</i> = 7.6, 1H), 4.59–4.48 (m, 1H), 4.36 (s, 1H), 4.22–4.12 (m, 1H), 3.90 (t, <i>J</i> = 7.6, 2H), 2.43–2.33 (s, 3H), 1.44 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 156.0, 154.4, 144.7, 138.0, 137.8, 132.2, 129.6, 128.7, 128.3, 122.9, 122.2, 120.6, 92.6, 85.4, 79.7, 68.7, 60.0, 47.0, 28.4, 21.1, 19.0. HRMS (ESI): exact mass calcd for C<sub>23</sub>H<sub>26</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 379.2022; found, 379.2031.</div></div><div id="sec4_4_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (<i>S</i>)-<i>tert</i>-Butyl-2-((5-((3-chlorophenyl)ethynyl)pyridin-3yloxy)methyl)azetidine-1-carboxylate(<b>29</b>)</h4><div class="NLM_p last">Route 2 (methods of f, g, h) in Scheme<a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 65% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.29 (d, <i>J</i> = 1.5, 1H), 8.24 (d, <i>J</i> = 2.8, 1H), 7.44 (dd, <i>J</i> = 2.5, 0.9, 1H), 7.33 (dt, <i>J</i> = 7.4, 1.5, 1H), 7.28 (ddd, <i>J</i> = 3.4, 2.4, 1.5, 1H), 7.25 (dd, <i>J</i> = 2.0, 1.4, 1H),7.24–7.18 (m, 1H), 4.56–4.38 (m, 1H), 4.28 (s, 1H), 4.08 (dd, <i>J</i> = 10.1, 2.9, 1H), 3.81 (t, <i>J</i> = 7.6, 2H), 2.37–2.12 (m, 2H), 1.35 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 156.0, 154.4, 144.7, 138.2, 134.2, 131.4, 129.7, 129.6, 128.9, 124.1,122.9, 120.0, 90.8, 86.9, 79.7, 68.7, 60.0, 47.0, 28.3, 19.02. HRMS (ESI): exact mass calcd for C<sub>22</sub>H<sub>23</sub>ClN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 399.1475; found, 399.1456.</div></div><div id="sec4_4_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (<i>S</i>)-<i>tert</i>-Butyl-2-((5-((3-(dimethylamino)-5-fluorophenyl)ethynyl)pyridin-3-yloxy)methyl)azetidine-1-carboxylate (<b>30</b>)</h4><div class="NLM_p last">Route 2 (methods of f, g, h) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 14% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.35 (s, 1H), 8.27 (s, 1H), 7.35 (s, 1H), 6.60 (s, 1H), 6.54 (d, <i>J</i> = 8.7, 1H), 6.37 (dt, <i>J</i> = 12.4, 2.2, 1H), 4.49 (s, 1H), 4.33 (s, 1H), 4.19–4.08 (m, 1H), 3.87 (t, <i>J</i> = 7.6, 2H), 2.94 (d, <i>J</i> = 9.7, 6H), 2.43–2.20 (m, 2H), 1.40 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 163.5 (d, <i>J</i><sub>F–C</sub> = 241 Hz), 156.1, 154.4, 151.6 (d, <i>J</i><sub>F–C</sub> = 12 Hz), 144.8, 138.0, 123.8 (d, <i>J</i><sub>F–C</sub> = 12 Hz), 123.0, 111.13 (d, <i>J</i><sub>F–C</sub> = 2.0), 106.45 (d, <i>J</i><sub>F–C</sub> = 76 Hz), 100.1 (d, <i>J</i><sub>F–C</sub> = 26 Hz), 92.42 (d, <i>J</i><sub>F–C</sub> = 4.2), 85.1, 79.7, 68.8 (d, <i>J</i><sub>F–C</sub> = 3 Hz), 60.0, 47.0, 40.2, 28.4, 19.0.</div></div><div id="sec4_4_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (<i>S</i>)-<i>tert</i>-Butyl-2-((5-((3-fluoro-5-methylphenyl)ethynyl)pyridin-3-yloxy)methyl)azetidine-1-carboxylate (<b>31</b>)</h4><div class="NLM_p last">Route 2 (methods of f, g, h) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 65% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.28 (d, <i>J</i> = 1.5, 1H), 8.22 (d, <i>J</i> = 2.8, 1H), 7.28 (dd, <i>J</i> = 2.6, 1.7, 1H), 7.06 (d, <i>J</i> = 0.5, 1H), 6.94 (dd, <i>J</i> = 9.1, 0.5, 1H), 6.80 (d, <i>J</i> = 9.5, 1H), 4.51–4.39 (m, 1H), 4.27 (s, 1H), 4.12–4.00 (m, 1H), 3.81 (t, <i>J</i> = 7.6, 2H), 2.35–2.09 (m, 5H), 1.35 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 162.3 (d, <i>J</i><sub>F–C</sub> = 245 Hz), 156.1, 151.4, 144.7, 140.5 (d, <i>J</i><sub>F–C</sub> = 8 Hz), 138.1, 128.2 (d, <i>J</i><sub>F–C</sub> = 2.8, 3H), 123.7 (d, <i>J</i><sub>F–C</sub> = 11 Hz), 123.0, 120.1, 116.8 (d, <i>J</i><sub>F–C</sub> = Hz), 115.4 (d, <i>J</i><sub>F–C</sub> = 23 Hz), 91.3 (d, <i>J</i><sub>F–C</sub> 3.7), 86.1, 79.7, 68.8, 60.0, 47.2, 28.3, 21.1, 19.0. HRMS (ESI): exact mass calcd for C<sub>23</sub>H<sub>25</sub>FN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 397.1927; found, 397.1929.</div></div><div id="sec4_4_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (<i>S</i>)-<i>tert</i>-Butyl-2-((5-((3-fluoro-5-methoxyphenyl)ethynyl)pyridin-3-yloxy)methyl)azetidine-1-carboxylate (<b>32</b>)</h4><div class="NLM_p last">Route 2 (methods f, g, h) in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was used and generated a yield of 37% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.27 (s, 1H), 8.21 (d, <i>J</i> = 2.7, 1H), 7.31–7.24 (m, 1H), 6.74 (ddd, <i>J</i> = 1.2, 2.1, 9.9, 2H), 6.54 (dt, <i>J</i> = 2.3, 10.6, 1H), 4.47–4.38 (m, 1H), 4.25 (s, 1H), 4.09–4.02 (m, 1H), 3.79 (t, <i>J</i> = 7.6, 2H), 3.72 (s, 3H), 2.32–2.13 (m, 2H), 1.32 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 163.1 (d, <i>J</i><sub>F–C</sub> = 245.8), 160.7 (d, <i>J</i><sub>F–C</sub> = 12.1), 156.1, 154.5, 144.8, 138.2, 124.34 (d, <i>J</i><sub>F–C</sub> = 12.1), 123.0, 120.0, 112.8 (d, <i>J</i><sub>F–C</sub> = 2.9), 110.9 (d, <i>J</i><sub>F–C</sub> = 23.5), 103.2 (d, <i>J</i><sub>F–C</sub> = 25.0), 91.2, 86.3, 79.7, 68.8, 60.0, 55.6, 47.3, 28.4, 19.05. HRMS (ESI): exact mass calcd for C<sub>23</sub>H<sub>25</sub>FN<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 413.1877; found, 413.1887.</div></div><div id="sec4_4_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 3-Bromo-5-(cyclobutylmethoxy)pyridine (<b>34</b>)</h4><div class="NLM_p last">Method a in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>A was used and generated a yield of 69% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.18 (dd, <i>J</i> = 11.0, 2.1, 2H), 7.28 (dd, <i>J</i> = 2.5, 1.9, 1H), 3.88 (dd, <i>J</i> = 6.4, 3.4, 2H), 2.78–2.64 (m, 1H), 2.14–2.02 (m, 2H), 1.99–1.74 (m, 4H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 155.4, 142.3, 136.3, 123.4, 120.1, 72.3, 34.1, 24.5, 18.40. HRMS (ESI): exact mass calcd for C<sub>10</sub>H<sub>12</sub>BrNO [M + H]<sup>+</sup>, 242.0181; found, 242.0181.</div></div><div id="sec4_4_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>tert</i>-Butyl-2-(5-bromopyridin-3-yloxy)ethyl(propyl)carbamate (<b>36</b>)</h4><div class="NLM_p last">Method a in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>B was used and generated a yield of 62% (liquid). <sup>1</sup>H NMR 400 MHz, CDCl<sub>3</sub>): δ 8.21 (s, 1H), 8.15 (d, <i>J</i> = 2.5, 1H), 7.29 (s, 1H), 4.06 (s, 2H), 3.51 (s, 2H), 3.16 (s, 2H), 1.56–1.43 (m, 2H), 1.39 (s, 9H), 0.82 (t, <i>J</i> = 7.4, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 155.0, 142.7, 136.3, 123.4, 120.1, 79.3, 67.0, 50.4, 46.6, 28.2, 21.8, 11.0. HRMS (ESI): exact mass calcd for C<sub>15</sub>H<sub>23</sub>BrN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 359.0970; found, 359.0978.</div></div><div id="sec4_4_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>tert</i>-Butyl-2-(5-(phenylethynyl)pyridin-3-yloxy)ethyl(propyl)carbamate (<b>37</b>)</h4><div class="NLM_p last">Methods of b, c, d in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>B was used and generated a yield of 53% (solid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.37 (s, 1H), 8.25 (d, <i>J</i> = 2.8, 1H), 7.59–7.49 (m, 2H), 7.37–7.28 (m, 4H), 4.14 (s, 2H), 3.59 (s, 2H), 3.25 (s, 2H), 1.64–1.51 (m, 2H), 1.47 (s, 9H), 0.89 (t, <i>J</i> = 7.4, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 155.6, 154.2, 144.5, 137.6, 131.6, 128.7, 128.3, 122.6, 122.4, 120.5, 92.4, 85.8, 79.5, 66.9, 50.5, 46.8, 28.3, 21.9, 11.1. HRMS (ESI): exact mass calcd for C<sub>23</sub>H<sub>28</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 381.2187; found, 381.2169</div></div><div id="sec4_4_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (<i>R</i>)-<i>tert</i>-Butyl-2-((5-bromopyridin-3-yloxy)methyl)azetidine-1-carboxylate (<b>39</b>)</h4><div class="NLM_p last">Method a in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>C was used and generated a yield of 30% (solid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.20 (d, <i>J</i> = 2.4, 2H), 7.35 (t, <i>J</i> = 1.9, 1H), 4.48–4.40 (m, 1H), 4.26 (s, 1H), 4.05 (dd, <i>J</i> = 10.1, 2.7, 1H), 3.86–3.76 (m, 2H), 2.70–2.01 (m, 2H), 1.35 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 156.0, 155.4, 143.1, 136.6, 124.0, 120.3, 79.7, 69.0, 59.9, 47.0, 28.3, 18.9. HRMS (ESI): exact mass calcd for C<sub>14</sub>H<sub>19</sub>BrN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 343.0657; found, 343.0680.</div></div><div id="sec4_4_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (<i>R</i>)-<i>tert</i>-Butyl-2-((5-(phenylethynyl)pyridin-3-yloxy)methyl)azetidine-1-carboxylate (<b>40</b>)</h4><div class="NLM_p last">Methods of b, c, d in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>C were used and generated a yield of 74% (liquid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.31 (s, 1H), 8.23 (s, 1H), 7.52–7.41 (m, 2H), 7.36–7.24 (m, 4H), 4.45 (d, <i>J</i> = 5.4, 1H), 4.28 (s, 1H), 4.08 (dd, <i>J</i> = 10.2, 2.6, 1H), 3.82 (t, <i>J</i> = 7.6, 2H), 2.28 (ddd, <i>J</i> = 25.0, 14.3, 7.1, 2H), 1.36 (d, <i>J</i> = 0.5, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 156.1, 154.5, 144.7, 137.8, 131.6, 128.7, 128.4, 123.0, 122.4, 120.6, 92.4, 85.7, 79.7, 68.8, 47.0, 60.0, 28.4, 19.0. HRMS (ESI): exact mass calcd for C<sub>22</sub>H<sub>24</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 365.1865; found, 343.1893.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Computational Studies</h3><div class="NLM_p">To study (<i>S</i>)-(−)-nicotine and (<i>R</i>)-(−)-deschloroepibatidine binding with the α4β2 nAChR in atomic detail, a structural model of the LBD of human α4β2 nAChR was built by using the Homology Model software MODELLERX9.10.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> The reference template is the X-ray crystal structure of the AChBP (PDB entry of <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UW6">1UW6</a>) and the rat α4β2 X-ray structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OLE">1OLE</a>). Multiple sequence alignment was generated by Psi-BLAST<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> and ClusterW.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Upon construction of the model, appropriate ionization states were maintained, the side chains were relaxed to remove possible side chain atom contacts with the neighboring residues, different rotamer states of the residue were assigned, and then local side chain atom dynamics followed by minimization were performed. Minimization and molecular dynamics simulations were carried out using the SANDER module of AMBER 10.0<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> with default parameters. The homology modeled structure was validated with PROCHECK<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> and WHATIF program.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><div class="NLM_p last">Molecular docking was carried out using SurFlexDock Module of Sybyl-X (Tripos Inc. St. Louis, USA). However, to be consistent with the nicotine structural conformation (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UW6">1UW6</a>), a manual intervention followed by constrained molecular dynamics simulations were carried out. This procedure was applied to compound <b>1</b>, varinicline, and sazetidine A. The α4β2 nAChR compound complexes were refined by molecular dynamics simulation using the Amber 10.0<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> with the PARM98 force-field parameter. The charge and force field parameters of the compounds were obtained using the most recent Antechamber module in the Amber 10.0 (4), where compounds were minimized at the MP2/6-31G* level using Gaussian 09.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The SHAKE algorithm<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> was used to keep all bonds involving hydrogen atoms rigid. Weak coupling temperature and pressure coupling algorithms<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> were used to maintain constant temperature and pressure, respectively. Electrostatic interactions were calculated with the Ewald particle mesh method<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> with a dielectric constant at 1<i>R</i><sub>ij</sub> and a nonbonded cutoff of 12 Å for the real part of electrostatic interactions and for van der Waals interactions. The total charge of the system was neutralized by addition of a chloride ion. The system was solvated in a 12 Å cubic box of water where the TIP3P model was used. 5000 steps of minimization of the system were performed in which the α4β2 nAChR was constrained by a force constant of 75 kcal/mol/Å. After minimization, a 20 ps simulation was used to gradually raise the temperature of the system to 298 K while the complex was constrained by a force constant of 20 kcal/mol/Å. Another 20 ps equilibration run was used where only the backbone atoms of the complex were constrained by a force constant of 5 kcal/mol/Å. Final production run of 200 ps was performed with no constraints. When applying constraints, the initial complex structure was used as a reference structure. The PME method was used and the time step was 5 fs, and a neighboring pairs list was updated every 25 steps.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> General Procedure for in Vitro Studies</h3><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Cell Lines and Cell Culture</h4><div class="NLM_p last">The cell line expressing rat α3β4 nAChRs, KXα3β4R2, was established previously by stably transfecting HEK 293 cells with combinations of rat nAChR α3 and β4 subunit genes.<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72, 73)</a> The cell line expressing human α4β2 nAChRs, YXα4β2H1, were established recently (Tuan et al., 2012, manuscript in preparation). These cell lines were maintained in minimum essential medium (MEM) supplemented with 10% fetal bovine serum, 100 units/mL penicillin G, 100 mg/mL streptomycin, and selective antibiotics at 37 °C with 5% CO<sub>2</sub> in a humidified incubator. Tissue culture medium and antibiotics were obtained from Invitrogen Corporation (Carlsbad, CA), unless otherwise stated. Fetal bovine serum and horse serum were provided by Gemini Bio-Products (Woodland, CA).</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> [<sup>3</sup>H]Epibatidine Radioligand Binding Assay</h4><div class="NLM_p last">Stably transfected cell lines, tissue culture conditions, membrane preparation procedures, and binding assays were described previously.<a onclick="showRef(event, 'ref72 ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref72 ref73 ref74">(72-74)</a> Briefly, cultured cells at >80% confluence were removed from their flasks (80 cm<sup>2</sup>) with a disposable cell scraper and placed in 10 mL of 50 mM Tris·HCl buffer (pH 7.4, 4 °C). The cell suspension was centrifuged at 10000<i>g</i> for 5 min, and the pellet was collected. The cell pellet was then homogenized in 10 mL of buffer with a polytron homogenizer and centrifuged at 36000<i>g</i> for 10 min at 4 °C. The membrane pellet was resuspended in fresh buffer, and aliquots of the membrane preparation were used for binding assays. The concentration of [<sup>3</sup>H]epibatidine used was ∼500 pM for competition binding assays. Nonspecific binding was assessed in parallel incubations in the presence of 300 μM nicotine. Bound and free ligands were separated by vacuum filtration through Whatman GF/C filters treated with 0.5% polyethylenimine. The filter-retained radioactivity was measured by liquid scintillation counting. Specific binding was defined as the difference between total binding and nonspecific binding. Data from competition binding assays were analyzed using Prism 5 (GraphPad Software, San Diego, CA).</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Binding Assays for Targets Other than nAChRS</h4><div class="NLM_p last">All binding assays for targets other than nAChRs were performed by the National Institute of Mental Health’s Psychoactive Drug Screening Program (PDSP) supported by NIMH grant HHSN-271-2008-00025-C (PI: Bryan Roth). For experimental details (<i>K</i><sub>i</sub> determinations, receptor binding profiles, functional data, MDR1 data, etc., as appropriate), refer to the PDSP Web site <a href="http://pdsp.med.unc.edu/" class="extLink">http://pdsp.med.unc.edu/</a>.</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <sup>86</sup>Rb<sup>+</sup> Efflux Assay</h4><div class="NLM_p last">Functional properties of compounds at nAChRs expressed in the transfected cells were measured using <sup>86</sup>Rb<sup>+</sup> efflux assays as described previously.<a onclick="showRef(event, 'ref23 ref71'); return false;" href="javascript:void(0);" class="ref ref23 ref71">(23, 71)</a> In brief, cells were plated into 24-well plates coated with poly-<span class="smallcaps smallerCapital">d</span>-lysine. The plated cells were grown at 37 °C for 18 to 24 h to reach 85–95% confluence. The cells were then incubated in growth medium (0.5 mL/well) containing <sup>86</sup>Rb<sup>+</sup> (2 μCi/mL) for 4 h at 37 °C. The loading mixture was then aspirated, and the cells were washed four times with 1 mL of buffer (15 mM HEPES, 140 mM NaCl, 2 mM KCl, 1 mM MgSO<sub>4</sub>, 1.8 mM CaCl<sub>2</sub>, 11 mM glucose, pH 7.4). Then 1 mL of buffer with or without compounds to be tested was added to each well. After incubation for 2 min, the assay buffer was collected for measurements of <sup>86</sup>Rb<sup>+</sup> released from the cells. Cells were then lysed by adding 1 mL of 100 mM NaOH to each well, and the lysate was collected for determination of the amount of <sup>86</sup>Rb<sup>+</sup> that was in the cells at the end of the efflux assay. Radioactivity of assay samples and lysates was measured by liquid scintillation counting. Total loading (cpm) was calculated as the sum of the assay sample and the lysate of each well. The amount of <sup>86</sup>Rb<sup>+</sup> efflux was expressed as a percentage of <sup>86</sup>Rb<sup>+</sup> loaded. Stimulated <sup>86</sup>Rb<sup>+</sup> efflux was defined as the difference between efflux in the presence and absence of nicotine. For obtaining EC<sub>50</sub> and <i>E</i><sub>max</sub> values, stimulation curves were constructed in which eight different concentrations of a ligand were included in the assay. For obtaining an IC<sub>50(10′)</sub> value, inhibition curves were constructed in which eight different concentrations of a compound were applied to cells for 10 min before 100 μM nicotine was applied to measure stimulated efflux. EC<sub>50</sub>, <i>E</i><sub>max</sub>, and IC<sub>50(10′)</sub> values were determined by nonlinear least-squares regression analyses (GraphPad, San Diego, CA).</div></div><div id="sec4_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Electrophysiological Studies</h4><div class="NLM_p">Whole-cell voltage clamp (holding potential −70 mV) recordings were made from YXα4β2H1 cells. For increasing functionality of cells, cells were treated with 1 mM carbachol for 48 h before studies. The recordings were made with patch electrodes (5–6 MΩ) containing a solution composed of (in mM; pH 7.2): K gluconate (145), EGTA (5), MgCl<sub>2</sub> (2.5), HEPES (10), ATP·Na (5), and GTP·Na (0.2). Cells were continuously perfused with recording solution having the following composition (mM): NaCl (130), KCl (5), CaCl<sub>2</sub> (2), MgCl<sub>2</sub> (2), glucose (10), and HEPES (10), pH 7.4, at a temperature of 24 °C. They were visually identified by infrared-differential interference contrast (IR-DIC) optics via a CCD camera (Dage S-75). A 60× water immersion objective (Nikon) was used for identifying and approaching cells. Only one cell per coverslip was recorded.</div><div class="NLM_p">The patch pipet was coupled to an amplifier (Axopatch 700B; Axon Instruments Inc.) and its signal filtered (5kHz), digitized (Digidata 1440A; Axon Instruments Inc.), and stored on a PC computer running the pClamp 10 software (Axon Instruments Inc.) for later analysis. Series resistance was typically <10 MΩ and was continuously monitored with a 10 mV pulse.</div><div class="NLM_p last">Acetylcholine (32 μM) was delivered by rapid focal application (500 ms; pressure ∼15 psi), whereas compound <b>1</b> (200nM) was applied via bath application. The whole-cell current response to compound <b>1</b> was normalized in relation to two stable prior applications of the 32 μM ACh-induced responses (interstimulus interval 5 min).</div></div><div id="sec4_6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Brain Tissue and Plasma Protein Binding Studies</h4><div class="NLM_p last">Briefly, each test compound at a concentration of 5 μM is incubated in plasma or homogenized brain tissue in a RED equilibrium dialysis device and dialyzed against PBS using the published procedure.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> After 4 h, each side is analyzed for test agent by LC/MS/MS. From this, the free drug in brain, free in plasma, and brain/plasma partitioning is calculated using this equation <i>f</i><sub>Umeans</sub> = 1 – {(PC – PF)/PC} PC = test compound concentration in protein-containing compartment, PF = test compound concentration in protein-free compartment, <i>f</i><sub>UBrain</sub> = 1/<i>D</i> { (1/<i>f</i><sub>Umeans</sub>) – 1 + 1/<i>D</i>}.</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> General Procedures for Animal Behavioral Studies</h3><div class="NLM_p">Separate sets of young adult female Sprague–Dawley rats were used for the nicotine self-administration study (<i>N</i> = 15) and for the locomotor activity study (<i>N</i> = 12). The studies were conducted in accordance with the regulations outlined by the Duke University Animal Care and Use Committee. The rats housed in approved standard laboratory conditions in a Duke University vivarium facility near the testing room to minimize stress induced by transporting the rats. The rats were kept on a 12:12 reverse day/night cycle so that they were in their active phase during behavioral testing. The rats in the drug iv self-administration studies were singly housed to prevent them from damaging each other’s catheters. The rats in the locomotor activity studies were housed in groups of 2–3. All rats were allowed access to water at all times; the rats in the nicotine-self-administration study were fed daily approximately 30 min after completing the sessions while those in the locomotor activity study had continuous access to food.</div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Compound <b>1</b> Administration</h4><div class="NLM_p last">Compound <b>1</b> was injected sc 10 min before testing in a volume of 1 mL/kg of saline. The doses (0, 0.3, 1, and 3 mg/kg) we given in a counterbalanced order with at least two days between successive injections. For the nicotine self-administration study, the compound <b>1</b> the acute dose–effect study was tested twice while for the locomotor activity study the dose–effect function was tested once.</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Nicotine Self-Administration</h4><div class="NLM_p last">Before beginning nicotine self-administration, the rats were trained for three sessions on lever pressing for food reinforcement. Then they were fitted with iv catheters, and they received nicotine infusions (0.03 mg/kg/infusion) on an FR1 schedule for 10 sessions. The rats were trained to self-administer nicotine (0.03 mg/kg/infusion, IV) via operant lever response (FR1) with a visual secondary reinforcer. Two levers were available to be pressed, and only one caused the delivery of nicotine on an FR1 schedule. Pressing the lever on the active side resulted in the activation of the feedback tone for 0.5 s and the immediate delivery of one 50 μL infusion of nicotine in less than 1 s. Each infusion was immediately followed by a 1 min period in which the cue lights went out, the house light came on and responses were recorded but not reinforced.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec4_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Locomotor Activity</h4><div class="NLM_p last">Another set of rats (<i>N</i> = 12) was tested for acute compound <b>1</b> effects on locomotor activity in a figure-eight maze over the course of a 1 h session. The mazes had continuous enclosed alleys 10 cm × 10 cm in the shape of a figure eight.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> The dimensions of the apparatus were 70 cm long and 42 cm wide, with a 21 cm × 16 cm central arena, a 20 cm high ceiling, and two blind alleys extending 20 cm from either side. Eight infrared photobeams, which crossed the alleys, indexed locomotor activity. One photobeam was located on each of the two blind alleys, and three were located on each of two loops of the figure eight. Numbers of photobeam breaks were recorded for 5 min blocks over the 1 h session. The repeated measures were compound <b>1</b> dose and the repeated administration of each dose. Significant interactions were followed up by tests of the simple main effects. Alpha of <i>p</i> < 0.05 (two-tailed) was used as the threshold for significance.</div></div></div><div id="sec4_7_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Physicochemical Properties and Ligand Efficiency</h3><div class="NLM_p last">Molecular properties of compounds in series 1 were calculated according the available software tools. Ligand binding efficiency was calculated according to the Hopkins equation: LE = 1.372 × (−log <i>K</i><sub>i</sub> (moles))/<i>N</i>. Molecular weight and cLogP were calculated from Chembiodraw Ultra 11.0. Polar surface area (PSA) was calculated from <a href="http://www.chemicalize.org" class="extLink">www.chemicalize.org</a>. Log BB was calculated from the following equation: Log BB = −0.0148PSA + 0.152CLogP + 0.139.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74"><a href="/doi/suppl/10.1021/jm4008455">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50400" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50400" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Details of broad screening data, functional assay, and experimental details of intermediate compound synthesis.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm4008455/suppl_file/jm4008455_si_001.pdf">jm4008455_si_001.pdf (155.79 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm4008455" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31204" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31204" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Milton L. Brown</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Georgetown University
Medical Center, 3970 Reservoir Road NW,
Research Building, EP-07, Washington, D.C. 20057, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3970 Reservoir Road NW, Research Building, Washington, D.C. 20057, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a4c9c6919090e4c3c1cbd6c3c1d0cbd3ca8ac1c0d1"><span class="__cf_email__" data-cfemail="026f603736364265676d706567766d756c2c676677">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Venkata M. Yenugonda</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Georgetown University
Medical Center, 3970 Reservoir Road NW,
Research Building, EP-07, Washington, D.C. 20057, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3970 Reservoir Road NW, Research Building, Washington, D.C. 20057, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yingxian Xiao</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Physiology, Georgetown
University School of Medicine, Washington, D.C. 20057, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edward D. Levin</span> - <span class="hlFld-Affiliation affiliation">Department
of Psychiatry and Behavioral Sciences, Duke
University Medical Center, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amir H. Rezvani</span> - <span class="hlFld-Affiliation affiliation">Department
of Psychiatry and Behavioral Sciences, Duke
University Medical Center, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thao Tran</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Physiology, Georgetown
University School of Medicine, Washington, D.C. 20057, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nour Al-Muhtasib</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Physiology, Georgetown
University School of Medicine, Washington, D.C. 20057, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Niaz Sahibzada</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Physiology, Georgetown
University School of Medicine, Washington, D.C. 20057, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Teresa Xie</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Physiology, Georgetown
University School of Medicine, Washington, D.C. 20057, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Corinne Wells</span> - <span class="hlFld-Affiliation affiliation">Department
of Psychiatry and Behavioral Sciences, Duke
University Medical Center, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan Slade</span> - <span class="hlFld-Affiliation affiliation">Department
of Psychiatry and Behavioral Sciences, Duke
University Medical Center, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joshua E. Johnson</span> - <span class="hlFld-Affiliation affiliation">Department
of Psychiatry and Behavioral Sciences, Duke
University Medical Center, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sivanesan Dakshanamurthy</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Georgetown University
Medical Center, 3970 Reservoir Road NW,
Research Building, EP-07, Washington, D.C. 20057, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3970 Reservoir Road NW, Research Building, Washington, D.C. 20057, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hye-Sik Kong</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Georgetown University
Medical Center, 3970 Reservoir Road NW,
Research Building, EP-07, Washington, D.C. 20057, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3970 Reservoir Road NW, Research Building, Washington, D.C. 20057, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">York Tomita</span> - <span class="hlFld-Affiliation affiliation">Department
of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3970 Reservoir Road NW, Research Building, Washington, D.C. 20057, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong Liu</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Georgetown University
Medical Center, 3970 Reservoir Road NW,
Research Building, EP-07, Washington, D.C. 20057, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3970 Reservoir Road NW, Research Building, Washington, D.C. 20057, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mikell Paige</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Georgetown University
Medical Center, 3970 Reservoir Road NW,
Research Building, EP-07, Washington, D.C. 20057, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3970 Reservoir Road NW, Research Building, Washington, D.C. 20057, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth J. Kellar</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Physiology, Georgetown
University School of Medicine, Washington, D.C. 20057, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): A patent application has been filed by Georgetown University to claim commercial rights of inventions in this work. The following authors were listed on the patent application as inventors: V.M.Y., Y.X., E.D.L., A.H.R., M.P., K.J.K., and M.L.B.<br /></br></div></li></ul></div><div class="ack" id="ACK-d471e6155-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07700" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07700" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Institutes of Health grant DA02799 and by the Georgetown University Center for Drug Discovery. We thank the National Institute of Mental Health Psychoactive Drug Screening Program for performing binding assays at targets other than nAChRs.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i76" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i76"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i77" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i77"> Abbreviations Used</h2><tr><td class="NLM_term">nAChR(s)</td><td class="NLM_def"><p class="first last">nicotinic acetylcholine receptor(s)</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">5-HT</td><td class="NLM_def"><p class="first last">serotonin</p></td></tr><tr><td class="NLM_term">GABA</td><td class="NLM_def"><p class="first last">γ-aminobutyric acid</p></td></tr><tr><td class="NLM_term">AChBP</td><td class="NLM_def"><p class="first last">acetylcholine binding protein</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, metabolism, distribution, metabolism</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53751" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53751" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 76 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riganti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vailati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span> </span><span class="NLM_article-title">Brain neuronal nicotinic receptors as new targets for drug discovery</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.2174%2F138161206775474486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=16472136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVKhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=407-428&author=C.+Gottiauthor=L.+Rigantiauthor=S.+Vailatiauthor=F.+Clementi&title=Brain+neuronal+nicotinic+receptors+as+new+targets+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Brain neuronal nicotinic receptors as new targets for drug discovery</span></div><div class="casAuthors">Gotti, C.; Riganti, L.; Vailati, S.; Clementi, F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">407-428</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neuronal nicotinic receptors (nAChRs) are a heterogeneous family of ion channels differently expressed in the nervous system where, by responding to the endogenous neurotransmitter acetylcholine, they contribute to a wide range of brain activities and influence a no. of physiol. functions.  Over recent years, the application of newly developed mol. and cellular biol. techniques has made it possible to correlate the subunit compn. of nAChRs with specific nicotine-elicited behaviors, and refine some of the in vivo physiol. functions of nAChR subtypes.  The major new findings are the widespread expression of nAChRs, outside the nervous system, their specific and complex organization, and their relevance to normal brain function.  Moreover, the combination of clin. and basic research has better defined the involvement of nAChRs in a growing no. of nervous pathologies other than degenerative diseases.  However, there are still only a limited no. of nicotinic-specific drugs and, although some nicotinic agonists have an interesting pharmacol., their clin. use is limited by undesirable side effects.  Some selective nicotinic ligands have recently been developed and used to explore the complexity of nAChR subtype structure and function in the expectation that they will become rational therapeutic alternatives in a no. of neurodegenerative, neuropsychiatric and neurol. disorders.  In this review, we will discuss the mol. basis of brain nAChR structural and functional diversity mainly in pharmacol. and biochem. terms, and summarize current knowledge concerning the newly discovered drugs used to classify the numerous receptor subtypes and treat the brain diseases in which nAChRs are involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjEcBfsbynaLVg90H21EOLACvtfcHk0lheEkjqT93fFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVKhtbo%253D&md5=81c77bfe30bc478e01a442359e35d2d6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F138161206775474486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206775474486%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DRiganti%26aufirst%3DL.%26aulast%3DVailati%26aufirst%3DS.%26aulast%3DClementi%26aufirst%3DF.%26atitle%3DBrain%2520neuronal%2520nicotinic%2520receptors%2520as%2520new%2520targets%2520for%2520drug%2520discovery%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D407%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Romanelli, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratteri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guandalini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaccini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualtieri, F.</span><span> </span><span class="NLM_article-title">Central nicotinic receptors: structure, function, ligands, and therapeutic potential</span> <span class="citation_source-journal">ChemMedChem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">746</span><span class="NLM_x">–</span> <span class="NLM_lpage">767</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=746-767&author=M.+N.+Romanelliauthor=P.+Gratteriauthor=L.+Guandaliniauthor=E.+Martiniauthor=C.+Bonacciniauthor=F.+Gualtieri&title=Central+nicotinic+receptors%3A+structure%2C+function%2C+ligands%2C+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRomanelli%26aufirst%3DM.%2BN.%26aulast%3DGratteri%26aufirst%3DP.%26aulast%3DGuandalini%26aufirst%3DL.%26aulast%3DMartini%26aufirst%3DE.%26aulast%3DBonaccini%26aufirst%3DC.%26aulast%3DGualtieri%26aufirst%3DF.%26atitle%3DCentral%2520nicotinic%2520receptors%253A%2520structure%252C%2520function%252C%2520ligands%252C%2520and%2520therapeutic%2520potential%26jtitle%3DChemMedChem.%26date%3D2007%26volume%3D2%26spage%3D746%26epage%3D767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrimpf, M. R.</span><span> </span><span class="NLM_article-title">Design of ligands for the nicotinic acetylcholine receptors: the quest for selectivity</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.2174%2F1568026043451438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=14754449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVOiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=299-334&author=W.+H.+Bunnelleauthor=M.+J.+Dartauthor=M.+R.+Schrimpf&title=Design+of+ligands+for+the+nicotinic+acetylcholine+receptors%3A+the+quest+for+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Design of ligands for the nicotinic acetylcholine receptors: The quest for selectivity</span></div><div class="casAuthors">Bunnelle, William H.; Dart, Michael J.; Schrimpf, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">299-334</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In the last decade, nicotinic acetylcholine receptors (nAChRs) have emerged as important targets for drug discovery.  The therapeutic potential of nicotinic agonists depends substantially on the ability to selectively activate certain receptor subtypes that mediate beneficial effects.  The design of such compds. has proceeded in spite of a general shortage of data pertaining to subtype selectivity.  Medicinal chem. efforts have been guided principally by binding affinities to the α4β2 and/or α7 subtypes, even though these are not predictive of agonist activity at either subtype.  Nevertheless, a diverse family of nAChR ligands has been developed, and several analogs with promising therapeutic potential have now advanced to human clin. trials.  This paper provides an overview of the structure-affinity relationships that continue to drive development of new nAChR ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG5dOTgvAdLbVg90H21EOLACvtfcHk0li08nmnAh7l5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVOiuw%253D%253D&md5=158b682f8eb51091cd9b03b74b65927d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568026043451438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026043451438%26sid%3Dliteratum%253Aachs%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DDart%26aufirst%3DM.%2BJ.%26aulast%3DSchrimpf%26aufirst%3DM.%2BR.%26atitle%3DDesign%2520of%2520ligands%2520for%2520the%2520nicotinic%2520acetylcholine%2520receptors%253A%2520the%2520quest%2520for%2520selectivity%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D299%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Arneric, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holladay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic receptors: a perspective on two decades of drug discovery research</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1092</span><span class="NLM_x">–</span> <span class="NLM_lpage">1101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=1092-1101&author=S.+P.+Arnericauthor=M.+Holladayauthor=M.+Williams&title=Neuronal+nicotinic+receptors%3A+a+perspective+on+two+decades+of+drug+discovery+research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArneric%26aufirst%3DS.%2BP.%26aulast%3DHolladay%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DNeuronal%2520nicotinic%2520receptors%253A%2520a%2520perspective%2520on%2520two%2520decades%2520of%2520drug%2520discovery%2520research%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D74%26spage%3D1092%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Lindstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerzanich, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic receptor subtypes</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">757</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=757&publication_year=1995&pages=100-116&author=J.+Lindstromauthor=R.+Anandauthor=X.+Pengauthor=V.+Gerzanichauthor=F.+Wangauthor=Y.+Li&title=Neuronal+nicotinic+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindstrom%26aufirst%3DJ.%26aulast%3DAnand%26aufirst%3DR.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DGerzanich%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DNeuronal%2520nicotinic%2520receptor%2520subtypes%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1995%26volume%3D757%26spage%3D100%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Boyd, R. T.</span><span> </span><span class="NLM_article-title">The molecular biology of neuronal nicotinic acetylcholine receptors</span> <span class="citation_source-journal">Crit. Rev. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.3109%2F10408449709089897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=9189657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADyaK2sXjvFyqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1997&pages=299-318&author=R.+T.+Boyd&title=The+molecular+biology+of+neuronal+nicotinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular biology of neuronal nicotinic acetylcholine receptors</span></div><div class="casAuthors">Boyd, R. Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Toxicology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">299-318</span>CODEN:
                <span class="NLM_cas:coden">CRTXB2</span>;
        ISSN:<span class="NLM_cas:issn">1040-8444</span>.
    
            (<span class="NLM_cas:orgname">CRC</span>)
        </div><div class="casAbstract">A review, with 163 refs.  The mol. cloning of genes encoding neuronal nicotinic acetylcholine receptors (nAChRs) has made possible a better understanding of the pharmacol. and toxicol. of cholinergic compds.  Neuronal nAChRs are related in structure to the nAChRs present at the neuromuscular junction.  They are composed of multiple subunits designated either α and β.  Eight α and 3 β subunit genes have been cloned.  The α subunits contain the ligand binding sites, whereas β subunits are structural subunits that contribute to the function of the receptor.  A large no. of nAChRs can be formed from different combinations of α and β subunits.  Different combinations of α and β subunits can produce receptors in vitro with distinct ion conducting properties.  Each subunit gene is expressed in a distinct pattern in the nervous system.  The expression of at least some of the nAChR subunit genes is regulated during development and by cell-cell interactions.  Each neuronal nAChR subtype has a distinct pharmacol.  Both α and β subunits contribute to the pharmacol. properties of each subtype.  The expression of multiple nAChR subtypes may allow for precise control of neurotransmission mediated by acetylcholine in diverse populations of neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8ulbOSn16U7Vg90H21EOLACvtfcHk0li08nmnAh7l5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjvFyqtrk%253D&md5=5b11ce7b241898dd2c80a37322300f8f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3109%2F10408449709089897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10408449709089897%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DR.%2BT.%26atitle%3DThe%2520molecular%2520biology%2520of%2520neuronal%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DCrit.%2520Rev.%2520Toxicol.%26date%3D1997%26volume%3D27%26spage%3D299%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fornari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaimarri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiducci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrazzi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span> </span><span class="NLM_article-title">Structural and functional diversity of native brain neuronal nicotinic receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=703-711&author=C.+Gottiauthor=F.+Clementiauthor=A.+Fornariauthor=A.+Gaimarriauthor=S.+Guiducciauthor=I.+Manfrediauthor=M.+Morettiauthor=P.+Pedrazziauthor=L.+Pucciauthor=M.+Zoli&title=Structural+and+functional+diversity+of+native+brain+neuronal+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DFornari%26aufirst%3DA.%26aulast%3DGaimarri%26aufirst%3DA.%26aulast%3DGuiducci%26aufirst%3DS.%26aulast%3DManfredi%26aufirst%3DI.%26aulast%3DMoretti%26aufirst%3DM.%26aulast%3DPedrazzi%26aufirst%3DP.%26aulast%3DPucci%26aufirst%3DL.%26aulast%3DZoli%26aufirst%3DM.%26atitle%3DStructural%2520and%2520functional%2520diversity%2520of%2520native%2520brain%2520neuronal%2520nicotinic%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D703%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kellar, K. J.; Xiao, Y.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic receptors: one hundred years of progress</span>. In  <span class="citation_source-book">Handbook of Contemporary Neuropharmacology</span>; <span class="NLM_publisher-name">John Wiley & Sons, Inc</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=107-145&author=K.+J.+Kellar&author=Y.+Xiao&title=Handbook+of+Contemporary+Neuropharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DNeuronal%2520nicotinic%2520receptors%253A%2520one%2520hundred%2520years%2520of%2520progress%26btitle%3DHandbook%2520of%2520Contemporary%2520Neuropharmacology%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2007%26spage%3D107%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Mao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Heterogeneity of nicotinic cholinergic receptors in rat superior cervical and nodose Ganglia</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1693</span><span class="NLM_x">–</span> <span class="NLM_lpage">1699</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1693-1699&author=D.+Maoauthor=R.+P.+Yasudaauthor=H.+Fanauthor=B.+B.+Wolfeauthor=K.+J.+Kellar&title=Heterogeneity+of+nicotinic+cholinergic+receptors+in+rat+superior+cervical+and+nodose+Ganglia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DD.%26aulast%3DYasuda%26aufirst%3DR.%2BP.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DWolfe%26aufirst%3DB.%2BB.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DHeterogeneity%2520of%2520nicotinic%2520cholinergic%2520receptors%2520in%2520rat%2520superior%2520cervical%2520and%2520nodose%2520Ganglia%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D1693%26epage%3D1699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Pidoplichko, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBiasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dani, J. A.</span><span> </span><span class="NLM_article-title">Nicotine activates and desensitizes midbrain dopamine neurons</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">390</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=1997&pages=401-404&author=V.+I.+Pidoplichkoauthor=M.+DeBiasiauthor=J.+T.+Williamsauthor=J.+A.+Dani&title=Nicotine+activates+and+desensitizes+midbrain+dopamine+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPidoplichko%26aufirst%3DV.%2BI.%26aulast%3DDeBiasi%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DJ.%2BT.%26aulast%3DDani%26aufirst%3DJ.%2BA.%26atitle%3DNicotine%2520activates%2520and%2520desensitizes%2520midbrain%2520dopamine%2520neurons%26jtitle%3DNature%26date%3D1997%26volume%3D390%26spage%3D401%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Nestler, E. J.</span><span> </span><span class="NLM_article-title">Is there a common molecular pathway for addiction?</span> <span class="citation_source-journal">Nature Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1445</span><span class="NLM_x">–</span> <span class="NLM_lpage">1449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1038%2Fnn1578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=16251986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCrurbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=1445-1449&author=E.+J.+Nestler&title=Is+there+a+common+molecular+pathway+for+addiction%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Is there a common molecular pathway for addiction?</span></div><div class="casAuthors">Nestler, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1445-1449</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Drugs of abuse have very different acute mechanisms of action but converge on the brain's reward pathways by producing a series of common functional effects after both acute and chronic administration.  Some similar actions occur for natural rewards as well.  Researchers are making progress in understanding the mol. and cellular basis of these common effects.  A major goal for future research is to det. whether such common underpinnings of addiction can be exploited for the development of more effective treatments for a wide range of addictive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfRgdStKikCLVg90H21EOLACvtfcHk0lg5LddcDH7omQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCrurbP&md5=9a213264a4be37b0b7e1a5d00b42ab02</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnn1578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn1578%26sid%3Dliteratum%253Aachs%26aulast%3DNestler%26aufirst%3DE.%2BJ.%26atitle%3DIs%2520there%2520a%2520common%2520molecular%2520pathway%2520for%2520addiction%253F%26jtitle%3DNature%2520Neurosci.%26date%3D2005%26volume%3D8%26spage%3D1445%26epage%3D1449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Picciotto, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimondini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lena, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marubio, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pich, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">391</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=1998&pages=173-177&author=M.+R.+Picciottoauthor=M.+Zoliauthor=R.+Rimondiniauthor=C.+Lenaauthor=L.+M.+Marubioauthor=E.+M.+Pichauthor=K.+Fuxeauthor=J.+P.+Changeux&title=Acetylcholine+receptors+containing+the+beta2+subunit+are+involved+in+the+reinforcing+properties+of+nicotine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPicciotto%26aufirst%3DM.%2BR.%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DRimondini%26aufirst%3DR.%26aulast%3DLena%26aufirst%3DC.%26aulast%3DMarubio%26aufirst%3DL.%2BM.%26aulast%3DPich%26aufirst%3DE.%2BM.%26aulast%3DFuxe%26aufirst%3DK.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DAcetylcholine%2520receptors%2520containing%2520the%2520beta2%2520subunit%2520are%2520involved%2520in%2520the%2520reinforcing%2520properties%2520of%2520nicotine%26jtitle%3DNature%26date%3D1998%26volume%3D391%26spage%3D173%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Marubio, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardier, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arroyo-Jimenez, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champtiaux, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1329</span><span class="NLM_x">–</span> <span class="NLM_lpage">1337</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1046%2Fj.1460-9568.2003.02564.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=12713636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A280%3ADC%252BD3s3islChtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=1329-1337&author=L.+M.+Marubioauthor=A.+M.+Gardierauthor=S.+Durierauthor=D.+Davidauthor=R.+Klinkauthor=M.+M.+Arroyo-Jimenezauthor=J.+M.+McIntoshauthor=F.+Rossiauthor=N.+Champtiauxauthor=M.+Zoliauthor=J.+P.+Changeux&title=Effects+of+nicotine+in+the+dopaminergic+system+of+mice+lacking+the+alpha4+subunit+of+neuronal+nicotinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors</span></div><div class="casAuthors">Marubio L M; Gardier A M; Durier S; David D; Klink R; Arroyo-Jimenez M M; McIntosh J M; Rossi F; Champtiaux N; Zoli M; Changeux J-P</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1329-37</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">The mesostriatal dopaminergic system influences locomotor activity and the reinforcing properties of many drugs of abuse including nicotine.  Here we investigate the role of the alpha4 nicotinic acetylcholine receptor (nAChR) subunit in mediating the effects of nicotine in the mesolimbic dopamine system in mice lacking the alpha4 subunit.  We show that there are two distinct populations of receptors in the substantia nigra and striatum by using autoradiographic labelling with 125I alpha-conotoxin MII.  These receptors are comprised of the alpha4, beta2 and alpha6 nAChR subunits and non-alpha4, beta2, and alpha6 nAChR subunits.  Non-alpha4 subunit-containing nAChRs are located on dopaminergic neurons, are functional and respond to nicotine as demonstrated by patch clamp recordings.  In vivo microdialysis performed in awake, freely moving mice reveal that mutant mice have basal striatal dopamine levels which are twice as high as those observed in wild-type mice.  Despite the fact that both wild-type and alpha4 null mutant mice show a similar increase in dopamine release in response to intrastriatal KCl perfusion, a nicotine-elicited increase in dopamine levels is not observed in mutant mice.  Locomotor activity experiments show that there is no difference between wild-type and mutant mice in basal activity in both habituated and non-habituated environments.  Interestingly, mutant mice sustain an increase in cocaine-elicited locomotor activity longer than wild-type mice.  In addition, mutant mice recover from depressant locomotor activity in response to nicotine at a faster rate.  Our results indicate that alpha4-containing nAChRs exert a tonic control on striatal basal dopamine release, which is mediated by a heterogeneous population of nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5BUVKIOYbam52AMpI4GK2fW6udTcc2eZmtp4WXrIuxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3islChtQ%253D%253D&md5=678f37fe5428c62f1fe7893c0e852e35</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1046%2Fj.1460-9568.2003.02564.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1460-9568.2003.02564.x%26sid%3Dliteratum%253Aachs%26aulast%3DMarubio%26aufirst%3DL.%2BM.%26aulast%3DGardier%26aufirst%3DA.%2BM.%26aulast%3DDurier%26aufirst%3DS.%26aulast%3DDavid%26aufirst%3DD.%26aulast%3DKlink%26aufirst%3DR.%26aulast%3DArroyo-Jimenez%26aufirst%3DM.%2BM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DRossi%26aufirst%3DF.%26aulast%3DChamptiaux%26aufirst%3DN.%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DEffects%2520of%2520nicotine%2520in%2520the%2520dopaminergic%2520system%2520of%2520mice%2520lacking%2520the%2520alpha4%2520subunit%2520of%2520neuronal%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2003%26volume%3D17%26spage%3D1329%26epage%3D1337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Maskos, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molles, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pons, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiard, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilloux, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cormier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mameli-Engvall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufour, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloez-Tayarani, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemelmans, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardier, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=103-107&author=U.+Maskosauthor=B.+E.+Mollesauthor=S.+Ponsauthor=M.+Bessonauthor=B.+P.+Guiardauthor=J.+P.+Guillouxauthor=A.+Evrardauthor=P.+Cazalaauthor=A.+Cormierauthor=M.+Mameli-Engvallauthor=N.+Dufourauthor=I.+Cloez-Tayaraniauthor=A.+P.+Bemelmansauthor=J.+Malletauthor=A.+M.+Gardierauthor=V.+Davidauthor=P.+Faureauthor=S.+Granonauthor=J.+P.+Changeux&title=Nicotine+reinforcement+and+cognition+restored+by+targeted+expression+of+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaskos%26aufirst%3DU.%26aulast%3DMolles%26aufirst%3DB.%2BE.%26aulast%3DPons%26aufirst%3DS.%26aulast%3DBesson%26aufirst%3DM.%26aulast%3DGuiard%26aufirst%3DB.%2BP.%26aulast%3DGuilloux%26aufirst%3DJ.%2BP.%26aulast%3DEvrard%26aufirst%3DA.%26aulast%3DCazala%26aufirst%3DP.%26aulast%3DCormier%26aufirst%3DA.%26aulast%3DMameli-Engvall%26aufirst%3DM.%26aulast%3DDufour%26aufirst%3DN.%26aulast%3DCloez-Tayarani%26aufirst%3DI.%26aulast%3DBemelmans%26aufirst%3DA.%2BP.%26aulast%3DMallet%26aufirst%3DJ.%26aulast%3DGardier%26aufirst%3DA.%2BM.%26aulast%3DDavid%26aufirst%3DV.%26aulast%3DFaure%26aufirst%3DP.%26aulast%3DGranon%26aufirst%3DS.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DNicotine%2520reinforcement%2520and%2520cognition%2520restored%2520by%2520targeted%2520expression%2520of%2520nicotinic%2520receptors%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D103%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Dani, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinemann, S.</span><span> </span><span class="NLM_article-title">Molecular and cellular aspects of nicotine abuse</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">908</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=905-908&author=J.+A.+Daniauthor=S.+Heinemann&title=Molecular+and+cellular+aspects+of+nicotine+abuse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDani%26aufirst%3DJ.%2BA.%26aulast%3DHeinemann%26aufirst%3DS.%26atitle%3DMolecular%2520and%2520cellular%2520aspects%2520of%2520nicotine%2520abuse%26jtitle%3DNeuron%26date%3D1996%26volume%3D16%26spage%3D905%26epage%3D908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Rollema, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span> </span><span class="NLM_article-title">Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=316-325&author=H.+Rollemaauthor=J.+W.+Coeauthor=L.+K.+Chambersauthor=R.+S.+Hurstauthor=S.+M.+Stahlauthor=K.+E.+Williams&title=Rationale%2C+pharmacology+and+clinical+efficacy+of+partial+agonists+of+alpha4beta2+nACh+receptors+for+smoking+cessation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRollema%26aufirst%3DH.%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DChambers%26aufirst%3DL.%2BK.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DStahl%26aufirst%3DS.%2BM.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26atitle%3DRationale%252C%2520pharmacology%2520and%2520clinical%2520efficacy%2520of%2520partial%2520agonists%2520of%2520alpha4beta2%2520nACh%2520receptors%2520for%2520smoking%2520cessation%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D316%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Gonzales, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennard, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nides, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oncken, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azoulay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billing, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watsky, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, K. R.</span><span> </span><span class="NLM_article-title">Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2006&pages=47-55&author=D.+Gonzalesauthor=S.+I.+Rennardauthor=M.+Nidesauthor=C.+Onckenauthor=S.+Azoulayauthor=C.+B.+Billingauthor=E.+J.+Watskyauthor=J.+Gongauthor=K.+E.+Williamsauthor=K.+R.+Reeves&title=Varenicline%2C+an+alpha4beta2+nicotinic+acetylcholine+receptor+partial+agonist%2C+vs+sustained-release+bupropion+and+placebo+for+smoking+cessation%3A+a+randomized+controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGonzales%26aufirst%3DD.%26aulast%3DRennard%26aufirst%3DS.%2BI.%26aulast%3DNides%26aufirst%3DM.%26aulast%3DOncken%26aufirst%3DC.%26aulast%3DAzoulay%26aufirst%3DS.%26aulast%3DBilling%26aufirst%3DC.%2BB.%26aulast%3DWatsky%26aufirst%3DE.%2BJ.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26aulast%3DReeves%26aufirst%3DK.%2BR.%26atitle%3DVarenicline%252C%2520an%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%252C%2520vs%2520sustained-release%2520bupropion%2520and%2520placebo%2520for%2520smoking%2520cessation%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2006%26volume%3D296%26spage%3D47%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Jorenby, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hays, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigotti, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azoulay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watsky, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billing, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, K. R.</span><span> </span><span class="NLM_article-title">Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2006&pages=56-63&author=D.+E.+Jorenbyauthor=J.+T.+Haysauthor=N.+A.+Rigottiauthor=S.+Azoulayauthor=E.+J.+Watskyauthor=K.+E.+Williamsauthor=C.+B.+Billingauthor=J.+Gongauthor=K.+R.+Reeves&title=Efficacy+of+varenicline%2C+an+alpha4beta2+nicotinic+acetylcholine+receptor+partial+agonist%2C+vs+placebo+or+sustained-release+bupropion+for+smoking+cessation%3A+a+randomized+controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJorenby%26aufirst%3DD.%2BE.%26aulast%3DHays%26aufirst%3DJ.%2BT.%26aulast%3DRigotti%26aufirst%3DN.%2BA.%26aulast%3DAzoulay%26aufirst%3DS.%26aulast%3DWatsky%26aufirst%3DE.%2BJ.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26aulast%3DBilling%26aufirst%3DC.%2BB.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DReeves%26aufirst%3DK.%2BR.%26atitle%3DEfficacy%2520of%2520varenicline%252C%2520an%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%252C%2520vs%2520placebo%2520or%2520sustained-release%2520bupropion%2520for%2520smoking%2520cessation%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2006%26volume%3D296%26spage%3D56%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Tonstad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonnesen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billing, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, K. R.</span><span> </span><span class="NLM_article-title">Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2006&pages=64-71&author=S.+Tonstadauthor=P.+Tonnesenauthor=P.+Hajekauthor=K.+E.+Williamsauthor=C.+B.+Billingauthor=K.+R.+Reeves&title=Effect+of+maintenance+therapy+with+varenicline+on+smoking+cessation%3A+a+randomized+controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTonstad%26aufirst%3DS.%26aulast%3DTonnesen%26aufirst%3DP.%26aulast%3DHajek%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26aulast%3DBilling%26aufirst%3DC.%2BB.%26aulast%3DReeves%26aufirst%3DK.%2BR.%26atitle%3DEffect%2520of%2520maintenance%2520therapy%2520with%2520varenicline%2520on%2520smoking%2520cessation%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2006%26volume%3D296%26spage%3D64%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Tsai, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsueh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billing, C. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span> </span><span class="NLM_article-title">A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1039</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1016%2Fj.clinthera.2007.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptlKjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2007&pages=1027-1039&author=S.+T.+Tsaiauthor=H.+J.+Choauthor=H.+S.+Chengauthor=C.+H.+Kimauthor=K.+C.+Hsuehauthor=C.+B.+Billingauthor=K.+E.+Williams&title=A+randomized%2C+placebo-controlled+trial+of+varenicline%2C+a+selective+alpha4beta2+nicotinic+acetylcholine+receptor+partial+agonist%2C+as+a+new+therapy+for+smoking+cessation+in+Asian+smokers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized, placebo-controlled trial of varenicline, a selective α4β2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers</span></div><div class="casAuthors">Tsai, Shih-Tzu; Cho, Hong-Jun; Cheng, Huey-Shinn; Kim, Cheol-Hwan; Hsueh, Kuang-Chieh; Billing, Clare B., Jr.; Williams, Kathryn E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1027-1039</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">Background: Rates of smoking in East Asian men range from >35% to >60%, and are increasing in women and the young.  Objective: This study evaluated the efficacy and tolerability of 1 mg BID varenicline, a novel α4β2 nicotinic acetylcholine receptor partial agonist, for smoking cessation in smokers in Taiwan and Korea.  Methods: A randomized, double-blind, placebo-controlled, 12-wk treatment, 12-wk follow-up trial was conducted at 5 sites each in Korea and Taiwan.  Eligible subjects, smoking ≥10 cigarettes/d, received brief smoking-cessation counseling and were randomly assigned in a 1:1 ratio to varenicline 1 mg BID (titrated during the first week) or placebo.  Smoking status was established by self-report and confirmed at clinic visits by end-expiratory carbon monoxide ≤10 ppm.  The primary end point was continuous abstinence rate (CAR) during the last 4 wk of treatment.  Secondary end points included CAR from weeks 9 to 24 and 7-day point prevalence (PP) of abstinence at weeks 12 and 24.  Craving, withdrawal, and smoking satisfaction were detd. by the Minnesota Nicotine Withdrawal Scale, the Brief Questionnaire of Smoking Urges, and the modified Cigarette Evaluation Questionnaire.  Obsd. or volunteered adverse-event data were recorded at clinic visits.  Results: Overall, 126 subjects (84.9% male) received varenicline, and 124 (92.7% male) received placebo.  Subjects were aged 21 to 73 years (mean age, 39.7 and 40.9 years for varenicline and placebo groups, resp.), and the mean (range) body wts. were 69.0 (44.8-110.0) kg and 71.4 (45.5-102.0) kg, resp.  Subjects had smoked for 3 to 52 years (mean, 20.2 and 22.1 years in the varenicline and placebo groups, resp.).  Subjects had smoked a mean of 23 cigarettes/d over the past month, with 51.6% (varenicline) and 46.0% (placebo) having made 1 or more prior serious quit attempts.  Smoking-cessation rates at the end of treatment were 59.5% with varenicline vs. 32.3% with placebo (P < 0.001).  CARs through 12 wk post-treatment (weeks 9-24) were 46.8% with varenicline and 21.8% with placebo (P < 0.001).  The 7-day PP was 67.5% with varenicline vs. 36.3% with placebo at week 12, and 57.1% vs. 29.0% with placebo at week 24 (both, P < 0.001).  Treatment-emergent, all-causality adverse events with an incidence ≥5% for varenicline were nausea (43.7% for varenicline vs 11.3% placebo), insomnia (15.1% vs 13.7%), increased appetite (7.9% vs 6.5%), constipation (7.1% vs 2.4%), anxiety (5.6% vs 2.4%), and abnormal dreams (5.6% vs 0.8%).  Adverse events resulted in <10% treatment discontinuations overall.  Conclusion: Varenicline was an efficacious and well-tolerated pharmacotherapy for smoking cessation in this group of Asian smokers over a 12-wk treatment period, and its effects persisted for a further 12-wk follow-up period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnYORkHS3RLbVg90H21EOLACvtfcHk0lgSR8RrESeZdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptlKjtL0%253D&md5=020fed1b102ff27627f9048084c6acc8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2007.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2007.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DS.%2BT.%26aulast%3DCho%26aufirst%3DH.%2BJ.%26aulast%3DCheng%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DC.%2BH.%26aulast%3DHsueh%26aufirst%3DK.%2BC.%26aulast%3DBilling%26aufirst%3DC.%2BB.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26atitle%3DA%2520randomized%252C%2520placebo-controlled%2520trial%2520of%2520varenicline%252C%2520a%2520selective%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%252C%2520as%2520a%2520new%2520therapy%2520for%2520smoking%2520cessation%2520in%2520Asian%2520smokers%26jtitle%3DClin.%2520Ther.%26date%3D2007%26volume%3D29%26spage%3D1027%26epage%3D1039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Moore, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furberg, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenmullen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltsberger, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S.</span><span> </span><span class="NLM_article-title">Suicidal behavior and depression in smoking cessation treatments</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e27016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e27016&author=T.+J.+Mooreauthor=C.+D.+Furbergauthor=J.+Glenmullenauthor=J.+T.+Maltsbergerauthor=S.+Singh&title=Suicidal+behavior+and+depression+in+smoking+cessation+treatments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DT.%2BJ.%26aulast%3DFurberg%26aufirst%3DC.%2BD.%26aulast%3DGlenmullen%26aufirst%3DJ.%26aulast%3DMaltsberger%26aufirst%3DJ.%2BT.%26aulast%3DSingh%26aufirst%3DS.%26atitle%3DSuicidal%2520behavior%2520and%2520depression%2520in%2520smoking%2520cessation%2520treatments%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De27016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Rollema, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glowa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansbach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovetti, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span> </span><span class="NLM_article-title">Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid</span> <span class="citation_source-journal">Neuropharmacology.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">985</span><span class="NLM_x">–</span> <span class="NLM_lpage">994</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1016%2Fj.neuropharm.2006.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=17157884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=985-994&author=H.+Rollemaauthor=L.+K.+Chambersauthor=J.+W.+Coeauthor=J.+Glowaauthor=R.+S.+Hurstauthor=L.+A.+Lebelauthor=Y.+Luauthor=R.+S.+Mansbachauthor=R.+J.+Matherauthor=C.+C.+Rovettiauthor=S.+B.+Sandsauthor=E.+Schaefferauthor=D.+W.+Schulzauthor=F.+D.+Tingleyauthor=K.+E.+Williams&title=Pharmacological+profile+of+the+alpha4beta2+nicotinic+acetylcholine+receptor+partial+agonist+varenicline%2C+an+effective+smoking+cessation+aid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid</span></div><div class="casAuthors">Rollema, H.; Chambers, L. K.; Coe, J. W.; Glowa, J.; Hurst, R. S.; Lebel, L. A.; Lu, Y.; Mansbach, R. S.; Mather, R. J.; Rovetti, C. C.; Sands, S. B.; Schaeffer, E.; Schulz, D. W.; Tingley, F. D.; Williams, K. E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">985-994</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The preclin. pharmacol. of the α4β2 nicotinic acetylcholine receptor (nAChR) partial agonist varenicline, a novel smoking cessation agent is described.  Varenicline binds with subnanomolar affinity only to α4β2 nAChRs and in vitro functional patch clamp studies in HEK cells expressing nAChRs show that varenicline is a partial agonist with 45% of nicotine's maximal efficacy at α4β2 nAChRs.  In neurochem. models varenicline has significantly lower (40-60%) efficacy than nicotine in stimulating [3H]-dopamine release from rat brain slices in vitro and in increasing dopamine release from rat nucleus accumbens in vivo, while it is more potent than nicotine.  In addn., when combined with nicotine, varenicline effectively attenuates the nicotine-induced dopamine release to the level of the effect of varenicline alone, consistent with partial agonism.  Finally, varenicline reduces nicotine self-administration in rats and supports lower self-administration break points than nicotine.  These data suggest that varenicline can reproduce to some extent the subjective effects of smoking by partially activating α4β2 nAChRs, while preventing full activation of these receptors by nicotine.  Based on these findings, varenicline was advanced into clin. development and recently shown to be an effective and safe aid for smoking cessation treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgBqovXuf1ALVg90H21EOLACvtfcHk0lgSR8RrESeZdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyqtbw%253D&md5=11199806966b56bd3f075a4a902fe206</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2006.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2006.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DRollema%26aufirst%3DH.%26aulast%3DChambers%26aufirst%3DL.%2BK.%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DGlowa%26aufirst%3DJ.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DLebel%26aufirst%3DL.%2BA.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMansbach%26aufirst%3DR.%2BS.%26aulast%3DMather%26aufirst%3DR.%2BJ.%26aulast%3DRovetti%26aufirst%3DC.%2BC.%26aulast%3DSands%26aufirst%3DS.%2BB.%26aulast%3DSchaeffer%26aufirst%3DE.%26aulast%3DSchulz%26aufirst%3DD.%2BW.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26atitle%3DPharmacological%2520profile%2520of%2520the%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%2520varenicline%252C%2520an%2520effective%2520smoking%2520cessation%2520aid%26jtitle%3DNeuropharmacology.%26date%3D2007%26volume%3D52%26spage%3D985%26epage%3D994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Mihalak, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luetje, C. W.</span><span> </span><span class="NLM_article-title">Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=801-805&author=K.+B.+Mihalakauthor=F.+I.+Carrollauthor=C.+W.+Luetje&title=Varenicline+is+a+partial+agonist+at+alpha4beta2+and+a+full+agonist+at+alpha7+neuronal+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMihalak%26aufirst%3DK.%2BB.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DLuetje%26aufirst%3DC.%2BW.%26atitle%3DVarenicline%2520is%2520a%2520partial%2520agonist%2520at%2520alpha4beta2%2520and%2520a%2520full%2520agonist%2520at%2520alpha7%2520neuronal%2520nicotinic%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D801%26epage%3D805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Bordia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrachova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quik, M.</span><span> </span><span class="NLM_article-title">Varenicline is a potent partial agonist at alpha6beta2* nicotinic acetylcholine receptors in rat and monkey striatum</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1124%2Fjpet.112.194852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=22550286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOru7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2012&pages=327-334&author=T.+Bordiaauthor=M.+Hrachovaauthor=M.+Chinauthor=J.+M.+McIntoshauthor=M.+Quik&title=Varenicline+is+a+potent+partial+agonist+at+alpha6beta2*+nicotinic+acetylcholine+receptors+in+rat+and+monkey+striatum"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum</span></div><div class="casAuthors">Bordia, Tanuja; Hrachova, Maya; Chin, Matthew; McIntosh, J. Michael; Quik, Maryka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">327-334</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Extensive evidence indicates that varenicline reduces nicotine craving and withdrawal symptoms by modulating dopaminergic function at α4β2* nicotinic acetylcholine receptors (nAChRs) (the asterisk indicates the possible presence of other nicotinic subunits in the receptor complex).  More recent data suggest that α6β2* nAChRs also regulate dopamine release and mediate nicotine reinforcement.  The present expts. were therefore done to test the effect of varenicline on α6β2* nAChRs and their function, because its interaction with this subtype is currently unclear.  Receptor competition studies showed that varenicline inhibited α6β2* nAChR binding (Ki = 0.12 nM) as potently as α4β2* nAChR binding (Ki = 0.14 nM) in rat striatal sections and with ∼20-fold greater affinity than nicotine.  Functionally, varenicline was more potent in stimulating α6β2* vs. a4β2* nAChR-mediated [3H]dopamine release from rat striatal synaptosomes with EC50 values of 0.007 and 0.086 μM, resp.  However, it acted as a partial agonist on α6β2* and α4β2* nAChR-mediated [3H]dopamine release with maximal efficacies of 49 and 24%, resp., compared with nicotine.  We also evaluated varenicline's action in striatum of monkeys, a useful animal model for comparison with humans.  Varenicline again potently inhibited monkey striatal α6β2* (Ki = 0.13 nM) and α4β2* (Ki = 0.19 nM) nAChRs in competition studies.  Functionally, it potently stimulated both α6β2* (EC50 = 0.014 μM) and α4β2* (EC50 = 0.029 μM) nAChR-mediated [3H]dopamine release from monkey striatal synaptosomes, again acting as a partial agonist relative to nicotine at both subtypes.  These data suggest that the ability of varenicline to interact at α6β2* nAChRs may contribute to its efficacy as a smoking cessation aid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC_jN4_gF91LVg90H21EOLACvtfcHk0lj5EZFzqB3TNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOru7nF&md5=01850188a8ffaf19580241ad4e30c99b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.194852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.194852%26sid%3Dliteratum%253Aachs%26aulast%3DBordia%26aufirst%3DT.%26aulast%3DHrachova%26aufirst%3DM.%26aulast%3DChin%26aufirst%3DM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DQuik%26aufirst%3DM.%26atitle%3DVarenicline%2520is%2520a%2520potent%2520partial%2520agonist%2520at%2520alpha6beta2%252A%2520nicotinic%2520acetylcholine%2520receptors%2520in%2520rat%2520and%2520monkey%2520striatum%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D342%26spage%3D327%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musachio, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1454</span><span class="NLM_x">–</span> <span class="NLM_lpage">1460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1454-1460&author=Y.+Xiaoauthor=H.+Fanauthor=J.+L.+Musachioauthor=Z.+L.+Weiauthor=S.+K.+Chellappanauthor=A.+P.+Kozikowskiauthor=K.+J.+Kellar&title=Sazetidine-A%2C+a+novel+ligand+that+desensitizes+alpha4beta2+nicotinic+acetylcholine+receptors+without+activating+them"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DMusachio%26aufirst%3DJ.%2BL.%26aulast%3DWei%26aufirst%3DZ.%2BL.%26aulast%3DChellappan%26aufirst%3DS.%2BK.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DSazetidine-A%252C%2520a%2520novel%2520ligand%2520that%2520desensitizes%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptors%2520without%2520activating%2520them%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D1454%26epage%3D1460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Xiao, Y.; Yasuda, R. P.; Sahibzada, N.; Wolfe, B. B.; Horton, L.; Paige, M.; Brown, M. L.; Kellar, K. J.</span><span> </span><span class="NLM_article-title">Sazetidine-A selectively induces a long lasting desensitization of α4β2 nicotinic acetylcholine receptors</span>. In  (), <span class="NLM_conf-name">2010 Neuroscience Meeting, Society for Neuroscience</span>, <span class="NLM_conf-loc">San Diego</span>, <span class="NLM_conf-date">2010</span>, 38.10.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Xiao%2C+Y.%3B+Yasuda%2C+R.+P.%3B+Sahibzada%2C+N.%3B+Wolfe%2C+B.+B.%3B+Horton%2C+L.%3B+Paige%2C+M.%3B+Brown%2C+M.+L.%3B+Kellar%2C+K.+J.+Sazetidine-A+selectively+induces+a+long+lasting+desensitization+of+%CE%B14%CE%B22+nicotinic+acetylcholine+receptors.+In+%28%29%2C+2010+Neuroscience+Meeting%2C+Society+for+Neuroscience%2C+San+Diego%2C+2010%2C+38.10."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26atitle%3DSazetidine-A%2520selectively%2520induces%2520a%2520long%2520lasting%2520desensitization%2520of%2520%25CE%25B14%25CE%25B22%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3D%2520%2528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Carbone, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groot-Kormelink, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bermudez, I.</span><span> </span><span class="NLM_article-title">Pentameric concatenated (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2) nicotinic acetylcholine receptors: subunit arrangement determines functional expression</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">970</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1111%2Fj.1476-5381.2008.00104.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=19366353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Oqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2009&pages=970-981&author=A.+L.+Carboneauthor=M.+Moroniauthor=P.+J.+Groot-Kormelinkauthor=I.+Bermudez&title=Pentameric+concatenated+%28alpha4%29%282%29%28beta2%29%283%29+and+%28alpha4%29%283%29%28beta2%29%282%29+nicotinic+acetylcholine+receptors%3A+subunit+arrangement+determines+functional+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Pentameric concatenated (α4)2(β2)3 and (α4)3(β2)2 nicotinic acetylcholine receptors: subunit arrangement determines functional expression</span></div><div class="casAuthors">Carbone, A.-L.; Moroni, M.; Groot-Kormelink, P.-J.; Bermudez, I.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">970-981</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and purpose: α4 and β2 nicotinic acetylcholine (ACh) receptor subunits expressed heterologously in Xenopus oocytes assemble into a mixed population of (α4)2(β2)3 and (α4)3(β2)2 receptors.  To express these receptors sep. in heterologous systems, the authors have engineered pentameric concatenated (α4)2(β2)3 and (α4)3(β2)2 receptors.  Exptl. approach: α4 and β2 subunits were concatenated by synthetic linkers into pentameric constructs to produce either (α4)2(β2)3 or (α4)3(β2)2 receptors.  Using two-electrode voltage-clamp techniques, the authors examd. the ability of the concatenated constructs to produce functional expression in Xenopus oocytes.  Functional constructs were further characterized in respect to agonists, competitive antagonists, Ca2+ permeability, sensitivity to modulation by Zn2+ and sensitivity to up-regulation by chaperone protein 14-3-3.  Key results: the authors found that pentameric concatamers with a subunit arrangement of β2_α4_β2_α4_β2 or β2_α4_β2_α4_α4 were stable and functional in Xenopus oocytes.  By comparison, when α4 and β2 were concatenated with a subunit order of β2_β2_α4_β2_α4 or β2_α4_α4_β2_α4, functional expression in Xenopus oocytes was very low, even though the proteins were synthesized and stable.  Both β2_α4_β2_α4_β2 and β2_α4_β2_α4_α4 concatamers recapitulated the ACh concn. response curve, the sensitivity to Zn2+ modulation, Ca2+ permeability and the sensitivity to up-regulation by chaperone protein 14-3-3 of the corresponding non-linked (α4)2(β2)3 and (α4)3(β2)2 receptors resp.  Using these concatamers, the authors found that most α4β2-preferring compds. studied, including A85380, 51-A85380, cytisine, epibatidine, TC2559 and dihydro-β-erythroidine, demonstrate stoichiometry-specific potencies and efficacies.  Conclusions and implications: the authors concluded that the α4β2 nicotinic ACh receptors produced with β2_α4_β2_α4_β2 or β2_α4_β2_α4_α4 pentameric constructs are valid models of non-linked (α4)2(β2)3 and (α4)3(β2)2 receptors resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVhdNVrexQfbVg90H21EOLACvtfcHk0ljqBLSO3PHELw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Oqs7s%253D&md5=bb40295f9b0d314304e0139959ce8676</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2008.00104.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2008.00104.x%26sid%3Dliteratum%253Aachs%26aulast%3DCarbone%26aufirst%3DA.%2BL.%26aulast%3DMoroni%26aufirst%3DM.%26aulast%3DGroot-Kormelink%26aufirst%3DP.%2BJ.%26aulast%3DBermudez%26aufirst%3DI.%26atitle%3DPentameric%2520concatenated%2520%2528alpha4%2529%25282%2529%2528beta2%2529%25283%2529%2520and%2520%2528alpha4%2529%25283%2529%2528beta2%2529%25282%2529%2520nicotinic%2520acetylcholine%2520receptors%253A%2520subunit%2520arrangement%2520determines%2520functional%2520expression%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D156%26spage%3D970%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Levin, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezvani, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cauley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1124%2Fjpet.109.162073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=20007754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFCjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2010&pages=933-939&author=E.+D.+Levinauthor=A.+H.+Rezvaniauthor=Y.+Xiaoauthor=S.+Sladeauthor=M.+Cauleyauthor=C.+Wellsauthor=D.+Hamptonauthor=A.+Petroauthor=J.+E.+Roseauthor=M.+L.+Brownauthor=M.+A.+Paigeauthor=B.+E.+McDowellauthor=K.+J.+Kellar&title=Sazetidine-A%2C+a+selective+alpha4beta2+nicotinic+receptor+desensitizing+agent+and+partial+agonist%2C+reduces+nicotine+self-administration+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Sazetidine-A, a selective α4β2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats</span></div><div class="casAuthors">Levin, Edward D.; Rezvani, Amir H.; Xiao, Yingxian; Slade, Susan; Cauley, Marty; Wells, Corinne; Hampton, Dawn; Petro, Ann; Rose, Jed E.; Brown, Milton L.; Paige, Mikell A.; McDowell, Brian E.; Kellar, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">933-939</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Adequate treatment of tobacco addiction remains problematic.  Part of the problem with treatment is a poor understanding of the pharmacol. aspects of nicotine contributing to addiction.  In addn. to activating nicotinic acetylcholine receptors, nicotine also desensitizes them.  It is currently not known how much of each of nicotine's actions contribute to its particular behavioral effects.  Sazetidine-A (saz-A) is a novel nicotinic receptor-desensitizing agent and partial agonist with high selectivity for α4β2 receptors.  The current expts. were conducted to det. whether saz-A would reduce nicotine self-administration in rats and to characterize its ancillary effects.  Adult male Sprague-Dawley rats were allowed to self-administer nicotine.  After initial food pellet training followed by 10 sessions of nicotine self-administration training, the rats were administered saz-A (0.1-3 mg/kg s.c.) or the saline vehicle in a repeated-measures counterbalanced design.  Saz-A at the 3 mg/kg dose significantly decreased nicotine self-administration relative to performance of the same rats after saline injections.  In a second study, long-term administration of this dose of sazetidine-A over the course of 10 sessions significantly reduced nicotine self-administration with no apparent diminution of effect.  Saz-A in this dose range had only modest effects on locomotor activity, without any overall decrease in activity over a 1-h-long session.  Saz-A significantly reduced food self-administration, but this effect was smaller than its effect on nicotine self-administration.  Saz-A, which is a selective α4β2-desensitizing agent and partial agonist, effectively reduces nicotine self-administration.  This type of treatment holds promise for a new therapy to aid smoking cessation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyXvn7dQpysLVg90H21EOLACvtfcHk0ljqBLSO3PHELw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFCjs7s%253D&md5=e6b4e73fc3c6373d3dbc6e249bb8a76c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.162073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.162073%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DE.%2BD.%26aulast%3DRezvani%26aufirst%3DA.%2BH.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DSlade%26aufirst%3DS.%26aulast%3DCauley%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DHampton%26aufirst%3DD.%26aulast%3DPetro%26aufirst%3DA.%26aulast%3DRose%26aufirst%3DJ.%2BE.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DPaige%26aufirst%3DM.%2BA.%26aulast%3DMcDowell%26aufirst%3DB.%2BE.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DSazetidine-A%252C%2520a%2520selective%2520alpha4beta2%2520nicotinic%2520receptor%2520desensitizing%2520agent%2520and%2520partial%2520agonist%252C%2520reduces%2520nicotine%2520self-administration%2520in%2520rats%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D332%26spage%3D933%26epage%3D939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Rezvani, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lumeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, E. D.</span><span> </span><span class="NLM_article-title">Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats</span> <span class="citation_source-journal">Psychopharmacology (Berlin, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">211</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1007%2Fs00213-010-1878-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=20535453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFGlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2010&pages=161-174&author=A.+H.+Rezvaniauthor=S.+Sladeauthor=C.+Wellsauthor=A.+Petroauthor=L.+Lumengauthor=T.+K.+Liauthor=Y.+Xiaoauthor=M.+L.+Brownauthor=M.+A.+Paigeauthor=B.+E.+McDowellauthor=J.+E.+Roseauthor=K.+J.+Kellarauthor=E.+D.+Levin&title=Effects+of+sazetidine-A%2C+a+selective+alpha4beta2+nicotinic+acetylcholine+receptor+desensitizing+agent+on+alcohol+and+nicotine+self-administration+in+selectively+bred+alcohol-preferring+%28P%29+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats</span></div><div class="casAuthors">Rezvani, Amir H.; Slade, Susan; Wells, Cori; Petro, Ann; Lumeng, Lawrence; Li, Ting-Kai; Xiao, Yingxian; Brown, Milton L.; Paige, Mikell A.; McDowell, Brian E.; Rose, Jed E.; Kellar, Kenneth J.; Levin, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-174</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: Manipulations of nicotinic cholinergic receptors have been shown to influence both alc. and nicotine intake.  Sazetidine-A [6-(5(((S)-azetidine-2-yl)methoxy)pyridine-3-yl)hex-5-yn-1-ol] is a novel compd. that potently and selectively desensitizes α4β2 nicotinic receptors with only modest receptor activation.  Objectives: The goal of the present study was to examine the effects of sazetidine-A on alc. and nicotine self-administration in alc.-preferring (P) rats.  Methods: P rats were given the choice of water or alc.  Once stable baselines were established, the acute (0, 0.1, 0.3, 1, and 3 mg/kg, s.c.) and chronic (3 mg/kg for 10 days) effects of sazetidine-A on alc. intake were assessed.  Naltrexone (2.5 mg/kg) served as a pos. control.  The effect of sazetidine-A (3 mg/kg) and naltrexone (4 mg/kg) on saccharin (0.2%) preference was also assessed.  In addn., the acute effects of sazetidine-A (3 mg/kg) and naltrexone (4 mg/kg) on alc. intake after alc. deprivation were evaluated.  In another expt., the effects of sazetidine-A (0, 1, or 3 mg/kg) on IV nicotine self-administration in P and NP rats were assessed.  Results: Sazetidine-A caused a dose-dependent redn. in alc. intake.  Chronic sazetidine-A also effectively reduced alc. intake until the seventh day of treatment, when partial tolerance appeared to develop.  In the post-deprivation study, sazetidine-A significantly reduced alc. intake and preference.  Sazetidine-A at 3 mg/kg significantly reduced nicotine self-administration in both lines.  Conclusions: Sazetidine-A significantly reduced alc. and nicotine intake in P rats that self-administer higher levels of both drugs.  Sazetidine-A may hold promise for the treatment of alc. and nicotine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZfW61FFrtlbVg90H21EOLACvtfcHk0ljqBLSO3PHELw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFGlsb0%253D&md5=18b4836f096b921e6ef22c8538528ecf</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs00213-010-1878-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-010-1878-8%26sid%3Dliteratum%253Aachs%26aulast%3DRezvani%26aufirst%3DA.%2BH.%26aulast%3DSlade%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DPetro%26aufirst%3DA.%26aulast%3DLumeng%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DT.%2BK.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DPaige%26aufirst%3DM.%2BA.%26aulast%3DMcDowell%26aufirst%3DB.%2BE.%26aulast%3DRose%26aufirst%3DJ.%2BE.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26aulast%3DLevin%26aufirst%3DE.%2BD.%26atitle%3DEffects%2520of%2520sazetidine-A%252C%2520a%2520selective%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520desensitizing%2520agent%2520on%2520alcohol%2520and%2520nicotine%2520self-administration%2520in%2520selectively%2520bred%2520alcohol-preferring%2520%2528P%2529%2520rats%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D2010%26volume%3D211%26spage%3D161%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Rezvani, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cauley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, E. D.</span><span> </span><span class="NLM_article-title">Sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats</span> <span class="citation_source-journal">Psychopharmacology (Berlin, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">215</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1007%2Fs00213-010-2161-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=21274704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2011&pages=621-630&author=A.+H.+Rezvaniauthor=M.+Cauleyauthor=H.+Sextonauthor=Y.+Xiaoauthor=M.+L.+Brownauthor=M.+A.+Paigeauthor=B.+E.+McDowellauthor=K.+J.+Kellarauthor=E.+D.+Levin&title=Sazetidine-A%2C+a+selective+alpha4beta2+nicotinic+acetylcholine+receptor+ligand%3A+effects+on+dizocilpine+and+scopolamine-induced+attentional+impairments+in+female+Sprague-Dawley+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats</span></div><div class="casAuthors">Rezvani, Amir H.; Cauley, Marty; Sexton, Hannah; Xiao, Yingxian; Brown, Milton L.; Paige, Mikell A.; McDowell, Brian E.; Kellar, Kenneth J.; Levin, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">621-630</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Neuronal nicotinic receptor systems were shown to play key roles in cognition.  Nicotine and nicotinic analogs improve attention and nicotinic antagonists impair it.  This study was conducted to investigate the role of α4β2 nicotinic receptors in sustained attention using a novel selective α4β2 nicotinic receptor ligand, sazetidine-A.  Female rats were trained to perform the signal detection task to a stable baseline of accuracy.  The rats were injected with saline, sazetidine-A (0.01, 0.03, and 0.1 mg/kg), dizocilpine (0.05 mg/kg), or their combination; or, in another expt., the rats were injected with the same doses of sazetidine-A, scopolamine (0.02 mg/kg), or their combination.  Percent hit and percent correct rejection showed that dizocilpine caused significant impairments in performance, which were significantly reversed by each of the sazetidine-A doses.  Response omissions were significantly increased by dizocilpine, and this was also significantly reversed by each of the sazetidine-A doses.  None of the sazetidine-A doses had significant effects on hit, correct rejection, or response omissions when given alone.  Scopolamine also caused significant impairments in percent hit and percent correct rejection and increased response omissions, which were significantly attenuated by all the sazetidine-A doses for percent hit and response omissions and by the highest dose of sazetidine-A for percent correct rejection.  Both scopolamine and dizocilpine significantly increased response latency, an effect which was significantly attenuated by sazetidine-A coadministration.  These studies imply an important role for α4β2 nicotinic receptors in improving sustained attention under conditions that disrupt it.  Very low doses of sazetidine-A or drugs with a similar profile may provide therapeutic benefit for reversing attentional impairment in patients suffering from mental disorders and/or cognitive impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwUk_GZLd5o7Vg90H21EOLACvtfcHk0lg1m6SB0zTZWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKqtrs%253D&md5=cea4f477d47522d42611860547b1cf68</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs00213-010-2161-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-010-2161-8%26sid%3Dliteratum%253Aachs%26aulast%3DRezvani%26aufirst%3DA.%2BH.%26aulast%3DCauley%26aufirst%3DM.%26aulast%3DSexton%26aufirst%3DH.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DPaige%26aufirst%3DM.%2BA.%26aulast%3DMcDowell%26aufirst%3DB.%2BE.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26aulast%3DLevin%26aufirst%3DE.%2BD.%26atitle%3DSazetidine-A%252C%2520a%2520selective%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520ligand%253A%2520effects%2520on%2520dizocilpine%2520and%2520scopolamine-induced%2520attentional%2520impairments%2520in%2520female%2520Sprague-Dawley%2520rats%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D2011%26volume%3D215%26spage%3D621%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajjuri, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karadi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Chemistry and pharmacology of nicotinic ligands based on 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol (AMOP-H-OH) for possible use in depression</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1279</span><span class="NLM_x">–</span> <span class="NLM_lpage">1291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1279-1291&author=A.+P.+Kozikowskiauthor=J.+B.+Eatonauthor=K.+M.+Bajjuriauthor=S.+K.+Chellappanauthor=Y.+Chenauthor=S.+Karadiauthor=R.+Heauthor=B.+Caldaroneauthor=M.+Manzanoauthor=P.+W.+Yuenauthor=R.+J.+Lukas&title=Chemistry+and+pharmacology+of+nicotinic+ligands+based+on+6-%5B5-%28azetidin-2-ylmethoxy%29pyridin-3-yl%5Dhex-5-yn-1-ol+%28AMOP-H-OH%29+for+possible+use+in+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DBajjuri%26aufirst%3DK.%2BM.%26aulast%3DChellappan%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKaradi%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DR.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DManzano%26aufirst%3DM.%26aulast%3DYuen%26aufirst%3DP.%2BW.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DChemistry%2520and%2520pharmacology%2520of%2520nicotinic%2520ligands%2520based%2520on%25206-%255B5-%2528azetidin-2-ylmethoxy%2529pyridin-3-yl%255Dhex-5-yn-1-ol%2520%2528AMOP-H-OH%2529%2520for%2520possible%2520use%2520in%2520depression%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1279%26epage%3D1291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Turner, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellano, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blendy, J. A.</span><span> </span><span class="NLM_article-title">Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1124%2Fjpet.110.166280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=20435920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Kisb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2010&pages=665-672&author=J.+R.+Turnerauthor=L.+M.+Castellanoauthor=J.+A.+Blendy&title=Nicotinic+partial+agonists+varenicline+and+sazetidine-A+have+differential+effects+on+affective+behavior"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior</span></div><div class="casAuthors">Turner, Jill R.; Castellano, Laura M.; Blendy, Julie A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">665-672</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Clin. and preclin. studies suggest that nicotinic acetylcholine receptors are involved in affective disorders; therefore, the potential therapeutic value of nicotinic partial agonists as treatments of these disorders is of growing interest.  This study evaluated the effects of acute and chronic administration of nicotine and the α4β2 nicotinic partial agonists varenicline and sazetidine-A in mouse models of anxiety and depression.  Acutely, only nicotine and varenicline had anxiolytic effects in the marble-burying test and in the novelty-induced hypophagia (NIH) test.  In contrast, in animal models of antidepressant efficacy, such as the forced swim and the tail suspension test, only acute sazetidine-A had significant antidepressant-like effects.  The NIH test provides an anxiety-related measure that is sensitive to the effects of chronic but not acute antidepressant treatment.  Chronic nicotine and chronic sazetidine-A treatment were effective in this paradigm, but varenicline was ineffective.  These results suggest that the partial agonists varenicline and sazetidine-A may have diverse therapeutic benefits in affective disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogo1Sj2UHr5bVg90H21EOLACvtfcHk0lg1m6SB0zTZWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Kisb%252FE&md5=79c7a0573c7aea5e0bb72ab5d5a4e05d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.166280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.166280%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DJ.%2BR.%26aulast%3DCastellano%26aufirst%3DL.%2BM.%26aulast%3DBlendy%26aufirst%3DJ.%2BA.%26atitle%3DNicotinic%2520partial%2520agonists%2520varenicline%2520and%2520sazetidine-A%2520have%2520differential%2520effects%2520on%2520affective%2520behavior%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D334%26spage%3D665%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Caldarone, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedolak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanania, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picciotto, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghavami, A.</span><span> </span><span class="NLM_article-title">Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380</span> <span class="citation_source-journal">Psychopharmacology (Berlin, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">217</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1007%2Fs00213-011-2271-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=21487659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksFymt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=2011&pages=199-210&author=B.+J.+Caldaroneauthor=D.+Wangauthor=N.+E.+Patersonauthor=M.+Manzanoauthor=A.+Fedolakauthor=K.+Cavinoauthor=M.+Kwanauthor=T.+Hananiaauthor=S.+K.+Chellappanauthor=A.+P.+Kozikowskiauthor=B.+Olivierauthor=M.+R.+Picciottoauthor=A.+Ghavami&title=Dissociation+between+duration+of+action+in+the+forced+swim+test+in+mice+and+nicotinic+acetylcholine+receptor+occupancy+with+sazetidine%2C+varenicline%2C+and+5-I-A85380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380</span></div><div class="casAuthors">Caldarone, Barbara J.; Wang, Daguang; Paterson, Neil E.; Manzano, Michael; Fedolak, Allison; Cavino, Katie; Kwan, Mei; Hanania, Taleen; Chellappan, Sheela K.; Kozikowski, Alan P.; Olivier, Berend; Picciotto, Marina R.; Ghavami, Afshin</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-210</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: Nicotinic acetylcholine receptor (nAChR) agonists, partial agonists, and antagonists have antidepressant-like effects in rodents and reduce symptoms of depression in humans.  Objectives: The study detd. whether the antidepressant-like effect of the nAChR β2* partial agonist sazetidine-A (sazetidine) in the forced swim test was due to activation or desensitization of β2* nAChRs.  The study also detd. if sazetidine's behavioral responses in the forced swim test corresponded to β2* nAChRs receptor occupancy and drug bioavailability.  Results: Acute antidepressant-like effects in the forced swim test were seen with sazetidine and the full β2* agonist 5-I-A8350 (BALB/cJ mice) and the less selective β2* partial agonist varenicline in C57BL/6J but not BALB/cJ mice.  The role of β2* nAChRs was confirmed by results showing: (1) reversal of sazetidine's antidepressant-like effects in the forced swim test by nAChR antagonists mecamylamine and dihydro-β-erythroidine; (2) absence of sazetidine's effect in mice lacking the β2 subunit of the nAChR; and (3) a high correspondence between behaviorally active doses of sazetidine and β2* receptor occupancy. β2* receptor occupancy following acute sazetidine, varenicline, and 5-I-A8350 lasted beyond the duration of action in the forced swim test.  Sazetidine's long lasting receptor occupancy did not diminish behavioral efficacy in the forced swim test following repeated dosing.  Conclusions: Results demonstrate that activation of a small population of β2* nAChRs (10-40%) is sufficient to elicit sazetidine's antidepressant-like actions without producing tolerance and suggest that ligands that activate β2* nAChRs would be promising targets for the development of a new class of antidepressant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriIAbTX2Qb67Vg90H21EOLACvtfcHk0lhCiadgfIZQSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksFymt7g%253D&md5=794495af9e8426b2ab966c35efa35c54</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2Fs00213-011-2271-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-011-2271-y%26sid%3Dliteratum%253Aachs%26aulast%3DCaldarone%26aufirst%3DB.%2BJ.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DPaterson%26aufirst%3DN.%2BE.%26aulast%3DManzano%26aufirst%3DM.%26aulast%3DFedolak%26aufirst%3DA.%26aulast%3DCavino%26aufirst%3DK.%26aulast%3DKwan%26aufirst%3DM.%26aulast%3DHanania%26aufirst%3DT.%26aulast%3DChellappan%26aufirst%3DS.%2BK.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DOlivier%26aufirst%3DB.%26aulast%3DPicciotto%26aufirst%3DM.%2BR.%26aulast%3DGhavami%26aufirst%3DA.%26atitle%3DDissociation%2520between%2520duration%2520of%2520action%2520in%2520the%2520forced%2520swim%2520test%2520in%2520mice%2520and%2520nicotinic%2520acetylcholine%2520receptor%2520occupancy%2520with%2520sazetidine%252C%2520varenicline%252C%2520and%25205-I-A85380%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D2011%26volume%3D217%26spage%3D199%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Hussmann, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">A new radioligand binding assay to measure the concentration of drugs in rodent brain ex vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">434</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1124%2Fjpet.112.198069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKktbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2012&pages=434-440&author=G.+P.+Hussmannauthor=K.+J.+Kellar&title=A+new+radioligand+binding+assay+to+measure+the+concentration+of+drugs+in+rodent+brain+ex+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A new radioligand binding assay to measure the concentration of drugs in rodent brain ex vivo</span></div><div class="casAuthors">Hussmann, G. Patrick; Kellar, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">434-440</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We have developed a new radioligand binding assay method to measure the concn. of nonradiolabeled drugs in the brain ex vivo.  This new method fuses the concepts of std. competition and satn. binding assays and uses a transformed version of the Cheng-Prusoff equation to calc. the drug concn.  After testing the validity of this method, we demonstrated its utility by measuring the brain concn. of sazetidine-A, a newly developed nicotinic receptor ligand, and its elimination rate after a single s.c. administration.  Our results indicate that sazetidine-A reaches brain concns. that are known to occupy and desensitize the majority of neuronal nicotinic acetylcholine receptor binding sites.  Furthermore, using this method, we estd. the half-life of sazetidine-A in the rat brain to be ∼65 min.  It is important to note that the method described here to measure sazetidine-A in brain should be generalizable to other drugs acting at any receptor that can be reliably measured with a radiolabeled ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow0WwOgz6LirVg90H21EOLACvtfcHk0lhCiadgfIZQSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKktbrJ&md5=ff350de1808d774bdca967d0339dba0e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.198069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.198069%26sid%3Dliteratum%253Aachs%26aulast%3DHussmann%26aufirst%3DG.%2BP.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DA%2520new%2520radioligand%2520binding%2520assay%2520to%2520measure%2520the%2520concentration%2520of%2520drugs%2520in%2520rodent%2520brain%2520ex%2520vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D343%26spage%3D434%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Severin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doye, S.</span><span> </span><span class="NLM_article-title">One-pot procedure for the synthesis of unsymmetrical diarylalkynes</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">3518</span><span class="NLM_x">–</span> <span class="NLM_lpage">3521</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo100460v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=3518-3521&author=R.+Severinauthor=J.+Reimerauthor=S.+Doye&title=One-pot+procedure+for+the+synthesis+of+unsymmetrical+diarylalkynes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjo100460v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo100460v%26sid%3Dliteratum%253Aachs%26aulast%3DSeverin%26aufirst%3DR.%26aulast%3DReimer%26aufirst%3DJ.%26aulast%3DDoye%26aufirst%3DS.%26atitle%3DOne-pot%2520procedure%2520for%2520the%2520synthesis%2520of%2520unsymmetrical%2520diarylalkynes%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D75%26spage%3D3518%26epage%3D3521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Holladay, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daanen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryther, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasicak, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kincaid, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hettinger, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannon, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly-Roberts, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunther, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntzweiler, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span> </span><span class="NLM_article-title">Structure–activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2797</span><span class="NLM_x">–</span> <span class="NLM_lpage">2802</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=2797-2802&author=M.+W.+Holladayauthor=H.+Baiauthor=Y.+Liauthor=N.+H.+Linauthor=J.+F.+Daanenauthor=K.+B.+Rytherauthor=J.+T.+Wasicakauthor=J.+F.+Kincaidauthor=Y.+Heauthor=A.+M.+Hettingerauthor=P.+Huangauthor=D.+J.+Andersonauthor=A.+W.+Bannonauthor=M.+J.+Buckleyauthor=J.+E.+Campbellauthor=D.+L.+Donnelly-Robertsauthor=K.+L.+Guntherauthor=D.+J.+Kimauthor=T.+A.+Kuntzweilerauthor=J.+P.+Sullivanauthor=M.+W.+Deckerauthor=S.+P.+Arneric&title=Structure%E2%80%93activity+studies+related+to+ABT-594%2C+a+potent+nonopioid+analgesic+agent%3A+effect+of+pyridine+and+azetidine+ring+substitutions+on+nicotinic+acetylcholine+receptor+binding+affinity+and+analgesic+activity+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolladay%26aufirst%3DM.%2BW.%26aulast%3DBai%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DN.%2BH.%26aulast%3DDaanen%26aufirst%3DJ.%2BF.%26aulast%3DRyther%26aufirst%3DK.%2BB.%26aulast%3DWasicak%26aufirst%3DJ.%2BT.%26aulast%3DKincaid%26aufirst%3DJ.%2BF.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DHettinger%26aufirst%3DA.%2BM.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DBannon%26aufirst%3DA.%2BW.%26aulast%3DBuckley%26aufirst%3DM.%2BJ.%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26aulast%3DGunther%26aufirst%3DK.%2BL.%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DKuntzweiler%26aufirst%3DT.%2BA.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26atitle%3DStructure%25E2%2580%2593activity%2520studies%2520related%2520to%2520ABT-594%252C%2520a%2520potent%2520nonopioid%2520analgesic%2520agent%253A%2520effect%2520of%2520pyridine%2520and%2520azetidine%2520ring%2520substitutions%2520on%2520nicotinic%2520acetylcholine%2520receptor%2520binding%2520affinity%2520and%2520analgesic%2520activity%2520in%2520mice%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D2797%26epage%3D2802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwoskin, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, C. G.</span><span> </span><span class="NLM_article-title">Modeling multiple species of nicotine and deschloroepibatidine interacting with alpha4beta2 nicotinic acetylcholine receptor: from microscopic binding to phenomenological binding affinity</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">14401</span><span class="NLM_x">–</span> <span class="NLM_lpage">14414</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja052681%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=14401-14414&author=X.+Huangauthor=F.+Zhengauthor=P.+A.+Crooksauthor=L.+P.+Dwoskinauthor=C.+G.+Zhan&title=Modeling+multiple+species+of+nicotine+and+deschloroepibatidine+interacting+with+alpha4beta2+nicotinic+acetylcholine+receptor%3A+from+microscopic+binding+to+phenomenological+binding+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fja052681%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja052681%252B%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DF.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26aulast%3DZhan%26aufirst%3DC.%2BG.%26atitle%3DModeling%2520multiple%2520species%2520of%2520nicotine%2520and%2520deschloroepibatidine%2520interacting%2520with%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%253A%2520from%2520microscopic%2520binding%2520to%2520phenomenological%2520binding%2520affinity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D14401%26epage%3D14414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Karlin, A.</span><span> </span><span class="NLM_article-title">Emerging structure of the nicotinic acetylcholine receptors</span> <span class="citation_source-journal">Nature Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1038%2Fnrn731" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=11836518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD38Xhslyju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=102-114&author=A.+Karlin&title=Emerging+structure+of+the+nicotinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging structure of the nicotinic acetylcholine receptors</span></div><div class="casAuthors">Karlin, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">102-114</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The conversion of acetylcholine binding into ion conduction across the membrane is becoming more clearly understood in terms of the structure of the receptor and its transitions.  A high-resoln. structure of a protein that is homologous to the extracellular domain of the receptor has revealed the binding sites and subunit interfaces in great detail.  Although the structures of the membrane and cytoplasmic domains are less well detd., the channel lining and the determinants of selectivity have been mapped.  The location and structure of the gates, and the coupling between binding sites and gates, remain to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonRXMxN_TWwbVg90H21EOLACvtfcHk0liAfDpqNnM6PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xhslyju7Y%253D&md5=c2f51e06285cb371e35aff13814f2858</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnrn731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn731%26sid%3Dliteratum%253Aachs%26aulast%3DKarlin%26aufirst%3DA.%26atitle%3DEmerging%2520structure%2520of%2520the%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DNature%2520Rev.%2520Neurosci.%26date%3D2002%26volume%3D3%26spage%3D102%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Karlin, A.</span><span> </span><span class="NLM_article-title">A touching picture of nicotinic binding</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">842</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2004&pages=841-842&author=A.+Karlin&title=A+touching+picture+of+nicotinic+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarlin%26aufirst%3DA.%26atitle%3DA%2520touching%2520picture%2520of%2520nicotinic%2520binding%26jtitle%3DNeuron%26date%3D2004%26volume%3D41%26spage%3D841%26epage%3D842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Lester, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dibas, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leite, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, D. A.</span><span> </span><span class="NLM_article-title">Cys-loop receptors: new twists and turns</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=329-336&author=H.+A.+Lesterauthor=M.+I.+Dibasauthor=D.+S.+Dahanauthor=J.+F.+Leiteauthor=D.+A.+Dougherty&title=Cys-loop+receptors%3A+new+twists+and+turns"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLester%26aufirst%3DH.%2BA.%26aulast%3DDibas%26aufirst%3DM.%2BI.%26aulast%3DDahan%26aufirst%3DD.%2BS.%26aulast%3DLeite%26aufirst%3DJ.%2BF.%26aulast%3DDougherty%26aufirst%3DD.%2BA.%26atitle%3DCys-loop%2520receptors%253A%2520new%2520twists%2520and%2520turns%26jtitle%3DTrends%2520Neurosci.%26date%3D2004%26volume%3D27%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Unwin, N.</span><span> </span><span class="NLM_article-title">Refined structure of the nicotinic acetylcholine receptor at 4A resolution</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">989</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2005&pages=967-989&author=N.+Unwin&title=Refined+structure+of+the+nicotinic+acetylcholine+receptor+at+4A+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUnwin%26aufirst%3DN.%26atitle%3DRefined%2520structure%2520of%2520the%2520nicotinic%2520acetylcholine%2520receptor%2520at%25204A%2520resolution%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D346%26spage%3D967%26epage%3D989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Brejc, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dijk, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaassen, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuurmans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Der, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sixma, T. K.</span><span> </span><span class="NLM_article-title">Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">411</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1038%2F35077011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=11357122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjvF2qsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=269-276&author=K.+Brejcauthor=W.+J.+van+Dijkauthor=R.+V.+Klaassenauthor=M.+Schuurmansauthor=O.+J.+van+Derauthor=A.+B.+Smitauthor=T.+K.+Sixma&title=Crystal+structure+of+an+ACh-binding+protein+reveals+the+ligand-binding+domain+of+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors</span></div><div class="casAuthors">Brejc, Katusa; van Dijk, Willem J.; Klaassen, Remco V.; Schuurmans, Mascha; van der Oost, John; Smit, August B.; Sixma, Lia K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">411</span>
        (<span class="NLM_cas:issue">6835</span>),
    <span class="NLM_cas:pages">269-276</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pentameric ligand gated ion-channels, or Cys-loop receptors, mediate rapid chem. transmission of signals.  This superfamily of allosteric transmembrane proteins includes the nicotinic acetylcholine (nAChR), serotonin 5-HT3, γ-aminobutyric-acid (GABAA and GABAC) and glycine receptors.  Biochem. and electrophysiol. information on the prototypic nAChRs is abundant but structural data at at. resoln. have been missing.  Here we present the crystal structure of molluscan acetylcholine-binding protein (AChBP), a structural and functional homolog of the amino-terminal ligand-binding domain of an nAChR a-subunit.  In the AChBP homopentamer, the protomers have an Ig-like topol.  Ligand-binding sites are located at each of five subunit interfaces and contain residues contributed by biochem. detd. 'loops' A to F.  The subunit interfaces are highly variable within the ion-channel family, whereas the conserved residues stabilize the protomer fold.  This AChBP structure is relevant for the development of drugs against, for example, Alzheimer's disease and nicotine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvp9q8syDJx7Vg90H21EOLACvtfcHk0lh4ZdLXpevZEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjvF2qsbc%253D&md5=db9f0bb3f46a8fc98cbb25781d6c4775</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2F35077011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35077011%26sid%3Dliteratum%253Aachs%26aulast%3DBrejc%26aufirst%3DK.%26aulast%3Dvan%2BDijk%26aufirst%3DW.%2BJ.%26aulast%3DKlaassen%26aufirst%3DR.%2BV.%26aulast%3DSchuurmans%26aufirst%3DM.%26aulast%3Dvan%2BDer%26aufirst%3DO.%2BJ.%26aulast%3DSmit%26aufirst%3DA.%2BB.%26aulast%3DSixma%26aufirst%3DT.%2BK.%26atitle%3DCrystal%2520structure%2520of%2520an%2520ACh-binding%2520protein%2520reveals%2520the%2520ligand-binding%2520domain%2520of%2520nicotinic%2520receptors%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D269%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Celie, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossum-Fikkert, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dijk, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brejc, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sixma, T. K.</span><span> </span><span class="NLM_article-title">Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">914</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1016%2FS0896-6273%2804%2900115-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=15046723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtValtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2004&pages=907-914&author=P.+H.+Celieauthor=S.+E.+Rossum-Fikkertauthor=W.+J.+van+Dijkauthor=K.+Brejcauthor=A.+B.+Smitauthor=T.+K.+Sixma&title=Nicotine+and+carbamylcholine+binding+to+nicotinic+acetylcholine+receptors+as+studied+in+AChBP+crystal+structures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures</span></div><div class="casAuthors">Celie, Patrick H. N.; Van Rossum-Fikkert, Sarah E.; Van Dijk, Willem J.; Brejc, Katjusa; Smit, August B.; Sixma, Titia K.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">907-914</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors are prototypes for the pharmaceutically important family of pentameric ligand-gated ion channels.  Here the authors present at. resoln. structures of nicotine and carbamylcholine binding to AChBP, a water-sol. homolog of the ligand binding domain of nicotinic receptors and their family members, GABAA, GABAC, 5HT3 serotonin, and glycine receptors.  Ligand binding is driven by enthalpy and is accompanied by conformational changes in the ligand binding site.  Residues in the binding site contract around the ligand, with the largest movement in the C loop.  As expected, the binding is characterized by substantial arom. and hydrophobic contributions, but addnl. there are close contacts between protein oxygens and pos. charged groups in the ligands.  The higher affinity of nicotine is due to a main chain hydrogen bond with the B loop and a closer packing of the arom. groups.  These structures will be useful tools for the development of new drugs involving nicotinic acetylcholine receptor-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUnXnRu5RRsrVg90H21EOLACvtfcHk0lh4ZdLXpevZEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtValtLg%253D&md5=4a4b5058b4b4543d25080dc86c8567f4</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2804%2900115-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252804%252900115-1%26sid%3Dliteratum%253Aachs%26aulast%3DCelie%26aufirst%3DP.%2BH.%26aulast%3DRossum-Fikkert%26aufirst%3DS.%2BE.%26aulast%3Dvan%2BDijk%26aufirst%3DW.%2BJ.%26aulast%3DBrejc%26aufirst%3DK.%26aulast%3DSmit%26aufirst%3DA.%2BB.%26aulast%3DSixma%26aufirst%3DT.%2BK.%26atitle%3DNicotine%2520and%2520carbamylcholine%2520binding%2520to%2520nicotinic%2520acetylcholine%2520receptors%2520as%2520studied%2520in%2520AChBP%2520crystal%2520structures%26jtitle%3DNeuron%26date%3D2004%26volume%3D41%26spage%3D907%26epage%3D914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Chico, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Eldik, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, D. M.</span><span> </span><span class="NLM_article-title">Targeting protein kinases in central nervous system disorders</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=892-909&author=L.+K.+Chicoauthor=L.+J.+Van+Eldikauthor=D.+M.+Watterson&title=Targeting+protein+kinases+in+central+nervous+system+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChico%26aufirst%3DL.%2BK.%26aulast%3DVan%2BEldik%26aufirst%3DL.%2BJ.%26aulast%3DWatterson%26aufirst%3DD.%2BM.%26atitle%3DTargeting%2520protein%2520kinases%2520in%2520central%2520nervous%2520system%2520disorders%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D892%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eYAh7_Y_hNoFbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Reichel, A.</span><span> </span><span class="NLM_article-title">Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept</span> <span class="citation_source-journal">Chem. Biodiversity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2030</span><span class="NLM_x">–</span> <span class="NLM_lpage">2049</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=2030-2049&author=A.+Reichel&title=Addressing+central+nervous+system+%28CNS%29+penetration+in+drug+discovery%3A+basics+and+implications+of+the+evolving+new+concept"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReichel%26aufirst%3DA.%26atitle%3DAddressing%2520central%2520nervous%2520system%2520%2528CNS%2529%2520penetration%2520in%2520drug%2520discovery%253A%2520basics%2520and%2520implications%2520of%2520the%2520evolving%2520new%2520concept%26jtitle%3DChem.%2520Biodiversity%26date%3D2009%26volume%3D6%26spage%3D2030%26epage%3D2049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudkins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200100h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=50-68&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=R.+L.+Hudkinsauthor=B.+D.+Dorseyauthor=J.+P.+Mallamo&title=Knowledge-Based%2C+Central+Nervous+System+%28CNS%29+Lead+Selection+and+Lead+Optimization+for+CNS+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Hudkins, Robert L.; Dorsey, Bruce D.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-68</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The central nervous system (CNS) is the major area that is affected by aging.  Alzheimer's disease (AD), Parkinson's disease (PD), brain cancer, and stroke are the CNS diseases that will cost trillions of dollars for their treatment.  Achievement of appropriate blood-brain barrier (BBB) penetration is often considered a significant hurdle in the CNS drug discovery process.  On the other hand, BBB penetration may be a liability for many of the non-CNS drug targets, and a clear understanding of the physicochem. and structural differences between CNS and non-CNS drugs may assist both research areas.  Because of the numerous and challenging issues in CNS drug discovery and the low success rates, pharmaceutical companies are beginning to deprioritize their drug discovery efforts in the CNS arena.  Prompted by these challenges and to aid in the design of high-quality, efficacious CNS compds., we analyzed the physicochem. property and the chem. structural profiles of 317 CNS and 626 non-CNS oral drugs.  The conclusions derived provide an ideal property profile for lead selection and the property modification strategy during the lead optimization process.  A list of substructural units that may be useful for CNS drug design was also provided here.  A classification tree was also developed to differentiate between CNS drugs and non-CNS oral drugs.  The combined anal. provided the following guidelines for designing high-quality CNS drugs: (i) topol. mol. polar surface area of <76 Å2 (25-60 Å2), (ii) at least one (one or two, including one aliph. amine) nitrogen, (iii) fewer than seven (two to four) linear chains outside of rings, (iv) fewer than three (zero or one) polar hydrogen atoms, (v) vol. of 740-970 Å3, (vi) solvent accessible surface area of 460-580 Å2, and (vii) pos. QikProp parameter CNS.  The ranges within parentheses may be used during lead optimization.  One violation to this proposed profile may be acceptable.  The chemoinformatics approaches for graphically analyzing multiple properties efficiently are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozqfO0vq2i5bVg90H21EOLACvtfcHk0lh66pOW2U5rRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO&md5=4c20ba34c3d5397170b50242975ce25d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fcn200100h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200100h%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge-Based%252C%2520Central%2520Nervous%2520System%2520%2528CNS%2529%2520Lead%2520Selection%2520and%2520Lead%2520Optimization%2520for%2520CNS%2520Drug%2520Discovery%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D50%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Goodwin, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, D. E.</span><span> </span><span class="NLM_article-title">In silico predictions of blood-brain barrier penetration: considerations to “keep in mind”</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1124%2Fjpet.104.075705" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=15919767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyhsbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=477-483&author=J.+T.+Goodwinauthor=D.+E.+Clark&title=In+silico+predictions+of+blood-brain+barrier+penetration%3A+considerations+to+%E2%80%9Ckeep+in+mind%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">In silico predictions of blood-brain barrier penetration: Considerations to "keep in mind"</span></div><div class="casAuthors">Goodwin, Jay T.; Clark, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">477-483</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Within drug discovery, it is desirable to det. whether a compd. will penetrate and distribute within the central nervous system (CNS) with the requisite pharmacokinetic and pharmacodynamic performance required for a CNS target or if it will be excluded from the CNS, wherein potential toxicities would mitigate its applicability.  A variety of in vivo and in vitro methods for assessing CNS penetration have therefore been developed and applied to advancing drug candidates with the desired properties.  In silico methods to predict CNS penetration from chem. structures have been developed to address virtual screening and prospective design.  In silico predictive methods are impacted by the quality, quantity, sources, and generation of the measured data available for model development.  Key considerations for predictions of CNS penetration include the comparison of local (in chem. space) vs. global (more structurally diverse) models and where in the drug discovery process such models may be best deployed.  Preference should also be given to in vitro and in vivo measurements of greater mechanistic clarity that better support the development of structure-property relationships.  Although there are numerous statistical methods that have been brought to bear on the prediction of CNS penetration, a greater concern is that such models are appropriate for the quality of measured data available and are statistically validated.  In addn., the assessment of prediction uncertainty and relevance of predictive models to structures of interest are crit.  This article will address these key considerations for the development and application of in silico methods in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkNjlmzY1VybVg90H21EOLACvtfcHk0lh66pOW2U5rRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyhsbbO&md5=c984d13b5cd032f2c686811af02d8be5</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.075705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.075705%26sid%3Dliteratum%253Aachs%26aulast%3DGoodwin%26aufirst%3DJ.%2BT.%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DIn%2520silico%2520predictions%2520of%2520blood-brain%2520barrier%2520penetration%253A%2520considerations%2520to%2520%25E2%2580%259Ckeep%2520in%2520mind%25E2%2580%259D%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26spage%3D477%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Clark, D. E.</span><span> </span><span class="NLM_article-title">Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood–brain barrier penetration</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=815-821&author=D.+E.+Clark&title=Rapid+calculation+of+polar+molecular+surface+area+and+its+application+to+the+prediction+of+transport+phenomena.+2.+Prediction+of+blood%E2%80%93brain+barrier+penetration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DRapid%2520calculation%2520of%2520polar%2520molecular%2520surface%2520area%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520transport%2520phenomena.%25202.%2520Prediction%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520penetration%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D815%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Abad-Zapatero, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perisic, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bento, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Lazikani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. E.</span><span> </span><span class="NLM_article-title">Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">804</span><span class="NLM_x">–</span> <span class="NLM_lpage">811</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=804-811&author=C.+Abad-Zapateroauthor=O.+Perisicauthor=J.+Wassauthor=A.+P.+Bentoauthor=J.+Overingtonauthor=B.+Al-Lazikaniauthor=M.+E.+Johnson&title=Ligand+efficiency+indices+for+an+effective+mapping+of+chemico-biological+space%3A+the+concept+of+an+atlas-like+representation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26aulast%3DPerisic%26aufirst%3DO.%26aulast%3DWass%26aufirst%3DJ.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DOverington%26aufirst%3DJ.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DM.%2BE.%26atitle%3DLigand%2520efficiency%2520indices%2520for%2520an%2520effective%2520mapping%2520of%2520chemico-biological%2520space%253A%2520the%2520concept%2520of%2520an%2520atlas-like%2520representation%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D804%26epage%3D811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eaVDUAQ4npgNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Hajek, P.; McRobbie, H.; Myers, K.</span><span> </span><span class="NLM_article-title">Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis</span>.  <span class="citation_source-journal">Thorax</span>.<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1136/thoraxjnl-2012-203035</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1136%2Fthoraxjnl-2012-203035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=P.+Hajek&author=H.+McRobbie&author=K.+Myers&title=Efficacy+of+cytisine+in+helping+smokers+quit%3A+systematic+review+and+meta-analysis&doi=10.1136%2Fthoraxjnl-2012-203035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1136%2Fthoraxjnl-2012-203035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fthoraxjnl-2012-203035%26sid%3Dliteratum%253Aachs%26aulast%3DHajek%26aufirst%3DP.%26atitle%3DEfficacy%2520of%2520cytisine%2520in%2520helping%2520smokers%2520quit%253A%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DThorax%26date%3D2013%26doi%3D10.1136%2Fthoraxjnl-2012-203035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Freedman, R.</span><span> </span><span class="NLM_article-title">Exacerbation of schizophrenia by varenicline</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">1269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1176%2Fappi.ajp.2007.07020326" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A280%3ADC%252BD2svltlWmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2007&pages=1269&author=R.+Freedman&title=Exacerbation+of+schizophrenia+by+varenicline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Exacerbation of schizophrenia by varenicline</span></div><div class="casAuthors">Freedman Robert</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1269</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgv_jWdHp-NexsqfvU0ziafW6udTcc2eaVDUAQ4npgNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svltlWmuw%253D%253D&md5=8389f7c87888934aedf57502ecff5f3c</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2007.07020326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2007.07020326%26sid%3Dliteratum%253Aachs%26aulast%3DFreedman%26aufirst%3DR.%26atitle%3DExacerbation%2520of%2520schizophrenia%2520by%2520varenicline%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2007%26volume%3D164%26spage%3D1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Kohen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremen, N.</span><span> </span><span class="NLM_article-title">Varenicline-induced manic episode in a patient with bipolar disorder</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">1269</span><span class="NLM_x">–</span> <span class="NLM_lpage">1270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1176%2Fappi.ajp.2007.07010173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A280%3ADC%252BD2svltlWmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2007&pages=1269-1270&author=I.+Kohenauthor=N.+Kremen&title=Varenicline-induced+manic+episode+in+a+patient+with+bipolar+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Varenicline-induced manic episode in a patient with bipolar disorder</span></div><div class="casAuthors">Kohen Izchak; Kremen Neil</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1269-70</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgv_jWdHp-NVMGsG_HTXYFfW6udTcc2eaVDUAQ4npgNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svltlWmug%253D%253D&md5=a3fbe2ee3eb4f13eeb6af62c5d843338</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2007.07010173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2007.07010173%26sid%3Dliteratum%253Aachs%26aulast%3DKohen%26aufirst%3DI.%26aulast%3DKremen%26aufirst%3DN.%26atitle%3DVarenicline-induced%2520manic%2520episode%2520in%2520a%2520patient%2520with%2520bipolar%2520disorder%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2007%26volume%3D164%26spage%3D1269%26epage%3D1270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loke, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spangler, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furberg, C. D.</span><span> </span><span class="NLM_article-title">Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis</span> <span class="citation_source-journal">Can. Med. Assoc. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">183</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1503%2Fcmaj.110218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A280%3ADC%252BC3MfhsFSmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2011&pages=1359-1366&author=S.+Singhauthor=Y.+K.+Lokeauthor=J.+G.+Spanglerauthor=C.+D.+Furberg&title=Risk+of+serious+adverse+cardiovascular+events+associated+with+varenicline%3A+a+systematic+review+and+meta-analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis</span></div><div class="casAuthors">Singh Sonal; Loke Yoon K; Spangler John G; Furberg Curt D</div><div class="citationInfo"><span class="NLM_cas:title">CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1359-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  There have been postmarketing reports of adverse cardiovascular events associated with the use of varenicline, a widely used smoking cessation drug.  We conducted a systematic review and meta-analysis of randomized controlled trials to ascertain the serious adverse cardiovascular effects of varenicline compared with placebo among tobacco users.  METHODS:  We searched MEDLINE, EMBASE, the Cochrane Database of Systematic Reviews, websites of regulatory authorities and registries of clinical trials, with no date or language restrictions, through September 2010 (updated March 2011) for published and unpublished studies.  We selected double-blind randomized controlled trials of at least one week's duration involving smokers or people who used smokeless tobacco that reported on cardiovascular events (ischemia, arrhythmia, congestive heart failure, sudden death or cardiovascular-related death) as serious adverse events asociated with the use of varenicline.  RESULTS:  We analyzed data from 14 double-blind randomized controlled trials involving 8216 participants.  The trials ranged in duration from 7 to 52 weeks.  Varenicline was associated with a significantly increased risk of serious adverse cardiovascular events compared with placebo (1.06% [52/4908] in varenicline group v. 0.82% [27/3308] in placebo group; Peto odds ratio [OR] 1.72, 95% confidence interval [CI] 1.09-2.71; I(2) = 0%).  The results of various sensitivity analyses were consistent with those of the main analysis, and a funnel plot showed no publication bias.  There were too few deaths to allow meaningful comparisons of mortality.  INTERPRETATION:  Our meta-analysis raises safety concerns about the potential for an increased risk of serious adverse cardiovascular events associated with the use of varenicline among tobacco users.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSrDMC_9K9Fp4JKJbLTgsvCfW6udTcc2eaVDUAQ4npgNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MfhsFSmsQ%253D%253D&md5=c2bb69c9bb341769a153c69d98440d9f</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1503%2Fcmaj.110218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1503%252Fcmaj.110218%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DLoke%26aufirst%3DY.%2BK.%26aulast%3DSpangler%26aufirst%3DJ.%2BG.%26aulast%3DFurberg%26aufirst%3DC.%2BD.%26atitle%3DRisk%2520of%2520serious%2520adverse%2520cardiovascular%2520events%2520associated%2520with%2520varenicline%253A%2520a%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DCan.%2520Med.%2520Assoc.%2520J.%26date%3D2011%26volume%3D183%26spage%3D1359%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Coe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetelino, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirtz, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrikhande, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heym, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollema, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansbach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovetti, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3474</span><span class="NLM_x">–</span> <span class="NLM_lpage">3477</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050069n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3474-3477&author=J.+W.+Coeauthor=P.+R.+Brooksauthor=M.+G.+Vetelinoauthor=M.+C.+Wirtzauthor=E.+P.+Arnoldauthor=J.+Huangauthor=S.+B.+Sandsauthor=T.+I.+Davisauthor=L.+A.+Lebelauthor=C.+B.+Foxauthor=A.+Shrikhandeauthor=J.+H.+Heymauthor=E.+Schaefferauthor=H.+Rollemaauthor=Y.+Luauthor=R.+S.+Mansbachauthor=L.+K.+Chambersauthor=C.+C.+Rovettiauthor=D.+W.+Schulzauthor=F.+D.+Tingleyauthor=B.+T.+O%E2%80%99Neill&title=Varenicline%3A+an+alpha4beta2+nicotinic+receptor+partial+agonist+for+smoking+cessation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm050069n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050069n%26sid%3Dliteratum%253Aachs%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DBrooks%26aufirst%3DP.%2BR.%26aulast%3DVetelino%26aufirst%3DM.%2BG.%26aulast%3DWirtz%26aufirst%3DM.%2BC.%26aulast%3DArnold%26aufirst%3DE.%2BP.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DSands%26aufirst%3DS.%2BB.%26aulast%3DDavis%26aufirst%3DT.%2BI.%26aulast%3DLebel%26aufirst%3DL.%2BA.%26aulast%3DFox%26aufirst%3DC.%2BB.%26aulast%3DShrikhande%26aufirst%3DA.%26aulast%3DHeym%26aufirst%3DJ.%2BH.%26aulast%3DSchaeffer%26aufirst%3DE.%26aulast%3DRollema%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMansbach%26aufirst%3DR.%2BS.%26aulast%3DChambers%26aufirst%3DL.%2BK.%26aulast%3DRovetti%26aufirst%3DC.%2BC.%26aulast%3DSchulz%26aufirst%3DD.%2BW.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DVarenicline%253A%2520an%2520alpha4beta2%2520nicotinic%2520receptor%2520partial%2520agonist%2520for%2520smoking%2520cessation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3474%26epage%3D3477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Lummis, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bencherif, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lester, H. A.</span><span> </span><span class="NLM_article-title">Varenicline is a potent agonist of the human 5-hydroxytryptamine3 receptor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1124%2Fjpet.111.185306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=21775477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2011&pages=125-131&author=S.+C.+Lummisauthor=A.+J.+Thompsonauthor=M.+Bencherifauthor=H.+A.+Lester&title=Varenicline+is+a+potent+agonist+of+the+human+5-hydroxytryptamine3+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Varenicline is a potent agonist of the human 5-hydroxytryptamine3 receptor</span></div><div class="casAuthors">Lummis, S. C. R.; Thompson, A. J.; Bencherif, M.; Lester, H. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-131</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Varenicline, a widely used and successful smoking cessation agent, acts as a partial agonist at nicotinic acetylcholine receptors.  Here, we explore the effects of varenicline at human and mouse 5-Hydroxytryptamine3 (5-HT3) receptors.  Application of varenicline to human 5-HT3 receptors expressed in Xenopus laevis oocytes reveal it is almost a full agonist (Rmax = 80%) with an EC50 (5.9 μM) 3-fold higher than 5-HT.  At mouse 5-HT3 receptors varenicline is a partial agonist (Rmax = 35%) with an EC50 (18 μM) 20-fold higher than 5-HT.  Displacement of the competitive 5-HT3 receptor antagonist [3H]granisetron reveals similar IC50 values for varenicline at mouse and human receptors expressed in human embryonic kidney 293 cells, although studies in these cells using a membrane potential-sensitive dye show that again varenicline is a 4- or 35-fold less potent agonist than 5-HT in human and mouse receptors, resp.  Thus the data suggest that the efficacy, but not the affinity, of varenicline is greater at human 5-HT3 receptors compared with mouse.  Docking studies provide a possible explanation for this difference, because they suggest distinct orientations of the ligand in the mouse vs. human 5-HT3 agonist binding sites.  Addnl. binding selectivity studies in a broad panel of recombinant receptors and enzymes confirmed an interaction with 5-HT3 receptors but revealed no addnl. interactions of varenicline.  Therefore, activation of human 5-HT3 receptors may be responsible for some of the side effects that preclude use of higher doses during varenicline treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-VGq4L9Bf07Vg90H21EOLACvtfcHk0lhiAPelALOQFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbnK&md5=9fb7fd670366ce842e5e252cdebbef15</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.185306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.185306%26sid%3Dliteratum%253Aachs%26aulast%3DLummis%26aufirst%3DS.%2BC.%26aulast%3DThompson%26aufirst%3DA.%2BJ.%26aulast%3DBencherif%26aufirst%3DM.%26aulast%3DLester%26aufirst%3DH.%2BA.%26atitle%3DVarenicline%2520is%2520a%2520potent%2520agonist%2520of%2520the%2520human%25205-hydroxytryptamine3%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D339%26spage%3D125%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Johnson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezvani, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, E. D.</span><span> </span><span class="NLM_article-title">Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats</span> <span class="citation_source-journal">Psychopharmacology (Berlin, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">222</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1007%2Fs00213-012-2642-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=22297831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Omtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=222&publication_year=2012&pages=269-276&author=J.+E.+Johnsonauthor=S.+Sladeauthor=C.+Wellsauthor=A.+Petroauthor=H.+Sextonauthor=A.+H.+Rezvaniauthor=M.+L.+Brownauthor=M.+A.+Paigeauthor=B.+E.+McDowellauthor=Y.+Xiaoauthor=K.+J.+Kellarauthor=E.+D.+Levin&title=Assessing+the+effects+of+chronic+sazetidine-A+delivery+on+nicotine+self-administration+in+both+male+and+female+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats</span></div><div class="casAuthors">Johnson, Joshua E.; Slade, Susan; Wells, Corinne; Petro, Ann; Sexton, Hannah; Rezvani, Amir H.; Brown, Milton L.; Paige, Mikell A.; McDowell, Brian E.; Xiao, Yingxian; Kellar, Kenneth J.; Levin, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">222</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-276</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: Sazetidine-A is a selective α4β2 nicotinic receptor desensitizing agent and partial agonist.  It has been shown in previous studies to significantly reduce nicotine self-administration in rats after acute or repeated injections.  However, the effects of continuous chronic infusions of sazetidine-A on maintenance of nicotine self-administration and relapse after abstinence have yet to be examd.  Objectives: This study evaluated the efficacy of continuous sazetidine-A infusions (s.c.) over a period of 4 wk to reduce nicotine self-administration in male and female Sprague-Dawley rats.  Methods: Sazetidine-A was administered via Alzet osmotic minipumps to young adult female and male rats at doses of 0, 2 or 6 mg/kg/day for 4 wk.  The effects of sazetidine-A on IV nicotine self-administration were examd. in repeated 3-h sessions over the first 2 wk of infusion followed by 1 wk of forced abstinence from nicotine and 1 wk of resumed nicotine access.  Results: The 6 mg/kg/day sazetidine-A dose significantly reduced overall nicotine self-administration compared with vehicle control across the sessions for both male (p < 0.001) and female (p < 0.05) rats.  The lower 2 mg/kg/day sazetidine-A infusion dose was effective in reducing nicotine self-administration for male (p < 0.001), but not female rats.  No attenuation in sazetidine-A effectiveness was seen over the course of the 4-wk treatment.  In the vehicle control group, male rats self-administered significantly (p < 0.001) more nicotine than females.  Conclusions: The continuing effectiveness of sazetidine-A in reducing nicotine self-administration in both male and female rats supports its promise as a new treatment to help people successfully quit smoking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBZjP3-lA4eLVg90H21EOLACvtfcHk0lhiAPelALOQFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Omtro%253D&md5=2528e80809dcac74a16e4e8d85dff6df</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1007%2Fs00213-012-2642-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-012-2642-z%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DJ.%2BE.%26aulast%3DSlade%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DPetro%26aufirst%3DA.%26aulast%3DSexton%26aufirst%3DH.%26aulast%3DRezvani%26aufirst%3DA.%2BH.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DPaige%26aufirst%3DM.%2BA.%26aulast%3DMcDowell%26aufirst%3DB.%2BE.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26aulast%3DLevin%26aufirst%3DE.%2BD.%26atitle%3DAssessing%2520the%2520effects%2520of%2520chronic%2520sazetidine-A%2520delivery%2520on%2520nicotine%2520self-administration%2520in%2520both%2520male%2520and%2520female%2520rats%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D2012%26volume%3D222%26spage%3D269%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Cucchiaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Sulser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Analgesic effects of sazetidine-A, a new nicotinic cholinergic drug</span> <span class="citation_source-journal">Anesthesiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2008&pages=512-519&author=G.+Cucchiaroauthor=Y.+Xiaoauthor=A.+Gonzalez-Sulserauthor=K.+J.+Kellar&title=Analgesic+effects+of+sazetidine-A%2C+a+new+nicotinic+cholinergic+drug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCucchiaro%26aufirst%3DG.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DGonzalez-Sulser%26aufirst%3DA.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DAnalgesic%2520effects%2520of%2520sazetidine-A%252C%2520a%2520new%2520nicotinic%2520cholinergic%2520drug%26jtitle%3DAnesthesiology%26date%3D2008%26volume%3D109%26spage%3D512%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">AlSharari, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span> </span><span class="NLM_article-title">The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain models</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1124%2Fjpet.112.194506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=22678099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlShu7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2012&pages=742-749&author=S.+D.+AlSharariauthor=F.+I.+Carrollauthor=J.+M.+McIntoshauthor=M.+I.+Damaj&title=The+antinociceptive+effects+of+nicotinic+partial+agonists+varenicline+and+sazetidine-A+in+murine+acute+and+tonic+pain+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain models</span></div><div class="casAuthors">AlSharari, Shakir D.; Carroll, F. Ivy; McIntosh, J. Michael; Damaj, M. Imad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">742-749</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Nicotinic agonists display a wide-range profile of antinociceptive activity in acute, tonic, and chronic pain models.  However, their effectiveness is limited by their unacceptable side effects.  We investigated the antinocicpetive effects of 2 new α4β2* nicotinic partial agonists, varenicline and sazetidine-A, in acute thermal and tonic pain mouse models.  Both drugs failed to induce significant effects in the tail-flick and hot-plate tests after s.c. administration.  However, they blocked nicotine's effects in these tests at very low doses.  In contrast to acute pain tests, varenicline and sazetidine-A dose-dependently induced an analgesic effect in the mouse formalin test after systemic administration.  Their antinociceptive effects were mediated, however, by different nicotinic acetylcholine receptor (nAChR) subtypes.  Sazetidine-A effects were mediated by β2* nAChR subtypes, whereas varenicline actions were attributed to α3β4 nAChRs.  Moreover, low inactive doses of varenicline blocked nicotine's actions in phase II of the formalin test.  Overall, our results suggest that the antagonistic actions of varenicline at low doses are mediated by β2*-nAChRs and at higher doses as an agonist by α3β4*-nAChRs.  In contrast, both actions of sazetidine-A are mediated by β2*-nAChR subtypes.  These results suggest that nicotinic partial agonists possess analgesic effects in a rodent tonic pain model and may provide a potential treatment for the treatment of chronic pain disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1FLMDJFGmn7Vg90H21EOLACvtfcHk0lgKBc7FHV6CHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlShu7nP&md5=2209ccba5e8e2aed3a5bdb09bd908521</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.194506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.194506%26sid%3Dliteratum%253Aachs%26aulast%3DAlSharari%26aufirst%3DS.%2BD.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26atitle%3DThe%2520antinociceptive%2520effects%2520of%2520nicotinic%2520partial%2520agonists%2520varenicline%2520and%2520sazetidine-A%2520in%2520murine%2520acute%2520and%2520tonic%2520pain%2520models%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D342%26spage%3D742%26epage%3D749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Chemistry and pharmacological characterization of novel nitrogen analogues of AMOP-H-OH (sazetidine-A, 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol) as alpha4beta2-nicotinic acetylcholine receptor-selective partial agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6973</span><span class="NLM_x">–</span> <span class="NLM_lpage">6985</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100765u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6973-6985&author=J.+Liuauthor=J.+B.+Eatonauthor=B.+Caldaroneauthor=R.+J.+Lukasauthor=A.+P.+Kozikowski&title=Chemistry+and+pharmacological+characterization+of+novel+nitrogen+analogues+of+AMOP-H-OH+%28sazetidine-A%2C+6-%5B5-%28azetidin-2-ylmethoxy%29pyridin-3-yl%5Dhex-5-yn-1-ol%29+as+alpha4beta2-nicotinic+acetylcholine+receptor-selective+partial+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm100765u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100765u%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DChemistry%2520and%2520pharmacological%2520characterization%2520of%2520novel%2520nitrogen%2520analogues%2520of%2520AMOP-H-OH%2520%2528sazetidine-A%252C%25206-%255B5-%2528azetidin-2-ylmethoxy%2529pyridin-3-yl%255Dhex-5-yn-1-ol%2529%2520as%2520alpha4beta2-nicotinic%2520acetylcholine%2520receptor-selective%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6973%26epage%3D6985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Fiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sali, A.</span><span> </span><span class="NLM_article-title">Modeling of loops in protein structures</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1753</span><span class="NLM_x">–</span> <span class="NLM_lpage">1773</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1110%2Fps.9.9.1753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=11045621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFamsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=1753-1773&author=A.+Fiserauthor=R.+K.+Doauthor=A.+Sali&title=Modeling+of+loops+in+protein+structures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling of loops in protein structures</span></div><div class="casAuthors">Fiser, Andras; Do, Richard Kinh Gian; Sali, Andrej</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1753-1773</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Comparative protein structure prediction is limited mostly by the errors in alignment and loop modeling.  We describe here a new automated modeling technique that significantly improves the accuracy of loop predictions in protein structures.  The positions of all nonhydrogen atoms of the loop are optimized in a fixed environment with respect to a pseudo energy function.  The energy is a sum of many spatial restraints that include the bond length, bond angle, and improper dihedral angle terms from the CHARMM-22 force field, statistical preferences for the main-chain and side-chain dihedral angles, and statistical preferences for nonbonded at. contacts that depend on the two atom types, their distance through space, and sepn. in sequence.  The energy function is optimized with the method of conjugate gradients combined with mol. dynamics and simulated annealing.  Typically, the predicted loop conformation corresponds to the lowest energy conformation among 500 independent optimizations.  Predictions were made for 40 loops of known structure at each length from 1 to 14 residues.  The accuracy of loop predictions is evaluated as a function of thoroughness of conformational sampling, loop length, and structural properties of native loops.  When accuracy is measured by local superposition of the model on the native loop, 100, 90, and 30% of 4-, 8-, and 12-residue loop predictions, resp., had <2 Å RMSD error for the mainchain N, Cα, C, and O atoms; the av. accuracies were 0.59±0.05, 1.16±0.10, and 2.61±0.16 Å, resp.  To simulate real comparative modeling problems, the method was also evaluated by predicting loops of known structure in only approx. correct environments with errors typical of comparative modeling without misalignment.  When the RMSD distortion of the main-chain stem atoms is 2.5 Å, the av. loop prediction error increased by 180, 25, and 3% for 4-, 8-, and 12-residue loops, resp.  The accuracy of the lowest energy prediction for a given loop can be estd. from the structural variability among a no. of low energy predictions.  The relative value of the present method is gauged by (1) comparing it with one of the most successful previously described methods, and (2) describing its accuracy in recent blind predictions of protein structure.  Finally, it is shown that the av. accuracy of prediction is limited primarily by the accuracy of the energy function rather than by the extent of conformational sampling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsbG2px_r_krVg90H21EOLACvtfcHk0lgKBc7FHV6CHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFamsL8%253D&md5=0bcdbfbddf54ecca0e3fee95ecdc3f8b</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1110%2Fps.9.9.1753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.9.9.1753%26sid%3Dliteratum%253Aachs%26aulast%3DFiser%26aufirst%3DA.%26aulast%3DDo%26aufirst%3DR.%2BK.%26aulast%3DSali%26aufirst%3DA.%26atitle%3DModeling%2520of%2520loops%2520in%2520protein%2520structures%26jtitle%3DProtein%2520Sci.%26date%3D2000%26volume%3D9%26spage%3D1753%26epage%3D1773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Altschul, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipman, D. J.</span><span> </span><span class="NLM_article-title">Basic local alignment search tool</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">215</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1016%2FS0022-2836%2805%2980360-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=2231712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADyaK3MXitVGmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=1990&pages=403-410&author=S.+F.+Altschulauthor=W.+Gishauthor=W.+Millerauthor=E.+W.+Myersauthor=D.+J.+Lipman&title=Basic+local+alignment+search+tool"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Basic local alignment search tool</span></div><div class="casAuthors">Altschul, Stephen F.; Gish, Warren; Miller, Webb; Myers, Eugene W.; Lipman, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">403-10</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">A new approach to rapid sequence comparison, basic local alignment search tool (BLAST), directly approximates alignments that optimize a measure of local similarity, the maximal segment pair (MSP) score.  Recent math. results on the stochastic properties of MSP scores allow an anal. of the performance of this method as well as the statistical significance of alignments it generates.  The basic algorithm is simple and robust; it can be implemented in a no. of ways and applied in a variety of contexts including straightforward DNA and protein sequence database searches, motif searches, gene identification searches, and in the anal. of multiple regions of similarity in long DNA sequences.  In addn. to its flexibility and tractability to math. anal., BLAST is an order of magnitude faster than existing sequence comparison tools of comparable sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGEHw-q53MfLVg90H21EOLACvtfcHk0lgCTAIOlZmBwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXitVGmsA%253D%253D&md5=009d2323eb82f0549356880e1101db16</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2805%2980360-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252805%252980360-2%26sid%3Dliteratum%253Aachs%26aulast%3DAltschul%26aufirst%3DS.%2BF.%26aulast%3DGish%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DW.%26aulast%3DMyers%26aufirst%3DE.%2BW.%26aulast%3DLipman%26aufirst%3DD.%2BJ.%26atitle%3DBasic%2520local%2520alignment%2520search%2520tool%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1990%26volume%3D215%26spage%3D403%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Chenna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugawara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. D.</span><span> </span><span class="NLM_article-title">Multiple sequence alignment with the Clustal series of programs</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">3497</span><span class="NLM_x">–</span> <span class="NLM_lpage">3500</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=3497-3500&author=R.+Chennaauthor=H.+Sugawaraauthor=T.+Koikeauthor=R.+Lopezauthor=T.+J.+Gibsonauthor=D.+G.+Higginsauthor=J.+D.+Thompson&title=Multiple+sequence+alignment+with+the+Clustal+series+of+programs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChenna%26aufirst%3DR.%26aulast%3DSugawara%26aufirst%3DH.%26aulast%3DKoike%26aufirst%3DT.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DGibson%26aufirst%3DT.%2BJ.%26aulast%3DHiggins%26aufirst%3DD.%2BG.%26aulast%3DThompson%26aufirst%3DJ.%2BD.%26atitle%3DMultiple%2520sequence%2520alignment%2520with%2520the%2520Clustal%2520series%2520of%2520programs%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2003%26volume%3D31%26spage%3D3497%26epage%3D3500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Case, D. A.; Darden, T. A.; Cheatham, T. E.; Simmerling, C. L.; Wang, J.; Duke, R. E.; Luo, R.; Merz, K. M.; Pearlman, D. A.; Crowley, M.; Walker, R. C.; Zhang, W.; Wang, B.; Hayik, S.; Roitberg, A.; Seabra, G.; Wong, K. F.; Paesani, F.; Wu, X.; Brozell, S.; Tsui, V.; Gohlke, H.; Yang, L.; Tan, C.; Mongan, J.; Hornak, V.; Cui, G.; Beroza, P.; Mathews, D. H.; Schafmeister, C.; Ross, W. S.; Kollman, P. A.</span>AMBER 9; <span class="NLM_publisher-name">University of California</span>: <span class="NLM_publisher-loc">San Francisco</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=D.+A.+Case&author=T.+A.+Darden&author=T.+E.+Cheatham&author=C.+L.+Simmerling&author=J.+Wang&author=R.+E.+Duke&author=R.+Luo&author=K.+M.+Merz&author=D.+A.+Pearlman&author=M.+Crowley&author=R.+C.+Walker&author=W.+Zhang&author=B.+Wang&author=S.+Hayik&author=A.+Roitberg&author=G.+Seabra&author=K.+F.+Wong&author=F.+Paesani&author=X.+Wu&author=S.+Brozell&author=V.+Tsui&author=H.+Gohlke&author=L.+Yang&author=C.+Tan&author=J.+Mongan&author=V.+Hornak&author=G.+Cui&author=P.+Beroza&author=D.+H.+Mathews&author=C.+Schafmeister&author=W.+S.+Ross&author=P.+A.+Kollman&title=AMBER+9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26jtitle%3DAMBER%25209%26pub%3DUniversity%2520of%2520California%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Laskowski, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacArthur, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, J. M.</span><span> </span><span class="NLM_article-title"><i>PROCHECK</i>: a program to check the stereochemical quality of protein structure</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1107%2FS0021889892009944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADyaK3sXit12lurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1993&pages=283-291&author=R.+A.+Laskowskiauthor=M.+W.+MacArthurauthor=D.+S.+Mossauthor=J.+M.+Thornton&title=PROCHECK%3A+a+program+to+check+the+stereochemical+quality+of+protein+structure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">PROCHECK: a program to check the stereochemical quality of protein structures</span></div><div class="casAuthors">Laskowski, Roman A.; MacArthur, Malcolm W.; Moss, David S.; Thornton, Janet M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">283-91</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    </div><div class="casAbstract">The PROCHECK suite of programs provides a detailed check on the stereochem. of a protein structure.  Its outputs comprise a no. of plots in PostScript format and a comprehensive residue-by-residue listing.  These give an assessment of the overall quality of the structure as compared with well-refined structures of the same resoln. and also highlight regions that may need further investigation.  The PROCHECK programs are useful for assessing the quality not only of protein structures in the process of being solved but also of existing structures and of those being modeled on known structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCe5FgJf4KH7Vg90H21EOLACvtfcHk0lgCTAIOlZmBwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit12lurY%253D&md5=fb69fc4410cd716aaaa7cc0db06b3ed2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1107%2FS0021889892009944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889892009944%26sid%3Dliteratum%253Aachs%26aulast%3DLaskowski%26aufirst%3DR.%2BA.%26aulast%3DMacArthur%26aufirst%3DM.%2BW.%26aulast%3DMoss%26aufirst%3DD.%2BS.%26aulast%3DThornton%26aufirst%3DJ.%2BM.%26atitle%3DPROCHECK%253A%2520a%2520program%2520to%2520check%2520the%2520stereochemical%2520quality%2520of%2520protein%2520structure%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1993%26volume%3D26%26spage%3D283%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Vriend, G.</span><span> </span><span class="NLM_article-title">WHAT IF: a molecular modeling and drug design program</span> <span class="citation_source-journal">J. Mol. Graphics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1016%2F0263-7855%2890%2980070-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=2268628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADyaK3cXitFGksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1990&pages=52-56&author=G.+Vriend&title=WHAT+IF%3A+a+molecular+modeling+and+drug+design+program"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">WHAT IF:  a molecular modeling and drug design program</span></div><div class="casAuthors">Vriend, G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-6, 29</span>CODEN:
                <span class="NLM_cas:coden">JMGRDV</span>;
        ISSN:<span class="NLM_cas:issn">0263-7855</span>.
    </div><div class="casAbstract">A FORTRAN 77 computer program has been written to aid with macromol. modeling and drug design.  Called WHAT IF, it provides an intelligent and flexible environment for displaying, manipulating, and analyzing small mols., proteins, nucleic acids, and their interactions.  A relational protein structure database is incorporated to be queried.  The program is suitable for most common crystallog. work.  The menu-driven operation of WHAT IF, combined with the use of default values wherever user input is required, makes it very easy to use for a novice user while keeping full flexibility for more sophisticated studies.  Although there are not too many unique features in WHAT IF, the fact that everything is integrated in one program makes if a unique tool for many purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ64OrfsqnR7Vg90H21EOLACvtfcHk0lheov4Ie8tpFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXitFGksL8%253D&md5=a764dc42ba008577f0076092ab4e6024</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2F0263-7855%2890%2980070-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0263-7855%252890%252980070-V%26sid%3Dliteratum%253Aachs%26aulast%3DVriend%26aufirst%3DG.%26atitle%3DWHAT%2520IF%253A%2520a%2520molecular%2520modeling%2520and%2520drug%2520design%2520program%26jtitle%3DJ.%2520Mol.%2520Graphics%26date%3D1990%26volume%3D8%26spage%3D52%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Frisch, M. J.; Trucks, G. W.; Cheeseman, J. R.; Scalmani, G.; Caricato, M.; Hratchian, H. P.; Li, X.; Barone, V.; Bloino, J.; Zheng, G.; Vreven, T.; Montgomery,  Jr., J. A.; Petersson, G. A.; Scuseria, G. E.; Schlegel, H. B.; Nakatsuji, H.; zmaylov, A. F.; Martin, R. L.; Sonnenberg, J. L.; Peralta, J. E.; Heyd, J. J.; Brothers, E.; Ogliaro, F.; Bearpark, M.; Robb, M. A.; Mennucci, B.; Kudin, K. N.; Staroverov, V. N.; Kobayashi, R.; Normand, J.; Rendell, A.; Gomperts, R.; Zakrzewski, V. G.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.</span>Gaussian 09; <span class="NLM_publisher-name">Gaussian, Inc.</span>: <span class="NLM_publisher-loc">Wallingford, CT</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+J.+Frisch&author=G.+W.+Trucks&author=J.+R.+Cheeseman&author=G.+Scalmani&author=M.+Caricato&author=H.+P.+Hratchian&author=X.+Li&author=V.+Barone&author=J.+Bloino&author=G.+Zheng&author=T.+Vreven&author=J.+A.+Montgomery&author=G.+A.+Petersson&author=G.+E.+Scuseria&author=H.+B.+Schlegel&author=H.+Nakatsuji&author=A.+F.+zmaylov&author=R.+L.+Martin&author=J.+L.+Sonnenberg&author=J.+E.+Peralta&author=J.+J.+Heyd&author=E.+Brothers&author=F.+Ogliaro&author=M.+Bearpark&author=M.+A.+Robb&author=B.+Mennucci&author=K.+N.+Kudin&author=V.+N.+Staroverov&author=R.+Kobayashi&author=J.+Normand&author=A.+Rendell&author=R.+Gomperts&author=V.+G.+Zakrzewski&author=M.+Hada&author=M.+Ehara&author=K.+Toyota&author=R.+Fukuda&author=J.+Hasegawa&author=M.+Ishida&author=T.+Nakajima&author=Y.+Honda&author=O.+Kitao&author=H.+Nakai&title=Gaussian+09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DFrisch%26aufirst%3DM.%2BJ.%26jtitle%3DGaussian%252009%26pub%3DGaussian%252C%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Hanson, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friel, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dilis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeSombre, E. R.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 17alpha-20<i>E</i>-21-(4-substituted phenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diols as probes for the estrogen receptor alpha hormone binding domain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2865</span><span class="NLM_x">–</span> <span class="NLM_lpage">2876</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0205806" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2865-2876&author=R.+N.+Hansonauthor=C.+Y.+Leeauthor=C.+J.+Frielauthor=R.+Dilisauthor=A.+Hughesauthor=E.+R.+DeSombre&title=Synthesis+and+evaluation+of+17alpha-20E-21-%284-substituted+phenyl%29-19-norpregna-1%2C3%2C5%2810%29%2C20-tetraene-3%2C17beta-diols+as+probes+for+the+estrogen+receptor+alpha+hormone+binding+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm0205806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0205806%26sid%3Dliteratum%253Aachs%26aulast%3DHanson%26aufirst%3DR.%2BN.%26aulast%3DLee%26aufirst%3DC.%2BY.%26aulast%3DFriel%26aufirst%3DC.%2BJ.%26aulast%3DDilis%26aufirst%3DR.%26aulast%3DHughes%26aufirst%3DA.%26aulast%3DDeSombre%26aufirst%3DE.%2BR.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%252017alpha-20E-21-%25284-substituted%2520phenyl%2529-19-norpregna-1%252C3%252C5%252810%2529%252C20-tetraene-3%252C17beta-diols%2520as%2520probes%2520for%2520the%2520estrogen%2520receptor%2520alpha%2520hormone%2520binding%2520domain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2865%26epage%3D2876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Berendsen, H. J.C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Postma, J. P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">vanGunsteren, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiNola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haak, J. R.</span><span> </span><span class="NLM_article-title">Molecular dynamics with coupling to an external bath</span> <span class="citation_source-journal">J. Chem. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">3684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1063%2F1.448118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADyaL2cXmtlGksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1984&pages=3684&author=H.+J.C.+Berendsenauthor=J.+P.+M.+Postmaauthor=W.+F.+vanGunsterenauthor=A.+DiNolaauthor=J.+R.+Haak&title=Molecular+dynamics+with+coupling+to+an+external+bath"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dynamics with coupling to an external bath</span></div><div class="casAuthors">Berendsen, H. J. C.; Postma, J. P. M.; Van Gunsteren, W. F.; DiNola, A.; Haak, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3684-90</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">In mol. dynamics (MD) simulations, the need often arises to maintain such parameters as temp. or pressure rather than energy and vol., or to impose gradients for studying transport properties in nonequil. MD.  A method is described to realize coupling to an external bath with const. temp. or pressure with adjustable time consts. for the coupling.  The method is easily extendable to other variables and to gradients, and can be applied also to polyat. mols. involving internal constraints.  The influence of coupling time consts. on dynamical variables is evaluated.  A leap-frog algorithm is presented for the general case involving constraints with coupling to both a const. temp. and a const. pressure bath.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoecrpUZWkh37Vg90H21EOLACvtfcHk0lheov4Ie8tpFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmtlGksbY%253D&md5=5510dc00297d63b91ee3a7a4ae5aacb1</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1063%2F1.448118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.448118%26sid%3Dliteratum%253Aachs%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.C.%26aulast%3DPostma%26aufirst%3DJ.%2BP.%2BM.%26aulast%3DvanGunsteren%26aufirst%3DW.%2BF.%26aulast%3DDiNola%26aufirst%3DA.%26aulast%3DHaak%26aufirst%3DJ.%2BR.%26atitle%3DMolecular%2520dynamics%2520with%2520coupling%2520to%2520an%2520external%2520bath%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1984%26volume%3D81%26spage%3D3684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Darden, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">York, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, L.</span><span> </span><span class="NLM_article-title">Particle mesh Ewald: An <i>N</i>·log(<i>N</i>) method for Ewald sums in large systems</span> <span class="citation_source-journal">J. Chem. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">10089</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1063%2F1.464397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADyaK3sXks1Ohsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1993&pages=10089&author=T.+Dardenauthor=D.+Yorkauthor=L.+Pedersen&title=Particle+mesh+Ewald%3A+An+N%C2%B7log%28N%29+method+for+Ewald+sums+in+large+systems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Particle mesh Ewald: an N·log(N) method for Ewald sums in large systems</span></div><div class="casAuthors">Darden, Tom; York, Darrin; Pedersen, Lee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">10089-92</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">An N·log(N) method for evaluating electrostatic energies and forces of large periodic systems is presented.  The method is based on interpolation of the reciprocal space Ewald sums and evaluation of the resulting convolution using fast Fourier transforms.  Timings and accuracies are presented for three large cryst. ionic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDIJavf7AZPbVg90H21EOLACvtfcHk0lheov4Ie8tpFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1Ohsr0%253D&md5=3c9f230bd01b7b714fd096d4d2e755f6</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1063%2F1.464397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.464397%26sid%3Dliteratum%253Aachs%26aulast%3DDarden%26aufirst%3DT.%26aulast%3DYork%26aufirst%3DD.%26aulast%3DPedersen%26aufirst%3DL.%26atitle%3DParticle%2520mesh%2520Ewald%253A%2520An%2520N%25C2%25B7log%2528N%2529%2520method%2520for%2520Ewald%2520sums%2520in%2520large%2520systems%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1993%26volume%3D98%26spage%3D10089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">310</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1124%2Fjpet.104.066787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=15016836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsVOjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2004&pages=98-107&author=Y.+Xiaoauthor=K.+J.+Kellar&title=The+comparative+pharmacology+and+up-regulation+of+rat+neuronal+nicotinic+receptor+subtype+binding+sites+stably+expressed+in+transfected+mammalian+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells</span></div><div class="casAuthors">Xiao, Yingxian; Kellar, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">98-107</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We stably transfected human embryonic kidney cells (HEK 293 cells) with genes encoding rat neuronal nicotinic receptor α2, α3, or α4 subunits in combination with the β2 or β4 subunit to generate six cell lines that express defined subunit combinations that represent potential subtypes of rat neuronal nicotinic acetylcholine receptors (nAChRs).  These cell lines were designated KXα2β2, KXα2β4, KXα3β2, KXα3β4, KXα4β2, and KXα4β4.  The Kd values of [3H](±)epibatidine ([3H]EB) binding to membranes from these six cell lines ranged from ∼0.02 to 0.3 nM.  The pharmacol. profiles of the agonist binding sites of these putative nAChR subtypes were examd. in competition studies in which unlabeled nicotinic ligands, including 10 agonists and two antagonists, competed against [3H]EB.  Most nicotinic ligands examd. had higher affinity for the receptor subtypes contg. the β2 subunit compared with those contg. the β4 subunit.  An excellent correlation (r > 0.99) of the binding affinities of the 10 agonists was obsd. between receptors from KXα4β2 cells and from rat forebrain tissue, in which [3H]EB binding represents predominantly α4β2 nAChRs.  More important, the affinities (Ki values) for the two tissues were nearly identical.  The densities of the binding sites of all six cell lines were increased after a 5-day exposure to (-)-nicotine or the quaternary amine agonist carbachol.  These data indicate that these cell lines expressing nAChR subunit combinations should be useful models for investigating pharmacol. properties and regulation of the binding sites of potential nAChR subtypes, as well as for studying the properties of nicotinic compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrumY0AkQpfKLVg90H21EOLACvtfcHk0liqOR_WnOZgEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsVOjs78%253D&md5=c46388f9756f0c00ee257d3cbea1ad80</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.066787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.066787%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DThe%2520comparative%2520pharmacology%2520and%2520up-regulation%2520of%2520rat%2520neuronal%2520nicotinic%2520receptor%2520subtype%2520binding%2520sites%2520stably%2520expressed%2520in%2520transfected%2520mammalian%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D310%26spage%3D98%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wroblewski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=322-333&author=Y.+Xiaoauthor=E.+L.+Meyerauthor=J.+M.+Thompsonauthor=A.+Surinauthor=J.+Wroblewskiauthor=K.+J.+Kellar&title=Rat+alpha3%2Fbeta4+subtype+of+neuronal+nicotinic+acetylcholine+receptor+stably+expressed+in+a+transfected+cell+line%3A+pharmacology+of+ligand+binding+and+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DMeyer%26aufirst%3DE.%2BL.%26aulast%3DThompson%26aufirst%3DJ.%2BM.%26aulast%3DSurin%26aufirst%3DA.%26aulast%3DWroblewski%26aufirst%3DJ.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DRat%2520alpha3%252Fbeta4%2520subtype%2520of%2520neuronal%2520nicotinic%2520acetylcholine%2520receptor%2520stably%2520expressed%2520in%2520a%2520transfected%2520cell%2520line%253A%2520pharmacology%2520of%2520ligand%2520binding%2520and%2520function%26jtitle%3DMol.%2520Pharmacol.%26date%3D1998%26volume%3D54%26spage%3D322%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdrakhmanova, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baydyuk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Rat neuronal nicotinic acetylcholine receptors containing alpha7 subunit: pharmacological properties of ligand binding and function</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">842</span><span class="NLM_x">–</span> <span class="NLM_lpage">850</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1038%2Faps.2009.69" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=19448648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvVSlt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=842-850&author=Y.+Xiaoauthor=G.+R.+Abdrakhmanovaauthor=M.+Baydyukauthor=S.+Hernandezauthor=K.+J.+Kellar&title=Rat+neuronal+nicotinic+acetylcholine+receptors+containing+alpha7+subunit%3A+pharmacological+properties+of+ligand+binding+and+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Rat neuronal nicotinic acetylcholine receptors containing α7 subunit: pharmacological properties of ligand binding and function</span></div><div class="casAuthors">Xiao, Yingxian; Abdrakhmanova, Galya R.; Baydyuk, Maryna; Hernandez, Susan; Kellar, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">842-850</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aim: To compare pharmacol. properties of heterologously expressed homomeric α7 nicotinic acetylcholine receptors (α7 nAChRs) with those of native nAChRs contg. α7 subunit (α7* nAChRs) in rat hippocampus and cerebral cortex.  Methods: the authors established a stably transfected HEK-293 cell line that expresses homomeric rat α7 nAChRs.  The authors studies ligand binding profiles and functional properties of nAChRs expressed in this cell line and native rat α7* nAChRs in rat hippocampus and cerebral cortex.  The authors used [125I]-α-bungarotoxin to compare ligand binding profiles in these cells with those in rat hippocampus and cerebral cortex.  The functional properties of the α7 nAChRs expressed in this cell line were studied using whole-cell current recording.  Results: The newly established cell line, KXα7R1, expresses homomeric α7 nAChRs that bind [125I]-α-bungarotoxin with a Kd value of 0.38±0.06 nmol/L, similar to Kd values of native rat α7* nAChRs from hippocampus (Kd=0.28±0.03 nmol/L) and cerebral cortex (Kd=0.33±0.05 nmol/L).  Using whole-cell current recording, the homomeric α7 nAChRs expressed in the cells were activated by acetylcholine and (-)-nicotine with EC50 values of 280±19 μM and 180±40 μM, resp.  The acetylcholine activated currents were potently blocked by two selective antagonists of α7 nAChRs, α-bungarotoxin (IC50=19±2 nmol/L) and methyllycaconitine (IC50=100±10 pmol/L).  A comparative study of ligand binding profiles, using 13 nicotinic ligands, showed many similarities between the homomeric α7 nAChRs and native α7* receptors in rat brain, but it also revealed several notable differences.  Conclusion: This newly established stable cell line should be very useful for studying the properties of homomeric α7 nAChRs and comparing these properties to native α7* nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIPwGzQ2wz07Vg90H21EOLACvtfcHk0liqOR_WnOZgEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvVSlt7o%253D&md5=f84bbeff9dac027b49d37e7ce5f24459</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1038%2Faps.2009.69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2009.69%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DAbdrakhmanova%26aufirst%3DG.%2BR.%26aulast%3DBaydyuk%26aufirst%3DM.%26aulast%3DHernandez%26aufirst%3DS.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DRat%2520neuronal%2520nicotinic%2520acetylcholine%2520receptors%2520containing%2520alpha7%2520subunit%253A%2520pharmacological%2520properties%2520of%2520ligand%2520binding%2520and%2520function%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2009%26volume%3D30%26spage%3D842%26epage%3D850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Maurer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debartolo, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tess, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span> </span><span class="NLM_article-title">Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1124%2Fdmd.104.001222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=15502010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=175-181&author=T.+S.+Maurerauthor=D.+B.+Debartoloauthor=D.+A.+Tessauthor=D.+O.+Scott&title=Relationship+between+exposure+and+nonspecific+binding+of+thirty-three+central+nervous+system+drugs+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice</span></div><div class="casAuthors">Maurer, Tristan S.; DeBartolo, Demetria B.; Tess, David A.; Scott, Dennis O.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-181</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Unbound fractions in mouse brain and plasma were detd. for 31 structurally diverse central nervous system (CNS) drugs and two active metabolites.  Three comparisons were made between in vitro binding and in vivo exposure data, namely: (1) mouse brain-to-plasma exposure vs. unbound plasma-to-unbound brain fraction ratio (fuplasma/fubrain), (2) cerebrospinal fluid-to-brain exposure vs. unbound brain fraction (fubrain), and (3) cerebrospinal fluid-to-plasma exposure vs. unbound plasma fraction (fuplasma).  Unbound fraction data were within 3-fold of in vivo exposure ratios for the majority of the drugs examd. (i.e., 22 of 33), indicating a predominately free equil. across the blood-brain and blood-CSF barriers.  Some degree of distributional impairment at either the blood-CSF or the blood-brain barrier was indicated for 8 of the 11 remaining drugs (i.e., carbamazepine, midazolam, phenytoin, sulpiride, thiopental, risperidone, 9-hydroxyrisperidone, and zolpidem).  In several cases, the indicated distributional impairment is consistent with other independent literature reports for these drugs.  Through the use of this approach, it appears that most CNS-active agents freely equilibrate across the blood-brain and blood-CSF barriers such that unbound drug concns. in brain approx. those in the plasma.  However, these results also support the intuitive concept that distributional impairment does not necessarily preclude CNS activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH6imduXukj7Vg90H21EOLACvtfcHk0li6M3DJhY5PRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlentA%253D%253D&md5=27e70989846ff3eeb4fa4a7d8c6e73b5</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.001222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.001222%26sid%3Dliteratum%253Aachs%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DDebartolo%26aufirst%3DD.%2BB.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DScott%26aufirst%3DD.%2BO.%26atitle%3DRelationship%2520between%2520exposure%2520and%2520nonspecific%2520binding%2520of%2520thirty-three%2520central%2520nervous%2520system%2520drugs%2520in%2520mice%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D175%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Crofton, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moser, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiter, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilson, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacPhail, R. C.</span><span> </span><span class="NLM_article-title">Interlaboratory comparison of motor activity experiments: implications for neurotoxicological assessments</span> <span class="citation_source-journal">Neurotoxicol. Teratol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">609</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1016%2F0892-0362%2891%2990043-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADyaK38XltlWmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1991&pages=599-609&author=K.+M.+Croftonauthor=J.+L.+Howardauthor=V.+C.+Moserauthor=M.+W.+Gillauthor=L.+W.+Reiterauthor=H.+A.+Tilsonauthor=R.+C.+MacPhail&title=Interlaboratory+comparison+of+motor+activity+experiments%3A+implications+for+neurotoxicological+assessments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Interlaboratory comparison of motor activity experiments:  implications for neurotoxicological assessments</span></div><div class="casAuthors">Crofton, Kevin M.; Howard, J. L.; Moser, V. C.; Gill, M. W.; Reiter, L. W.; Tilson, H. A.; MacPhail, R. C.</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicology and Teratology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">599-609</span>CODEN:
                <span class="NLM_cas:coden">NETEEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-0362</span>.
    </div><div class="casAbstract">This study exmad. historical data from a no. of labs. that employed different devices and exptl. protocols to measure motor activity.  Four aspects of the motor activity data were compared: (1) within-lab. control variability across time; (2) within-lab. replicability of control data (3) between-lab. variability in the effects of chems.; and (4) between lab. comparison of the control rates of habituation.  The analyses indicated that there was a relatively restricted range of within-lab. variability and reliability in control values, and that these ranges were comparable across labs.  Similar profiles of habituation were also seen across the different labs.  Moreover, in virtually every case, all labs. were capable of detecting qual. similar changes in motor activity following acute exposure to a variety of chem.  These data indicate a high degree of comparability in the data generated by the different devices and exptl. protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHN8847ggH4rVg90H21EOLACvtfcHk0li6M3DJhY5PRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XltlWmtw%253D%253D&md5=7358cdf72f0d7a970a1b451aa7462d6b</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2F0892-0362%2891%2990043-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0892-0362%252891%252990043-V%26sid%3Dliteratum%253Aachs%26aulast%3DCrofton%26aufirst%3DK.%2BM.%26aulast%3DHoward%26aufirst%3DJ.%2BL.%26aulast%3DMoser%26aufirst%3DV.%2BC.%26aulast%3DGill%26aufirst%3DM.%2BW.%26aulast%3DReiter%26aufirst%3DL.%2BW.%26aulast%3DTilson%26aufirst%3DH.%2BA.%26aulast%3DMacPhail%26aufirst%3DR.%2BC.%26atitle%3DInterlaboratory%2520comparison%2520of%2520motor%2520activity%2520experiments%253A%2520implications%2520for%2520neurotoxicological%2520assessments%26jtitle%3DNeurotoxicol.%2520Teratol.%26date%3D1991%26volume%3D13%26spage%3D599%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyesik  Kong</span>, <span class="hlFld-ContribAuthor ">Jun-ke  Song</span>, <span class="hlFld-ContribAuthor ">Venkata Mahidhar  Yenugonda</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Tian  Shuo</span>, <span class="hlFld-ContribAuthor ">Amrita K.  Cheema</span>, <span class="hlFld-ContribAuthor ">Yali  Kong</span>, <span class="hlFld-ContribAuthor ">Guan-hua  Du</span>, and <span class="hlFld-ContribAuthor ">Milton L.  Brown</span>  . </span><span class="cited-content_cbyCitation_article-title">Preclinical Studies of the Potent and Selective Nicotinic α4β2 Receptor Ligand VMY-2-95. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2015,</strong> <em>12 </em>
                                    (2)
                                     , 393-402. <a href="https://doi.org/10.1021/mp5003569" title="DOI URL">https://doi.org/10.1021/mp5003569</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/mp5003569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fmp5003569%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DPreclinical%252BStudies%252Bof%252Bthe%252BPotent%252Band%252BSelective%252BNicotinic%252B%2525CE%2525B14%2525CE%2525B22%252BReceptor%252BLigand%252BVMY-2-95%26aulast%3DKong%26aufirst%3DHyesik%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D13052014%26date%3D22122014%26date%3D17122014%26date%3D20012015%26date%3D02022015%26date%3D23122014%26volume%3D12%26issue%3D2%26spage%3D393%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ziru  Yu</span>, <span class="hlFld-ContribAuthor ">Dewen  Kong</span>, <span class="hlFld-ContribAuthor ">Yu  Liang</span>, <span class="hlFld-ContribAuthor ">Xiaoyue  Zhao</span>, <span class="hlFld-ContribAuthor ">Guanhua  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (7)
                                     , 1903-1913. <a href="https://doi.org/10.1016/j.apsb.2021.03.002" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.03.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.03.002%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DProtective%252Beffects%252Bof%252BVMY-2-95%252Bon%252Bcorticosterone-induced%252Binjuries%252Bin%252Bmice%252Band%252Bcellular%252Bmodels%26aulast%3DYu%26aufirst%3DZiru%26date%3D2021%26volume%3D11%26issue%3D7%26spage%3D1903%26epage%3D1913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edward D.  Levin</span>, <span class="hlFld-ContribAuthor ">Amir H.  Rezvani</span>, <span class="hlFld-ContribAuthor ">Corinne  Wells</span>, <span class="hlFld-ContribAuthor ">Susan  Slade</span>, <span class="hlFld-ContribAuthor ">Venkata M.  Yenugonda</span>, <span class="hlFld-ContribAuthor ">Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Milton L.  Brown</span>, <span class="hlFld-ContribAuthor ">Yingxian  Xiao</span>, <span class="hlFld-ContribAuthor ">Kenneth J.  Kellar</span>. </span><span class="cited-content_cbyCitation_article-title">α4β2 Nicotinic receptor desensitizing compounds can decrease self-administration of cocaine and methamphetamine in rats. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2019,</strong> <em>845 </em>, 1-7. <a href="https://doi.org/10.1016/j.ejphar.2018.12.010" title="DOI URL">https://doi.org/10.1016/j.ejphar.2018.12.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2018.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2018.12.010%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3D%2525CE%2525B14%2525CE%2525B22%252BNicotinic%252Breceptor%252Bdesensitizing%252Bcompounds%252Bcan%252Bdecrease%252Bself-administration%252Bof%252Bcocaine%252Band%252Bmethamphetamine%252Bin%252Brats%26aulast%3DLevin%26aufirst%3DEdward%2BD.%26date%3D2019%26volume%3D845%26spage%3D1%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John J.  Maurer</span>, <span class="hlFld-ContribAuthor ">Heath D.  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">Nicotine Addiction and Alpha4beta2* Nicotinic Acetylcholine Receptors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 243-250. <a href="https://doi.org/10.1016/B978-0-12-813035-3.00031-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-813035-3.00031-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-813035-3.00031-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-813035-3.00031-9%26sid%3Dliteratum%253Aachs%26atitle%3DNicotine%252BAddiction%252Band%252BAlpha4beta2%252A%252BNicotinic%252BAcetylcholine%252BReceptors%26aulast%3DMaurer%26aufirst%3DJohn%2BJ.%26date%3D2019%26spage%3D243%26epage%3D250%26pub%3DElsevier%26atitle%3DNeuroscience%252Bof%252BNicotine%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah L.  Withey</span>, <span class="hlFld-ContribAuthor ">Michelle R.  Doyle</span>, <span class="hlFld-ContribAuthor ">Jack  Bergman</span>, <span class="hlFld-ContribAuthor ">Rajeev I.  Desai</span>. </span><span class="cited-content_cbyCitation_article-title">Involvement of Nicotinic Receptor Subtypes in the Behavioral Effects of Nicotinic Drugs in Squirrel Monkeys. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2018,</strong> <em>366 </em>
                                    (2)
                                     , 397-409. <a href="https://doi.org/10.1124/jpet.118.248070" title="DOI URL">https://doi.org/10.1124/jpet.118.248070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.118.248070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.118.248070%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DInvolvement%252Bof%252BNicotinic%252BReceptor%252BSubtypes%252Bin%252Bthe%252BBehavioral%252BEffects%252Bof%252BNicotinic%252BDrugs%252Bin%252BSquirrel%252BMonkeys%26aulast%3DWithey%26aufirst%3DSarah%2BL.%26date%3D2018%26date%3D2018%26volume%3D366%26issue%3D2%26spage%3D397%26epage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Echterbille</span>, <span class="hlFld-ContribAuthor ">Nicolas  Gilles</span>, <span class="hlFld-ContribAuthor ">Romulo  Araóz</span>, <span class="hlFld-ContribAuthor ">Gilles  Mourier</span>, <span class="hlFld-ContribAuthor ">Muriel  Amar</span>, <span class="hlFld-ContribAuthor ">Denis  Servent</span>, <span class="hlFld-ContribAuthor ">Edwin  De Pauw</span>, <span class="hlFld-ContribAuthor ">Loic  Quinton</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and characterization of EII B, a new α-conotoxin from Conus ermineus venom by nAChRs affinity capture monitored by MALDI-TOF/TOF mass spectrometry. </span><span class="cited-content_cbyCitation_journal-name">Toxicon</span><span> <strong>2017,</strong> <em>130 </em>, 1-10. <a href="https://doi.org/10.1016/j.toxicon.2017.02.023" title="DOI URL">https://doi.org/10.1016/j.toxicon.2017.02.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.toxicon.2017.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.toxicon.2017.02.023%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicon%26atitle%3DDiscovery%252Band%252Bcharacterization%252Bof%252BEII%252BB%25252C%252Ba%252Bnew%252B%2525CE%2525B1-conotoxin%252Bfrom%252BConus%252Bermineus%252Bvenom%252Bby%252BnAChRs%252Baffinity%252Bcapture%252Bmonitored%252Bby%252BMALDI-TOF%25252FTOF%252Bmass%252Bspectrometry%26aulast%3DEchterbille%26aufirst%3DJulien%26date%3D2017%26volume%3D130%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristiano  Bolchi</span>, <span class="hlFld-ContribAuthor ">Francesco  Bavo</span>, <span class="hlFld-ContribAuthor ">Cecilia  Gotti</span>, <span class="hlFld-ContribAuthor ">Laura  Fumagalli</span>, <span class="hlFld-ContribAuthor ">Francesca  Fasoli</span>, <span class="hlFld-ContribAuthor ">Matteo  Binda</span>, <span class="hlFld-ContribAuthor ">Vanessa  Mucchietto</span>, <span class="hlFld-ContribAuthor ">Miriam  Sciaccaluga</span>, <span class="hlFld-ContribAuthor ">Simona  Plutino</span>, <span class="hlFld-ContribAuthor ">Sergio  Fucile</span>, <span class="hlFld-ContribAuthor ">Marco  Pallavicini</span>. </span><span class="cited-content_cbyCitation_article-title">From pyrrolidinyl-benzodioxane to pyrrolidinyl-pyridodioxanes, or from unselective antagonism to selective partial agonism at α4β2 nicotinic acetylcholine receptor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>125 </em>, 1132-1144. <a href="https://doi.org/10.1016/j.ejmech.2016.10.048" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.10.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.10.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.10.048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFrom%252Bpyrrolidinyl-benzodioxane%252Bto%252Bpyrrolidinyl-pyridodioxanes%25252C%252Bor%252Bfrom%252Bunselective%252Bantagonism%252Bto%252Bselective%252Bpartial%252Bagonism%252Bat%252B%2525CE%2525B14%2525CE%2525B22%252Bnicotinic%252Bacetylcholine%252Breceptor%26aulast%3DBolchi%26aufirst%3DCristiano%26date%3D2017%26volume%3D125%26spage%3D1132%26epage%3D1144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Shen</span>, <span class="hlFld-ContribAuthor ">Xi-cheng  Yang</span>, <span class="hlFld-ContribAuthor ">Ming-cheng  Yu</span>, <span class="hlFld-ContribAuthor ">Li  Xiao</span>, <span class="hlFld-ContribAuthor ">Xun-jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Hui-jiao  Sun</span>, <span class="hlFld-ContribAuthor ">Hao  Chen</span>, <span class="hlFld-ContribAuthor ">Guan-xin  Pan</span>, <span class="hlFld-ContribAuthor ">Yu-rong  Yan</span>, <span class="hlFld-ContribAuthor ">Si-chen  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Lu  Zhou</span>, <span class="hlFld-ContribAuthor ">Qiong  Xie</span>, <span class="hlFld-ContribAuthor ">Lin-qian  Yu</span>, <span class="hlFld-ContribAuthor ">Yong-hui  Wang</span>, <span class="hlFld-ContribAuthor ">Li-ming  Shao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery, synthesis, biological evaluation and structure-based optimization of novel piperidine derivatives as acetylcholine-binding protein ligands. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2017,</strong> <em>38 </em>
                                    (1)
                                     , 146-155. <a href="https://doi.org/10.1038/aps.2016.124" title="DOI URL">https://doi.org/10.1038/aps.2016.124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/aps.2016.124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Faps.2016.124%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DDiscovery%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bstructure-based%252Boptimization%252Bof%252Bnovel%252Bpiperidine%252Bderivatives%252Bas%252Bacetylcholine-binding%252Bprotein%252Bligands%26aulast%3DShen%26aufirst%3DJian%26date%3D2017%26date%3D2016%26volume%3D38%26issue%3D1%26spage%3D146%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristiano  Bolchi</span>, <span class="hlFld-ContribAuthor ">Francesco  Bavo</span>, <span class="hlFld-ContribAuthor ">Laura  Fumagalli</span>, <span class="hlFld-ContribAuthor ">Cecilia  Gotti</span>, <span class="hlFld-ContribAuthor ">Francesca  Fasoli</span>, <span class="hlFld-ContribAuthor ">Milena  Moretti</span>, <span class="hlFld-ContribAuthor ">Marco  Pallavicini</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 5-substituted 3-hydroxyphenyl and 3-nitrophenyl ethers of S -prolinol as α4β2-nicotinic acetylcholine receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (23)
                                     , 5613-5617. <a href="https://doi.org/10.1016/j.bmcl.2016.10.078" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.10.078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.10.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.10.078%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252B5-substituted%252B3-hydroxyphenyl%252Band%252B3-nitrophenyl%252Bethers%252Bof%252BS%252B-prolinol%252Bas%252B%2525CE%2525B14%2525CE%2525B22-nicotinic%252Bacetylcholine%252Breceptor%252Bligands%26aulast%3DBolchi%26aufirst%3DCristiano%26date%3D2016%26volume%3D26%26issue%3D23%26spage%3D5613%26epage%3D5617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucia  Tamborini</span>, <span class="hlFld-ContribAuthor ">Andrea  Pinto</span>, <span class="hlFld-ContribAuthor ">Roberta  Ettari</span>, <span class="hlFld-ContribAuthor ">Cecilia  Gotti</span>, <span class="hlFld-ContribAuthor ">Francesca  Fasoli</span>, <span class="hlFld-ContribAuthor ">Paola  Conti</span>, <span class="hlFld-ContribAuthor ">Carlo  De Micheli</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Pharmacological Evaluation of α
              4
              β
              2
              Nicotinic Ligands with a 3-Fluoropyrrolidine Nucleus. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2015,</strong> <em>10 </em>
                                    (6)
                                     , 1071-1078. <a href="https://doi.org/10.1002/cmdc.201500073" title="DOI URL">https://doi.org/10.1002/cmdc.201500073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500073%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%252Band%252BPharmacological%252BEvaluation%252Bof%252B%2525CE%2525B1%252B4%252B%2525CE%2525B2%252B2%252BNicotinic%252BLigands%252Bwith%252Ba%252B3-Fluoropyrrolidine%252BNucleus%26aulast%3DTamborini%26aufirst%3DLucia%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D6%26spage%3D1071%26epage%3D1078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Mikell  Paige</span>, <span class="hlFld-ContribAuthor ">Thao T.  Olson</span>, <span class="hlFld-ContribAuthor ">Nour  Al-Muhtasib</span>, <span class="hlFld-ContribAuthor ">Teresa  Xie</span>, <span class="hlFld-ContribAuthor ">Shujie  Hou</span>, <span class="hlFld-ContribAuthor ">Michael P.  White</span>, <span class="hlFld-ContribAuthor ">Antoinette  Cordova</span>, <span class="hlFld-ContribAuthor ">Jessica L.  Guo</span>, <span class="hlFld-ContribAuthor ">Kenneth J.  Kellar</span>, <span class="hlFld-ContribAuthor ">Yingxian  Xiao</span>, <span class="hlFld-ContribAuthor ">Milton L.  Brown</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and pharmacological characterization of new neuronal nicotinic acetylcholine receptor ligands derived from Sazetidine-A. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (13)
                                     , 2954-2956. <a href="https://doi.org/10.1016/j.bmcl.2014.04.036" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.04.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.04.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bpharmacological%252Bcharacterization%252Bof%252Bnew%252Bneuronal%252Bnicotinic%252Bacetylcholine%252Breceptor%252Bligands%252Bderived%252Bfrom%252BSazetidine-A%26aulast%3DLiu%26aufirst%3DYong%26date%3D2014%26volume%3D24%26issue%3D13%26spage%3D2954%26epage%3D2956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benito  Alcaide</span>, <span class="hlFld-ContribAuthor ">Pedro  Almendros</span>. </span><span class="cited-content_cbyCitation_article-title">Four-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 85-113. <a href="https://doi.org/10.1016/B978-0-08-100017-5.00004-2" title="DOI URL">https://doi.org/10.1016/B978-0-08-100017-5.00004-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-100017-5.00004-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-100017-5.00004-2%26sid%3Dliteratum%253Aachs%26atitle%3DFour-Membered%252BRing%252BSystems%26aulast%3DAlcaide%26aufirst%3DBenito%26date%3D2014%26spage%3D85%26epage%3D113%26pub%3DElsevier%26date%3D2014%26volume%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edward D.  Levin</span>, <span class="hlFld-ContribAuthor ">Hannah G.  Sexton</span>, <span class="hlFld-ContribAuthor ">Karen  Gordon</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Gordon</span>, <span class="hlFld-ContribAuthor ">Yingxian  Xiao</span>, <span class="hlFld-ContribAuthor ">Kenneth J.  Kellar</span>, <span class="hlFld-ContribAuthor ">Venkata Mahidhar  Yenugonda</span>, <span class="hlFld-ContribAuthor ">Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Michael P.  White</span>, <span class="hlFld-ContribAuthor ">Mikell  Paige</span>, <span class="hlFld-ContribAuthor ">Milton L.  Brown</span>, <span class="hlFld-ContribAuthor ">Amir H.  Rezvani</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of the sazetidine-a family of compounds on the body temperature in wildtype, nicotinic receptor β2−/− and α7−/− mice. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2013,</strong> <em>718 </em>
                                    (1-3)
                                     , 167-172. <a href="https://doi.org/10.1016/j.ejphar.2013.08.037" title="DOI URL">https://doi.org/10.1016/j.ejphar.2013.08.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2013.08.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2013.08.037%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DEffects%252Bof%252Bthe%252Bsazetidine-a%252Bfamily%252Bof%252Bcompounds%252Bon%252Bthe%252Bbody%252Btemperature%252Bin%252Bwildtype%25252C%252Bnicotinic%252Breceptor%252B%2525CE%2525B22%2525E2%252588%252592%25252F%2525E2%252588%252592%252Band%252B%2525CE%2525B17%2525E2%252588%252592%25252F%2525E2%252588%252592%252Bmice%26aulast%3DLevin%26aufirst%3DEdward%2BD.%26date%3D2013%26volume%3D718%26issue%3D1-3%26spage%3D167%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/medium/jm-2013-008455_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008455&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/medium/jm-2013-008455_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Selected examples of natural and synthetic nAChR ligands. (B) Design strategy for compound <b>1</b>. (C) General structures of the present series of compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008455&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/medium/jm-2013-008455_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Predicted structural models of α4β2 nAChR. (A) Atomic level interactions between compound <b>1</b> with α4β2 nAChR. Binding site residues are labeled and shown in a stick model rendering. Molecular modeling overlay of compound <b>1</b> (colored green) with <i>S</i>-nicotine (B), varenecline (C), and Saz-A (D) in the α4β2 nAChR binding site. Residues are labeled and shown in a stick model rendering.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008455&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/medium/jm-2013-008455_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds in Series 1<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008455&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DEAD, PPh<sub>3</sub>, THF, O °C, 48 h; (b) 2 mol % Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, 4 mol % PPh<sub>3</sub>, 2 mol % CUI, iPr<sub>2</sub>NH, toluene, 80 °C, 18 h; (c) KOH, MeOH/H<sub>2</sub>O (20:1), 25 °C, 3 h; (d) 2 mol % Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, 4 mol % PPh<sub>3</sub>, 2 mol % CUI, iPr<sub>2</sub>NH, toluene, 25 °C, 18 h; (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C–rt 4–6 h then 2 M NaOH methanol in water (9:1), methanol, 18 h; (f) 4 mol% Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, 8 mol % PPh<sub>3</sub>, 8 mol% CUI, iPr<sub>2</sub>NH, toluene, 80 °C, 18 h; (g) KOH, MeOH/H<sub>2</sub>O (4:1), 25 °C, 3 h; (h) substituted aryl iodides, 25 °C, 16 h or substituted aryl bromide, 80 °C, 16 h; (i) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C–rt , 4–6 h then 2M NaOH methanol in water (9:1), methanol, 18 h.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/medium/jm-2013-008455_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds in Series 2<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008455&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DEAD, PPh<sub>3</sub>, THF, 0 °C, 48 h; (b) 4 mol % Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, 8 mol % PPh<sub>3</sub>, 8 mol % CUI, iPr<sub>2</sub>NH, toluene, 80 °C, 18 h; (c) KOH, MeOH/H<sub>2</sub>O (4:1), 25 °C, 3 h; (d) iodobenzene, 25 °C, 16 h; (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C–rt 4–6 h then 2 M NaoH in methanol in water (9:1), methanol, 18 h; (f) HCHO, NaCNBH<sub>3</sub>, PH = 4–5 (CH<sub>3</sub>COOH:CH<sub>3</sub>COONa), ethanol.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/medium/jm-2013-008455_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008455&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, toluene:ethanol (3:1), 90 °C, 18 h; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C–rt, 6 h then 2 M NaOH methanol in water (9:1), methanol, 18 h.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/medium/jm-2013-008455_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Acute compound <b>1</b> effects on nicotine self-administration (0.03 mg/kg/infusion). Compound <b>1</b> (3 mg/kg) resulted in a significant (<i>p</i> < 0.025) decrease in nicotine self-administration relative to nicotine self-administration after control saline injections (mean ± SEM; <i>n</i> = 15). (B) Compound <b>1</b> effects on nicotine self-administration during each 15 min time period within session. (C) Acute compound <b>1</b> effects on locomotor activity. Effect of compound <b>1</b> on locomotor activity in the figure-eight maze during the 1 h session (mean + SEM; <i>n</i> = 12). (D) Compound <b>1</b> effects on locomotor activity during each 15 min time period within session.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008455&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/medium/jm-2013-008455_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Unbound fraction of each compound in the rat brain tissue and plasma protein using an equilibrium dialysis method. (A) Representative percentage of free fraction of rat plasma and brain tissue against each compound tested at 5 μM for 4 h. (B) Representative data summary of free fractions of the brain tissue and plasma protein against each compound.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4008455/production/images/large/jm-2013-008455_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008455&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i78">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 76 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riganti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vailati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span> </span><span class="NLM_article-title">Brain neuronal nicotinic receptors as new targets for drug discovery</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.2174%2F138161206775474486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=16472136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVKhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=407-428&author=C.+Gottiauthor=L.+Rigantiauthor=S.+Vailatiauthor=F.+Clementi&title=Brain+neuronal+nicotinic+receptors+as+new+targets+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Brain neuronal nicotinic receptors as new targets for drug discovery</span></div><div class="casAuthors">Gotti, C.; Riganti, L.; Vailati, S.; Clementi, F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">407-428</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neuronal nicotinic receptors (nAChRs) are a heterogeneous family of ion channels differently expressed in the nervous system where, by responding to the endogenous neurotransmitter acetylcholine, they contribute to a wide range of brain activities and influence a no. of physiol. functions.  Over recent years, the application of newly developed mol. and cellular biol. techniques has made it possible to correlate the subunit compn. of nAChRs with specific nicotine-elicited behaviors, and refine some of the in vivo physiol. functions of nAChR subtypes.  The major new findings are the widespread expression of nAChRs, outside the nervous system, their specific and complex organization, and their relevance to normal brain function.  Moreover, the combination of clin. and basic research has better defined the involvement of nAChRs in a growing no. of nervous pathologies other than degenerative diseases.  However, there are still only a limited no. of nicotinic-specific drugs and, although some nicotinic agonists have an interesting pharmacol., their clin. use is limited by undesirable side effects.  Some selective nicotinic ligands have recently been developed and used to explore the complexity of nAChR subtype structure and function in the expectation that they will become rational therapeutic alternatives in a no. of neurodegenerative, neuropsychiatric and neurol. disorders.  In this review, we will discuss the mol. basis of brain nAChR structural and functional diversity mainly in pharmacol. and biochem. terms, and summarize current knowledge concerning the newly discovered drugs used to classify the numerous receptor subtypes and treat the brain diseases in which nAChRs are involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjEcBfsbynaLVg90H21EOLACvtfcHk0lj76zrvmVYtSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVKhtbo%253D&md5=81c77bfe30bc478e01a442359e35d2d6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F138161206775474486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206775474486%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DRiganti%26aufirst%3DL.%26aulast%3DVailati%26aufirst%3DS.%26aulast%3DClementi%26aufirst%3DF.%26atitle%3DBrain%2520neuronal%2520nicotinic%2520receptors%2520as%2520new%2520targets%2520for%2520drug%2520discovery%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D407%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Romanelli, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratteri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guandalini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaccini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualtieri, F.</span><span> </span><span class="NLM_article-title">Central nicotinic receptors: structure, function, ligands, and therapeutic potential</span> <span class="citation_source-journal">ChemMedChem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">746</span><span class="NLM_x">–</span> <span class="NLM_lpage">767</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=746-767&author=M.+N.+Romanelliauthor=P.+Gratteriauthor=L.+Guandaliniauthor=E.+Martiniauthor=C.+Bonacciniauthor=F.+Gualtieri&title=Central+nicotinic+receptors%3A+structure%2C+function%2C+ligands%2C+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRomanelli%26aufirst%3DM.%2BN.%26aulast%3DGratteri%26aufirst%3DP.%26aulast%3DGuandalini%26aufirst%3DL.%26aulast%3DMartini%26aufirst%3DE.%26aulast%3DBonaccini%26aufirst%3DC.%26aulast%3DGualtieri%26aufirst%3DF.%26atitle%3DCentral%2520nicotinic%2520receptors%253A%2520structure%252C%2520function%252C%2520ligands%252C%2520and%2520therapeutic%2520potential%26jtitle%3DChemMedChem.%26date%3D2007%26volume%3D2%26spage%3D746%26epage%3D767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrimpf, M. R.</span><span> </span><span class="NLM_article-title">Design of ligands for the nicotinic acetylcholine receptors: the quest for selectivity</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.2174%2F1568026043451438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=14754449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVOiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=299-334&author=W.+H.+Bunnelleauthor=M.+J.+Dartauthor=M.+R.+Schrimpf&title=Design+of+ligands+for+the+nicotinic+acetylcholine+receptors%3A+the+quest+for+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Design of ligands for the nicotinic acetylcholine receptors: The quest for selectivity</span></div><div class="casAuthors">Bunnelle, William H.; Dart, Michael J.; Schrimpf, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">299-334</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In the last decade, nicotinic acetylcholine receptors (nAChRs) have emerged as important targets for drug discovery.  The therapeutic potential of nicotinic agonists depends substantially on the ability to selectively activate certain receptor subtypes that mediate beneficial effects.  The design of such compds. has proceeded in spite of a general shortage of data pertaining to subtype selectivity.  Medicinal chem. efforts have been guided principally by binding affinities to the α4β2 and/or α7 subtypes, even though these are not predictive of agonist activity at either subtype.  Nevertheless, a diverse family of nAChR ligands has been developed, and several analogs with promising therapeutic potential have now advanced to human clin. trials.  This paper provides an overview of the structure-affinity relationships that continue to drive development of new nAChR ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG5dOTgvAdLbVg90H21EOLACvtfcHk0lhRubUJnfjTMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVOiuw%253D%253D&md5=158b682f8eb51091cd9b03b74b65927d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568026043451438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026043451438%26sid%3Dliteratum%253Aachs%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DDart%26aufirst%3DM.%2BJ.%26aulast%3DSchrimpf%26aufirst%3DM.%2BR.%26atitle%3DDesign%2520of%2520ligands%2520for%2520the%2520nicotinic%2520acetylcholine%2520receptors%253A%2520the%2520quest%2520for%2520selectivity%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D299%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Arneric, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holladay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic receptors: a perspective on two decades of drug discovery research</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1092</span><span class="NLM_x">–</span> <span class="NLM_lpage">1101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=1092-1101&author=S.+P.+Arnericauthor=M.+Holladayauthor=M.+Williams&title=Neuronal+nicotinic+receptors%3A+a+perspective+on+two+decades+of+drug+discovery+research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArneric%26aufirst%3DS.%2BP.%26aulast%3DHolladay%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DNeuronal%2520nicotinic%2520receptors%253A%2520a%2520perspective%2520on%2520two%2520decades%2520of%2520drug%2520discovery%2520research%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D74%26spage%3D1092%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Lindstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerzanich, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic receptor subtypes</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">757</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=757&publication_year=1995&pages=100-116&author=J.+Lindstromauthor=R.+Anandauthor=X.+Pengauthor=V.+Gerzanichauthor=F.+Wangauthor=Y.+Li&title=Neuronal+nicotinic+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindstrom%26aufirst%3DJ.%26aulast%3DAnand%26aufirst%3DR.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DGerzanich%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DNeuronal%2520nicotinic%2520receptor%2520subtypes%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1995%26volume%3D757%26spage%3D100%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Boyd, R. T.</span><span> </span><span class="NLM_article-title">The molecular biology of neuronal nicotinic acetylcholine receptors</span> <span class="citation_source-journal">Crit. Rev. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.3109%2F10408449709089897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=9189657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADyaK2sXjvFyqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1997&pages=299-318&author=R.+T.+Boyd&title=The+molecular+biology+of+neuronal+nicotinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular biology of neuronal nicotinic acetylcholine receptors</span></div><div class="casAuthors">Boyd, R. Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Toxicology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">299-318</span>CODEN:
                <span class="NLM_cas:coden">CRTXB2</span>;
        ISSN:<span class="NLM_cas:issn">1040-8444</span>.
    
            (<span class="NLM_cas:orgname">CRC</span>)
        </div><div class="casAbstract">A review, with 163 refs.  The mol. cloning of genes encoding neuronal nicotinic acetylcholine receptors (nAChRs) has made possible a better understanding of the pharmacol. and toxicol. of cholinergic compds.  Neuronal nAChRs are related in structure to the nAChRs present at the neuromuscular junction.  They are composed of multiple subunits designated either α and β.  Eight α and 3 β subunit genes have been cloned.  The α subunits contain the ligand binding sites, whereas β subunits are structural subunits that contribute to the function of the receptor.  A large no. of nAChRs can be formed from different combinations of α and β subunits.  Different combinations of α and β subunits can produce receptors in vitro with distinct ion conducting properties.  Each subunit gene is expressed in a distinct pattern in the nervous system.  The expression of at least some of the nAChR subunit genes is regulated during development and by cell-cell interactions.  Each neuronal nAChR subtype has a distinct pharmacol.  Both α and β subunits contribute to the pharmacol. properties of each subtype.  The expression of multiple nAChR subtypes may allow for precise control of neurotransmission mediated by acetylcholine in diverse populations of neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8ulbOSn16U7Vg90H21EOLACvtfcHk0lhKdnLnNnV-Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjvFyqtrk%253D&md5=5b11ce7b241898dd2c80a37322300f8f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3109%2F10408449709089897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10408449709089897%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DR.%2BT.%26atitle%3DThe%2520molecular%2520biology%2520of%2520neuronal%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DCrit.%2520Rev.%2520Toxicol.%26date%3D1997%26volume%3D27%26spage%3D299%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fornari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaimarri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiducci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrazzi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span> </span><span class="NLM_article-title">Structural and functional diversity of native brain neuronal nicotinic receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=703-711&author=C.+Gottiauthor=F.+Clementiauthor=A.+Fornariauthor=A.+Gaimarriauthor=S.+Guiducciauthor=I.+Manfrediauthor=M.+Morettiauthor=P.+Pedrazziauthor=L.+Pucciauthor=M.+Zoli&title=Structural+and+functional+diversity+of+native+brain+neuronal+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DFornari%26aufirst%3DA.%26aulast%3DGaimarri%26aufirst%3DA.%26aulast%3DGuiducci%26aufirst%3DS.%26aulast%3DManfredi%26aufirst%3DI.%26aulast%3DMoretti%26aufirst%3DM.%26aulast%3DPedrazzi%26aufirst%3DP.%26aulast%3DPucci%26aufirst%3DL.%26aulast%3DZoli%26aufirst%3DM.%26atitle%3DStructural%2520and%2520functional%2520diversity%2520of%2520native%2520brain%2520neuronal%2520nicotinic%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D703%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kellar, K. J.; Xiao, Y.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic receptors: one hundred years of progress</span>. In  <span class="citation_source-book">Handbook of Contemporary Neuropharmacology</span>; <span class="NLM_publisher-name">John Wiley & Sons, Inc</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=107-145&author=K.+J.+Kellar&author=Y.+Xiao&title=Handbook+of+Contemporary+Neuropharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DNeuronal%2520nicotinic%2520receptors%253A%2520one%2520hundred%2520years%2520of%2520progress%26btitle%3DHandbook%2520of%2520Contemporary%2520Neuropharmacology%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2007%26spage%3D107%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Mao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Heterogeneity of nicotinic cholinergic receptors in rat superior cervical and nodose Ganglia</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1693</span><span class="NLM_x">–</span> <span class="NLM_lpage">1699</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1693-1699&author=D.+Maoauthor=R.+P.+Yasudaauthor=H.+Fanauthor=B.+B.+Wolfeauthor=K.+J.+Kellar&title=Heterogeneity+of+nicotinic+cholinergic+receptors+in+rat+superior+cervical+and+nodose+Ganglia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DD.%26aulast%3DYasuda%26aufirst%3DR.%2BP.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DWolfe%26aufirst%3DB.%2BB.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DHeterogeneity%2520of%2520nicotinic%2520cholinergic%2520receptors%2520in%2520rat%2520superior%2520cervical%2520and%2520nodose%2520Ganglia%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D1693%26epage%3D1699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Pidoplichko, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBiasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dani, J. A.</span><span> </span><span class="NLM_article-title">Nicotine activates and desensitizes midbrain dopamine neurons</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">390</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=1997&pages=401-404&author=V.+I.+Pidoplichkoauthor=M.+DeBiasiauthor=J.+T.+Williamsauthor=J.+A.+Dani&title=Nicotine+activates+and+desensitizes+midbrain+dopamine+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPidoplichko%26aufirst%3DV.%2BI.%26aulast%3DDeBiasi%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DJ.%2BT.%26aulast%3DDani%26aufirst%3DJ.%2BA.%26atitle%3DNicotine%2520activates%2520and%2520desensitizes%2520midbrain%2520dopamine%2520neurons%26jtitle%3DNature%26date%3D1997%26volume%3D390%26spage%3D401%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Nestler, E. J.</span><span> </span><span class="NLM_article-title">Is there a common molecular pathway for addiction?</span> <span class="citation_source-journal">Nature Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1445</span><span class="NLM_x">–</span> <span class="NLM_lpage">1449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1038%2Fnn1578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=16251986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCrurbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=1445-1449&author=E.+J.+Nestler&title=Is+there+a+common+molecular+pathway+for+addiction%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Is there a common molecular pathway for addiction?</span></div><div class="casAuthors">Nestler, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1445-1449</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Drugs of abuse have very different acute mechanisms of action but converge on the brain's reward pathways by producing a series of common functional effects after both acute and chronic administration.  Some similar actions occur for natural rewards as well.  Researchers are making progress in understanding the mol. and cellular basis of these common effects.  A major goal for future research is to det. whether such common underpinnings of addiction can be exploited for the development of more effective treatments for a wide range of addictive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfRgdStKikCLVg90H21EOLACvtfcHk0ljRSgV6Ks72Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCrurbP&md5=9a213264a4be37b0b7e1a5d00b42ab02</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnn1578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn1578%26sid%3Dliteratum%253Aachs%26aulast%3DNestler%26aufirst%3DE.%2BJ.%26atitle%3DIs%2520there%2520a%2520common%2520molecular%2520pathway%2520for%2520addiction%253F%26jtitle%3DNature%2520Neurosci.%26date%3D2005%26volume%3D8%26spage%3D1445%26epage%3D1449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Picciotto, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimondini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lena, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marubio, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pich, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">391</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=1998&pages=173-177&author=M.+R.+Picciottoauthor=M.+Zoliauthor=R.+Rimondiniauthor=C.+Lenaauthor=L.+M.+Marubioauthor=E.+M.+Pichauthor=K.+Fuxeauthor=J.+P.+Changeux&title=Acetylcholine+receptors+containing+the+beta2+subunit+are+involved+in+the+reinforcing+properties+of+nicotine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPicciotto%26aufirst%3DM.%2BR.%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DRimondini%26aufirst%3DR.%26aulast%3DLena%26aufirst%3DC.%26aulast%3DMarubio%26aufirst%3DL.%2BM.%26aulast%3DPich%26aufirst%3DE.%2BM.%26aulast%3DFuxe%26aufirst%3DK.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DAcetylcholine%2520receptors%2520containing%2520the%2520beta2%2520subunit%2520are%2520involved%2520in%2520the%2520reinforcing%2520properties%2520of%2520nicotine%26jtitle%3DNature%26date%3D1998%26volume%3D391%26spage%3D173%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Marubio, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardier, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arroyo-Jimenez, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champtiaux, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1329</span><span class="NLM_x">–</span> <span class="NLM_lpage">1337</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1046%2Fj.1460-9568.2003.02564.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=12713636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A280%3ADC%252BD3s3islChtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=1329-1337&author=L.+M.+Marubioauthor=A.+M.+Gardierauthor=S.+Durierauthor=D.+Davidauthor=R.+Klinkauthor=M.+M.+Arroyo-Jimenezauthor=J.+M.+McIntoshauthor=F.+Rossiauthor=N.+Champtiauxauthor=M.+Zoliauthor=J.+P.+Changeux&title=Effects+of+nicotine+in+the+dopaminergic+system+of+mice+lacking+the+alpha4+subunit+of+neuronal+nicotinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors</span></div><div class="casAuthors">Marubio L M; Gardier A M; Durier S; David D; Klink R; Arroyo-Jimenez M M; McIntosh J M; Rossi F; Champtiaux N; Zoli M; Changeux J-P</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1329-37</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">The mesostriatal dopaminergic system influences locomotor activity and the reinforcing properties of many drugs of abuse including nicotine.  Here we investigate the role of the alpha4 nicotinic acetylcholine receptor (nAChR) subunit in mediating the effects of nicotine in the mesolimbic dopamine system in mice lacking the alpha4 subunit.  We show that there are two distinct populations of receptors in the substantia nigra and striatum by using autoradiographic labelling with 125I alpha-conotoxin MII.  These receptors are comprised of the alpha4, beta2 and alpha6 nAChR subunits and non-alpha4, beta2, and alpha6 nAChR subunits.  Non-alpha4 subunit-containing nAChRs are located on dopaminergic neurons, are functional and respond to nicotine as demonstrated by patch clamp recordings.  In vivo microdialysis performed in awake, freely moving mice reveal that mutant mice have basal striatal dopamine levels which are twice as high as those observed in wild-type mice.  Despite the fact that both wild-type and alpha4 null mutant mice show a similar increase in dopamine release in response to intrastriatal KCl perfusion, a nicotine-elicited increase in dopamine levels is not observed in mutant mice.  Locomotor activity experiments show that there is no difference between wild-type and mutant mice in basal activity in both habituated and non-habituated environments.  Interestingly, mutant mice sustain an increase in cocaine-elicited locomotor activity longer than wild-type mice.  In addition, mutant mice recover from depressant locomotor activity in response to nicotine at a faster rate.  Our results indicate that alpha4-containing nAChRs exert a tonic control on striatal basal dopamine release, which is mediated by a heterogeneous population of nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5BUVKIOYbam52AMpI4GK2fW6udTcc2eYI0ECvDRNWAbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3islChtQ%253D%253D&md5=678f37fe5428c62f1fe7893c0e852e35</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1046%2Fj.1460-9568.2003.02564.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1460-9568.2003.02564.x%26sid%3Dliteratum%253Aachs%26aulast%3DMarubio%26aufirst%3DL.%2BM.%26aulast%3DGardier%26aufirst%3DA.%2BM.%26aulast%3DDurier%26aufirst%3DS.%26aulast%3DDavid%26aufirst%3DD.%26aulast%3DKlink%26aufirst%3DR.%26aulast%3DArroyo-Jimenez%26aufirst%3DM.%2BM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DRossi%26aufirst%3DF.%26aulast%3DChamptiaux%26aufirst%3DN.%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DEffects%2520of%2520nicotine%2520in%2520the%2520dopaminergic%2520system%2520of%2520mice%2520lacking%2520the%2520alpha4%2520subunit%2520of%2520neuronal%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2003%26volume%3D17%26spage%3D1329%26epage%3D1337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Maskos, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molles, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pons, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiard, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilloux, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cormier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mameli-Engvall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufour, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloez-Tayarani, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemelmans, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardier, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=103-107&author=U.+Maskosauthor=B.+E.+Mollesauthor=S.+Ponsauthor=M.+Bessonauthor=B.+P.+Guiardauthor=J.+P.+Guillouxauthor=A.+Evrardauthor=P.+Cazalaauthor=A.+Cormierauthor=M.+Mameli-Engvallauthor=N.+Dufourauthor=I.+Cloez-Tayaraniauthor=A.+P.+Bemelmansauthor=J.+Malletauthor=A.+M.+Gardierauthor=V.+Davidauthor=P.+Faureauthor=S.+Granonauthor=J.+P.+Changeux&title=Nicotine+reinforcement+and+cognition+restored+by+targeted+expression+of+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaskos%26aufirst%3DU.%26aulast%3DMolles%26aufirst%3DB.%2BE.%26aulast%3DPons%26aufirst%3DS.%26aulast%3DBesson%26aufirst%3DM.%26aulast%3DGuiard%26aufirst%3DB.%2BP.%26aulast%3DGuilloux%26aufirst%3DJ.%2BP.%26aulast%3DEvrard%26aufirst%3DA.%26aulast%3DCazala%26aufirst%3DP.%26aulast%3DCormier%26aufirst%3DA.%26aulast%3DMameli-Engvall%26aufirst%3DM.%26aulast%3DDufour%26aufirst%3DN.%26aulast%3DCloez-Tayarani%26aufirst%3DI.%26aulast%3DBemelmans%26aufirst%3DA.%2BP.%26aulast%3DMallet%26aufirst%3DJ.%26aulast%3DGardier%26aufirst%3DA.%2BM.%26aulast%3DDavid%26aufirst%3DV.%26aulast%3DFaure%26aufirst%3DP.%26aulast%3DGranon%26aufirst%3DS.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DNicotine%2520reinforcement%2520and%2520cognition%2520restored%2520by%2520targeted%2520expression%2520of%2520nicotinic%2520receptors%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D103%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Dani, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinemann, S.</span><span> </span><span class="NLM_article-title">Molecular and cellular aspects of nicotine abuse</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">908</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=905-908&author=J.+A.+Daniauthor=S.+Heinemann&title=Molecular+and+cellular+aspects+of+nicotine+abuse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDani%26aufirst%3DJ.%2BA.%26aulast%3DHeinemann%26aufirst%3DS.%26atitle%3DMolecular%2520and%2520cellular%2520aspects%2520of%2520nicotine%2520abuse%26jtitle%3DNeuron%26date%3D1996%26volume%3D16%26spage%3D905%26epage%3D908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Rollema, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span> </span><span class="NLM_article-title">Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=316-325&author=H.+Rollemaauthor=J.+W.+Coeauthor=L.+K.+Chambersauthor=R.+S.+Hurstauthor=S.+M.+Stahlauthor=K.+E.+Williams&title=Rationale%2C+pharmacology+and+clinical+efficacy+of+partial+agonists+of+alpha4beta2+nACh+receptors+for+smoking+cessation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRollema%26aufirst%3DH.%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DChambers%26aufirst%3DL.%2BK.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DStahl%26aufirst%3DS.%2BM.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26atitle%3DRationale%252C%2520pharmacology%2520and%2520clinical%2520efficacy%2520of%2520partial%2520agonists%2520of%2520alpha4beta2%2520nACh%2520receptors%2520for%2520smoking%2520cessation%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D316%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Gonzales, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennard, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nides, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oncken, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azoulay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billing, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watsky, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, K. R.</span><span> </span><span class="NLM_article-title">Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2006&pages=47-55&author=D.+Gonzalesauthor=S.+I.+Rennardauthor=M.+Nidesauthor=C.+Onckenauthor=S.+Azoulayauthor=C.+B.+Billingauthor=E.+J.+Watskyauthor=J.+Gongauthor=K.+E.+Williamsauthor=K.+R.+Reeves&title=Varenicline%2C+an+alpha4beta2+nicotinic+acetylcholine+receptor+partial+agonist%2C+vs+sustained-release+bupropion+and+placebo+for+smoking+cessation%3A+a+randomized+controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGonzales%26aufirst%3DD.%26aulast%3DRennard%26aufirst%3DS.%2BI.%26aulast%3DNides%26aufirst%3DM.%26aulast%3DOncken%26aufirst%3DC.%26aulast%3DAzoulay%26aufirst%3DS.%26aulast%3DBilling%26aufirst%3DC.%2BB.%26aulast%3DWatsky%26aufirst%3DE.%2BJ.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26aulast%3DReeves%26aufirst%3DK.%2BR.%26atitle%3DVarenicline%252C%2520an%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%252C%2520vs%2520sustained-release%2520bupropion%2520and%2520placebo%2520for%2520smoking%2520cessation%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2006%26volume%3D296%26spage%3D47%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Jorenby, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hays, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigotti, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azoulay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watsky, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billing, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, K. R.</span><span> </span><span class="NLM_article-title">Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2006&pages=56-63&author=D.+E.+Jorenbyauthor=J.+T.+Haysauthor=N.+A.+Rigottiauthor=S.+Azoulayauthor=E.+J.+Watskyauthor=K.+E.+Williamsauthor=C.+B.+Billingauthor=J.+Gongauthor=K.+R.+Reeves&title=Efficacy+of+varenicline%2C+an+alpha4beta2+nicotinic+acetylcholine+receptor+partial+agonist%2C+vs+placebo+or+sustained-release+bupropion+for+smoking+cessation%3A+a+randomized+controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJorenby%26aufirst%3DD.%2BE.%26aulast%3DHays%26aufirst%3DJ.%2BT.%26aulast%3DRigotti%26aufirst%3DN.%2BA.%26aulast%3DAzoulay%26aufirst%3DS.%26aulast%3DWatsky%26aufirst%3DE.%2BJ.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26aulast%3DBilling%26aufirst%3DC.%2BB.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DReeves%26aufirst%3DK.%2BR.%26atitle%3DEfficacy%2520of%2520varenicline%252C%2520an%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%252C%2520vs%2520placebo%2520or%2520sustained-release%2520bupropion%2520for%2520smoking%2520cessation%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2006%26volume%3D296%26spage%3D56%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Tonstad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonnesen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billing, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, K. R.</span><span> </span><span class="NLM_article-title">Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2006&pages=64-71&author=S.+Tonstadauthor=P.+Tonnesenauthor=P.+Hajekauthor=K.+E.+Williamsauthor=C.+B.+Billingauthor=K.+R.+Reeves&title=Effect+of+maintenance+therapy+with+varenicline+on+smoking+cessation%3A+a+randomized+controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTonstad%26aufirst%3DS.%26aulast%3DTonnesen%26aufirst%3DP.%26aulast%3DHajek%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26aulast%3DBilling%26aufirst%3DC.%2BB.%26aulast%3DReeves%26aufirst%3DK.%2BR.%26atitle%3DEffect%2520of%2520maintenance%2520therapy%2520with%2520varenicline%2520on%2520smoking%2520cessation%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2006%26volume%3D296%26spage%3D64%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Tsai, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsueh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billing, C. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span> </span><span class="NLM_article-title">A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1039</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1016%2Fj.clinthera.2007.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptlKjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2007&pages=1027-1039&author=S.+T.+Tsaiauthor=H.+J.+Choauthor=H.+S.+Chengauthor=C.+H.+Kimauthor=K.+C.+Hsuehauthor=C.+B.+Billingauthor=K.+E.+Williams&title=A+randomized%2C+placebo-controlled+trial+of+varenicline%2C+a+selective+alpha4beta2+nicotinic+acetylcholine+receptor+partial+agonist%2C+as+a+new+therapy+for+smoking+cessation+in+Asian+smokers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized, placebo-controlled trial of varenicline, a selective α4β2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers</span></div><div class="casAuthors">Tsai, Shih-Tzu; Cho, Hong-Jun; Cheng, Huey-Shinn; Kim, Cheol-Hwan; Hsueh, Kuang-Chieh; Billing, Clare B., Jr.; Williams, Kathryn E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1027-1039</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">Background: Rates of smoking in East Asian men range from >35% to >60%, and are increasing in women and the young.  Objective: This study evaluated the efficacy and tolerability of 1 mg BID varenicline, a novel α4β2 nicotinic acetylcholine receptor partial agonist, for smoking cessation in smokers in Taiwan and Korea.  Methods: A randomized, double-blind, placebo-controlled, 12-wk treatment, 12-wk follow-up trial was conducted at 5 sites each in Korea and Taiwan.  Eligible subjects, smoking ≥10 cigarettes/d, received brief smoking-cessation counseling and were randomly assigned in a 1:1 ratio to varenicline 1 mg BID (titrated during the first week) or placebo.  Smoking status was established by self-report and confirmed at clinic visits by end-expiratory carbon monoxide ≤10 ppm.  The primary end point was continuous abstinence rate (CAR) during the last 4 wk of treatment.  Secondary end points included CAR from weeks 9 to 24 and 7-day point prevalence (PP) of abstinence at weeks 12 and 24.  Craving, withdrawal, and smoking satisfaction were detd. by the Minnesota Nicotine Withdrawal Scale, the Brief Questionnaire of Smoking Urges, and the modified Cigarette Evaluation Questionnaire.  Obsd. or volunteered adverse-event data were recorded at clinic visits.  Results: Overall, 126 subjects (84.9% male) received varenicline, and 124 (92.7% male) received placebo.  Subjects were aged 21 to 73 years (mean age, 39.7 and 40.9 years for varenicline and placebo groups, resp.), and the mean (range) body wts. were 69.0 (44.8-110.0) kg and 71.4 (45.5-102.0) kg, resp.  Subjects had smoked for 3 to 52 years (mean, 20.2 and 22.1 years in the varenicline and placebo groups, resp.).  Subjects had smoked a mean of 23 cigarettes/d over the past month, with 51.6% (varenicline) and 46.0% (placebo) having made 1 or more prior serious quit attempts.  Smoking-cessation rates at the end of treatment were 59.5% with varenicline vs. 32.3% with placebo (P < 0.001).  CARs through 12 wk post-treatment (weeks 9-24) were 46.8% with varenicline and 21.8% with placebo (P < 0.001).  The 7-day PP was 67.5% with varenicline vs. 36.3% with placebo at week 12, and 57.1% vs. 29.0% with placebo at week 24 (both, P < 0.001).  Treatment-emergent, all-causality adverse events with an incidence ≥5% for varenicline were nausea (43.7% for varenicline vs 11.3% placebo), insomnia (15.1% vs 13.7%), increased appetite (7.9% vs 6.5%), constipation (7.1% vs 2.4%), anxiety (5.6% vs 2.4%), and abnormal dreams (5.6% vs 0.8%).  Adverse events resulted in <10% treatment discontinuations overall.  Conclusion: Varenicline was an efficacious and well-tolerated pharmacotherapy for smoking cessation in this group of Asian smokers over a 12-wk treatment period, and its effects persisted for a further 12-wk follow-up period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnYORkHS3RLbVg90H21EOLACvtfcHk0liDZXzLYHD1Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptlKjtL0%253D&md5=020fed1b102ff27627f9048084c6acc8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2007.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2007.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DS.%2BT.%26aulast%3DCho%26aufirst%3DH.%2BJ.%26aulast%3DCheng%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DC.%2BH.%26aulast%3DHsueh%26aufirst%3DK.%2BC.%26aulast%3DBilling%26aufirst%3DC.%2BB.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26atitle%3DA%2520randomized%252C%2520placebo-controlled%2520trial%2520of%2520varenicline%252C%2520a%2520selective%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%252C%2520as%2520a%2520new%2520therapy%2520for%2520smoking%2520cessation%2520in%2520Asian%2520smokers%26jtitle%3DClin.%2520Ther.%26date%3D2007%26volume%3D29%26spage%3D1027%26epage%3D1039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Moore, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furberg, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenmullen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltsberger, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S.</span><span> </span><span class="NLM_article-title">Suicidal behavior and depression in smoking cessation treatments</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e27016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e27016&author=T.+J.+Mooreauthor=C.+D.+Furbergauthor=J.+Glenmullenauthor=J.+T.+Maltsbergerauthor=S.+Singh&title=Suicidal+behavior+and+depression+in+smoking+cessation+treatments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DT.%2BJ.%26aulast%3DFurberg%26aufirst%3DC.%2BD.%26aulast%3DGlenmullen%26aufirst%3DJ.%26aulast%3DMaltsberger%26aufirst%3DJ.%2BT.%26aulast%3DSingh%26aufirst%3DS.%26atitle%3DSuicidal%2520behavior%2520and%2520depression%2520in%2520smoking%2520cessation%2520treatments%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De27016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Rollema, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glowa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansbach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovetti, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span> </span><span class="NLM_article-title">Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid</span> <span class="citation_source-journal">Neuropharmacology.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">985</span><span class="NLM_x">–</span> <span class="NLM_lpage">994</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1016%2Fj.neuropharm.2006.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=17157884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=985-994&author=H.+Rollemaauthor=L.+K.+Chambersauthor=J.+W.+Coeauthor=J.+Glowaauthor=R.+S.+Hurstauthor=L.+A.+Lebelauthor=Y.+Luauthor=R.+S.+Mansbachauthor=R.+J.+Matherauthor=C.+C.+Rovettiauthor=S.+B.+Sandsauthor=E.+Schaefferauthor=D.+W.+Schulzauthor=F.+D.+Tingleyauthor=K.+E.+Williams&title=Pharmacological+profile+of+the+alpha4beta2+nicotinic+acetylcholine+receptor+partial+agonist+varenicline%2C+an+effective+smoking+cessation+aid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid</span></div><div class="casAuthors">Rollema, H.; Chambers, L. K.; Coe, J. W.; Glowa, J.; Hurst, R. S.; Lebel, L. A.; Lu, Y.; Mansbach, R. S.; Mather, R. J.; Rovetti, C. C.; Sands, S. B.; Schaeffer, E.; Schulz, D. W.; Tingley, F. D.; Williams, K. E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">985-994</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The preclin. pharmacol. of the α4β2 nicotinic acetylcholine receptor (nAChR) partial agonist varenicline, a novel smoking cessation agent is described.  Varenicline binds with subnanomolar affinity only to α4β2 nAChRs and in vitro functional patch clamp studies in HEK cells expressing nAChRs show that varenicline is a partial agonist with 45% of nicotine's maximal efficacy at α4β2 nAChRs.  In neurochem. models varenicline has significantly lower (40-60%) efficacy than nicotine in stimulating [3H]-dopamine release from rat brain slices in vitro and in increasing dopamine release from rat nucleus accumbens in vivo, while it is more potent than nicotine.  In addn., when combined with nicotine, varenicline effectively attenuates the nicotine-induced dopamine release to the level of the effect of varenicline alone, consistent with partial agonism.  Finally, varenicline reduces nicotine self-administration in rats and supports lower self-administration break points than nicotine.  These data suggest that varenicline can reproduce to some extent the subjective effects of smoking by partially activating α4β2 nAChRs, while preventing full activation of these receptors by nicotine.  Based on these findings, varenicline was advanced into clin. development and recently shown to be an effective and safe aid for smoking cessation treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgBqovXuf1ALVg90H21EOLACvtfcHk0liDZXzLYHD1Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyqtbw%253D&md5=11199806966b56bd3f075a4a902fe206</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2006.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2006.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DRollema%26aufirst%3DH.%26aulast%3DChambers%26aufirst%3DL.%2BK.%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DGlowa%26aufirst%3DJ.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DLebel%26aufirst%3DL.%2BA.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMansbach%26aufirst%3DR.%2BS.%26aulast%3DMather%26aufirst%3DR.%2BJ.%26aulast%3DRovetti%26aufirst%3DC.%2BC.%26aulast%3DSands%26aufirst%3DS.%2BB.%26aulast%3DSchaeffer%26aufirst%3DE.%26aulast%3DSchulz%26aufirst%3DD.%2BW.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26atitle%3DPharmacological%2520profile%2520of%2520the%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%2520varenicline%252C%2520an%2520effective%2520smoking%2520cessation%2520aid%26jtitle%3DNeuropharmacology.%26date%3D2007%26volume%3D52%26spage%3D985%26epage%3D994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Mihalak, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luetje, C. W.</span><span> </span><span class="NLM_article-title">Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=801-805&author=K.+B.+Mihalakauthor=F.+I.+Carrollauthor=C.+W.+Luetje&title=Varenicline+is+a+partial+agonist+at+alpha4beta2+and+a+full+agonist+at+alpha7+neuronal+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMihalak%26aufirst%3DK.%2BB.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DLuetje%26aufirst%3DC.%2BW.%26atitle%3DVarenicline%2520is%2520a%2520partial%2520agonist%2520at%2520alpha4beta2%2520and%2520a%2520full%2520agonist%2520at%2520alpha7%2520neuronal%2520nicotinic%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D801%26epage%3D805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Bordia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrachova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quik, M.</span><span> </span><span class="NLM_article-title">Varenicline is a potent partial agonist at alpha6beta2* nicotinic acetylcholine receptors in rat and monkey striatum</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1124%2Fjpet.112.194852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=22550286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOru7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2012&pages=327-334&author=T.+Bordiaauthor=M.+Hrachovaauthor=M.+Chinauthor=J.+M.+McIntoshauthor=M.+Quik&title=Varenicline+is+a+potent+partial+agonist+at+alpha6beta2*+nicotinic+acetylcholine+receptors+in+rat+and+monkey+striatum"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum</span></div><div class="casAuthors">Bordia, Tanuja; Hrachova, Maya; Chin, Matthew; McIntosh, J. Michael; Quik, Maryka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">327-334</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Extensive evidence indicates that varenicline reduces nicotine craving and withdrawal symptoms by modulating dopaminergic function at α4β2* nicotinic acetylcholine receptors (nAChRs) (the asterisk indicates the possible presence of other nicotinic subunits in the receptor complex).  More recent data suggest that α6β2* nAChRs also regulate dopamine release and mediate nicotine reinforcement.  The present expts. were therefore done to test the effect of varenicline on α6β2* nAChRs and their function, because its interaction with this subtype is currently unclear.  Receptor competition studies showed that varenicline inhibited α6β2* nAChR binding (Ki = 0.12 nM) as potently as α4β2* nAChR binding (Ki = 0.14 nM) in rat striatal sections and with ∼20-fold greater affinity than nicotine.  Functionally, varenicline was more potent in stimulating α6β2* vs. a4β2* nAChR-mediated [3H]dopamine release from rat striatal synaptosomes with EC50 values of 0.007 and 0.086 μM, resp.  However, it acted as a partial agonist on α6β2* and α4β2* nAChR-mediated [3H]dopamine release with maximal efficacies of 49 and 24%, resp., compared with nicotine.  We also evaluated varenicline's action in striatum of monkeys, a useful animal model for comparison with humans.  Varenicline again potently inhibited monkey striatal α6β2* (Ki = 0.13 nM) and α4β2* (Ki = 0.19 nM) nAChRs in competition studies.  Functionally, it potently stimulated both α6β2* (EC50 = 0.014 μM) and α4β2* (EC50 = 0.029 μM) nAChR-mediated [3H]dopamine release from monkey striatal synaptosomes, again acting as a partial agonist relative to nicotine at both subtypes.  These data suggest that the ability of varenicline to interact at α6β2* nAChRs may contribute to its efficacy as a smoking cessation aid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC_jN4_gF91LVg90H21EOLACvtfcHk0lgZkpXcHbmxZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOru7nF&md5=01850188a8ffaf19580241ad4e30c99b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.194852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.194852%26sid%3Dliteratum%253Aachs%26aulast%3DBordia%26aufirst%3DT.%26aulast%3DHrachova%26aufirst%3DM.%26aulast%3DChin%26aufirst%3DM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DQuik%26aufirst%3DM.%26atitle%3DVarenicline%2520is%2520a%2520potent%2520partial%2520agonist%2520at%2520alpha6beta2%252A%2520nicotinic%2520acetylcholine%2520receptors%2520in%2520rat%2520and%2520monkey%2520striatum%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D342%26spage%3D327%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musachio, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1454</span><span class="NLM_x">–</span> <span class="NLM_lpage">1460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1454-1460&author=Y.+Xiaoauthor=H.+Fanauthor=J.+L.+Musachioauthor=Z.+L.+Weiauthor=S.+K.+Chellappanauthor=A.+P.+Kozikowskiauthor=K.+J.+Kellar&title=Sazetidine-A%2C+a+novel+ligand+that+desensitizes+alpha4beta2+nicotinic+acetylcholine+receptors+without+activating+them"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DMusachio%26aufirst%3DJ.%2BL.%26aulast%3DWei%26aufirst%3DZ.%2BL.%26aulast%3DChellappan%26aufirst%3DS.%2BK.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DSazetidine-A%252C%2520a%2520novel%2520ligand%2520that%2520desensitizes%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptors%2520without%2520activating%2520them%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D1454%26epage%3D1460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Xiao, Y.; Yasuda, R. P.; Sahibzada, N.; Wolfe, B. B.; Horton, L.; Paige, M.; Brown, M. L.; Kellar, K. J.</span><span> </span><span class="NLM_article-title">Sazetidine-A selectively induces a long lasting desensitization of α4β2 nicotinic acetylcholine receptors</span>. In  (), <span class="NLM_conf-name">2010 Neuroscience Meeting, Society for Neuroscience</span>, <span class="NLM_conf-loc">San Diego</span>, <span class="NLM_conf-date">2010</span>, 38.10.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Xiao%2C+Y.%3B+Yasuda%2C+R.+P.%3B+Sahibzada%2C+N.%3B+Wolfe%2C+B.+B.%3B+Horton%2C+L.%3B+Paige%2C+M.%3B+Brown%2C+M.+L.%3B+Kellar%2C+K.+J.+Sazetidine-A+selectively+induces+a+long+lasting+desensitization+of+%CE%B14%CE%B22+nicotinic+acetylcholine+receptors.+In+%28%29%2C+2010+Neuroscience+Meeting%2C+Society+for+Neuroscience%2C+San+Diego%2C+2010%2C+38.10."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26atitle%3DSazetidine-A%2520selectively%2520induces%2520a%2520long%2520lasting%2520desensitization%2520of%2520%25CE%25B14%25CE%25B22%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3D%2520%2528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Carbone, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groot-Kormelink, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bermudez, I.</span><span> </span><span class="NLM_article-title">Pentameric concatenated (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2) nicotinic acetylcholine receptors: subunit arrangement determines functional expression</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">970</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1111%2Fj.1476-5381.2008.00104.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=19366353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Oqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2009&pages=970-981&author=A.+L.+Carboneauthor=M.+Moroniauthor=P.+J.+Groot-Kormelinkauthor=I.+Bermudez&title=Pentameric+concatenated+%28alpha4%29%282%29%28beta2%29%283%29+and+%28alpha4%29%283%29%28beta2%29%282%29+nicotinic+acetylcholine+receptors%3A+subunit+arrangement+determines+functional+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Pentameric concatenated (α4)2(β2)3 and (α4)3(β2)2 nicotinic acetylcholine receptors: subunit arrangement determines functional expression</span></div><div class="casAuthors">Carbone, A.-L.; Moroni, M.; Groot-Kormelink, P.-J.; Bermudez, I.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">970-981</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and purpose: α4 and β2 nicotinic acetylcholine (ACh) receptor subunits expressed heterologously in Xenopus oocytes assemble into a mixed population of (α4)2(β2)3 and (α4)3(β2)2 receptors.  To express these receptors sep. in heterologous systems, the authors have engineered pentameric concatenated (α4)2(β2)3 and (α4)3(β2)2 receptors.  Exptl. approach: α4 and β2 subunits were concatenated by synthetic linkers into pentameric constructs to produce either (α4)2(β2)3 or (α4)3(β2)2 receptors.  Using two-electrode voltage-clamp techniques, the authors examd. the ability of the concatenated constructs to produce functional expression in Xenopus oocytes.  Functional constructs were further characterized in respect to agonists, competitive antagonists, Ca2+ permeability, sensitivity to modulation by Zn2+ and sensitivity to up-regulation by chaperone protein 14-3-3.  Key results: the authors found that pentameric concatamers with a subunit arrangement of β2_α4_β2_α4_β2 or β2_α4_β2_α4_α4 were stable and functional in Xenopus oocytes.  By comparison, when α4 and β2 were concatenated with a subunit order of β2_β2_α4_β2_α4 or β2_α4_α4_β2_α4, functional expression in Xenopus oocytes was very low, even though the proteins were synthesized and stable.  Both β2_α4_β2_α4_β2 and β2_α4_β2_α4_α4 concatamers recapitulated the ACh concn. response curve, the sensitivity to Zn2+ modulation, Ca2+ permeability and the sensitivity to up-regulation by chaperone protein 14-3-3 of the corresponding non-linked (α4)2(β2)3 and (α4)3(β2)2 receptors resp.  Using these concatamers, the authors found that most α4β2-preferring compds. studied, including A85380, 51-A85380, cytisine, epibatidine, TC2559 and dihydro-β-erythroidine, demonstrate stoichiometry-specific potencies and efficacies.  Conclusions and implications: the authors concluded that the α4β2 nicotinic ACh receptors produced with β2_α4_β2_α4_β2 or β2_α4_β2_α4_α4 pentameric constructs are valid models of non-linked (α4)2(β2)3 and (α4)3(β2)2 receptors resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVhdNVrexQfbVg90H21EOLACvtfcHk0lgZkpXcHbmxZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Oqs7s%253D&md5=bb40295f9b0d314304e0139959ce8676</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2008.00104.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2008.00104.x%26sid%3Dliteratum%253Aachs%26aulast%3DCarbone%26aufirst%3DA.%2BL.%26aulast%3DMoroni%26aufirst%3DM.%26aulast%3DGroot-Kormelink%26aufirst%3DP.%2BJ.%26aulast%3DBermudez%26aufirst%3DI.%26atitle%3DPentameric%2520concatenated%2520%2528alpha4%2529%25282%2529%2528beta2%2529%25283%2529%2520and%2520%2528alpha4%2529%25283%2529%2528beta2%2529%25282%2529%2520nicotinic%2520acetylcholine%2520receptors%253A%2520subunit%2520arrangement%2520determines%2520functional%2520expression%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D156%26spage%3D970%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Levin, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezvani, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cauley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1124%2Fjpet.109.162073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=20007754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFCjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2010&pages=933-939&author=E.+D.+Levinauthor=A.+H.+Rezvaniauthor=Y.+Xiaoauthor=S.+Sladeauthor=M.+Cauleyauthor=C.+Wellsauthor=D.+Hamptonauthor=A.+Petroauthor=J.+E.+Roseauthor=M.+L.+Brownauthor=M.+A.+Paigeauthor=B.+E.+McDowellauthor=K.+J.+Kellar&title=Sazetidine-A%2C+a+selective+alpha4beta2+nicotinic+receptor+desensitizing+agent+and+partial+agonist%2C+reduces+nicotine+self-administration+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Sazetidine-A, a selective α4β2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats</span></div><div class="casAuthors">Levin, Edward D.; Rezvani, Amir H.; Xiao, Yingxian; Slade, Susan; Cauley, Marty; Wells, Corinne; Hampton, Dawn; Petro, Ann; Rose, Jed E.; Brown, Milton L.; Paige, Mikell A.; McDowell, Brian E.; Kellar, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">933-939</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Adequate treatment of tobacco addiction remains problematic.  Part of the problem with treatment is a poor understanding of the pharmacol. aspects of nicotine contributing to addiction.  In addn. to activating nicotinic acetylcholine receptors, nicotine also desensitizes them.  It is currently not known how much of each of nicotine's actions contribute to its particular behavioral effects.  Sazetidine-A (saz-A) is a novel nicotinic receptor-desensitizing agent and partial agonist with high selectivity for α4β2 receptors.  The current expts. were conducted to det. whether saz-A would reduce nicotine self-administration in rats and to characterize its ancillary effects.  Adult male Sprague-Dawley rats were allowed to self-administer nicotine.  After initial food pellet training followed by 10 sessions of nicotine self-administration training, the rats were administered saz-A (0.1-3 mg/kg s.c.) or the saline vehicle in a repeated-measures counterbalanced design.  Saz-A at the 3 mg/kg dose significantly decreased nicotine self-administration relative to performance of the same rats after saline injections.  In a second study, long-term administration of this dose of sazetidine-A over the course of 10 sessions significantly reduced nicotine self-administration with no apparent diminution of effect.  Saz-A in this dose range had only modest effects on locomotor activity, without any overall decrease in activity over a 1-h-long session.  Saz-A significantly reduced food self-administration, but this effect was smaller than its effect on nicotine self-administration.  Saz-A, which is a selective α4β2-desensitizing agent and partial agonist, effectively reduces nicotine self-administration.  This type of treatment holds promise for a new therapy to aid smoking cessation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyXvn7dQpysLVg90H21EOLACvtfcHk0lgZkpXcHbmxZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFCjs7s%253D&md5=e6b4e73fc3c6373d3dbc6e249bb8a76c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.162073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.162073%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DE.%2BD.%26aulast%3DRezvani%26aufirst%3DA.%2BH.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DSlade%26aufirst%3DS.%26aulast%3DCauley%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DHampton%26aufirst%3DD.%26aulast%3DPetro%26aufirst%3DA.%26aulast%3DRose%26aufirst%3DJ.%2BE.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DPaige%26aufirst%3DM.%2BA.%26aulast%3DMcDowell%26aufirst%3DB.%2BE.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DSazetidine-A%252C%2520a%2520selective%2520alpha4beta2%2520nicotinic%2520receptor%2520desensitizing%2520agent%2520and%2520partial%2520agonist%252C%2520reduces%2520nicotine%2520self-administration%2520in%2520rats%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D332%26spage%3D933%26epage%3D939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Rezvani, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lumeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, E. D.</span><span> </span><span class="NLM_article-title">Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats</span> <span class="citation_source-journal">Psychopharmacology (Berlin, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">211</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1007%2Fs00213-010-1878-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=20535453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFGlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2010&pages=161-174&author=A.+H.+Rezvaniauthor=S.+Sladeauthor=C.+Wellsauthor=A.+Petroauthor=L.+Lumengauthor=T.+K.+Liauthor=Y.+Xiaoauthor=M.+L.+Brownauthor=M.+A.+Paigeauthor=B.+E.+McDowellauthor=J.+E.+Roseauthor=K.+J.+Kellarauthor=E.+D.+Levin&title=Effects+of+sazetidine-A%2C+a+selective+alpha4beta2+nicotinic+acetylcholine+receptor+desensitizing+agent+on+alcohol+and+nicotine+self-administration+in+selectively+bred+alcohol-preferring+%28P%29+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats</span></div><div class="casAuthors">Rezvani, Amir H.; Slade, Susan; Wells, Cori; Petro, Ann; Lumeng, Lawrence; Li, Ting-Kai; Xiao, Yingxian; Brown, Milton L.; Paige, Mikell A.; McDowell, Brian E.; Rose, Jed E.; Kellar, Kenneth J.; Levin, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-174</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: Manipulations of nicotinic cholinergic receptors have been shown to influence both alc. and nicotine intake.  Sazetidine-A [6-(5(((S)-azetidine-2-yl)methoxy)pyridine-3-yl)hex-5-yn-1-ol] is a novel compd. that potently and selectively desensitizes α4β2 nicotinic receptors with only modest receptor activation.  Objectives: The goal of the present study was to examine the effects of sazetidine-A on alc. and nicotine self-administration in alc.-preferring (P) rats.  Methods: P rats were given the choice of water or alc.  Once stable baselines were established, the acute (0, 0.1, 0.3, 1, and 3 mg/kg, s.c.) and chronic (3 mg/kg for 10 days) effects of sazetidine-A on alc. intake were assessed.  Naltrexone (2.5 mg/kg) served as a pos. control.  The effect of sazetidine-A (3 mg/kg) and naltrexone (4 mg/kg) on saccharin (0.2%) preference was also assessed.  In addn., the acute effects of sazetidine-A (3 mg/kg) and naltrexone (4 mg/kg) on alc. intake after alc. deprivation were evaluated.  In another expt., the effects of sazetidine-A (0, 1, or 3 mg/kg) on IV nicotine self-administration in P and NP rats were assessed.  Results: Sazetidine-A caused a dose-dependent redn. in alc. intake.  Chronic sazetidine-A also effectively reduced alc. intake until the seventh day of treatment, when partial tolerance appeared to develop.  In the post-deprivation study, sazetidine-A significantly reduced alc. intake and preference.  Sazetidine-A at 3 mg/kg significantly reduced nicotine self-administration in both lines.  Conclusions: Sazetidine-A significantly reduced alc. and nicotine intake in P rats that self-administer higher levels of both drugs.  Sazetidine-A may hold promise for the treatment of alc. and nicotine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZfW61FFrtlbVg90H21EOLACvtfcHk0ljwohXl_1cGNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFGlsb0%253D&md5=18b4836f096b921e6ef22c8538528ecf</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs00213-010-1878-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-010-1878-8%26sid%3Dliteratum%253Aachs%26aulast%3DRezvani%26aufirst%3DA.%2BH.%26aulast%3DSlade%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DPetro%26aufirst%3DA.%26aulast%3DLumeng%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DT.%2BK.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DPaige%26aufirst%3DM.%2BA.%26aulast%3DMcDowell%26aufirst%3DB.%2BE.%26aulast%3DRose%26aufirst%3DJ.%2BE.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26aulast%3DLevin%26aufirst%3DE.%2BD.%26atitle%3DEffects%2520of%2520sazetidine-A%252C%2520a%2520selective%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520desensitizing%2520agent%2520on%2520alcohol%2520and%2520nicotine%2520self-administration%2520in%2520selectively%2520bred%2520alcohol-preferring%2520%2528P%2529%2520rats%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D2010%26volume%3D211%26spage%3D161%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Rezvani, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cauley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, E. D.</span><span> </span><span class="NLM_article-title">Sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats</span> <span class="citation_source-journal">Psychopharmacology (Berlin, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">215</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1007%2Fs00213-010-2161-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=21274704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2011&pages=621-630&author=A.+H.+Rezvaniauthor=M.+Cauleyauthor=H.+Sextonauthor=Y.+Xiaoauthor=M.+L.+Brownauthor=M.+A.+Paigeauthor=B.+E.+McDowellauthor=K.+J.+Kellarauthor=E.+D.+Levin&title=Sazetidine-A%2C+a+selective+alpha4beta2+nicotinic+acetylcholine+receptor+ligand%3A+effects+on+dizocilpine+and+scopolamine-induced+attentional+impairments+in+female+Sprague-Dawley+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats</span></div><div class="casAuthors">Rezvani, Amir H.; Cauley, Marty; Sexton, Hannah; Xiao, Yingxian; Brown, Milton L.; Paige, Mikell A.; McDowell, Brian E.; Kellar, Kenneth J.; Levin, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">621-630</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Neuronal nicotinic receptor systems were shown to play key roles in cognition.  Nicotine and nicotinic analogs improve attention and nicotinic antagonists impair it.  This study was conducted to investigate the role of α4β2 nicotinic receptors in sustained attention using a novel selective α4β2 nicotinic receptor ligand, sazetidine-A.  Female rats were trained to perform the signal detection task to a stable baseline of accuracy.  The rats were injected with saline, sazetidine-A (0.01, 0.03, and 0.1 mg/kg), dizocilpine (0.05 mg/kg), or their combination; or, in another expt., the rats were injected with the same doses of sazetidine-A, scopolamine (0.02 mg/kg), or their combination.  Percent hit and percent correct rejection showed that dizocilpine caused significant impairments in performance, which were significantly reversed by each of the sazetidine-A doses.  Response omissions were significantly increased by dizocilpine, and this was also significantly reversed by each of the sazetidine-A doses.  None of the sazetidine-A doses had significant effects on hit, correct rejection, or response omissions when given alone.  Scopolamine also caused significant impairments in percent hit and percent correct rejection and increased response omissions, which were significantly attenuated by all the sazetidine-A doses for percent hit and response omissions and by the highest dose of sazetidine-A for percent correct rejection.  Both scopolamine and dizocilpine significantly increased response latency, an effect which was significantly attenuated by sazetidine-A coadministration.  These studies imply an important role for α4β2 nicotinic receptors in improving sustained attention under conditions that disrupt it.  Very low doses of sazetidine-A or drugs with a similar profile may provide therapeutic benefit for reversing attentional impairment in patients suffering from mental disorders and/or cognitive impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwUk_GZLd5o7Vg90H21EOLACvtfcHk0ljwohXl_1cGNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKqtrs%253D&md5=cea4f477d47522d42611860547b1cf68</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs00213-010-2161-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-010-2161-8%26sid%3Dliteratum%253Aachs%26aulast%3DRezvani%26aufirst%3DA.%2BH.%26aulast%3DCauley%26aufirst%3DM.%26aulast%3DSexton%26aufirst%3DH.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DPaige%26aufirst%3DM.%2BA.%26aulast%3DMcDowell%26aufirst%3DB.%2BE.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26aulast%3DLevin%26aufirst%3DE.%2BD.%26atitle%3DSazetidine-A%252C%2520a%2520selective%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520ligand%253A%2520effects%2520on%2520dizocilpine%2520and%2520scopolamine-induced%2520attentional%2520impairments%2520in%2520female%2520Sprague-Dawley%2520rats%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D2011%26volume%3D215%26spage%3D621%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajjuri, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karadi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Chemistry and pharmacology of nicotinic ligands based on 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol (AMOP-H-OH) for possible use in depression</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1279</span><span class="NLM_x">–</span> <span class="NLM_lpage">1291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1279-1291&author=A.+P.+Kozikowskiauthor=J.+B.+Eatonauthor=K.+M.+Bajjuriauthor=S.+K.+Chellappanauthor=Y.+Chenauthor=S.+Karadiauthor=R.+Heauthor=B.+Caldaroneauthor=M.+Manzanoauthor=P.+W.+Yuenauthor=R.+J.+Lukas&title=Chemistry+and+pharmacology+of+nicotinic+ligands+based+on+6-%5B5-%28azetidin-2-ylmethoxy%29pyridin-3-yl%5Dhex-5-yn-1-ol+%28AMOP-H-OH%29+for+possible+use+in+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DBajjuri%26aufirst%3DK.%2BM.%26aulast%3DChellappan%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKaradi%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DR.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DManzano%26aufirst%3DM.%26aulast%3DYuen%26aufirst%3DP.%2BW.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DChemistry%2520and%2520pharmacology%2520of%2520nicotinic%2520ligands%2520based%2520on%25206-%255B5-%2528azetidin-2-ylmethoxy%2529pyridin-3-yl%255Dhex-5-yn-1-ol%2520%2528AMOP-H-OH%2529%2520for%2520possible%2520use%2520in%2520depression%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1279%26epage%3D1291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Turner, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellano, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blendy, J. A.</span><span> </span><span class="NLM_article-title">Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1124%2Fjpet.110.166280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=20435920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Kisb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2010&pages=665-672&author=J.+R.+Turnerauthor=L.+M.+Castellanoauthor=J.+A.+Blendy&title=Nicotinic+partial+agonists+varenicline+and+sazetidine-A+have+differential+effects+on+affective+behavior"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior</span></div><div class="casAuthors">Turner, Jill R.; Castellano, Laura M.; Blendy, Julie A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">665-672</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Clin. and preclin. studies suggest that nicotinic acetylcholine receptors are involved in affective disorders; therefore, the potential therapeutic value of nicotinic partial agonists as treatments of these disorders is of growing interest.  This study evaluated the effects of acute and chronic administration of nicotine and the α4β2 nicotinic partial agonists varenicline and sazetidine-A in mouse models of anxiety and depression.  Acutely, only nicotine and varenicline had anxiolytic effects in the marble-burying test and in the novelty-induced hypophagia (NIH) test.  In contrast, in animal models of antidepressant efficacy, such as the forced swim and the tail suspension test, only acute sazetidine-A had significant antidepressant-like effects.  The NIH test provides an anxiety-related measure that is sensitive to the effects of chronic but not acute antidepressant treatment.  Chronic nicotine and chronic sazetidine-A treatment were effective in this paradigm, but varenicline was ineffective.  These results suggest that the partial agonists varenicline and sazetidine-A may have diverse therapeutic benefits in affective disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogo1Sj2UHr5bVg90H21EOLACvtfcHk0lh93PYkw-hsHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Kisb%252FE&md5=79c7a0573c7aea5e0bb72ab5d5a4e05d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.166280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.166280%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DJ.%2BR.%26aulast%3DCastellano%26aufirst%3DL.%2BM.%26aulast%3DBlendy%26aufirst%3DJ.%2BA.%26atitle%3DNicotinic%2520partial%2520agonists%2520varenicline%2520and%2520sazetidine-A%2520have%2520differential%2520effects%2520on%2520affective%2520behavior%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D334%26spage%3D665%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Caldarone, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedolak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanania, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picciotto, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghavami, A.</span><span> </span><span class="NLM_article-title">Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380</span> <span class="citation_source-journal">Psychopharmacology (Berlin, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">217</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1007%2Fs00213-011-2271-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=21487659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksFymt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=2011&pages=199-210&author=B.+J.+Caldaroneauthor=D.+Wangauthor=N.+E.+Patersonauthor=M.+Manzanoauthor=A.+Fedolakauthor=K.+Cavinoauthor=M.+Kwanauthor=T.+Hananiaauthor=S.+K.+Chellappanauthor=A.+P.+Kozikowskiauthor=B.+Olivierauthor=M.+R.+Picciottoauthor=A.+Ghavami&title=Dissociation+between+duration+of+action+in+the+forced+swim+test+in+mice+and+nicotinic+acetylcholine+receptor+occupancy+with+sazetidine%2C+varenicline%2C+and+5-I-A85380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380</span></div><div class="casAuthors">Caldarone, Barbara J.; Wang, Daguang; Paterson, Neil E.; Manzano, Michael; Fedolak, Allison; Cavino, Katie; Kwan, Mei; Hanania, Taleen; Chellappan, Sheela K.; Kozikowski, Alan P.; Olivier, Berend; Picciotto, Marina R.; Ghavami, Afshin</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-210</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: Nicotinic acetylcholine receptor (nAChR) agonists, partial agonists, and antagonists have antidepressant-like effects in rodents and reduce symptoms of depression in humans.  Objectives: The study detd. whether the antidepressant-like effect of the nAChR β2* partial agonist sazetidine-A (sazetidine) in the forced swim test was due to activation or desensitization of β2* nAChRs.  The study also detd. if sazetidine's behavioral responses in the forced swim test corresponded to β2* nAChRs receptor occupancy and drug bioavailability.  Results: Acute antidepressant-like effects in the forced swim test were seen with sazetidine and the full β2* agonist 5-I-A8350 (BALB/cJ mice) and the less selective β2* partial agonist varenicline in C57BL/6J but not BALB/cJ mice.  The role of β2* nAChRs was confirmed by results showing: (1) reversal of sazetidine's antidepressant-like effects in the forced swim test by nAChR antagonists mecamylamine and dihydro-β-erythroidine; (2) absence of sazetidine's effect in mice lacking the β2 subunit of the nAChR; and (3) a high correspondence between behaviorally active doses of sazetidine and β2* receptor occupancy. β2* receptor occupancy following acute sazetidine, varenicline, and 5-I-A8350 lasted beyond the duration of action in the forced swim test.  Sazetidine's long lasting receptor occupancy did not diminish behavioral efficacy in the forced swim test following repeated dosing.  Conclusions: Results demonstrate that activation of a small population of β2* nAChRs (10-40%) is sufficient to elicit sazetidine's antidepressant-like actions without producing tolerance and suggest that ligands that activate β2* nAChRs would be promising targets for the development of a new class of antidepressant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriIAbTX2Qb67Vg90H21EOLACvtfcHk0lh93PYkw-hsHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksFymt7g%253D&md5=794495af9e8426b2ab966c35efa35c54</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2Fs00213-011-2271-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-011-2271-y%26sid%3Dliteratum%253Aachs%26aulast%3DCaldarone%26aufirst%3DB.%2BJ.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DPaterson%26aufirst%3DN.%2BE.%26aulast%3DManzano%26aufirst%3DM.%26aulast%3DFedolak%26aufirst%3DA.%26aulast%3DCavino%26aufirst%3DK.%26aulast%3DKwan%26aufirst%3DM.%26aulast%3DHanania%26aufirst%3DT.%26aulast%3DChellappan%26aufirst%3DS.%2BK.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DOlivier%26aufirst%3DB.%26aulast%3DPicciotto%26aufirst%3DM.%2BR.%26aulast%3DGhavami%26aufirst%3DA.%26atitle%3DDissociation%2520between%2520duration%2520of%2520action%2520in%2520the%2520forced%2520swim%2520test%2520in%2520mice%2520and%2520nicotinic%2520acetylcholine%2520receptor%2520occupancy%2520with%2520sazetidine%252C%2520varenicline%252C%2520and%25205-I-A85380%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D2011%26volume%3D217%26spage%3D199%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Hussmann, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">A new radioligand binding assay to measure the concentration of drugs in rodent brain ex vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">434</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1124%2Fjpet.112.198069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKktbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2012&pages=434-440&author=G.+P.+Hussmannauthor=K.+J.+Kellar&title=A+new+radioligand+binding+assay+to+measure+the+concentration+of+drugs+in+rodent+brain+ex+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A new radioligand binding assay to measure the concentration of drugs in rodent brain ex vivo</span></div><div class="casAuthors">Hussmann, G. Patrick; Kellar, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">434-440</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We have developed a new radioligand binding assay method to measure the concn. of nonradiolabeled drugs in the brain ex vivo.  This new method fuses the concepts of std. competition and satn. binding assays and uses a transformed version of the Cheng-Prusoff equation to calc. the drug concn.  After testing the validity of this method, we demonstrated its utility by measuring the brain concn. of sazetidine-A, a newly developed nicotinic receptor ligand, and its elimination rate after a single s.c. administration.  Our results indicate that sazetidine-A reaches brain concns. that are known to occupy and desensitize the majority of neuronal nicotinic acetylcholine receptor binding sites.  Furthermore, using this method, we estd. the half-life of sazetidine-A in the rat brain to be ∼65 min.  It is important to note that the method described here to measure sazetidine-A in brain should be generalizable to other drugs acting at any receptor that can be reliably measured with a radiolabeled ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow0WwOgz6LirVg90H21EOLACvtfcHk0li3fCP9uKuNdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKktbrJ&md5=ff350de1808d774bdca967d0339dba0e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.198069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.198069%26sid%3Dliteratum%253Aachs%26aulast%3DHussmann%26aufirst%3DG.%2BP.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DA%2520new%2520radioligand%2520binding%2520assay%2520to%2520measure%2520the%2520concentration%2520of%2520drugs%2520in%2520rodent%2520brain%2520ex%2520vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D343%26spage%3D434%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Severin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doye, S.</span><span> </span><span class="NLM_article-title">One-pot procedure for the synthesis of unsymmetrical diarylalkynes</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">3518</span><span class="NLM_x">–</span> <span class="NLM_lpage">3521</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo100460v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=3518-3521&author=R.+Severinauthor=J.+Reimerauthor=S.+Doye&title=One-pot+procedure+for+the+synthesis+of+unsymmetrical+diarylalkynes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjo100460v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo100460v%26sid%3Dliteratum%253Aachs%26aulast%3DSeverin%26aufirst%3DR.%26aulast%3DReimer%26aufirst%3DJ.%26aulast%3DDoye%26aufirst%3DS.%26atitle%3DOne-pot%2520procedure%2520for%2520the%2520synthesis%2520of%2520unsymmetrical%2520diarylalkynes%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D75%26spage%3D3518%26epage%3D3521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Holladay, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daanen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryther, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasicak, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kincaid, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hettinger, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannon, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly-Roberts, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunther, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntzweiler, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span> </span><span class="NLM_article-title">Structure–activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2797</span><span class="NLM_x">–</span> <span class="NLM_lpage">2802</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=2797-2802&author=M.+W.+Holladayauthor=H.+Baiauthor=Y.+Liauthor=N.+H.+Linauthor=J.+F.+Daanenauthor=K.+B.+Rytherauthor=J.+T.+Wasicakauthor=J.+F.+Kincaidauthor=Y.+Heauthor=A.+M.+Hettingerauthor=P.+Huangauthor=D.+J.+Andersonauthor=A.+W.+Bannonauthor=M.+J.+Buckleyauthor=J.+E.+Campbellauthor=D.+L.+Donnelly-Robertsauthor=K.+L.+Guntherauthor=D.+J.+Kimauthor=T.+A.+Kuntzweilerauthor=J.+P.+Sullivanauthor=M.+W.+Deckerauthor=S.+P.+Arneric&title=Structure%E2%80%93activity+studies+related+to+ABT-594%2C+a+potent+nonopioid+analgesic+agent%3A+effect+of+pyridine+and+azetidine+ring+substitutions+on+nicotinic+acetylcholine+receptor+binding+affinity+and+analgesic+activity+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolladay%26aufirst%3DM.%2BW.%26aulast%3DBai%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DN.%2BH.%26aulast%3DDaanen%26aufirst%3DJ.%2BF.%26aulast%3DRyther%26aufirst%3DK.%2BB.%26aulast%3DWasicak%26aufirst%3DJ.%2BT.%26aulast%3DKincaid%26aufirst%3DJ.%2BF.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DHettinger%26aufirst%3DA.%2BM.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DBannon%26aufirst%3DA.%2BW.%26aulast%3DBuckley%26aufirst%3DM.%2BJ.%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26aulast%3DGunther%26aufirst%3DK.%2BL.%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DKuntzweiler%26aufirst%3DT.%2BA.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26atitle%3DStructure%25E2%2580%2593activity%2520studies%2520related%2520to%2520ABT-594%252C%2520a%2520potent%2520nonopioid%2520analgesic%2520agent%253A%2520effect%2520of%2520pyridine%2520and%2520azetidine%2520ring%2520substitutions%2520on%2520nicotinic%2520acetylcholine%2520receptor%2520binding%2520affinity%2520and%2520analgesic%2520activity%2520in%2520mice%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D2797%26epage%3D2802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwoskin, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, C. G.</span><span> </span><span class="NLM_article-title">Modeling multiple species of nicotine and deschloroepibatidine interacting with alpha4beta2 nicotinic acetylcholine receptor: from microscopic binding to phenomenological binding affinity</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">14401</span><span class="NLM_x">–</span> <span class="NLM_lpage">14414</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja052681%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=14401-14414&author=X.+Huangauthor=F.+Zhengauthor=P.+A.+Crooksauthor=L.+P.+Dwoskinauthor=C.+G.+Zhan&title=Modeling+multiple+species+of+nicotine+and+deschloroepibatidine+interacting+with+alpha4beta2+nicotinic+acetylcholine+receptor%3A+from+microscopic+binding+to+phenomenological+binding+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fja052681%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja052681%252B%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DF.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26aulast%3DZhan%26aufirst%3DC.%2BG.%26atitle%3DModeling%2520multiple%2520species%2520of%2520nicotine%2520and%2520deschloroepibatidine%2520interacting%2520with%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%253A%2520from%2520microscopic%2520binding%2520to%2520phenomenological%2520binding%2520affinity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D14401%26epage%3D14414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Karlin, A.</span><span> </span><span class="NLM_article-title">Emerging structure of the nicotinic acetylcholine receptors</span> <span class="citation_source-journal">Nature Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1038%2Fnrn731" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=11836518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD38Xhslyju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=102-114&author=A.+Karlin&title=Emerging+structure+of+the+nicotinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging structure of the nicotinic acetylcholine receptors</span></div><div class="casAuthors">Karlin, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">102-114</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The conversion of acetylcholine binding into ion conduction across the membrane is becoming more clearly understood in terms of the structure of the receptor and its transitions.  A high-resoln. structure of a protein that is homologous to the extracellular domain of the receptor has revealed the binding sites and subunit interfaces in great detail.  Although the structures of the membrane and cytoplasmic domains are less well detd., the channel lining and the determinants of selectivity have been mapped.  The location and structure of the gates, and the coupling between binding sites and gates, remain to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonRXMxN_TWwbVg90H21EOLACvtfcHk0li3fCP9uKuNdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xhslyju7Y%253D&md5=c2f51e06285cb371e35aff13814f2858</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnrn731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn731%26sid%3Dliteratum%253Aachs%26aulast%3DKarlin%26aufirst%3DA.%26atitle%3DEmerging%2520structure%2520of%2520the%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DNature%2520Rev.%2520Neurosci.%26date%3D2002%26volume%3D3%26spage%3D102%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Karlin, A.</span><span> </span><span class="NLM_article-title">A touching picture of nicotinic binding</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">842</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2004&pages=841-842&author=A.+Karlin&title=A+touching+picture+of+nicotinic+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarlin%26aufirst%3DA.%26atitle%3DA%2520touching%2520picture%2520of%2520nicotinic%2520binding%26jtitle%3DNeuron%26date%3D2004%26volume%3D41%26spage%3D841%26epage%3D842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Lester, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dibas, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leite, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, D. A.</span><span> </span><span class="NLM_article-title">Cys-loop receptors: new twists and turns</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=329-336&author=H.+A.+Lesterauthor=M.+I.+Dibasauthor=D.+S.+Dahanauthor=J.+F.+Leiteauthor=D.+A.+Dougherty&title=Cys-loop+receptors%3A+new+twists+and+turns"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLester%26aufirst%3DH.%2BA.%26aulast%3DDibas%26aufirst%3DM.%2BI.%26aulast%3DDahan%26aufirst%3DD.%2BS.%26aulast%3DLeite%26aufirst%3DJ.%2BF.%26aulast%3DDougherty%26aufirst%3DD.%2BA.%26atitle%3DCys-loop%2520receptors%253A%2520new%2520twists%2520and%2520turns%26jtitle%3DTrends%2520Neurosci.%26date%3D2004%26volume%3D27%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Unwin, N.</span><span> </span><span class="NLM_article-title">Refined structure of the nicotinic acetylcholine receptor at 4A resolution</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">989</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2005&pages=967-989&author=N.+Unwin&title=Refined+structure+of+the+nicotinic+acetylcholine+receptor+at+4A+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUnwin%26aufirst%3DN.%26atitle%3DRefined%2520structure%2520of%2520the%2520nicotinic%2520acetylcholine%2520receptor%2520at%25204A%2520resolution%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D346%26spage%3D967%26epage%3D989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Brejc, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dijk, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaassen, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuurmans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Der, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sixma, T. K.</span><span> </span><span class="NLM_article-title">Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">411</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1038%2F35077011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=11357122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjvF2qsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=269-276&author=K.+Brejcauthor=W.+J.+van+Dijkauthor=R.+V.+Klaassenauthor=M.+Schuurmansauthor=O.+J.+van+Derauthor=A.+B.+Smitauthor=T.+K.+Sixma&title=Crystal+structure+of+an+ACh-binding+protein+reveals+the+ligand-binding+domain+of+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors</span></div><div class="casAuthors">Brejc, Katusa; van Dijk, Willem J.; Klaassen, Remco V.; Schuurmans, Mascha; van der Oost, John; Smit, August B.; Sixma, Lia K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">411</span>
        (<span class="NLM_cas:issue">6835</span>),
    <span class="NLM_cas:pages">269-276</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pentameric ligand gated ion-channels, or Cys-loop receptors, mediate rapid chem. transmission of signals.  This superfamily of allosteric transmembrane proteins includes the nicotinic acetylcholine (nAChR), serotonin 5-HT3, γ-aminobutyric-acid (GABAA and GABAC) and glycine receptors.  Biochem. and electrophysiol. information on the prototypic nAChRs is abundant but structural data at at. resoln. have been missing.  Here we present the crystal structure of molluscan acetylcholine-binding protein (AChBP), a structural and functional homolog of the amino-terminal ligand-binding domain of an nAChR a-subunit.  In the AChBP homopentamer, the protomers have an Ig-like topol.  Ligand-binding sites are located at each of five subunit interfaces and contain residues contributed by biochem. detd. 'loops' A to F.  The subunit interfaces are highly variable within the ion-channel family, whereas the conserved residues stabilize the protomer fold.  This AChBP structure is relevant for the development of drugs against, for example, Alzheimer's disease and nicotine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvp9q8syDJx7Vg90H21EOLACvtfcHk0lgpRRRsWEfjfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjvF2qsbc%253D&md5=db9f0bb3f46a8fc98cbb25781d6c4775</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2F35077011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35077011%26sid%3Dliteratum%253Aachs%26aulast%3DBrejc%26aufirst%3DK.%26aulast%3Dvan%2BDijk%26aufirst%3DW.%2BJ.%26aulast%3DKlaassen%26aufirst%3DR.%2BV.%26aulast%3DSchuurmans%26aufirst%3DM.%26aulast%3Dvan%2BDer%26aufirst%3DO.%2BJ.%26aulast%3DSmit%26aufirst%3DA.%2BB.%26aulast%3DSixma%26aufirst%3DT.%2BK.%26atitle%3DCrystal%2520structure%2520of%2520an%2520ACh-binding%2520protein%2520reveals%2520the%2520ligand-binding%2520domain%2520of%2520nicotinic%2520receptors%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D269%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Celie, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossum-Fikkert, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dijk, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brejc, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sixma, T. K.</span><span> </span><span class="NLM_article-title">Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">914</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1016%2FS0896-6273%2804%2900115-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=15046723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtValtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2004&pages=907-914&author=P.+H.+Celieauthor=S.+E.+Rossum-Fikkertauthor=W.+J.+van+Dijkauthor=K.+Brejcauthor=A.+B.+Smitauthor=T.+K.+Sixma&title=Nicotine+and+carbamylcholine+binding+to+nicotinic+acetylcholine+receptors+as+studied+in+AChBP+crystal+structures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures</span></div><div class="casAuthors">Celie, Patrick H. N.; Van Rossum-Fikkert, Sarah E.; Van Dijk, Willem J.; Brejc, Katjusa; Smit, August B.; Sixma, Titia K.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">907-914</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors are prototypes for the pharmaceutically important family of pentameric ligand-gated ion channels.  Here the authors present at. resoln. structures of nicotine and carbamylcholine binding to AChBP, a water-sol. homolog of the ligand binding domain of nicotinic receptors and their family members, GABAA, GABAC, 5HT3 serotonin, and glycine receptors.  Ligand binding is driven by enthalpy and is accompanied by conformational changes in the ligand binding site.  Residues in the binding site contract around the ligand, with the largest movement in the C loop.  As expected, the binding is characterized by substantial arom. and hydrophobic contributions, but addnl. there are close contacts between protein oxygens and pos. charged groups in the ligands.  The higher affinity of nicotine is due to a main chain hydrogen bond with the B loop and a closer packing of the arom. groups.  These structures will be useful tools for the development of new drugs involving nicotinic acetylcholine receptor-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUnXnRu5RRsrVg90H21EOLACvtfcHk0lgpRRRsWEfjfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtValtLg%253D&md5=4a4b5058b4b4543d25080dc86c8567f4</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2804%2900115-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252804%252900115-1%26sid%3Dliteratum%253Aachs%26aulast%3DCelie%26aufirst%3DP.%2BH.%26aulast%3DRossum-Fikkert%26aufirst%3DS.%2BE.%26aulast%3Dvan%2BDijk%26aufirst%3DW.%2BJ.%26aulast%3DBrejc%26aufirst%3DK.%26aulast%3DSmit%26aufirst%3DA.%2BB.%26aulast%3DSixma%26aufirst%3DT.%2BK.%26atitle%3DNicotine%2520and%2520carbamylcholine%2520binding%2520to%2520nicotinic%2520acetylcholine%2520receptors%2520as%2520studied%2520in%2520AChBP%2520crystal%2520structures%26jtitle%3DNeuron%26date%3D2004%26volume%3D41%26spage%3D907%26epage%3D914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Chico, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Eldik, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, D. M.</span><span> </span><span class="NLM_article-title">Targeting protein kinases in central nervous system disorders</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=892-909&author=L.+K.+Chicoauthor=L.+J.+Van+Eldikauthor=D.+M.+Watterson&title=Targeting+protein+kinases+in+central+nervous+system+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChico%26aufirst%3DL.%2BK.%26aulast%3DVan%2BEldik%26aufirst%3DL.%2BJ.%26aulast%3DWatterson%26aufirst%3DD.%2BM.%26atitle%3DTargeting%2520protein%2520kinases%2520in%2520central%2520nervous%2520system%2520disorders%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D892%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2ea0sh_1nzC_nbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Reichel, A.</span><span> </span><span class="NLM_article-title">Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept</span> <span class="citation_source-journal">Chem. Biodiversity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2030</span><span class="NLM_x">–</span> <span class="NLM_lpage">2049</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=2030-2049&author=A.+Reichel&title=Addressing+central+nervous+system+%28CNS%29+penetration+in+drug+discovery%3A+basics+and+implications+of+the+evolving+new+concept"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReichel%26aufirst%3DA.%26atitle%3DAddressing%2520central%2520nervous%2520system%2520%2528CNS%2529%2520penetration%2520in%2520drug%2520discovery%253A%2520basics%2520and%2520implications%2520of%2520the%2520evolving%2520new%2520concept%26jtitle%3DChem.%2520Biodiversity%26date%3D2009%26volume%3D6%26spage%3D2030%26epage%3D2049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudkins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200100h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=50-68&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=R.+L.+Hudkinsauthor=B.+D.+Dorseyauthor=J.+P.+Mallamo&title=Knowledge-Based%2C+Central+Nervous+System+%28CNS%29+Lead+Selection+and+Lead+Optimization+for+CNS+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Hudkins, Robert L.; Dorsey, Bruce D.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-68</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The central nervous system (CNS) is the major area that is affected by aging.  Alzheimer's disease (AD), Parkinson's disease (PD), brain cancer, and stroke are the CNS diseases that will cost trillions of dollars for their treatment.  Achievement of appropriate blood-brain barrier (BBB) penetration is often considered a significant hurdle in the CNS drug discovery process.  On the other hand, BBB penetration may be a liability for many of the non-CNS drug targets, and a clear understanding of the physicochem. and structural differences between CNS and non-CNS drugs may assist both research areas.  Because of the numerous and challenging issues in CNS drug discovery and the low success rates, pharmaceutical companies are beginning to deprioritize their drug discovery efforts in the CNS arena.  Prompted by these challenges and to aid in the design of high-quality, efficacious CNS compds., we analyzed the physicochem. property and the chem. structural profiles of 317 CNS and 626 non-CNS oral drugs.  The conclusions derived provide an ideal property profile for lead selection and the property modification strategy during the lead optimization process.  A list of substructural units that may be useful for CNS drug design was also provided here.  A classification tree was also developed to differentiate between CNS drugs and non-CNS oral drugs.  The combined anal. provided the following guidelines for designing high-quality CNS drugs: (i) topol. mol. polar surface area of <76 Å2 (25-60 Å2), (ii) at least one (one or two, including one aliph. amine) nitrogen, (iii) fewer than seven (two to four) linear chains outside of rings, (iv) fewer than three (zero or one) polar hydrogen atoms, (v) vol. of 740-970 Å3, (vi) solvent accessible surface area of 460-580 Å2, and (vii) pos. QikProp parameter CNS.  The ranges within parentheses may be used during lead optimization.  One violation to this proposed profile may be acceptable.  The chemoinformatics approaches for graphically analyzing multiple properties efficiently are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozqfO0vq2i5bVg90H21EOLACvtfcHk0ljFZEBV3a8WkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO&md5=4c20ba34c3d5397170b50242975ce25d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fcn200100h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200100h%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge-Based%252C%2520Central%2520Nervous%2520System%2520%2528CNS%2529%2520Lead%2520Selection%2520and%2520Lead%2520Optimization%2520for%2520CNS%2520Drug%2520Discovery%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D50%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Goodwin, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, D. E.</span><span> </span><span class="NLM_article-title">In silico predictions of blood-brain barrier penetration: considerations to “keep in mind”</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1124%2Fjpet.104.075705" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=15919767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyhsbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=477-483&author=J.+T.+Goodwinauthor=D.+E.+Clark&title=In+silico+predictions+of+blood-brain+barrier+penetration%3A+considerations+to+%E2%80%9Ckeep+in+mind%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">In silico predictions of blood-brain barrier penetration: Considerations to "keep in mind"</span></div><div class="casAuthors">Goodwin, Jay T.; Clark, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">477-483</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Within drug discovery, it is desirable to det. whether a compd. will penetrate and distribute within the central nervous system (CNS) with the requisite pharmacokinetic and pharmacodynamic performance required for a CNS target or if it will be excluded from the CNS, wherein potential toxicities would mitigate its applicability.  A variety of in vivo and in vitro methods for assessing CNS penetration have therefore been developed and applied to advancing drug candidates with the desired properties.  In silico methods to predict CNS penetration from chem. structures have been developed to address virtual screening and prospective design.  In silico predictive methods are impacted by the quality, quantity, sources, and generation of the measured data available for model development.  Key considerations for predictions of CNS penetration include the comparison of local (in chem. space) vs. global (more structurally diverse) models and where in the drug discovery process such models may be best deployed.  Preference should also be given to in vitro and in vivo measurements of greater mechanistic clarity that better support the development of structure-property relationships.  Although there are numerous statistical methods that have been brought to bear on the prediction of CNS penetration, a greater concern is that such models are appropriate for the quality of measured data available and are statistically validated.  In addn., the assessment of prediction uncertainty and relevance of predictive models to structures of interest are crit.  This article will address these key considerations for the development and application of in silico methods in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkNjlmzY1VybVg90H21EOLACvtfcHk0ljFZEBV3a8WkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyhsbbO&md5=c984d13b5cd032f2c686811af02d8be5</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.075705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.075705%26sid%3Dliteratum%253Aachs%26aulast%3DGoodwin%26aufirst%3DJ.%2BT.%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DIn%2520silico%2520predictions%2520of%2520blood-brain%2520barrier%2520penetration%253A%2520considerations%2520to%2520%25E2%2580%259Ckeep%2520in%2520mind%25E2%2580%259D%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26spage%3D477%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Clark, D. E.</span><span> </span><span class="NLM_article-title">Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood–brain barrier penetration</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=815-821&author=D.+E.+Clark&title=Rapid+calculation+of+polar+molecular+surface+area+and+its+application+to+the+prediction+of+transport+phenomena.+2.+Prediction+of+blood%E2%80%93brain+barrier+penetration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DRapid%2520calculation%2520of%2520polar%2520molecular%2520surface%2520area%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520transport%2520phenomena.%25202.%2520Prediction%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520penetration%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D815%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Abad-Zapatero, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perisic, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bento, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Lazikani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. E.</span><span> </span><span class="NLM_article-title">Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">804</span><span class="NLM_x">–</span> <span class="NLM_lpage">811</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=804-811&author=C.+Abad-Zapateroauthor=O.+Perisicauthor=J.+Wassauthor=A.+P.+Bentoauthor=J.+Overingtonauthor=B.+Al-Lazikaniauthor=M.+E.+Johnson&title=Ligand+efficiency+indices+for+an+effective+mapping+of+chemico-biological+space%3A+the+concept+of+an+atlas-like+representation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26aulast%3DPerisic%26aufirst%3DO.%26aulast%3DWass%26aufirst%3DJ.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DOverington%26aufirst%3DJ.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DM.%2BE.%26atitle%3DLigand%2520efficiency%2520indices%2520for%2520an%2520effective%2520mapping%2520of%2520chemico-biological%2520space%253A%2520the%2520concept%2520of%2520an%2520atlas-like%2520representation%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D804%26epage%3D811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eZiBzZ3kH6k0bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Hajek, P.; McRobbie, H.; Myers, K.</span><span> </span><span class="NLM_article-title">Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis</span>.  <span class="citation_source-journal">Thorax</span>.<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1136/thoraxjnl-2012-203035</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1136%2Fthoraxjnl-2012-203035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=P.+Hajek&author=H.+McRobbie&author=K.+Myers&title=Efficacy+of+cytisine+in+helping+smokers+quit%3A+systematic+review+and+meta-analysis&doi=10.1136%2Fthoraxjnl-2012-203035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1136%2Fthoraxjnl-2012-203035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fthoraxjnl-2012-203035%26sid%3Dliteratum%253Aachs%26aulast%3DHajek%26aufirst%3DP.%26atitle%3DEfficacy%2520of%2520cytisine%2520in%2520helping%2520smokers%2520quit%253A%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DThorax%26date%3D2013%26doi%3D10.1136%2Fthoraxjnl-2012-203035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Freedman, R.</span><span> </span><span class="NLM_article-title">Exacerbation of schizophrenia by varenicline</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">1269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1176%2Fappi.ajp.2007.07020326" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A280%3ADC%252BD2svltlWmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2007&pages=1269&author=R.+Freedman&title=Exacerbation+of+schizophrenia+by+varenicline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Exacerbation of schizophrenia by varenicline</span></div><div class="casAuthors">Freedman Robert</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1269</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgv_jWdHp-NexsqfvU0ziafW6udTcc2eZiBzZ3kH6k0bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svltlWmuw%253D%253D&md5=8389f7c87888934aedf57502ecff5f3c</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2007.07020326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2007.07020326%26sid%3Dliteratum%253Aachs%26aulast%3DFreedman%26aufirst%3DR.%26atitle%3DExacerbation%2520of%2520schizophrenia%2520by%2520varenicline%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2007%26volume%3D164%26spage%3D1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Kohen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremen, N.</span><span> </span><span class="NLM_article-title">Varenicline-induced manic episode in a patient with bipolar disorder</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">1269</span><span class="NLM_x">–</span> <span class="NLM_lpage">1270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1176%2Fappi.ajp.2007.07010173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A280%3ADC%252BD2svltlWmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2007&pages=1269-1270&author=I.+Kohenauthor=N.+Kremen&title=Varenicline-induced+manic+episode+in+a+patient+with+bipolar+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Varenicline-induced manic episode in a patient with bipolar disorder</span></div><div class="casAuthors">Kohen Izchak; Kremen Neil</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1269-70</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgv_jWdHp-NVMGsG_HTXYFfW6udTcc2eb3eojeAXBMlrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svltlWmug%253D%253D&md5=a3fbe2ee3eb4f13eeb6af62c5d843338</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2007.07010173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2007.07010173%26sid%3Dliteratum%253Aachs%26aulast%3DKohen%26aufirst%3DI.%26aulast%3DKremen%26aufirst%3DN.%26atitle%3DVarenicline-induced%2520manic%2520episode%2520in%2520a%2520patient%2520with%2520bipolar%2520disorder%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2007%26volume%3D164%26spage%3D1269%26epage%3D1270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loke, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spangler, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furberg, C. D.</span><span> </span><span class="NLM_article-title">Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis</span> <span class="citation_source-journal">Can. Med. Assoc. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">183</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1503%2Fcmaj.110218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A280%3ADC%252BC3MfhsFSmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2011&pages=1359-1366&author=S.+Singhauthor=Y.+K.+Lokeauthor=J.+G.+Spanglerauthor=C.+D.+Furberg&title=Risk+of+serious+adverse+cardiovascular+events+associated+with+varenicline%3A+a+systematic+review+and+meta-analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis</span></div><div class="casAuthors">Singh Sonal; Loke Yoon K; Spangler John G; Furberg Curt D</div><div class="citationInfo"><span class="NLM_cas:title">CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1359-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  There have been postmarketing reports of adverse cardiovascular events associated with the use of varenicline, a widely used smoking cessation drug.  We conducted a systematic review and meta-analysis of randomized controlled trials to ascertain the serious adverse cardiovascular effects of varenicline compared with placebo among tobacco users.  METHODS:  We searched MEDLINE, EMBASE, the Cochrane Database of Systematic Reviews, websites of regulatory authorities and registries of clinical trials, with no date or language restrictions, through September 2010 (updated March 2011) for published and unpublished studies.  We selected double-blind randomized controlled trials of at least one week's duration involving smokers or people who used smokeless tobacco that reported on cardiovascular events (ischemia, arrhythmia, congestive heart failure, sudden death or cardiovascular-related death) as serious adverse events asociated with the use of varenicline.  RESULTS:  We analyzed data from 14 double-blind randomized controlled trials involving 8216 participants.  The trials ranged in duration from 7 to 52 weeks.  Varenicline was associated with a significantly increased risk of serious adverse cardiovascular events compared with placebo (1.06% [52/4908] in varenicline group v. 0.82% [27/3308] in placebo group; Peto odds ratio [OR] 1.72, 95% confidence interval [CI] 1.09-2.71; I(2) = 0%).  The results of various sensitivity analyses were consistent with those of the main analysis, and a funnel plot showed no publication bias.  There were too few deaths to allow meaningful comparisons of mortality.  INTERPRETATION:  Our meta-analysis raises safety concerns about the potential for an increased risk of serious adverse cardiovascular events associated with the use of varenicline among tobacco users.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSrDMC_9K9Fp4JKJbLTgsvCfW6udTcc2eb3eojeAXBMlrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MfhsFSmsQ%253D%253D&md5=c2bb69c9bb341769a153c69d98440d9f</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1503%2Fcmaj.110218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1503%252Fcmaj.110218%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DLoke%26aufirst%3DY.%2BK.%26aulast%3DSpangler%26aufirst%3DJ.%2BG.%26aulast%3DFurberg%26aufirst%3DC.%2BD.%26atitle%3DRisk%2520of%2520serious%2520adverse%2520cardiovascular%2520events%2520associated%2520with%2520varenicline%253A%2520a%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DCan.%2520Med.%2520Assoc.%2520J.%26date%3D2011%26volume%3D183%26spage%3D1359%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Coe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetelino, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirtz, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrikhande, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heym, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollema, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansbach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovetti, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3474</span><span class="NLM_x">–</span> <span class="NLM_lpage">3477</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050069n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3474-3477&author=J.+W.+Coeauthor=P.+R.+Brooksauthor=M.+G.+Vetelinoauthor=M.+C.+Wirtzauthor=E.+P.+Arnoldauthor=J.+Huangauthor=S.+B.+Sandsauthor=T.+I.+Davisauthor=L.+A.+Lebelauthor=C.+B.+Foxauthor=A.+Shrikhandeauthor=J.+H.+Heymauthor=E.+Schaefferauthor=H.+Rollemaauthor=Y.+Luauthor=R.+S.+Mansbachauthor=L.+K.+Chambersauthor=C.+C.+Rovettiauthor=D.+W.+Schulzauthor=F.+D.+Tingleyauthor=B.+T.+O%E2%80%99Neill&title=Varenicline%3A+an+alpha4beta2+nicotinic+receptor+partial+agonist+for+smoking+cessation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm050069n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050069n%26sid%3Dliteratum%253Aachs%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DBrooks%26aufirst%3DP.%2BR.%26aulast%3DVetelino%26aufirst%3DM.%2BG.%26aulast%3DWirtz%26aufirst%3DM.%2BC.%26aulast%3DArnold%26aufirst%3DE.%2BP.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DSands%26aufirst%3DS.%2BB.%26aulast%3DDavis%26aufirst%3DT.%2BI.%26aulast%3DLebel%26aufirst%3DL.%2BA.%26aulast%3DFox%26aufirst%3DC.%2BB.%26aulast%3DShrikhande%26aufirst%3DA.%26aulast%3DHeym%26aufirst%3DJ.%2BH.%26aulast%3DSchaeffer%26aufirst%3DE.%26aulast%3DRollema%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMansbach%26aufirst%3DR.%2BS.%26aulast%3DChambers%26aufirst%3DL.%2BK.%26aulast%3DRovetti%26aufirst%3DC.%2BC.%26aulast%3DSchulz%26aufirst%3DD.%2BW.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DVarenicline%253A%2520an%2520alpha4beta2%2520nicotinic%2520receptor%2520partial%2520agonist%2520for%2520smoking%2520cessation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3474%26epage%3D3477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Lummis, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bencherif, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lester, H. A.</span><span> </span><span class="NLM_article-title">Varenicline is a potent agonist of the human 5-hydroxytryptamine3 receptor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1124%2Fjpet.111.185306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=21775477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2011&pages=125-131&author=S.+C.+Lummisauthor=A.+J.+Thompsonauthor=M.+Bencherifauthor=H.+A.+Lester&title=Varenicline+is+a+potent+agonist+of+the+human+5-hydroxytryptamine3+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Varenicline is a potent agonist of the human 5-hydroxytryptamine3 receptor</span></div><div class="casAuthors">Lummis, S. C. R.; Thompson, A. J.; Bencherif, M.; Lester, H. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-131</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Varenicline, a widely used and successful smoking cessation agent, acts as a partial agonist at nicotinic acetylcholine receptors.  Here, we explore the effects of varenicline at human and mouse 5-Hydroxytryptamine3 (5-HT3) receptors.  Application of varenicline to human 5-HT3 receptors expressed in Xenopus laevis oocytes reveal it is almost a full agonist (Rmax = 80%) with an EC50 (5.9 μM) 3-fold higher than 5-HT.  At mouse 5-HT3 receptors varenicline is a partial agonist (Rmax = 35%) with an EC50 (18 μM) 20-fold higher than 5-HT.  Displacement of the competitive 5-HT3 receptor antagonist [3H]granisetron reveals similar IC50 values for varenicline at mouse and human receptors expressed in human embryonic kidney 293 cells, although studies in these cells using a membrane potential-sensitive dye show that again varenicline is a 4- or 35-fold less potent agonist than 5-HT in human and mouse receptors, resp.  Thus the data suggest that the efficacy, but not the affinity, of varenicline is greater at human 5-HT3 receptors compared with mouse.  Docking studies provide a possible explanation for this difference, because they suggest distinct orientations of the ligand in the mouse vs. human 5-HT3 agonist binding sites.  Addnl. binding selectivity studies in a broad panel of recombinant receptors and enzymes confirmed an interaction with 5-HT3 receptors but revealed no addnl. interactions of varenicline.  Therefore, activation of human 5-HT3 receptors may be responsible for some of the side effects that preclude use of higher doses during varenicline treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-VGq4L9Bf07Vg90H21EOLACvtfcHk0liCaDIC7tmVJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbnK&md5=9fb7fd670366ce842e5e252cdebbef15</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.185306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.185306%26sid%3Dliteratum%253Aachs%26aulast%3DLummis%26aufirst%3DS.%2BC.%26aulast%3DThompson%26aufirst%3DA.%2BJ.%26aulast%3DBencherif%26aufirst%3DM.%26aulast%3DLester%26aufirst%3DH.%2BA.%26atitle%3DVarenicline%2520is%2520a%2520potent%2520agonist%2520of%2520the%2520human%25205-hydroxytryptamine3%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D339%26spage%3D125%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Johnson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezvani, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, E. D.</span><span> </span><span class="NLM_article-title">Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats</span> <span class="citation_source-journal">Psychopharmacology (Berlin, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">222</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1007%2Fs00213-012-2642-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=22297831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Omtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=222&publication_year=2012&pages=269-276&author=J.+E.+Johnsonauthor=S.+Sladeauthor=C.+Wellsauthor=A.+Petroauthor=H.+Sextonauthor=A.+H.+Rezvaniauthor=M.+L.+Brownauthor=M.+A.+Paigeauthor=B.+E.+McDowellauthor=Y.+Xiaoauthor=K.+J.+Kellarauthor=E.+D.+Levin&title=Assessing+the+effects+of+chronic+sazetidine-A+delivery+on+nicotine+self-administration+in+both+male+and+female+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats</span></div><div class="casAuthors">Johnson, Joshua E.; Slade, Susan; Wells, Corinne; Petro, Ann; Sexton, Hannah; Rezvani, Amir H.; Brown, Milton L.; Paige, Mikell A.; McDowell, Brian E.; Xiao, Yingxian; Kellar, Kenneth J.; Levin, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">222</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-276</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: Sazetidine-A is a selective α4β2 nicotinic receptor desensitizing agent and partial agonist.  It has been shown in previous studies to significantly reduce nicotine self-administration in rats after acute or repeated injections.  However, the effects of continuous chronic infusions of sazetidine-A on maintenance of nicotine self-administration and relapse after abstinence have yet to be examd.  Objectives: This study evaluated the efficacy of continuous sazetidine-A infusions (s.c.) over a period of 4 wk to reduce nicotine self-administration in male and female Sprague-Dawley rats.  Methods: Sazetidine-A was administered via Alzet osmotic minipumps to young adult female and male rats at doses of 0, 2 or 6 mg/kg/day for 4 wk.  The effects of sazetidine-A on IV nicotine self-administration were examd. in repeated 3-h sessions over the first 2 wk of infusion followed by 1 wk of forced abstinence from nicotine and 1 wk of resumed nicotine access.  Results: The 6 mg/kg/day sazetidine-A dose significantly reduced overall nicotine self-administration compared with vehicle control across the sessions for both male (p < 0.001) and female (p < 0.05) rats.  The lower 2 mg/kg/day sazetidine-A infusion dose was effective in reducing nicotine self-administration for male (p < 0.001), but not female rats.  No attenuation in sazetidine-A effectiveness was seen over the course of the 4-wk treatment.  In the vehicle control group, male rats self-administered significantly (p < 0.001) more nicotine than females.  Conclusions: The continuing effectiveness of sazetidine-A in reducing nicotine self-administration in both male and female rats supports its promise as a new treatment to help people successfully quit smoking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBZjP3-lA4eLVg90H21EOLACvtfcHk0liCaDIC7tmVJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Omtro%253D&md5=2528e80809dcac74a16e4e8d85dff6df</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1007%2Fs00213-012-2642-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-012-2642-z%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DJ.%2BE.%26aulast%3DSlade%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DPetro%26aufirst%3DA.%26aulast%3DSexton%26aufirst%3DH.%26aulast%3DRezvani%26aufirst%3DA.%2BH.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DPaige%26aufirst%3DM.%2BA.%26aulast%3DMcDowell%26aufirst%3DB.%2BE.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26aulast%3DLevin%26aufirst%3DE.%2BD.%26atitle%3DAssessing%2520the%2520effects%2520of%2520chronic%2520sazetidine-A%2520delivery%2520on%2520nicotine%2520self-administration%2520in%2520both%2520male%2520and%2520female%2520rats%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D2012%26volume%3D222%26spage%3D269%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Cucchiaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Sulser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Analgesic effects of sazetidine-A, a new nicotinic cholinergic drug</span> <span class="citation_source-journal">Anesthesiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2008&pages=512-519&author=G.+Cucchiaroauthor=Y.+Xiaoauthor=A.+Gonzalez-Sulserauthor=K.+J.+Kellar&title=Analgesic+effects+of+sazetidine-A%2C+a+new+nicotinic+cholinergic+drug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCucchiaro%26aufirst%3DG.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DGonzalez-Sulser%26aufirst%3DA.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DAnalgesic%2520effects%2520of%2520sazetidine-A%252C%2520a%2520new%2520nicotinic%2520cholinergic%2520drug%26jtitle%3DAnesthesiology%26date%3D2008%26volume%3D109%26spage%3D512%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">AlSharari, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span> </span><span class="NLM_article-title">The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain models</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1124%2Fjpet.112.194506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=22678099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlShu7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2012&pages=742-749&author=S.+D.+AlSharariauthor=F.+I.+Carrollauthor=J.+M.+McIntoshauthor=M.+I.+Damaj&title=The+antinociceptive+effects+of+nicotinic+partial+agonists+varenicline+and+sazetidine-A+in+murine+acute+and+tonic+pain+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain models</span></div><div class="casAuthors">AlSharari, Shakir D.; Carroll, F. Ivy; McIntosh, J. Michael; Damaj, M. Imad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">742-749</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Nicotinic agonists display a wide-range profile of antinociceptive activity in acute, tonic, and chronic pain models.  However, their effectiveness is limited by their unacceptable side effects.  We investigated the antinocicpetive effects of 2 new α4β2* nicotinic partial agonists, varenicline and sazetidine-A, in acute thermal and tonic pain mouse models.  Both drugs failed to induce significant effects in the tail-flick and hot-plate tests after s.c. administration.  However, they blocked nicotine's effects in these tests at very low doses.  In contrast to acute pain tests, varenicline and sazetidine-A dose-dependently induced an analgesic effect in the mouse formalin test after systemic administration.  Their antinociceptive effects were mediated, however, by different nicotinic acetylcholine receptor (nAChR) subtypes.  Sazetidine-A effects were mediated by β2* nAChR subtypes, whereas varenicline actions were attributed to α3β4 nAChRs.  Moreover, low inactive doses of varenicline blocked nicotine's actions in phase II of the formalin test.  Overall, our results suggest that the antagonistic actions of varenicline at low doses are mediated by β2*-nAChRs and at higher doses as an agonist by α3β4*-nAChRs.  In contrast, both actions of sazetidine-A are mediated by β2*-nAChR subtypes.  These results suggest that nicotinic partial agonists possess analgesic effects in a rodent tonic pain model and may provide a potential treatment for the treatment of chronic pain disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1FLMDJFGmn7Vg90H21EOLACvtfcHk0liCaDIC7tmVJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlShu7nP&md5=2209ccba5e8e2aed3a5bdb09bd908521</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.194506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.194506%26sid%3Dliteratum%253Aachs%26aulast%3DAlSharari%26aufirst%3DS.%2BD.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26atitle%3DThe%2520antinociceptive%2520effects%2520of%2520nicotinic%2520partial%2520agonists%2520varenicline%2520and%2520sazetidine-A%2520in%2520murine%2520acute%2520and%2520tonic%2520pain%2520models%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D342%26spage%3D742%26epage%3D749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Chemistry and pharmacological characterization of novel nitrogen analogues of AMOP-H-OH (sazetidine-A, 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol) as alpha4beta2-nicotinic acetylcholine receptor-selective partial agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6973</span><span class="NLM_x">–</span> <span class="NLM_lpage">6985</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100765u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6973-6985&author=J.+Liuauthor=J.+B.+Eatonauthor=B.+Caldaroneauthor=R.+J.+Lukasauthor=A.+P.+Kozikowski&title=Chemistry+and+pharmacological+characterization+of+novel+nitrogen+analogues+of+AMOP-H-OH+%28sazetidine-A%2C+6-%5B5-%28azetidin-2-ylmethoxy%29pyridin-3-yl%5Dhex-5-yn-1-ol%29+as+alpha4beta2-nicotinic+acetylcholine+receptor-selective+partial+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm100765u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100765u%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DChemistry%2520and%2520pharmacological%2520characterization%2520of%2520novel%2520nitrogen%2520analogues%2520of%2520AMOP-H-OH%2520%2528sazetidine-A%252C%25206-%255B5-%2528azetidin-2-ylmethoxy%2529pyridin-3-yl%255Dhex-5-yn-1-ol%2529%2520as%2520alpha4beta2-nicotinic%2520acetylcholine%2520receptor-selective%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6973%26epage%3D6985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Fiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sali, A.</span><span> </span><span class="NLM_article-title">Modeling of loops in protein structures</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1753</span><span class="NLM_x">–</span> <span class="NLM_lpage">1773</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1110%2Fps.9.9.1753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=11045621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFamsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=1753-1773&author=A.+Fiserauthor=R.+K.+Doauthor=A.+Sali&title=Modeling+of+loops+in+protein+structures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling of loops in protein structures</span></div><div class="casAuthors">Fiser, Andras; Do, Richard Kinh Gian; Sali, Andrej</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1753-1773</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Comparative protein structure prediction is limited mostly by the errors in alignment and loop modeling.  We describe here a new automated modeling technique that significantly improves the accuracy of loop predictions in protein structures.  The positions of all nonhydrogen atoms of the loop are optimized in a fixed environment with respect to a pseudo energy function.  The energy is a sum of many spatial restraints that include the bond length, bond angle, and improper dihedral angle terms from the CHARMM-22 force field, statistical preferences for the main-chain and side-chain dihedral angles, and statistical preferences for nonbonded at. contacts that depend on the two atom types, their distance through space, and sepn. in sequence.  The energy function is optimized with the method of conjugate gradients combined with mol. dynamics and simulated annealing.  Typically, the predicted loop conformation corresponds to the lowest energy conformation among 500 independent optimizations.  Predictions were made for 40 loops of known structure at each length from 1 to 14 residues.  The accuracy of loop predictions is evaluated as a function of thoroughness of conformational sampling, loop length, and structural properties of native loops.  When accuracy is measured by local superposition of the model on the native loop, 100, 90, and 30% of 4-, 8-, and 12-residue loop predictions, resp., had <2 Å RMSD error for the mainchain N, Cα, C, and O atoms; the av. accuracies were 0.59±0.05, 1.16±0.10, and 2.61±0.16 Å, resp.  To simulate real comparative modeling problems, the method was also evaluated by predicting loops of known structure in only approx. correct environments with errors typical of comparative modeling without misalignment.  When the RMSD distortion of the main-chain stem atoms is 2.5 Å, the av. loop prediction error increased by 180, 25, and 3% for 4-, 8-, and 12-residue loops, resp.  The accuracy of the lowest energy prediction for a given loop can be estd. from the structural variability among a no. of low energy predictions.  The relative value of the present method is gauged by (1) comparing it with one of the most successful previously described methods, and (2) describing its accuracy in recent blind predictions of protein structure.  Finally, it is shown that the av. accuracy of prediction is limited primarily by the accuracy of the energy function rather than by the extent of conformational sampling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsbG2px_r_krVg90H21EOLACvtfcHk0lhtcjbSv2rkjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFamsL8%253D&md5=0bcdbfbddf54ecca0e3fee95ecdc3f8b</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1110%2Fps.9.9.1753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.9.9.1753%26sid%3Dliteratum%253Aachs%26aulast%3DFiser%26aufirst%3DA.%26aulast%3DDo%26aufirst%3DR.%2BK.%26aulast%3DSali%26aufirst%3DA.%26atitle%3DModeling%2520of%2520loops%2520in%2520protein%2520structures%26jtitle%3DProtein%2520Sci.%26date%3D2000%26volume%3D9%26spage%3D1753%26epage%3D1773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Altschul, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipman, D. J.</span><span> </span><span class="NLM_article-title">Basic local alignment search tool</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">215</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1016%2FS0022-2836%2805%2980360-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=2231712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADyaK3MXitVGmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=1990&pages=403-410&author=S.+F.+Altschulauthor=W.+Gishauthor=W.+Millerauthor=E.+W.+Myersauthor=D.+J.+Lipman&title=Basic+local+alignment+search+tool"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Basic local alignment search tool</span></div><div class="casAuthors">Altschul, Stephen F.; Gish, Warren; Miller, Webb; Myers, Eugene W.; Lipman, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">403-10</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">A new approach to rapid sequence comparison, basic local alignment search tool (BLAST), directly approximates alignments that optimize a measure of local similarity, the maximal segment pair (MSP) score.  Recent math. results on the stochastic properties of MSP scores allow an anal. of the performance of this method as well as the statistical significance of alignments it generates.  The basic algorithm is simple and robust; it can be implemented in a no. of ways and applied in a variety of contexts including straightforward DNA and protein sequence database searches, motif searches, gene identification searches, and in the anal. of multiple regions of similarity in long DNA sequences.  In addn. to its flexibility and tractability to math. anal., BLAST is an order of magnitude faster than existing sequence comparison tools of comparable sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGEHw-q53MfLVg90H21EOLACvtfcHk0lhtcjbSv2rkjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXitVGmsA%253D%253D&md5=009d2323eb82f0549356880e1101db16</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2805%2980360-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252805%252980360-2%26sid%3Dliteratum%253Aachs%26aulast%3DAltschul%26aufirst%3DS.%2BF.%26aulast%3DGish%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DW.%26aulast%3DMyers%26aufirst%3DE.%2BW.%26aulast%3DLipman%26aufirst%3DD.%2BJ.%26atitle%3DBasic%2520local%2520alignment%2520search%2520tool%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1990%26volume%3D215%26spage%3D403%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Chenna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugawara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. D.</span><span> </span><span class="NLM_article-title">Multiple sequence alignment with the Clustal series of programs</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">3497</span><span class="NLM_x">–</span> <span class="NLM_lpage">3500</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=3497-3500&author=R.+Chennaauthor=H.+Sugawaraauthor=T.+Koikeauthor=R.+Lopezauthor=T.+J.+Gibsonauthor=D.+G.+Higginsauthor=J.+D.+Thompson&title=Multiple+sequence+alignment+with+the+Clustal+series+of+programs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChenna%26aufirst%3DR.%26aulast%3DSugawara%26aufirst%3DH.%26aulast%3DKoike%26aufirst%3DT.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DGibson%26aufirst%3DT.%2BJ.%26aulast%3DHiggins%26aufirst%3DD.%2BG.%26aulast%3DThompson%26aufirst%3DJ.%2BD.%26atitle%3DMultiple%2520sequence%2520alignment%2520with%2520the%2520Clustal%2520series%2520of%2520programs%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2003%26volume%3D31%26spage%3D3497%26epage%3D3500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Case, D. A.; Darden, T. A.; Cheatham, T. E.; Simmerling, C. L.; Wang, J.; Duke, R. E.; Luo, R.; Merz, K. M.; Pearlman, D. A.; Crowley, M.; Walker, R. C.; Zhang, W.; Wang, B.; Hayik, S.; Roitberg, A.; Seabra, G.; Wong, K. F.; Paesani, F.; Wu, X.; Brozell, S.; Tsui, V.; Gohlke, H.; Yang, L.; Tan, C.; Mongan, J.; Hornak, V.; Cui, G.; Beroza, P.; Mathews, D. H.; Schafmeister, C.; Ross, W. S.; Kollman, P. A.</span>AMBER 9; <span class="NLM_publisher-name">University of California</span>: <span class="NLM_publisher-loc">San Francisco</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=D.+A.+Case&author=T.+A.+Darden&author=T.+E.+Cheatham&author=C.+L.+Simmerling&author=J.+Wang&author=R.+E.+Duke&author=R.+Luo&author=K.+M.+Merz&author=D.+A.+Pearlman&author=M.+Crowley&author=R.+C.+Walker&author=W.+Zhang&author=B.+Wang&author=S.+Hayik&author=A.+Roitberg&author=G.+Seabra&author=K.+F.+Wong&author=F.+Paesani&author=X.+Wu&author=S.+Brozell&author=V.+Tsui&author=H.+Gohlke&author=L.+Yang&author=C.+Tan&author=J.+Mongan&author=V.+Hornak&author=G.+Cui&author=P.+Beroza&author=D.+H.+Mathews&author=C.+Schafmeister&author=W.+S.+Ross&author=P.+A.+Kollman&title=AMBER+9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26jtitle%3DAMBER%25209%26pub%3DUniversity%2520of%2520California%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Laskowski, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacArthur, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, J. M.</span><span> </span><span class="NLM_article-title"><i>PROCHECK</i>: a program to check the stereochemical quality of protein structure</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1107%2FS0021889892009944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADyaK3sXit12lurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1993&pages=283-291&author=R.+A.+Laskowskiauthor=M.+W.+MacArthurauthor=D.+S.+Mossauthor=J.+M.+Thornton&title=PROCHECK%3A+a+program+to+check+the+stereochemical+quality+of+protein+structure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">PROCHECK: a program to check the stereochemical quality of protein structures</span></div><div class="casAuthors">Laskowski, Roman A.; MacArthur, Malcolm W.; Moss, David S.; Thornton, Janet M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">283-91</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    </div><div class="casAbstract">The PROCHECK suite of programs provides a detailed check on the stereochem. of a protein structure.  Its outputs comprise a no. of plots in PostScript format and a comprehensive residue-by-residue listing.  These give an assessment of the overall quality of the structure as compared with well-refined structures of the same resoln. and also highlight regions that may need further investigation.  The PROCHECK programs are useful for assessing the quality not only of protein structures in the process of being solved but also of existing structures and of those being modeled on known structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCe5FgJf4KH7Vg90H21EOLACvtfcHk0lgJqX-mr-csQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit12lurY%253D&md5=fb69fc4410cd716aaaa7cc0db06b3ed2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1107%2FS0021889892009944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889892009944%26sid%3Dliteratum%253Aachs%26aulast%3DLaskowski%26aufirst%3DR.%2BA.%26aulast%3DMacArthur%26aufirst%3DM.%2BW.%26aulast%3DMoss%26aufirst%3DD.%2BS.%26aulast%3DThornton%26aufirst%3DJ.%2BM.%26atitle%3DPROCHECK%253A%2520a%2520program%2520to%2520check%2520the%2520stereochemical%2520quality%2520of%2520protein%2520structure%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1993%26volume%3D26%26spage%3D283%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Vriend, G.</span><span> </span><span class="NLM_article-title">WHAT IF: a molecular modeling and drug design program</span> <span class="citation_source-journal">J. Mol. Graphics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1016%2F0263-7855%2890%2980070-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=2268628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADyaK3cXitFGksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1990&pages=52-56&author=G.+Vriend&title=WHAT+IF%3A+a+molecular+modeling+and+drug+design+program"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">WHAT IF:  a molecular modeling and drug design program</span></div><div class="casAuthors">Vriend, G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-6, 29</span>CODEN:
                <span class="NLM_cas:coden">JMGRDV</span>;
        ISSN:<span class="NLM_cas:issn">0263-7855</span>.
    </div><div class="casAbstract">A FORTRAN 77 computer program has been written to aid with macromol. modeling and drug design.  Called WHAT IF, it provides an intelligent and flexible environment for displaying, manipulating, and analyzing small mols., proteins, nucleic acids, and their interactions.  A relational protein structure database is incorporated to be queried.  The program is suitable for most common crystallog. work.  The menu-driven operation of WHAT IF, combined with the use of default values wherever user input is required, makes it very easy to use for a novice user while keeping full flexibility for more sophisticated studies.  Although there are not too many unique features in WHAT IF, the fact that everything is integrated in one program makes if a unique tool for many purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ64OrfsqnR7Vg90H21EOLACvtfcHk0lgJqX-mr-csQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXitFGksL8%253D&md5=a764dc42ba008577f0076092ab4e6024</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2F0263-7855%2890%2980070-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0263-7855%252890%252980070-V%26sid%3Dliteratum%253Aachs%26aulast%3DVriend%26aufirst%3DG.%26atitle%3DWHAT%2520IF%253A%2520a%2520molecular%2520modeling%2520and%2520drug%2520design%2520program%26jtitle%3DJ.%2520Mol.%2520Graphics%26date%3D1990%26volume%3D8%26spage%3D52%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Frisch, M. J.; Trucks, G. W.; Cheeseman, J. R.; Scalmani, G.; Caricato, M.; Hratchian, H. P.; Li, X.; Barone, V.; Bloino, J.; Zheng, G.; Vreven, T.; Montgomery,  Jr., J. A.; Petersson, G. A.; Scuseria, G. E.; Schlegel, H. B.; Nakatsuji, H.; zmaylov, A. F.; Martin, R. L.; Sonnenberg, J. L.; Peralta, J. E.; Heyd, J. J.; Brothers, E.; Ogliaro, F.; Bearpark, M.; Robb, M. A.; Mennucci, B.; Kudin, K. N.; Staroverov, V. N.; Kobayashi, R.; Normand, J.; Rendell, A.; Gomperts, R.; Zakrzewski, V. G.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.</span>Gaussian 09; <span class="NLM_publisher-name">Gaussian, Inc.</span>: <span class="NLM_publisher-loc">Wallingford, CT</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+J.+Frisch&author=G.+W.+Trucks&author=J.+R.+Cheeseman&author=G.+Scalmani&author=M.+Caricato&author=H.+P.+Hratchian&author=X.+Li&author=V.+Barone&author=J.+Bloino&author=G.+Zheng&author=T.+Vreven&author=J.+A.+Montgomery&author=G.+A.+Petersson&author=G.+E.+Scuseria&author=H.+B.+Schlegel&author=H.+Nakatsuji&author=A.+F.+zmaylov&author=R.+L.+Martin&author=J.+L.+Sonnenberg&author=J.+E.+Peralta&author=J.+J.+Heyd&author=E.+Brothers&author=F.+Ogliaro&author=M.+Bearpark&author=M.+A.+Robb&author=B.+Mennucci&author=K.+N.+Kudin&author=V.+N.+Staroverov&author=R.+Kobayashi&author=J.+Normand&author=A.+Rendell&author=R.+Gomperts&author=V.+G.+Zakrzewski&author=M.+Hada&author=M.+Ehara&author=K.+Toyota&author=R.+Fukuda&author=J.+Hasegawa&author=M.+Ishida&author=T.+Nakajima&author=Y.+Honda&author=O.+Kitao&author=H.+Nakai&title=Gaussian+09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DFrisch%26aufirst%3DM.%2BJ.%26jtitle%3DGaussian%252009%26pub%3DGaussian%252C%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Hanson, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friel, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dilis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeSombre, E. R.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 17alpha-20<i>E</i>-21-(4-substituted phenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diols as probes for the estrogen receptor alpha hormone binding domain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2865</span><span class="NLM_x">–</span> <span class="NLM_lpage">2876</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0205806" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2865-2876&author=R.+N.+Hansonauthor=C.+Y.+Leeauthor=C.+J.+Frielauthor=R.+Dilisauthor=A.+Hughesauthor=E.+R.+DeSombre&title=Synthesis+and+evaluation+of+17alpha-20E-21-%284-substituted+phenyl%29-19-norpregna-1%2C3%2C5%2810%29%2C20-tetraene-3%2C17beta-diols+as+probes+for+the+estrogen+receptor+alpha+hormone+binding+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm0205806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0205806%26sid%3Dliteratum%253Aachs%26aulast%3DHanson%26aufirst%3DR.%2BN.%26aulast%3DLee%26aufirst%3DC.%2BY.%26aulast%3DFriel%26aufirst%3DC.%2BJ.%26aulast%3DDilis%26aufirst%3DR.%26aulast%3DHughes%26aufirst%3DA.%26aulast%3DDeSombre%26aufirst%3DE.%2BR.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%252017alpha-20E-21-%25284-substituted%2520phenyl%2529-19-norpregna-1%252C3%252C5%252810%2529%252C20-tetraene-3%252C17beta-diols%2520as%2520probes%2520for%2520the%2520estrogen%2520receptor%2520alpha%2520hormone%2520binding%2520domain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2865%26epage%3D2876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Berendsen, H. J.C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Postma, J. P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">vanGunsteren, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiNola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haak, J. R.</span><span> </span><span class="NLM_article-title">Molecular dynamics with coupling to an external bath</span> <span class="citation_source-journal">J. Chem. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">3684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1063%2F1.448118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADyaL2cXmtlGksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1984&pages=3684&author=H.+J.C.+Berendsenauthor=J.+P.+M.+Postmaauthor=W.+F.+vanGunsterenauthor=A.+DiNolaauthor=J.+R.+Haak&title=Molecular+dynamics+with+coupling+to+an+external+bath"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dynamics with coupling to an external bath</span></div><div class="casAuthors">Berendsen, H. J. C.; Postma, J. P. M.; Van Gunsteren, W. F.; DiNola, A.; Haak, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3684-90</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">In mol. dynamics (MD) simulations, the need often arises to maintain such parameters as temp. or pressure rather than energy and vol., or to impose gradients for studying transport properties in nonequil. MD.  A method is described to realize coupling to an external bath with const. temp. or pressure with adjustable time consts. for the coupling.  The method is easily extendable to other variables and to gradients, and can be applied also to polyat. mols. involving internal constraints.  The influence of coupling time consts. on dynamical variables is evaluated.  A leap-frog algorithm is presented for the general case involving constraints with coupling to both a const. temp. and a const. pressure bath.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoecrpUZWkh37Vg90H21EOLACvtfcHk0lgq4Z6cRg-f3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmtlGksbY%253D&md5=5510dc00297d63b91ee3a7a4ae5aacb1</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1063%2F1.448118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.448118%26sid%3Dliteratum%253Aachs%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.C.%26aulast%3DPostma%26aufirst%3DJ.%2BP.%2BM.%26aulast%3DvanGunsteren%26aufirst%3DW.%2BF.%26aulast%3DDiNola%26aufirst%3DA.%26aulast%3DHaak%26aufirst%3DJ.%2BR.%26atitle%3DMolecular%2520dynamics%2520with%2520coupling%2520to%2520an%2520external%2520bath%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1984%26volume%3D81%26spage%3D3684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Darden, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">York, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, L.</span><span> </span><span class="NLM_article-title">Particle mesh Ewald: An <i>N</i>·log(<i>N</i>) method for Ewald sums in large systems</span> <span class="citation_source-journal">J. Chem. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">10089</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1063%2F1.464397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADyaK3sXks1Ohsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1993&pages=10089&author=T.+Dardenauthor=D.+Yorkauthor=L.+Pedersen&title=Particle+mesh+Ewald%3A+An+N%C2%B7log%28N%29+method+for+Ewald+sums+in+large+systems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Particle mesh Ewald: an N·log(N) method for Ewald sums in large systems</span></div><div class="casAuthors">Darden, Tom; York, Darrin; Pedersen, Lee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">10089-92</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">An N·log(N) method for evaluating electrostatic energies and forces of large periodic systems is presented.  The method is based on interpolation of the reciprocal space Ewald sums and evaluation of the resulting convolution using fast Fourier transforms.  Timings and accuracies are presented for three large cryst. ionic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDIJavf7AZPbVg90H21EOLACvtfcHk0lgq4Z6cRg-f3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1Ohsr0%253D&md5=3c9f230bd01b7b714fd096d4d2e755f6</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1063%2F1.464397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.464397%26sid%3Dliteratum%253Aachs%26aulast%3DDarden%26aufirst%3DT.%26aulast%3DYork%26aufirst%3DD.%26aulast%3DPedersen%26aufirst%3DL.%26atitle%3DParticle%2520mesh%2520Ewald%253A%2520An%2520N%25C2%25B7log%2528N%2529%2520method%2520for%2520Ewald%2520sums%2520in%2520large%2520systems%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1993%26volume%3D98%26spage%3D10089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">310</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1124%2Fjpet.104.066787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=15016836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsVOjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2004&pages=98-107&author=Y.+Xiaoauthor=K.+J.+Kellar&title=The+comparative+pharmacology+and+up-regulation+of+rat+neuronal+nicotinic+receptor+subtype+binding+sites+stably+expressed+in+transfected+mammalian+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells</span></div><div class="casAuthors">Xiao, Yingxian; Kellar, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">98-107</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We stably transfected human embryonic kidney cells (HEK 293 cells) with genes encoding rat neuronal nicotinic receptor α2, α3, or α4 subunits in combination with the β2 or β4 subunit to generate six cell lines that express defined subunit combinations that represent potential subtypes of rat neuronal nicotinic acetylcholine receptors (nAChRs).  These cell lines were designated KXα2β2, KXα2β4, KXα3β2, KXα3β4, KXα4β2, and KXα4β4.  The Kd values of [3H](±)epibatidine ([3H]EB) binding to membranes from these six cell lines ranged from ∼0.02 to 0.3 nM.  The pharmacol. profiles of the agonist binding sites of these putative nAChR subtypes were examd. in competition studies in which unlabeled nicotinic ligands, including 10 agonists and two antagonists, competed against [3H]EB.  Most nicotinic ligands examd. had higher affinity for the receptor subtypes contg. the β2 subunit compared with those contg. the β4 subunit.  An excellent correlation (r > 0.99) of the binding affinities of the 10 agonists was obsd. between receptors from KXα4β2 cells and from rat forebrain tissue, in which [3H]EB binding represents predominantly α4β2 nAChRs.  More important, the affinities (Ki values) for the two tissues were nearly identical.  The densities of the binding sites of all six cell lines were increased after a 5-day exposure to (-)-nicotine or the quaternary amine agonist carbachol.  These data indicate that these cell lines expressing nAChR subunit combinations should be useful models for investigating pharmacol. properties and regulation of the binding sites of potential nAChR subtypes, as well as for studying the properties of nicotinic compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrumY0AkQpfKLVg90H21EOLACvtfcHk0lgq4Z6cRg-f3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsVOjs78%253D&md5=c46388f9756f0c00ee257d3cbea1ad80</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.066787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.066787%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DThe%2520comparative%2520pharmacology%2520and%2520up-regulation%2520of%2520rat%2520neuronal%2520nicotinic%2520receptor%2520subtype%2520binding%2520sites%2520stably%2520expressed%2520in%2520transfected%2520mammalian%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D310%26spage%3D98%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wroblewski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=322-333&author=Y.+Xiaoauthor=E.+L.+Meyerauthor=J.+M.+Thompsonauthor=A.+Surinauthor=J.+Wroblewskiauthor=K.+J.+Kellar&title=Rat+alpha3%2Fbeta4+subtype+of+neuronal+nicotinic+acetylcholine+receptor+stably+expressed+in+a+transfected+cell+line%3A+pharmacology+of+ligand+binding+and+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DMeyer%26aufirst%3DE.%2BL.%26aulast%3DThompson%26aufirst%3DJ.%2BM.%26aulast%3DSurin%26aufirst%3DA.%26aulast%3DWroblewski%26aufirst%3DJ.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DRat%2520alpha3%252Fbeta4%2520subtype%2520of%2520neuronal%2520nicotinic%2520acetylcholine%2520receptor%2520stably%2520expressed%2520in%2520a%2520transfected%2520cell%2520line%253A%2520pharmacology%2520of%2520ligand%2520binding%2520and%2520function%26jtitle%3DMol.%2520Pharmacol.%26date%3D1998%26volume%3D54%26spage%3D322%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdrakhmanova, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baydyuk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Rat neuronal nicotinic acetylcholine receptors containing alpha7 subunit: pharmacological properties of ligand binding and function</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">842</span><span class="NLM_x">–</span> <span class="NLM_lpage">850</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1038%2Faps.2009.69" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=19448648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvVSlt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=842-850&author=Y.+Xiaoauthor=G.+R.+Abdrakhmanovaauthor=M.+Baydyukauthor=S.+Hernandezauthor=K.+J.+Kellar&title=Rat+neuronal+nicotinic+acetylcholine+receptors+containing+alpha7+subunit%3A+pharmacological+properties+of+ligand+binding+and+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Rat neuronal nicotinic acetylcholine receptors containing α7 subunit: pharmacological properties of ligand binding and function</span></div><div class="casAuthors">Xiao, Yingxian; Abdrakhmanova, Galya R.; Baydyuk, Maryna; Hernandez, Susan; Kellar, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">842-850</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aim: To compare pharmacol. properties of heterologously expressed homomeric α7 nicotinic acetylcholine receptors (α7 nAChRs) with those of native nAChRs contg. α7 subunit (α7* nAChRs) in rat hippocampus and cerebral cortex.  Methods: the authors established a stably transfected HEK-293 cell line that expresses homomeric rat α7 nAChRs.  The authors studies ligand binding profiles and functional properties of nAChRs expressed in this cell line and native rat α7* nAChRs in rat hippocampus and cerebral cortex.  The authors used [125I]-α-bungarotoxin to compare ligand binding profiles in these cells with those in rat hippocampus and cerebral cortex.  The functional properties of the α7 nAChRs expressed in this cell line were studied using whole-cell current recording.  Results: The newly established cell line, KXα7R1, expresses homomeric α7 nAChRs that bind [125I]-α-bungarotoxin with a Kd value of 0.38±0.06 nmol/L, similar to Kd values of native rat α7* nAChRs from hippocampus (Kd=0.28±0.03 nmol/L) and cerebral cortex (Kd=0.33±0.05 nmol/L).  Using whole-cell current recording, the homomeric α7 nAChRs expressed in the cells were activated by acetylcholine and (-)-nicotine with EC50 values of 280±19 μM and 180±40 μM, resp.  The acetylcholine activated currents were potently blocked by two selective antagonists of α7 nAChRs, α-bungarotoxin (IC50=19±2 nmol/L) and methyllycaconitine (IC50=100±10 pmol/L).  A comparative study of ligand binding profiles, using 13 nicotinic ligands, showed many similarities between the homomeric α7 nAChRs and native α7* receptors in rat brain, but it also revealed several notable differences.  Conclusion: This newly established stable cell line should be very useful for studying the properties of homomeric α7 nAChRs and comparing these properties to native α7* nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIPwGzQ2wz07Vg90H21EOLACvtfcHk0ljvkjApYcGo6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvVSlt7o%253D&md5=f84bbeff9dac027b49d37e7ce5f24459</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1038%2Faps.2009.69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2009.69%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DAbdrakhmanova%26aufirst%3DG.%2BR.%26aulast%3DBaydyuk%26aufirst%3DM.%26aulast%3DHernandez%26aufirst%3DS.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DRat%2520neuronal%2520nicotinic%2520acetylcholine%2520receptors%2520containing%2520alpha7%2520subunit%253A%2520pharmacological%2520properties%2520of%2520ligand%2520binding%2520and%2520function%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2009%26volume%3D30%26spage%3D842%26epage%3D850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Maurer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debartolo, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tess, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span> </span><span class="NLM_article-title">Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1124%2Fdmd.104.001222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm4008455&amp;key=15502010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=175-181&author=T.+S.+Maurerauthor=D.+B.+Debartoloauthor=D.+A.+Tessauthor=D.+O.+Scott&title=Relationship+between+exposure+and+nonspecific+binding+of+thirty-three+central+nervous+system+drugs+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice</span></div><div class="casAuthors">Maurer, Tristan S.; DeBartolo, Demetria B.; Tess, David A.; Scott, Dennis O.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-181</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Unbound fractions in mouse brain and plasma were detd. for 31 structurally diverse central nervous system (CNS) drugs and two active metabolites.  Three comparisons were made between in vitro binding and in vivo exposure data, namely: (1) mouse brain-to-plasma exposure vs. unbound plasma-to-unbound brain fraction ratio (fuplasma/fubrain), (2) cerebrospinal fluid-to-brain exposure vs. unbound brain fraction (fubrain), and (3) cerebrospinal fluid-to-plasma exposure vs. unbound plasma fraction (fuplasma).  Unbound fraction data were within 3-fold of in vivo exposure ratios for the majority of the drugs examd. (i.e., 22 of 33), indicating a predominately free equil. across the blood-brain and blood-CSF barriers.  Some degree of distributional impairment at either the blood-CSF or the blood-brain barrier was indicated for 8 of the 11 remaining drugs (i.e., carbamazepine, midazolam, phenytoin, sulpiride, thiopental, risperidone, 9-hydroxyrisperidone, and zolpidem).  In several cases, the indicated distributional impairment is consistent with other independent literature reports for these drugs.  Through the use of this approach, it appears that most CNS-active agents freely equilibrate across the blood-brain and blood-CSF barriers such that unbound drug concns. in brain approx. those in the plasma.  However, these results also support the intuitive concept that distributional impairment does not necessarily preclude CNS activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH6imduXukj7Vg90H21EOLACvtfcHk0ljvkjApYcGo6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlentA%253D%253D&md5=27e70989846ff3eeb4fa4a7d8c6e73b5</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.001222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.001222%26sid%3Dliteratum%253Aachs%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DDebartolo%26aufirst%3DD.%2BB.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DScott%26aufirst%3DD.%2BO.%26atitle%3DRelationship%2520between%2520exposure%2520and%2520nonspecific%2520binding%2520of%2520thirty-three%2520central%2520nervous%2520system%2520drugs%2520in%2520mice%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D175%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Crofton, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moser, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiter, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilson, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacPhail, R. C.</span><span> </span><span class="NLM_article-title">Interlaboratory comparison of motor activity experiments: implications for neurotoxicological assessments</span> <span class="citation_source-journal">Neurotoxicol. Teratol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">609</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm4008455&amp;key=10.1016%2F0892-0362%2891%2990043-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm4008455&amp;key=1%3ACAS%3A528%3ADyaK38XltlWmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1991&pages=599-609&author=K.+M.+Croftonauthor=J.+L.+Howardauthor=V.+C.+Moserauthor=M.+W.+Gillauthor=L.+W.+Reiterauthor=H.+A.+Tilsonauthor=R.+C.+MacPhail&title=Interlaboratory+comparison+of+motor+activity+experiments%3A+implications+for+neurotoxicological+assessments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Interlaboratory comparison of motor activity experiments:  implications for neurotoxicological assessments</span></div><div class="casAuthors">Crofton, Kevin M.; Howard, J. L.; Moser, V. C.; Gill, M. W.; Reiter, L. W.; Tilson, H. A.; MacPhail, R. C.</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicology and Teratology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">599-609</span>CODEN:
                <span class="NLM_cas:coden">NETEEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-0362</span>.
    </div><div class="casAbstract">This study exmad. historical data from a no. of labs. that employed different devices and exptl. protocols to measure motor activity.  Four aspects of the motor activity data were compared: (1) within-lab. control variability across time; (2) within-lab. replicability of control data (3) between-lab. variability in the effects of chems.; and (4) between lab. comparison of the control rates of habituation.  The analyses indicated that there was a relatively restricted range of within-lab. variability and reliability in control values, and that these ranges were comparable across labs.  Similar profiles of habituation were also seen across the different labs.  Moreover, in virtually every case, all labs. were capable of detecting qual. similar changes in motor activity following acute exposure to a variety of chem.  These data indicate a high degree of comparability in the data generated by the different devices and exptl. protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHN8847ggH4rVg90H21EOLACvtfcHk0ljvkjApYcGo6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XltlWmtw%253D%253D&md5=7358cdf72f0d7a970a1b451aa7462d6b</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2F0892-0362%2891%2990043-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0892-0362%252891%252990043-V%26sid%3Dliteratum%253Aachs%26aulast%3DCrofton%26aufirst%3DK.%2BM.%26aulast%3DHoward%26aufirst%3DJ.%2BL.%26aulast%3DMoser%26aufirst%3DV.%2BC.%26aulast%3DGill%26aufirst%3DM.%2BW.%26aulast%3DReiter%26aufirst%3DL.%2BW.%26aulast%3DTilson%26aufirst%3DH.%2BA.%26aulast%3DMacPhail%26aufirst%3DR.%2BC.%26atitle%3DInterlaboratory%2520comparison%2520of%2520motor%2520activity%2520experiments%253A%2520implications%2520for%2520neurotoxicological%2520assessments%26jtitle%3DNeurotoxicol.%2520Teratol.%26date%3D1991%26volume%3D13%26spage%3D599%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UW6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UW6','PDB','1UW6'); return false;">PDB: 1UW6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OLE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OLE','PDB','1OLE'); return false;">PDB: 1OLE</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i74"><a href="/doi/suppl/10.1021/jm4008455">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_18315"></div></div></div></div></div><hr /></hr><p class="last">Details of broad screening data, functional assay, and experimental details of intermediate compound synthesis.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm4008455/suppl_file/jm4008455_si_001.pdf">jm4008455_si_001.pdf (155.79 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm4008455&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-21%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm4008455%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm4008455" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679aadd60c26221c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
